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11. Abstract 
The amount of inter- and intra-specific cross-immunity between three 
nematode parasites was studied using 5.venezue/ensis and two strains of 
S.ratti Reciprocal cross-challenge experiments were carried out where rats 
were primed with either full infections or transferred immune mesenteric 
lymph node cells. The response of mesenteric lymph node cells obtained from 
uninfected donors, or donors infected with 2000 third-stage larvae of the 
relevant parasite, to in vitro stimulation with homologous and heterologous 
parasite antigens was also studied. 
Results of experiments using full infections demonstrated that prior 
infection with as few as 91 third-stage S.ratti larvae produced up to a 90% 
reduction in the worm burden on day 8 and 80% reduction in the number of 
eggs in utero per worm after homologous challenge, regardless of the strain 
used. Reciprocal cross-challenge experiments using the two S.ratti parasites 
revealed a difference in the level of protection produced post-challenge, which 
depended on the strain used at priming. Immunising rats with the heterogonic 
strain produced a significantly greater resistance against homologous 
compared with heterologous challenge. If the homogonic strain was the 
priming agent there was no significant difference in the relative protection 
produced by either type of challenge. 
Adoptive transfer studies revealed a strain-specific, dose-dependent effect 
in homologous challenged rats, primed with 1-2 x 108  immune mesenteric 
lymph node cells from donors infected with either an "exact" dose of less than 
100, or 2000, third-stage larvae. If the homogonic strain of S.ratti was used to 
prime the cell donors then a significantly greater immunity was expressed by 
iv 
recipients of cells from donors given the higher infection dose. However, if the 
heterogonic strain was used to prime cell donors there was no significant 
difference in the level of resistance transferred by the two cell populations. 
Reciprocal cross-immunity studies using this technique confirmed that the two 
S.ratti strains expressed different functional antigens and that asymmetry 
found from full infections was based in "immunological" events. They also 
showed that all three Strongylo/des spp. parasites possessed common 
functional antigens. 
It was found that primary infection rates with S.venezue/ensis in rats of the 
Edinburgh Wistar colony were low, so that direct quantitative comparison 
between S.ratti and S.venezuelensis was not possible in all contexts. Various 
methods were attempted to overcome this problem, i.e. priming rats with 
surgically transferred worms, trickle infections, heat-killed third-stage larvae, 
and full infections using immature rats. Of these., some success was 
achieved with the last named in confirming that all three parasites expressed 
common antigens and that there was a differ.erice between the two strains of 
S.ratti S.venezue/ensis appears to be antigenicall-y more similar to the 
heterogonic strain of S.ratt/than to the homogonic variety of that species. 
Theories to explain how the asymmetery in the host's immune response 
against the two S.ratti strains might arise are proposed, and the significance of 
these results in the general framework of experimental immunology of 
nematode infection is discussed. 
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CHAPTER 1 
GENERAL INTRODUCTION 
From the 1930's to the early 1970's, experimental immunology of nematode 
parasitism of warm blooded animals was dominated by attempts to ascertain 
whether humoral rather than cellular components of the immune system were 
the more important in parasite expulsion. The idea fundamental to studies 
over this period was that the two pathways could act independently, even 
though their effects were additive. A breakthrough came in 1971, when 
Ogilvie and Jones first clearly defined the idea that worm rejection was due to 
a "two step" process, specific models of which had already been suggested 
(Barth at al., 1966). According to this general scheme each step is only 
effective in synergy with its partner, a concept which revitalised research in 
this field. Ogilvie and Jones applied the principle to studies of 
Nippostrong v/us bras/liens/s in rats and, consistent with the knowledge at that 
time, proposed a first step in which specific humoral antibody inflicted damage 
on the worms but did not reject them. Rejection itself was brought about by 
a second step which was thought to be non-specific and effective against 
damaged, but not undamaged worms. In several respects Ogilvie and Jones 
detailed suggestion proved to be incomplete, but study of the "two-step" 
principle in a number of laboratories has led to the realization that synergy 
encompasses both humoral and cellular components of the immune system. 
Keller and Keist (1972) showed that antibodies alone could not cause rejection 
of damaged N.brasiiensis but that rejection did occur in the presence of 
sensitized lymphocytes. Therefore the theory proposed by Ogilvie and Jones 
(1971) was adapted to include the requirement of specifically primed "cells" in 
addition to antibody. Confirmation that the cells involved in the 
ftlippostrongy/us bras/liens/s system were T-lymphocytes was provided by 
Ogilvie et at (1977). A similar conclusion was reached by Crum at al. (1977) 
for Tricli/nella spiral/s 
Thus it seems clear that in certain systems, at least, cells and antibodies 
interact to cause worm expulsion. In the light of present day knowledge of 
the immune system, this principle presents us with a complex of possible 
pathways. Figure 1:1, page 3, shows a simple diagrammatic representation of 
the basic reactions now thought to occur during the host's anti-worm 
response. Initially parasite antigen interacts with lymphocytes to cause the 
production of specific antibody and activation of specific T cells (Fig.1:2, page 
4). The next step in the host's response seems to depend on the particular 
parasite involved, since the location of the worm will to some extent control 
which effector mechanisms can actually reach the organism, and the type of 
antigens produced by the parasite probably vary with species. The following is 
a summary of the possible systems that may be recruited during an 
immunologically mediated rejection of the parasite population. 
M. Antibodies 
Originally it was suggested that antibodies had a purely mechanical 
function, since antigen-antibody precipitates were demonstrated in vitro at 
oral and anal pores (Sarles, 1938; Taliaferro and Sarles, 1939). This led to the 
suggestion that these complexes blocked the feeding of the parasite and 
caused its death by starvation. This is rather a crude idea and no one has 
demonstrated that such plugs have a detrimental effect on worm survival. 
An alternative function was proposed for antibodies, as effectors in the 
"leak lesion" hypothesis suggested by Urquhart (1965). It was proposed that 
2 
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specific anti-worm reagins, (now known to be immunoglobulin Es), sensitised 
mast cells and then the interaction of the worm antigen with the lgE led to 
the degranulation of mast cells, the release of vasoactive amines, and a local 
anaphylaxis. This increased the traffic of more parasite- specific antibody 
(mainly immunoglobulin G) to the site of the infection, which caused worm 
damage and expulsion. In support of this theory Barth (1966) showed that an 
anaphylactic response induced to an unrelated antigen did potentiate the 
effect of antiserum and enhanced the rejection of N.brasiliensis compared with 
unshocked controls. However, Ogilvie (1967) repeated the experiments of 
Barth using an adult N.brasi/iens/s antigen to cause a specific anaphylactic 
response, but it was incapable of producing worm expulsion. Thus although 
the leak lesion hypothesis could explain results within a particular experimental 
framework, that framework was revealed to be an inadequate representation of 
real host parasite relations. 
Classically, IgE has been the main immunoglobulin class associated with 
helminth infections but only a relatively small proportion has been found to be 
parasite-specific (reviewed by Jarrett, 1978). lgG seems to be the main class 
responsible for protection. Thus the major role of antibody in an immune 
response seems to be one of mediation, since lgG is capable of increasing the 
effectiveness of other non-specific effector mechanisms, and it can bring 
these components into close contact with the parasite. Despite a number of 
attempts to incorporate IgE into a theoretical framework, the actual role of this 
class of antibody produced during infection remains unknown. It may be 
selectively induced by the worm to hinder an effective immune response since 
the non-specific lgE may interfere competitively with the binding of 
parasite-specific IgE to mast cells, eosinophils or macrophages and thus 
restrict the amount of damage which could be inflicted by these cells on the 
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parasites (Jarrett and Miller, 1982). 
L2. T ceOs 
Theoretically T lymphocytes should be capable of damaging nematodes, 
but the evidence suggests that this is unlikely (F.1:3, page 7), for the type of 
reactions which could occur. 
The action of cytotoxic T cells is restricted since targets must express a 
"self-molecule", a product of the major histocompatability complex, as well as 
foreign antigenic determinants. There is no logical reason why nematodes 
should express such a molecule, but it has been shown that, among the 
platyhelminths, the schistosomes do acquire a variety of host derived 
molecules on their surface (Smithers et al. 1969; Clegg et a!, 1971), including 
products of the major histocompatibility complex (Sher et 8/. 1978). It has 
been demonstrated in vitro that cytotoxic T cells attach to and damage 
schistosomes under certain conditions (Ellner et al., 1982), but there is no 
similar evidence for nematodes. Natural Killer and Killer cells are not similarly 
restricted, but little is known about their function. So far in vitro experiments 
using these cells have been negative (Vadas et al., 1979a; Mackenzie et a!, 
1980, 1981; Greene et al, 1981), implying that they are not involved in worm 
expulsion. Therefore the major role of T cells seems to be analagous to that 
of antibodies, that is, primarily one of mediation. 
'03. The macrophage 
The main role of the macrophage in nematode immunity also seems to be 
one of mediation, as the "antigen-presenting cell" (Fig.1:2, page 4), although it 
appears to have an active role in killing other parasites, such as intra-cellular.  
Fig0l3 
	




presented by "antigen presenting cello? 
ACTIVATED SPECIFIC EFFECTOR T CRr.r.S 
NATURAL KILLER CELLS 	 KILLER CELLS 
Antibody dependent 
CYTOTOXIC T CELLS 
restricted since target 
must express a product 
















viruses and protozoa (Figj.1:4, page 9). In vitro studies have shown that 
macrophages are capable of damaging microfilariae of Litomosoides car/nh 
(Mehta of a!, 1980), and Dipetalonema viteae (Haque et a!, 1980), but there is 
no evidence that they damage adult worms. They are probably involved in 
clearing damaged worms from the body, and perhaps they have an effector 
role against the migratory larval stages of the parasite. 
1.4. The mast cell 
The importance of the mast cell as an effector was suggested as part of 
the "leak lesion" hypothesis of Urquhart (1965). Since then its function in 
nematode rejection has been studied in detail (Fig.1:5, page 10) for its possible 
effects. In rats infected with Trichinella spiralis mucosal mastocytosis and 
degranulation of the cells has been demonstrated to be temporally associated 
with the immune expulsion of the adults worms (Alizadeh and Wakelin, 1982a). 
A similar increase in the number of mast cells over the course of infection has 
also been shown in rats infected with Strongyloides ratti (Moqbel, 1980; 
Mimori et a!, 1982), implying that the cells are important in parasite rejection. 
It was originally thought that mast cells acted as effectors in the expulsion of 
N.brasiiens/s from rats since a similar increase in mast cell number has been 
observed (Taliaferro and Sarles, 1939). However cell degranulation often did 
not occur until parasite expulsion was completed, and lactating rats, which 
show mast cell infiltration at the same time and to the same extent as 
non-lactating controls, are unable to expel their worms. Recently, Woodbury 
et al. (1984) have shown that the systemic release of mast cell protease II, 
specifically from mucosal mast cells, coincides with the immune rejection of 
N.brasiiensis and ispiraIi.% implying that it has a functional role in both 
systems. However, secretion of this enzyme occurs in the absence of 
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detectable parasite-specific IgE. 
15. The eosiophiU/ neutrophil/ basophill 
Other cells which may have an effector role in parasite rejection are the 
eosinophil, the neutrophil and the basophil (lFigs.1:6, 1:7 and 1:8, pages 12, 13 
and 14), for their possible actions in worm expulsion. 
A rise in the number of tissue eosinophils within the lamina propria of the 
small intestine during the course of infection has been demonstrated in rats 
infected with S.ratti (Moqbel, 1980), N.brasi/iens/s (Taliaferro and Sarles, 1939; 
Wells, 1962; Kelly and Ogilvie, 1972), and Tsp/rails (Race et a!, 1974). It has 
also been shown in mice infected with isp/rails (Ruitenberg et al.. 1977), thus 
leading to the suggestion that these cells were involved in the host's 
anti-worm response. in vitro studies have shown that eosinophils are capable 
of killing infective larvae of Dictyocaulus viviparus (Knapp and Oakley, 1981), 
and microfilariae of Dipetalonema v/teae (Mehta et a!, 1981b). Moqbel (1980) 
found that eosinophils were in close contact, and perhaps even adhered to, 
infective S.ratri larvae present in the skin of rats that were hyperimmune, 
implying that they may be functional in the host's immune response against 
the parasite. 
Neutrophils have also been suggested as important effectors. They can kill 
a number of targets In vitro, such as microfilariae of L.carin/i (Hopper et al. 
1981), and schistosomula of the trematode, Schistosoma mansoni (McLaren et 
al, 1981), but there is little evidence to implicate them in viva 
Basophils 	are 	thought 	to be 	important 	in the 	rejection of 	the 	sheep 
nematode 	Trichostrongyius co/ubriformis from guinea 	pigs (reviewed 	by 
11 
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Askenase, 1977), since basophil infiltration of the intestine correlates well with 
the course of infection. However there is little evidence to suggest that they 
have an active role in other, more natural, host/parasite systems. 
1.6. Other possible effector mechanisms in worm rejection 
A variety of other non-specific responses have been implicated as having a 
role in the host's anti-worm response. An increase in the number of 
mucus-secreting cells and in the amount of mucus secreted into the intestine, 
has been demonstrated in many parasite infections (Miller et al.. 1982, Lee and 
Ogilvie, 1981). It has been suggested that mucus could have a direct anti-
worm effect (Miller et al., 1981) by excluding the parasite from its preferred 
site, affecting the worm's respiration, or possibly paralysing it, since mucus 
contains substances which have the same physical properties as leukotriene 
C 4 and 04 (slow-reacting substance A) which causes smooth muscle 
contraction (Fig.1:9, page 16). The increased mucus production could however 
be purely a host protective response, to prevent the intestinal wall from being 
damaged bV the mediators released during inflammatory responses. 
An increase in the level of gut motility has also been demonstrated in rats 
infected with A/.brasiiensls (Farmer, 1981), and it has been shown that 
infection of rats with Tsp/rails causes an increase in the amount of fluid 
secreted into the intestine (Castro et al., 1979). Both of these manifestations 
could assist in dislodging adults during worm rejection. 
1.7. Parasite antigens 
The parasite antigens responsible for eliciting an immune response in the 
broadest terms have been divided into two main types, either 
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excretory/secretory or somatic. It is relatively simple to demonstrate that 
preparations of either one are antigenic, but it is difficult to pinpoint the 
substances which act as functional antigens. On the whole, most of the 
evidence implies that the excretory/secretory antigens are the most active, 
since immunization with somatic preparations often fails to protect the host 
against re-infection even though specific antibody against them can be 
demonstrated (reviewed by Clegg and Smith, 1978; and Llyod, 1981). It has 
been shown that the cuticular antigens of many parasites, such as 
N.brasi/ensis (Maizels et a/ 1982), and Tsp/rails (Mackenzie et al. 1978; Philipp 
et al., 1980b; Parkhouse et al., 1981), show stage specificity. Therefore perhaps 
successful immunization requires priming with a preparation containing 
antigens expressed by all parasitic stages of the worm. However the only 
commercial vaccines produced against nematode parasites, that is, against 
D/ctyocaufus viviparus in cattle, D/ctyocau/us f//aria in sheep and Ancy/ostoma 
caninum in dogs, are theoretically based on the ability of the irradiated larvae 
to produce metabolic antigens in vivo (reviewed by Peacock and Poynter, 
1981). 
In experimental systems excretory/secretory antigens can be potent 
inducers of a protective response, but how valid is such a distinction? 
Stichosome antigens derived from the trichuroid nematodes, Tsp/rails and 
Tr/churis muris have been shown to be very immunogenic and protective 
(Despomrnier, 1981; Jenkins and Wakelin, 1977), and analysis of the proteins 
from the granules demonstrated the presence of several groups of antigens 
(Despommier, 1981) which were identical to those secreted by the larvae in 
culture (Despommier and Muller, 1976). This observation calls into question 
the categorisation of parasite products into two groups, since 
excretory/secretory and somatic preparations may possess the same epitopes. 
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Discarding crude ideas such as those referred to earlier (Section 1, page 2) 
it is difficult to envisage how excretory/secretory antigens could be protective 
in any simple way, since once produced they probably diffuse away from the 
vicinity of the parasite. Perhaps their effect is one of localising the immune 
response and directing the effector mechanisms against the nematode, with 
the "somatic" antigens being targets involved directly in worm damage. Thus 
the two types of antigen, if they are so described, may act in synergy (Fig.1:10, 
page 19, which shows the reactions which could occur). It has been 
demonstrated that Tsp/rails sheds surface antigens when cultured in vitro 
(Philipp et al. 1980), therefore it is possible that this occurs in vivo. Thus cells 
recruited against excretory/secretory antigens, could also contain a proportion 
of lymphocytes with specificities for somatic antigens, which would also 
migrate up the concentration gradient to the site of antigen production, and be 
able to direct specific effector mechanisms against the worm, and mediate in 
worm damage by non-specific components of the immune system. 
1.8. The rote of specific and non-specific components of the host's immune 
response against nematode parasites 
Once it was apparent that cellular and humoral components acted in 
synergy to cause worm rejection research began to be directed towards 
discovering the relative contribution of specific and non-specific mechanisms 
in bringing about this effect. One approach to this question, adopted by a 
number of workers, was to attempt to define the specificity of the response by 
studying cross-resistance against different sorts of parasite. 
When parasites are present together in a host no consistent picture 
emerges. Concurrent infection with a nematode and a virus, or bacterium, 
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often leads to the enhanced survival of the micro-organism, possibly because 
there is competition for effector mechanisms. In other systems the increased 
survival of one of a pair may be because its partner is capable of causing 
immunosuppression. Mice, concurrently infected with He/igmosomo/des 
po/ygyrug(TVematospiro/des dub/us) and another helminth produce a diminished 
response to the second species (Behnke et al. 1978 for Tsp/rails and 1V.dub/u 
Hopkins, 1980 for Hymeno/epis diminuta and N.dubiu and Jenkins, 1975 for 
N.brasiiensis and N.dub/us). It is thought that N.dubius produces 
immunomodulatory factors, believed to be excretory/secretory antigens, which 
somehow induce the production of suppressor T cells, causing a general 
"switching off" of the host's immune response. 
In contrast, concurrent infection can also enable the host to express 
increased resistance. For example, infection with Tsp/rails increased the 
resistance of mice to the intra-cellular bacterium, Llsteria monocytogenes 
(Cypess, 1974), and to the protozoan parasite Plasmodium berghei (Ngwenya, 
1982). This was thought to be due to an increase in systemic cellular 
immunity brought about by the nematode infection. Similarly, if mice are 
infected with Tsp/rails during the acute phase of the inflammatory response 
against an existing A.can/num infection, there is a reduction in the number of 
adult Tsp/rails recovered compared to controls (Goulson, 1958). In this case it 
was thought that the inflammatory response elicited against one parasite is 
acting non-specifically against the other. 
Probably a better system in which to investigate the basic question is one 
designed to test the specificity of the immunological memory. This can 
hopefully be done by sequential infections of the different parasites. Within 
this sort of framework protozoan parasites seem to generate strict 
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species-specific immunity, for example, cross-resistance studies using 
non-concurrent infections of different species of the coccidean genus, Elmer/a 
snowed there was little or no cross-immunity induced (Becker et al. 1933; 
Tyzer, 1929; Levine, 1938; Moore and Brown, 1951). At a finer level, there is 
some evidence for the existence of intra-specific cross-immunity from studies 
using two strains of E.acervu/ina (Joyner, 1969). In contrast, studies with 
nematode parasites suggest that inter-specific cross-immunity is the general 
rule. Some degree of reciprocal cross-immunity has been demonstrated for 
the following pairs of parasites; S.rattl and N.brasiiensis in rats (Nawa et a!, 
1982), Tsp/rails and S.ratti in rats (Moqbel and Wakelin, 1979), and Trichuris 
muris and Tsp/rails in mice (Lee et al., 1982). These vary in their morphology, 
inhabit different locations in the gastro-intestinal tract, and have a different 
biology, compared with their respective partner. However in all cases 
homologous challenge produced a higher level of protection, demonstrating 
that the host could differentiate between the two parasites. 
No one has set out to discover the limit of the host's ability to distinguish 
between parasites, which could be vital since it might provide a framework in 
which the contribution of specific and non-specific components of the 
immune system in worm damage and rejection could be explored. Some work 
has been carried out comparing the host's response to closely related worms, 
by using parasites from the same genus; for example, reciprocal 
cross-immunity has been shown between Trichostrongylus co/ubriformis and 
Trichostrongylus vitrinus in sheep (Dineen et al. 1977) and Cooper/a oncophera 
and Cooper/a pectinata in calves (Herlich, 1965). More recently, Dawkins and 
Grove (1982), showed that mice primed with Strongyloides stercora/is 
expressed some resistance against S.ratti and Coop et al. (1986, in press) 
showed that prior infection of lambs with Ostertagia ostertagi conferred some 
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protection against heterologous challenge with Ostertagia circumcinct4 but in 
neither study was the reciprocal challenge experiment carried out. Moreover, 
both Strong yb/des spp. and O.circumcincta were in an unnatural host. 
There seem to be no studies on the existence of reciprocal intra-specific 
cross-immunity between nematode parasites, which would be a real test of 
the host's ability to differentiate between worms. 
In the following experiments this aspect of nematode immunology was 
investigated, using two strains of S.ratti; and S.venezue/ensis Since these 
parasites occur naturally in the rat it was anticipated that there would be no 
problem in carrying out reciprocal challenge experiments, and in interpreting 
cross-reactions in a consistent quantitative framework. S.ratti and 
S.venezuefensis parasitic female worms can be differentiated using a 
morphological characteristic; adults of the two S.ratt/ strains are structurally 
indistinguishable. The strains differ in the type of development they express 
during the free-living stages of their life cycle. In assaying for small changes 
in the host's immune response as precise an experimental system as possible 
was used having the minimum error variance. Throughout the study, 
therefore, rats were infected with small "exact" doses of infective 
Strongyloides larvae, using a method pioneeered in this laboratory. As many 
relationships as possible were investigated, in terms of priming and challenge 
with the three parasites, using a variety of immunological parameters. 
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CHAPTER 2 
GENERAL MATERIALS AD METHODS 
2.1. Parasites used in study 
Strongyloides venezuelensis (Brumpt, 1934) and two strains of 
Strongy/oides ratti (Sandground, 1925), designated the "homogonic" and the 
"heterogonic" strain were maintained by weekly passage. The "homogonic" 
strain was originally obtained from the Wellcome Laboratory, (Langley Court, 
Beckenham, Kent) in the 1960's; however over the years there have been 
various replacement stocks, which were also believed to have originated from 
Wellcome. The "heterogonic" strain was obtained in 1973 from Professor Guta 
Wertheim, (Jerusalem, Israel). It was originally isolated from a wild rat in 
Philadelphia, USA, by Dr. G. Graham in 1960, and became known as the 0-60 
strain. The S.venezuelensis stock was obtained specifically for this study from 
Dr. F.Katz (Seton Hall University, South Orange, New Jersey, USA), in February 
1983 and August 1984. He originally obtained it from Professor G.Wertheim in 
Israel. The two S.ratti strains are differentiated by their type of life cycle 
(Figs.2:1 and 2:2, pages 24 and 25), since the "heterogonic" biology includes 
free-living males and females, morphologically distinct from the parasitic 
parthenogenetic females (Fig.2:3, pages 26-29) and absent from the cycle of 
the homogonic strain. S.venezue/ensis is reported to have a "heterogonic" 
type of life history (IFig.2:2, page 25) - personal communication from Dr. F.Katz 
to Dr. P.A.G.Wilson - but the "homogonic" phase seems to predominate, since 
no free-living males and females have been seen in cultures in this laboratory. 
Parasitic female worms of the two Strong/oides spp. could be distinguished 
using a morphological characteristic since the uterus and intestine of S.ratti 
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Figj.2:3s Parasitic parthenogenetic female S.ratt/ worm recovered from the 
host's intestine. Note that the worm has a straight intestine and uterus (size 
approximately 3mm). 
Fig.2:3b Posterior end of female parasitic S.venezuelenis worm. Note spiralling 
of intestine and uterus (size approximately 0.4mm). 
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F.2:3c Free-living female heterogonic S.ratti worm from cultured faeces 
(centre, size approximately 2mm). Note how the appearance differs from the 
parasitic female shown in (a). 
Fig.2:3d Free-living male heterogonic S.ratti worm from cultured faeces. 







Fig.2:3e S.venezue/ensis eggs from a fresh faecal smear. The eggs do not 
contain a fully formed first-stage larva (size 40-70pm). 
Fig.2:3f Eggs of S.ratti in section of the small intestine. The eggs already 
contain the first-stage larva which will probably hatch out of the egg before it 








F9.2:3g Filariform oesophagus of parasitic S.ratfi 
female worm (size 
approximately 0.5mm). 
Fig.2:3h Rhabditiform oesophagus of free—living heterogonic S.ratti female 
worm (size approximately 0.3mm). 
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parasitic females are straight, whereas those of S.venezuelensis are coiled 
around each other (Fij.2:3a and b, page 26). There was also a difference in the 
type of development exhibited by the egg of the two species. Eggs of S.ratti 
contain a fully developed first- stage larva and often hatch before they pass 
out of the host; whereas those of S.venezue/ensis are still in the early stages 
of cleavage when they pass out of the host. 
The culture method for both species was essentially the same (after Wilson 
et a/.,1978b). Rats with stock infections were held in cages with grid bottoms 
suspended over trays lined with moist paper towelling which was replaced 
daily. Starting on day 7 of an infection, overnight faeces were collected, 
checked by microscopy for patency, and then rinsed with distilled water to 
limit urine contamination. Approximately 8-12 faecal pellets were placed on a 
watch-glass, which was transferred to a glass Petri-dish. Distilled water was 
added to the faeces and under the watch-glass, before replacing the Petri-dish 
lid (Figj.2:4, page 31). The cultures were maintained for 3 days for "homogonic" 
S.ratti and S.venezue/ensis and 7 days for "heterogonic" S.catti in an anhydric 
incubator with an internal circulation of air (Vindon Scientific Ltd.) at 19 ° C 
1 °C for S.ratti and. 25°C t. 2 °C for S.venezue/ensis Usually six Petri-dishes 
were set up on any day and on average 4000 third-stage larvae were 
harvested per dish. After 48 hours distilled water was added to the faeces of 
S.venezueleflS/S and "homogonic" S.ratti cultures, and infective filariform larvae 
were collected 24 hours later. In the case of "heterogonic" S.ratti cultures 
distilled water was added to the faeces on days 3 and 6, the larvae which 
emerged on day 4 (i.e. the "homogonic" larvae) being removed and discarded. 
The truly "heterogonic" S.ratti larvae were harvested on day 7. Material 
collected from all dishes, was pooled, and washed by centrifugation 
(approximately 500g. MSE.) in a lOmI graduated glass tube (MSE.), then 
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resuspended in lOmI of distilled water. A 0.5ml sample was made up to lOml 
with distilled water and 0.2m1 aliquot samples were transferred to a three-well 
glass dimple slide. The number of motilo and non-motile larvae present in 
each 0.2m1 of the diluted solution (1:20) was counted using a 
stereo-microscope. From these data the mean number of larvae present per 
ml of the stock suspension and the percentage of non-motile larvae - which 
was taken as a measure of mortality, was estimated, from six aliquots. 
In experiments only freshly emerged larvae were used, but third-stage 
larvae stored at 19 °C ± 1 °C in distilled water in an anhydric incubator with an 
internal fan circulation of air, were often used to infect stock rats. Stock rats 
were infected under ether anaesthesia by subcutaneous injection of 1000 
third-stage larvae in 0.3m1 distilled water, using a 19G needle (Sabre, Gillette) 
and a imI Plastipak syringe (B.D.). 
2.2. Rats 
Two strains of rat were used throughout this study, random-bred Rattus 
norvegicus Wistar strain, and inbred Rattus ,iorvegicus PVG strain. The rat 
colonies involved were constant and originally managed by the Centre for 
Laboratory Animals, Bush Estate, Penicuik, but from 4th. Septtember 1984 they 
were taken over by the Institute of Occupational Medicine which maintained 
them in the same premises. Three-week old female Wistar rats were used for 
passage and from October 1982 to the 16th October 1984 four rats were 
infected for each strain or species. However, from 23rd. October 1984 to the 
end of the study the number was reduced to two for financial reasons. The 
Zoology Department started its own stock breeding programme in December 
1984 using Wistars from the Bush Estate as the original parents, and became 
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self-sufficient in regard to this strain by January 1985. From this time both 
male and female rats were then used for passage to avoid wastage. Animals 
were housed in one of twc types of cage: stock cages, (Model RB3, North Kent 
Plastics Ltd., Home Garden, Dartford, Kent) with white wood shavings in the 
bottom, or grid cages. (Model Ri, North Kent Plastics Ltd.). Water, provided by 
an automatic watering system, and food (Diet 41B, Oxoid, manufactured by 
Herbert C. Styles Ltd., Bewdley). were provided ad I/b/turn The rats were kept 
in either of two rooms, designated M and G, at 20-22 °C, with a continuous 
light cycle, a carryover of former migration studies. From December 11th. 
1984, rats in room M were placed on a 12 hour light:12 hour dark regime to 
facilitate the stock rat breeding programme. 
2.3. Production of radio-active labelled third-stage larvae and estimation of the 
proportion of labelled dose recovered 
(After Wilson and Simpson, 1982) 
23.1. Production of radio-active labelled third-stage larvae 
(Figj.2:5, page 34) 
The underlying culture method was essentially the same as previously 
described (Section 2:1, page 30). One or two faecal pellets were placed in 
each well of a three-well glass dimple slide, which was placed in a Petri-dish 
and 0.3m1 of diluted 75-Se-selenomethionine (Amersham International Ltd, 
Appendix 1, page 278 ) solution was added to each well using a imi Plastipak 
syringe (B.D.), and distilled water was added to the dish, before covering with 
its lid. After the required culture period the Strongyloides spp. third-stage 
larvae were harvested using a 5ml Plastipak syringe (B.D.) with a plastic tube 
attachment instead of a needle. Their number and the percentage non-motile 
were estimated (Section 2:1, page 30). Free radio-active label was removed by 
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repeated washing with distilled water, until the gamma emission from a 0.5m1 
sample of the supernatant approached background levels using a Panax 
counter. Having estimated the number of larvae per unit volume of a 
suspension (page 30), three samples of different volume were taken to 
measure the mean counts per minute per larva. 
2.3.2. Proportion of the radio-labelled dose recovered 
Rats were infected by skin-application (see Section 2:10:1, page 48.) of 
third-stage larvae in 0.3m1 (approximately 2000 larvae). At the appointed time 
they were killed by carbon dioxide asphyxiation, their body cavities were 
opened using scissors, and their intestines removed with forceps. The 
intestines were treated in one of two ways:- 
separated into anterior and posterior sections and placed into glass 
counter vials with 5% formalin. The amount of activity per 1000sec for each 
section was counted using a Nuclear Enterprises gamma spectrometer (setting 
for 75-Se, threshold E=270KeV, window width E=170KeV). Supernatants and 
larval suspensions were counted at the same time to avoid discrepancies 
caused by decay. 
divided into anterior and posterior sections and stored at -20 °C until an 
appropriate time when the amount of activity for each section per 1000sec 
was estimated with the Panax counter and expressed as counts per minute 
(cpm). The number of adult worms in each section was then counted with a 
stereo-microscope (Section 2:10, page 50) to find Out how well the levels of 
radio-activity correlated with the actual numbers of adults present. Similarly 
supernatants and larval suspensions were counted at the same time to correct 
for radio-active decay. From these data the proportion of the radio-labelled 
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P 	= 	proportion of the dose recovered 
m = cpm per gut section (i.e. anterior or posterior) 
V 	= 	cpm of the original dose used to infect rats 
Background counts were subtracted from all data. 
2.4. Preparation of heat-killed larvae to test for protective antigens 
The number of third-stage larvae harvested from cultures was estimated 
(Section 2:1, page 30), and the stock larval suspension concentration adjusted 
to 10,000 infective larvae per 0.3ml. Larvae were heat-killed by placing in a 
boiling water-bath for two minutes, since preliminary studies had shown this 
was sufficient time to render all larvae non-motile (which was taken as an 
indication of death), and clumping did not occur. The suspension was allowed 
to cool before it was transferred to Eppendorf tubes, and then stored at -20 ° C 
until required. When needed the suspension was defrosted at room 
temperature. The freezing process did not induce clumping and re-estimation 
of larval numbers showed that little fluid was lost at any time, so that the 
concentration of the suspension remained at 10,000 third-stage larvae per 
0.3m1. 
W. 
2.5. Adoptive transfer of mesenteric lymph node cells 
(after Moqbel and Wakelin, 1981) 
2.5.li. Preparation of mesenteric lymph node cells 
Rats, killed by carbon dioxide asphyxiation in batches of not more than 7 
animals, had their ventral surface swabbed with 90% alcohol and the body 
cavity opened using clean, flamed scissors. The mesenteric lymph nodes were 
located and removed using fine, curved forceps, which had been flamed. 
Nodes from the same treatment were pooled in a small sterile beaker 
containing cell medium (Appendix 1 , page 278 ). This dissection was 
completed within ten minutes of the death of each animal. Cell suspensions 
were prepared from a few nodes at a time in a tissue grinder containing cell 
medium held in an ice pack. The nodes were carefully disrupted until the 
membranes were free of most cells, and the resulting cell suspension was 
passed through a fine sterile sieve into a sterile glass tube held in an ice pack. 
Cells from individual treatments were pooled. 
A 2Opl aliquot taken from an even suspension of each cell preparation was 
resuspended with 180il of the vital stain acridine orange /ethidium bromide 
(Appendix 1, page 278), in an Eppendorf tube. A small sample of the stained 
cells (approximately 20JJl) was loaded into a haemacytometer (standard 
counting chamber, depth 0.1mm, 1/400mm, Hawksley, Lancing, Sussex), and 
viewed under a fluorescence microscope (Vickers photoplan with 100 and 200 
watt power units, 495nm primary filter and 515nm secondary filter) to 
determine the number of live (green) and dead (red) cells. By this test the 
viability of cell preparations used for transfer experiments always exceeded 
85%. 
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2.5.2. Moptva transfer 
Each rat received 1-2.5x10 8 cells in 0.5ml of cell medium. The cells were 
injected into a tail vein of an unanaesthetised, restrained animal (Fig.2:6, page 
39) using a imi Plastipak syringe (B.D.) and a 25G needle (Sabre, Gillette). 
Control animals received 0.5m1 of cell medium. Prior to injection rats were 
placed in a "hot-box" (a plastic container heated with two 60 watt bulbs), for a 
few minutes, in order to bring the veins to the surface. 
2.6. Lymphocyte transformation assay 
(Fi9.2:7, page 40). 
A mesenteric lymph node cell suspension in cell medium (Appendix 1, page 
278) was prepared (Section 2:5, page 37), the concentration was adjusted to 
2x10 6 cells per ml and lOOul added to each well of a 96 well flat-bottomed 
microtitre-plate (NUNC). Cells were stimulated with 50pl of different antigen 
preparations at various concentrations, or concanavalin A (Appendix 1, page 279) 
which acted as a positive control to show that cells were capable of being 
stimulated. Unstimulated cells, received 50,iil of serum-free medium (Appendix 
1, page 279). Six replicates were set up for each treatment and an individual 
plate was prepared per rat. The plates were incubated at 37 °C for 4 days in a 
carbon dioxide incubator (Forma Scientific, 5% carbon dioxide: 95% air). 
A small sample was removed from one well in each treatment, immediately 
before the addition of tritiated thymidine (Appendix 1, page27jro the cells. The 
sample was transferred to an Eppendorf tube in order to check cell viability by 
direct on slide centrifugation (Cytospin; Shandon Scientific) followed by 
staining. A one minute centrifugation with cell medium was executed to 
facilitate the attachment of cells to the slide surface following which the 
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sampled cells were loaded into the cytospin and spun at 1500g for 4 minutes. 
Excess suspension was absorbed by a filter card (Shandon 450gm/mm), 
leaving a distinct circle of cells on each slide, which was air-dried, fixed in 
methanol for 30 seconds, then stained for 30 minutes in lO% Giemsa (Gurr). 
"Healthy" cells had distinct nuclear and cell membranes. If >40% of the cells 
were dead the experiment was abandoned: In experiments involving a variety 
of treatments (i.e. more than 5), cell samples from only 2 or 3 treatments were 
taken for assessment of cell viability, but different treatments were randomly 
chosen for each rat. 
On day 3 (at approximately 4pm), 18.5kBq of [methy$- 3 1­1]- thymidine 
(Appendix 1:1, page27in 20pl of serum-free medium was added to each well 
which would be harvested, before replacing the plate in the incubator. 
Seventeen hours later the cells were collected using a Titertek Cell Harvester, 
which washed them free of unincorporated tritiated-thymidine and 
concentrated the cells from each well on to a small disc of filter paper 
(Titertek, Flow Laboratories). After drying, each disc was placed into a glass 
scintillation vial with 5m1 of scintillant (Appendix 1, page 279) or later into 
disposable plastic scintillation vials in imi of scintillant. 
2.7. Preparation of parasite antigens 
2.71. Parasite homogenate 
Approximately 600-1000 mature parthenogenetic females were recovered 
at day 8 post-infection (Section 2:9:1, page 44), or 60-100,000 freshly emerged 
third-stage larvae (Section 2:1, page 30, for method of production). These were 
repeatedly washed in phosphate buffered saline, supplemented with 
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penicillin/streptomycin (Appendix 1, page 278). Each type of preparation was 
transferred in approximately 2m1 of supplemented saline to a tissue grinder 
held in an ice pack. The parasites were ground until microscopical 
examination of a small aliquot of the suspension revealed that considerable 
disruption had occurred (approximately 10-15 mins). The homogenate was 
spun at 500g for five minutes on a bench centrifuge (MSE) to remove the 
larger debris, it was then spun at 3000g for 30 minutes at 4 °C on a Prepspin 
50 (MSE, Fisons, Ti lOxlO rotor) to remove most of the particulate material. 
The resulting supernatant was sterilised by passing through a 0.22pm filter 
(Millipore Corporation, Bedford, Massachusetts) held in a Swinnex 25mm filter 
holder (Millipore, S.A., 67120 Molsheim, France) and then stored at -20 °C. 
2.7.2. Aduft worm excretory /secretory antigen 
Approximately 600-1000 day 8 parthenogenetic female worms were 
recovered (Section 2:9:1, page 44), repeatedly washed in supplemented 
phosphate buffered saline and then adult culture medium (Appendix 1, page 279) 
The adults were resuspended in lOmi of the adult culture medium, transferred 
to a 50ml tissue culture flask with an angled neck (NUNC) and incubated at 
37 °C in a carbon dioxide incubator, with the top of the flask loose to allow for 
gas entry. The medium was collected and changed every week until more 
than 50% of the adults were dead (which usually occurred after 2-3 weeks). 
The collected medium was dialysed against phosphate buffered saline at 4 °C 
for 48 hours, concentrated by 50% using polyethylene glycol (Appendix 1:4, 
page279)and then sterilised by passing it through a 0.22im filter held in a 
Swinnex 25mm filter holder before storing at -20 °C. The antigenic preparation 
obtained in this way consisted of a complex mixture of material produced by 
adults and first-stage larvae, since eggs laid by females hatched in culture. It 
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may have also contained autolysis products, since the first-stage larvae 
produced did not develop any further, but died. 
2.7.3. Larval excretory /secretory antigen 
2: 2" 
The method was similar to that given in 	, 60-100,000 freshly emerged 
third-stage larvae (produced as described in Section 2:1, page 30) were 
repeatedly washed in supplemented phosphate buffered saline and then 
resuspended in lOmI of the saline solution before transfer to a 50m1 tissue 
culture flask with an angled neck. The larvae were cultured at 19 °C j. 1 °C in 
an anhydric incubator with internal fan circulation of air for a week or more. 
The supernatant containing larval products was collected and renewed every 
week and treated exactly as described in for the adult antigen. 
2.8. Protein determination using a micro-Lowry technique 
(After Lowry et at, 1951) One millilitre of ice-cold trichloracetic acid 
(Appendix 1:5, page 281) was added to 100,pl of the test sample before 
vortexing for 15 minutes (Whirlimix, Fisons). The mixture was then spun at 
13,000g for 2 minutes on a micro-centaur (MSE), and the resulting supernatant 
was aspirated off and discarded. One hundred microlitres of 1M sodium 
hyroxide solution (Appendix 1:5, page281 was added to the pellet, the mixture 
was vortexed and then incubated for ten minutes at room temperature. One 
millilitre of solution D (Appendix 1:5, page 281 ) was added with mixing, and 
then the solution was incubated for a further 10 minutes before lOOjul of 
solution E (Appendix 1:5, page 28 was added with mixing. This final solution 
was incubated for another 30 minutes and then the absorbance of the samples 
at 750nm was read using a SP8 4000 UV/VIS spectrometer (Pye, Unicam). The 
protein concentration of the test samples (two replicates for each sample) was 
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found from a standard curve plotted from protein standards (BSA, Sigma), 
ranging from 0.125-1mg protein per ml, run at the same time. 
2.9. Surgical transfer of adult parthenogenetic female worms from one rat to 
another 
2.9.1. Recovery of adult worms 
Mature female worms were recovered on day 8 post-infection from four 
three-week old Wistar stock rats infected by subcutaneous injection under 
ether anaesthesia with 2000 third-stage larvae. Rats had been starved since 
day 7 post-infection (p.m.) in order to minimise the amount of food present in 
their intestines. 
Rats were killed by carbon dioxide asphyxiation, their ventral surface 
swabbed with 70% alcohol and the body cavity opened using flamed scissors. 
The stomach and 20cm of the attached small intestine was removed, using 
flamed scissors and large forceps, to a Petri-dish containing supplemented 
phosphate buffered saline at 37 °C. The stomach was removed and the 
intestine opened longitudinally using small scissors and fine forceps. Large 
intestinal debris was carefully scraped away and fresh saline added to cover 
the intestine, which was then incubated for 80 minutes at 37 °C, by which time 
the adults had migrated into the saline. This process was usually completed 
within 10-15 minutes of the death of the rats. 
2.9.2. Adult transfer 
Adult parasites from a particular rat were collected and a maximum of 6 
doses of 50 adults, in approximately 0.3m1 saline, were individually 
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hand-counted into a solid watch-glass. Rats which were to receive adults 
recovered from one animal were anaesthetised with "Sagatal(O-3mg per 100gm 
body weight, pentobarbitone sodium, May and Baker) and their abdominal and 
chest fur removed using lmmac R cream (Anne French, London). The ventral 
surface of the rat was swabbed with 70% alcohol, before making a longitudinal 
incision of approximately 2cm into the body cavity behind and slightly to the 
left of the sternum using a sterile scalpel (No. 3, Paragon; with a No.10 blade, 
Swann Morton Ltd.,Sheffield). The intestine was exposed by lifting one of the 
cut edges of the tissue layer with sterile forceps. The pyloric end of the small 
intestine was raised from behind the liver, through the incision with fine 
forceps. Holding it, now, with large forceps, the loop of the small intestine 
was secured in its external position by passing the fine forceps through it, so 
as to form a bridge across the incision in the body wall (Fig.2:8, page 46). The 
dose of 50 adults was injected into the intestine, using a imI Plastipak syringe 
and a 19G needle , before allowing it to return to the body cavity by removing 
the restraining fine forceps. A small amount of Terramycin R powder (<5mg, 
oxytetracycline, Pfizer) was placed inside the body cavity before the muscle 
layer of the peritoneum was sewn up using a 1/2 inch spring-eyed, 
round-bodied, surgical needle (No.20, Surgicraft, A.W. Showell Ltd., Redditch) 
threaded with black braid non-capillary suture silk (Suture Ltd., Dyffryn Estate, 
Newtown, Powys). The skin layers were autoclipped together using 12mm 
autoclips (Michel. Germany). The incision area was sprayed with Al amyc i n R 
(oxytetracycline hydrochloride B.P. Gentian Violet, Norbrook Laboratories Ltd., 
Newry, Northern Ireland), before replacing the rat in its cage. All instruments 
were swabbed with absolute alcohol between transfers. The surgical needle 
and autoclips were stored in the same liquid. 
Rats were maintained on TerramycinR  (165mg per litre) in their drinking 
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water for 5 days post-infection. On day 4 post-infection autoclips were 
removed whilst the animals were held by an assistant. The exact number of 
adults injected into each rat was found by recovering those that remained in 
the watch-glass and syringe with its attached needle. 
thus: 
0 = 50 - [a + b] 
Aitifi 
D 	= 	exact dose for a particular rat 
a = number of adults left in the solid watch-glass for 
the same rat 
b 	= 	number of adults recovered in washings from syringe and 
its attached needle for the same rat 
Donors were killed as worms from the proceeding animal were used up. 
This ensured that recipients were given parasites exposed to the outside 
environment for a minimum time of approximately 80 minutes. 
2.10. Onfection procedure used in experiments 
Newly emerged third-stage larvae were collected from faecal cultures 
(Section 2:1, page 30), pooled, and then doses of 100 larvae in approximately 
0.3m1 of distilled water were individually hand-counted into a solid 
watch-glasss from one of three Petri-dishes containing the larval suspension. 
The dishes were rotated to ensure that the time any one was exposed to the 
sub-stage illumination was less than 4 minutes, thus attempting to avoid the 
possibility that heat from the stage of the microscope might impair larval 
viability. The temperature of the stage was approximately 20 °C. Rats were 
infected in one of four ways:- 
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2.1)0.1. Skin-application, after WiOson Ot .a4 1)984 
Rats were immobilised for two-three hours under "Sagatal" anaesthesia 
(0.3mg per 100gm of body weight, pentobarbitone sodium, May and Baker), 
given one hour prior to infection. The interim period of one hour is required 
to eliminate the effects of the anaesthetic on the infection process which 
otherwise occur (Wilson, Simpson and Seaton, 1986). During this hour a 0.5cm 
recess was clipped into the fur on the right flank of each rat, to expose the 
skin without breaking its surface, using flat-bladed scissors. The larval dose 
was applied to the wetted recess in the rat's fur using a lml Plastipak syringe, 
whilst it laid in its cage. The rats were then left undisturbed until they 
recovered consciousness. 
2.10.2. 1nectOon under ether, after Wilson and Simpson, 1981 
Rats were injected subcutaneously in the right flank with the larval dose 
using a lml Plastipak syringe and a 19G needle, whilst under ether 
anaesthesia. A second injection of 0.3m1 of distilled water was given in the 
same area with the same syringe, in an attempt to flush out any larvae 
trapped in the needle. Animals were returned to their cages and allowed to 
recover. Wilson and Simpson (1981) have shown that ether anaesthesia 
administered in this way does not affect worm development. 
2.10.3. Onjection, no anaesthesia 
The same procedure described in 	was followed, rats were injected 
whilst held by an assistant. 
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2.JO.4. Onfectiori w ith a Ogje estimated dose 
In some experiments rats were infected with a large dose of larvae, e.g. 
2000 third-stage larvae. In this case the total number of larvae recovered 
from fresh cultures was estimated (Section 2:1, page30)and the concentration 
of the stock larval suspension adjusted to give the required mean number of 
larvae per 0.3ml. 
After injection or skin-application of hand-counted doses the exact number 
of larvae given to each rat was determined as precisely as possible by 
counting the number of residual larvae. The number of larvae left in each 
watch-glass was obtained by adding a small drop of distilled water to it 
(approximately 0.2m1), and then scanning with a stereo-microscope. Larvae 
trapped in the syringe or syringe with its attached needle were dislodged by 
repeated flushing with distilled water into a glass centrifuge tube. The larvae 
were concentrated by centrifuging at 500g for 3-4 minutes on a bench 
centrifuge (MSE), the supernatant was aspirated off and discarded, and the 




0 = 100 - [a + b] 
Where: - 
0 	= 	exact dose for a particular rat 
a = number of infective larvae present in solid watch-glass 
after infection for the same rat 
b 	= 	number of larvae recovered from the washings of the syringe or 
syringe and its attached needle for the same rat 
On the required day post-infection (usually day 8) the rats starved from the 
proceeding afternoon, were killed by carbon dioxide asphyxiation, the body 
cavity was opened with scissors and the intestine, including the stomach and 
caecum, was removed and stored in a sealable plastic bag at -20 °C. At a 
convenient time a gut was defrosted under a bench lamp, the stomach 
removed, and the intestine was divided into 8 sections from the pylorus to the 
beginning of the caecum. Each intestinal segment was opened longitudinally 
and large debris removed with fine forceps, before squashing it between two 
glass slides (approximately 14x14cm 2). Four sections were loaded per plate 
and the number of adults present in each section was counted using a 
stereo-microscope (x40 magnification). To facilitate counting the top slide had 
a 12x12cm 2 grid of 144 squares etched on its surface. The same preparations 
were used to estimate the mean number of eggs in utero per worm for each 
rat by counting this feature in 20 randomly chosen worms. In order to prevent 
rats carrying a worm burden from re-infecting themselves from their own 
faeces, their cage bottoms were replaced every two days from day 7 
post-infection. Worm burdens were expressed as a proportion of the exact 
dose given to each rat and the results were analysed as shown in Section 2:11 
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(page 51). 
Within each experiment there was a group of animals (commonly referred 
to as "cosmic controls") infected with an exact dose of <100 third-stage 
larvae of the relevant parasite, which were killed on day 8 post-infection. 
These were used to assess the viability of the larvae used at priming since 
comparison of the proportion of the dose recovered from these animals with 
past data collected in this laboratory indicated whether there was a possibility 
that the larvae used were defective. Initially these animals were infected by 
subcutaneous injection without anaesthesia since this was the mode of 
infection used in the past in this laboratory, but in later studies rats were 
infected using the skin-application technique (see section 2:10:1, page 48) 
since the majority of the animals were infected in this manner and by this 
time enough data had been collected to use as reference. 
2.11. Statistical analysis of results 
2111. Worm data 
(after Wilson and Simpson, 1981) 
Worm burdens were expressed as a proportion of the exact dose given to 




P 	= 	proportion of the dose recovered from a particular rat 
N = total number of parasites recovered from the same rat 
0 	= 	exact dose given to the same rat 
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7/ 
The mean proportion of the dose recovered for a particular treatment was 
calculated as shown below:- 
n 
Where: - 
P 	= 	mean proportion of the dose recovered 
for a treatment 
n 	= 	number of rats within the treatment 
Treatments within experiments were compared using a one-way or a 
two-way analysis of variance on the arc sines of the data. Least significant 
differences between means were estimated from the pooled error variance in 
the standard way (see Sokal and Rohlf, 1969, pages 240-246) 
2.111.2. Egg data 
Preliminary studies showed that the egg data, although discontinuous, had 
a distribution which was not significantly different from normal (Chapter 3, 
Section 3:8, page 77). The mean number of eggs in utero per worm for 
different treatments (groups) within an experiment were compared using a 
two-level nested analysis of variance. If there was no significant difference 
between rats within groups but a significant difference between groups, then 
the least significant difference between means was calculated (as given in 
"2:11:1") from the pooled error variance, using the mean number of worms per 
rat as the divisor to calculate the pooled standard error. The "t" value of the 
degrees of freedom related to the error variance was used in calculations. 
Ideally the subgroup (=rat) and the group mean squares and the subgroup 
degrees of freedom should be corrected for unequal sample sizes by a 
somewhat complicated procedure (Sokal and Rohlf, 1969, pages 274-281); 
however experience showed that such corrections had little quantitative effect 
and led to no changes in terms of the significance of differences between 
group means (Appendix 1, shows an example, page282). These corrections 
therefore were not routinely made. 
If results of the two-level nested analysis of variance showed there was a 
significant difference between subgroups (rats) within groups, the subgroup 
means were used as single observations in a simple single classification 
analysis of variance. Least significant differences between group means were 
then calculated in the standard way (Section "2:11:1", page 51) using a "t" 
value with the degrees of freedom related to the number of rats per group. 
2.11.3. Lymphocyte transformation data 
Differential counts were calculated for each replicate per treatment, where 
appropriate, as follows:- 
D.C. = E - U 
Where:- 
D.C. 	= 	differential count 
E = the cpm for a particular treatment (e.g. cells 
stimulated with mitogen) 
U 	= 	the mean cpm for the unstimulated control of 
the same rat 
The differential counts were log e transformed (without the usual addition of 
one, since there were no zero values), because the standard deviations of the 
raw data were proportional to the means. Once transformed in this way the 
data fitted a normal distribution (Chapter 3, Section 3:8, page 76) allowing the 
application of parametric statistics. If a negative differential count was 
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obtained, then the negative value of the l09e  was used in calculations. Thus:- 
D.C. = ( - [lO9 e D.C.]) 
Where: - 
D.C. = differential count 
Transformed data were analysed by a two-way, one-way, or a nested 
analysis of variance depending on the particular protocol involved (examples 
are shown in Appendix 8:6, pages 359-364). 
Differential counts were not corrected for background since throughout 
experiments the background remained fairly constant at 16 cpm (Appendix 1:6, 
page 281). Also, the method of analysis meant that background was 
automatically subtracted from most results during the calculation of differential 
counts. To simplify the analyses of variance,equal sample sizes were used 
throughout. Where, occasionally, numbers of samples successfully assayed per 
treatment were not equal, results from individual replicates were omitted on a 
random basis to create a symmetrical pattern of degrees of freedom. The 
minimum number of replicates following this procedure was 4, though the 
usual number was 5, in any one treatment. 
Unstimulated background -controls are represented as 
mean- 	 counts per minute. - 
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2A L4. Qunflive comparison oV homollogovs and hoteroQogous che9Oeuj 
resOts 
In order to compare the relative reduction in the number of eggs in utero 
per worm, or the relative reduction in the proportion of the dose recovered, 
after homologous and heterologous challenge, it was necessary to calculate 
"resistance ratios", which took into account differences in the control values 
for individual treatments. Where:- 
2.1L4.1. Worm data 
Rw = Pe 
Pc 
Pc'= EaRG  
n 
Where:- 
Rw 	= 	resistance ratio for the worm data (homologous or 
heterologous challenge group) 
Pe 	= 	proportion of the dose recovered from either 
homologous or heterologous challenged rats 
(i.e. one observation) 
Pc 	= 	proportion of the dose recovered from corresponding 
controls (i.e. one observation) 
Pc' 	= 	mean proportion of the dose recovered from 
corresponding controls 
n 	= 	number of rats 
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2.1114.2. Egg date 





Re 	= 	resistance ratio for egg data (homologous or 
heterologous challenge treatment 
Ute 	= 	mean number of eggs in utero per worm 
per rat of homologous or heterologous challenged 
rats (i.e. one observation) 
Utc 	= 	mean number of eggs in utero per worm per rat of 
corresponding controls (i.e. one observation) 
Utc' 	= 	mean of means of corresponding control eggs 
in utero per worm per rat 
n 	= 	number of rats 
The resistance ratios for different treatments were then analysed in the 
same way as described in "2:11:1" for the worm data (page 51), and in 
"2:11:2b" for the egg data (page 52), treating each resistance ratio as a single 
replicate within its corresponding treatment. Least significant differences 
between group means were then calculated, using the pooled error variance, 
with its related degrees of freedom (see Sokal and Rohlf, 1969, page 240-246). 
For simplicity these resistance ratios were diagrammatically expressed as a 
"resistance quotient", calculated as shown below:- 
ReQ = 1 - ( R 
Where: - 
ReQ 	= 	resistance quotient 
R = mean resistance ratio for a particular treatment (either 
the homologous or heterologous challenge group) 
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Thus the height of a bar In the relevant histograms is related to the amount of 
protection expressed. The higher the bar, the greater the immunity 
demonstrated. The "P" value calculated using the resistance ratios are shown 
on these diagrams since the mean resistance ratio per treatment and the 
mean resistance quotient for the same treatment, have the same standard 
error and standard deviation (Appendix 1:8, page 2g8,shows a worked example 
of how the resistance ratios and resistance quotients were calculated and their 
relationship). 
2.1 1.4.3. Presentation of date 
Throughout this study the results of a particular experiment are either 
shown in a figure, in a table, or quoted directly (where the standard error is 
given along with the mean of a particular treatment). 
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CHAPTER 3 
TESTS OF METHOD 
3.11. Onroduc1io 
This chapter includes a number of experiments which were carried out for 
one of two reasons:- 
either a) to show that some alteration in the experimental protocol did not 
affect the result obtained 
or b) to develop a new experimental system For simplicity the chapter is 
divided into sections, each of which contains an integrated description of 
experiments on a common theme. 
3.2. Section 3:1 
3.2.1. Pairing of rats [EApt 11 
Since experiments usually covered a period of 4-6 weeks, individual 
experiments overlapped in time. There was insufficient cage space in the 
animal house to accommodate the large number of rats involved, one to a 
cage, therefore it was necessary to house them in pairs. The interactions 
between the paired animals could include potentially stressful relationships 
with concommitant increases in blood corticosteroids. Bailenger and 
Cabannes (1976) have shown endocrine changes of this type may have an 
antagonistic effect on the non-specific inflammatory response, possibly 
leading to higher numbers of intestinal parasites. This experiment was carried 
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out to discover if this method of housing could have an effect on the 
proportion of the dose recovered. Rats were not killed until day 20 
post-infection so that any difference in the worm burden of the two groups 
would be emphaised. 
12.11.1. IVJateuiaOs and methods 
36 rats were divided into two groups:- 
Gp.A - 30 rats - experimentals, killed day 20 post-infection 
Gp.B - 6 rats - controls, killed day 8 post-infection 
All rats were infected with an exact dose of under 100 third-stage 
homogonic strain S.ratti larvae either by skin-application (Gp.A), or 
subcutaneous injection (Gp.B, "cosmic controls"). On day 1 post-infection 16 
animals from Gp. A were paired, the remainder were housed singly in cages. 
Animals in Gp.B were killed on day 8 post-infection and were used to assess 
the viability of the larvae used at infection (page 51). 
3.2.1.2. Resufts 
Housing rats singly or in pairs had no effect since there was obviously no 
difference in the proportion of the dose recovered from the two treatments 
(mean 0.247 ± 0.031 single; 0.223 ± 0.039 paired). 
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3.3. Sectöon 3:2 
3.3.1. Self-Orfection [Expt 2)) 
Throughout the study, experimental rats carrying a worm burden were 
maintained in the same cage for up to six weeks. Therefore there was a 
possibility that these animals could become re-infected by the skin 
penetrating third-stage larvae, which had developed from their own faeces; so 
it was nessary to find out whether this actually happened, and if so, whether a 
strict cleaning regime prevented its occurrence. 
3.3.1.1. Materials and methods 
34 rats were divided into three main groups:- 
C - 6 rats - controls, killed day 8 post-infection 
! - 14 rats - infected, killed day 20 post-infection 
U - 14 rats - uninfected, killed day 20 post-infection 
All animals were kept in cages with closed plastic bottoms containing 
wood shavings. Members of Gps. I and C were infected with an exact dose of 
below 100 third-stage homogonic S.ratti larvae either by subcutaneous 
injection (Gp.C, "cosmic controls" used to estimate viability of larvae used to 
prime rats, page 51) or skin-application (Gp.l). On the day after infection 
animals were paired by placing infected rats (Gp.l) into the cages already 
occupied by the uninfected ones (Gp.U). In the case of 7 of the pairs, cage 
bottoms were renewed on day 8 and every 2 days subsequently. The cage 




Microscopical examination of faeces collected from infected rats showed 
that eggs were not present until day 6 post-infection therefore third-stage 
larvae, capable of infecting animals, would have been produced by day 9 
post-infection. However none of the uninfected rats became infected 
suggesting that rats are unable to re-infect themselves from their own 
contaminated faeces. In confirmation, there was no significant difference in 
the parasite burden of infected rats exposed to either cleaning regime (mean 
proportion of the dose recovered 0.340 ± 0.045 changed every two days; 0.403 
±. 0.067 changed once). 
3.4. Section 3:3 
Surgical transfer of adult worms between rats [Expts 3, 4 and 51 
A new experimental system had to be developed to carry out surgical 
transfer of adult worms, in which various factors that could adversely affect 
the survival of parasites were explored and eliminated. Additionally, practical 
information on the donor:recipient ratio had to be obtained. 
3.4.11. Expt 3, Time course of emergence of adult parasites from the intestines 
of freshily tdilled rats 
3.411. Materials and methods 
Two, three-week old, female Wistar stock rats infected with 1000 infective 
larvae of homogonic S.ratti heterogonic S.ratt, or S.venezuelensis were killed 
61 
on day 7 post-infection. The body cavity of each rat was opened using 
scissors and the first 20cm of their small intestine was removed to a 
Petri-dish containing warm saline in an incubator at 37 °C; a process 
completed within 5 minutes of the donor's death. The number of adults which 
had migrated out into the saline was counted at 30 minute intervals, starting 
with the time when the first ones appeared. 
3.4.1.2. Results 
The majority of parasites were recovered between 90-120 minutes of 
incubation and appeared to be very active, in contrast those gathered after 
four hours, were sluggish or dead, and obviously unsuitable for transfer. In 
both strains of S.ratti and S.venezue/ensis 200 or more adults were collected 
in the 90-120 minute period (Table 2:3(i), Appendix 2, page29l)suggesting that 
a 1:4 or 1:5 donor to recipient ratio would be feasible if rats were to be 
infected with 50 adult worms. 
3.4.2. Expt 4, The effect of time spent in culture on worm survival 
3.4.2.1. Materials and methods 
Four groups of four rats (Gps.A, B, C and D) were infected by the surgical 
transfer technique (Section 2:9, Chapter 2, page 44) with an exact dose of less 
than fifty adult homogonic S.ratti worms (mean 49.10). All doses were 
prepared from the pooled worm burdens of 4 donor rats killed at the same 
time. Parasites were taken from this pool at 1.5h, 2.5h, 3.5h and 4.5h to infect 




There was a significant reduction in the proportion of the dose recovered if 
rats were infected with doses which had been prepared more than one and a 
half hours after the donor's death (Table 2:3(ii), Appendix 2, page 29111-lowever, 
there was no significant difference in the mean number of eggs in utero per 
worm for the four treatments. Therefore the results suggested that to ensure 
maximum survival adult worms should be transferred within two hours of the 
donor's death. 
3.4.3. Expt 5, Viability of transplanted worms from different donors 
The results of Expt 4 had shown that parasitic female worms used for 
transfer should only be exposed to the external environment for up to 2 hours, 
since those transferred any later than this have a reduced ability to establish. 
It was only possible to infect a maximum of six rats within 30 minutes and 
sufficient adults for transfer only emerged from culture after 90 minutes. 
Therefore it would be necessary to stagger the death of the donors to ensure 
that adults were transplanted within this time limit. Thus it was essential to 
discover if females obtained from different donors had equal abilities to 
establish in a new host. 
3.4.3.1. aterials and methods 
Four batches of four rats were infected by lapoiotomy (Section 2:9, Chapter 
2, page 44) with an exact dose of <50 adult S.venezue/ensis worms prepared 
from one of four donors, the time of whose deaths had been staggered by 
hourly intervals to ensure that the transferred worms had only been exposed 
63 
to the external environment for a maximum of two hours. Animals with 
surgically transferred worms were killed four days later. 
3.4.3.2. ResuOts 
There was no significant difference in the proportion of the dose recovered 
from animals which received worms from different donors (overall mean 0.281 
± 0.043), suggesting that varying the donor had no effect on the ability of 
transplanted worms to establish in a new host. 
3.5. Section 3:4 
3.5.1. Autonfection [Expt 6 
Although never proven, the process of "autoinfection" is still implicated by 
some authors in the biology of Strongyloides spp. including S.ratti(Moqbel and 
Denham, 1978). According to their idea, first-stage larvae produced by adults 
in the intestine need not pass to the outside of the host, but may 
"metamorphose" into infective larvae endogenously and thus add to an 
existing worm burden. All the experimental results were explicable without 
recourse to the idea of autoinfection, but the surgical transfer technique was 
employed, using first-stage larvae instead of adult worms, in an attempt to 
test the hypothesis. 
3.5.11.1. Materiags and methods 
First-stage homogonic S.ratti larvae were obtained by passing the 
supernatant, collected from culturing the small intestines of four stock rats in 
supplemented phosphate buffered saline at 37 °C (Section 2:9:1, Chapter 2, 
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page 44), through double thickness cotton gauze. This procedure removed 
intestinal debris and adult worms leaving a solution containing only first-stage 
larvae. The larvae were washed in saline, their number estimated, and the 
suspension was adjusted to give 450 larvae per 0.5mI. Eight rats were infected 
by laporatomy (Section 2:9:2, Chapter 2, page 44) with 450 larvae using a 25G 
needle and a imi Plastipak syringe and killed eight days later. 
3.51.2. Results 
Using this experimental technique no adults were recovered from any rat 
suggesting that auto-infection does not occur under these conditions. 
3.6. Section 3:5 
Cell transfer EExpts 7 and 81 
It was necessary to ensure that any reduction in the worm burden obtained 
after transfer of immune mesenteric lymph node cells could not be attributed 
to an adverse effect of the cell-transfer medium on the parasites. Therefore 
the effect of administering cell medium was investigated to find out if it had a 
detrimental effect on the establishment and survival of S.ratti In the cell 
transfer experiments the protocol of Moqbel and Wakelin (1981) who primed 
rats with 2.500 8  mesenteric lymph node cells was followed, therefore it was 
necessary to ascertain how many experimental animals could be supplied with 
this dose of cells from one donor. 
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3.6.1. apt 7, The effect ol c&O transfer medium 
3.6.11.U. Materials and methods 
Twelve rats were infected by skin-application with an exact dose of <100 
third-stage homogonic S.ratti larvae (mean 98.25). Approximately 4 hours 
later, after the animals had recovered from the effects of the anaesthetic, half 
the rats were injected with 0.5m1 of the cell transfer medium in a lateral tail 
vein (Section 2:5:2, Chapter 2, page 38). The rats were killed 8 days later. 
3.6.1.2. ResuOts 
There was obviously no difference in the proportion of the dose recovered 
from the two groups (mean 0.541 ± 0.035 no medium; 0.542 ± 0.046 medium) 
or in the number of eggs in utero per worm for the two treatments (mean 
7.229 ± 0.125 no medium; 7.129 ± 0.137 medium). Therefore any reduction in 
the proportion of the dose recovered from animals which receive immune cells 
cannot be attributed to any effect of the medium. 
3.6.2. apt 8, Donor:recipient ratio 
3.6.2.1. Materials and methods 
Cell suspensions of mesenteric lymph node cells were individually prepared 
from three uninfected rats (Section 2:5:1, Chapter 2, page 37) and the number 
of cells present in each and the percentage dead found. 
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3.6.2.2. IVesuO1s 
One rat was capable of providing up to 1.1 1x10 9 cells (mean 1.44x10 8 ) 
therefore a donor:recipient ratio of 1:3 or 1:4 should be possible if rats are to 
receive 2.5x10 8 cells each. 
3.7. Section 3: 
Investigation into factors involved in the lymphocyte transformation assay 
(Expts 9, 10, 11 and 12) 
A series of experiments were carried out to discover the optimum culture 
conditions for mesenteric lymph node cells from the inbred PVC rats used. 
The effect that using different concentrations of concanavalin A and harvesting 
cells at different times, had on the level of blastogeriesis obtained in vitro was 
also investigated since a system which gave a high level of incorporation of 
tritiated-thymidine was required. Initially the followed the procedure of Genta 
et a/. (1983), but various parameters in their protocol were altered to produce 
the optimum conditions for use. 
3.71. ExpI 9, The effect of serum concentration in the cell medium 
3.711. Materials and methods 
Suspensions of mesenteric lymph node cells were prepared from three 
uninfected rats (Section 2:5:1, Chapter 2, page 37) using cell medium 
containing 5% human serum. The numbers of live and dead cells were 
estimated for each suspension. Aliquots of the original cell suspension from 
each rat were spun down and made up to lOmI with cell medium containing 
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5%, 10% or 15% human serum to give a final concentration of 200 6 cells per 
ml. Cultures of the lymphocytes were prepared in multiwell plates with a 
separate plate for each rat (Section 2:6, Chapter 2, page 38) and either 
serum-free medium or concanavalin A (2.5j.ig/ml) was added to the cells 
(Fig.3:1, page 69). Four days later they were harvested. 
3.7.11.2. Results 
There was no significant difference in the level of unstimulated activity of 
cells incubated in medium containing 5 or 10% human serum. However 
incubation of cells in medium containing 15% human serum caused a 
significant reduction in the level of unstimulated blastogenesis (P<0.001, 
Fig.3:31b, page 71) suggesting that the higher serum concentration was 
suppressing the spontaneous activity of the cells. Each rat varied significantly 
in its response to mitogenic stimulation at each serum concentration (Fig.3:38, 
page 71) but cells incubated in medium containing 15% human serum 
expressed a consistantly higher activity compared to that obtained at the 
lower serum concentrations. 
3.7.2. Expt 10, The effect of varying the concanavalin A concentration 
3.7.2.1. Materials and methods 
Suspensions of mesenteric lymph node cells were prepared from three 
uninfected rats (Section 2:5:1, Chapter 2, page 37) and their concentration was 
adjusted to give 200 6  cells/mi. Aliquots of the cell suspension from each rat 
were placed in the wells of a microtitre plate (Fig.3:2, page 69) and either 
serum-free medium (unstimulated control treatment) or concanavalin A, at 
concentrations 2.5, 5, 10 or 20pg/mI (experimentals) was added. On day 4 of 
Fig.3:1 
Cells from all three infected rats were cultured on the same plate. Only one 
plate was set up in Expt 9, but in Expts 11 and 12 three plates were prepared. 
Either 50)Jl of serum-free medium (unstimulated control treatment) or the 
mitogen, concanavalin A, was added to the cell suspension (100F') contained 
in each well. 
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Fig.3:2 
Aliquots of cells (lOOjul) from all three infected rats were dispensed into 
separate microtitre plates and either 50pl of serum-free medium (unstimulated 
cells) or concanavalin A (2.5, 5, 10, or 20jjg/ml) was added. On day 4 of 
culture the cells were harvested and their response to the various treatments 
assessed. 
3:1 
ppearanoe of inicrotitreplaite In Expts 9 ,  11 and 12 
Column no. 1 	2 	3 	4 	5 	6 	7 	8 	9 	10 	U. 	12 
Row no. 	A in in m m 
B in Xl X2 X2 
C in Xl X2 X2 
D in XI X2 X2 
E in XI X2 X2 
F in Xl X2 X2 
G in Xl X2 X2 
H in in in in 
<—cells fràm rat 1 
Where:- 
IM in in in m in in in 
Yl Y2 Y2 Z1 Z2 Z2 in m 
Yl Y2 Y2 Zl Z2 Z2 in in 
Yl Y2 Y2 Z1 Z2 Z2 in in 
Yl Y2 Y2 Zi Z2 Z2 in m 
Yl Y2 Y2 Zl Z2 Z2 in in 
Yl Y2 Y2 Zi Z2 Z2 in in 
IM in in in in in in in 
—X-cells frazn ><-- cells frcm rat 3 --> 
rat 2 
in = medium only added to the cells which are not harvested 
1 = unstimulated cells (same as cells with medium added but the cells were 
harvested) 
2 = cells stimulated with concanavalin A (2.5pg per ml) 
X = cells in 	5% human serum (Expt 9) or cells of rat 1 (Expts 11 and 12) 
Y = cells in 10% human serum (Expt 9) or cells of rat 2 (Expts 11 and 12) 
Z = cells in 15% human serum (Expt 9) or cells of rat 3 (Expts 11 and 12) 
!9 .3:2 
Appearance of microtitre plate in Expt 10 
Column no. 1 	2 	3 	4 	5 	6 	7 	8 	9 	10 	11 	12 
Row no. 	A in in in in in in in in in in in in 
B in U U 20 20 10 10 5 5 2.5 2.5 in 
C in U 0 20 20 10 10 5 5 2.5 2.5 in 
D in U U 20 20 10 10 5 5 2.5 2.5 in 
E in U U 20 20 10 10 5 5 2.5 2.5 in 
F in U U 20 20 10 10 5 5 2.5 2.5 in 
G in U U 20 20 10 10 5 5 2.5 2.5 in 
H in in in in in in in in in in in in 
<-- concentration of concanavalin A —> 
in ua/ml 
Where:- 
in = medium only added to the cells which are not harvested 
U = unstimulated control treatment (same treatment as cells with medium but 
cells were harvested) 
A plate was set up for each individual rat. 
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culture the cells were harvested and their response to the various treatments 
assessed (Section 2:6, Chapter 2, page 38). 
3.7.2.2. Resujilts 
The highest level of stimulation was produced using concanavalin A at a 
concentration of 2.5)Jg/mI (Fig.3:4, page 73). 
3.7.3. Expts U and 112, The effect of harvesting cells on different days 
3.7.3.1. Materials and methods 
Mesenteric lymph node cell suspensions were prepared from three 
uninfected rats (Section 2:5:1, Chapter 2, page 37) and their concentration was 
adjusted to give 2x10 6 cells/mi. The cells from each rat were plated out 
(FLçj.31  page 69) and either serum-free medium (unstimulated controls) or 
concanavalin A (2.5jig/ml) was added. Three plates were prepared, one of 
which was harvested on each of days 3, 4 and 5 of culture. 
Tritiated-thymidine was added to the wells seventeen hours prior to 
harvesting. The response of the cells to the two treatments was assessed as 
described in Section 2:6, Chapter 2, page 38). 
3.7.3.2. Results 
In both experiments the highest level of mitogenic stimulation was 
produced when cells were collected on day 3 of culture (Figs.3:5a and 3:6a, 
pages 74 and 75). If collected later, the level of stimulation was lower. in 
Expt 12 blastogenesis was reduced by 30-40% of its day 3 value on day 4, and 
the level of stimulation was reduced by 62-68% of its day 4 value on day 5. 
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Mesenteric lymph node cells obtained from three uninfected animals were 
suspended in culture medium containing 5. 10 or 15% human serum. The 
cells were cultured in vitro with either serum-free medium (unstimulated 
controls, FLg.3:30)or concanavalin A (FiQJ.3:3b)to find out what effect altering 




















Fig. 3: 3 
Effect of varying serum concentration in the medium, Expt 9 
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Unfortunately there are no results for day 5 from Expt 10 since the plate 
became infected and had to be discarded. 
3.8. Section 3:7 
3.8.1. Possible seasonal changes in faecaO output of infective larvae (Expt 13) 
Many parasites exhibit a biological rhythm which can be related to their 
biology, the ecology of the host or vector, or climactic conditions (reviewed by 
Hawking, 1975). Graham (1939) suggested there was a seasonal variation in 
the production of free-living adults from faecal cultures of S.ratt, which could 
be correlated to changes in the environmental conditions to which the host 
was exposed. Therefore data on the output of third-stage larvae over 2 years 
from faecal cultures of both strains of S.ratti and S.venezue/ens/s was 
collected to discover if there was any obvious pattern of this sort. 
3.8.1.1. Materials and methods 
Faecal cultures of each strain of S.ratti and S.venezuelensis were routinely 
prepared on day 7 post-infection (Section 2:1, Chapter 2, page 30). The 
number of infective larvae produced per gm of faeces, the total number of 
larvae which could theoretically have been produced by the total amount of 
faeces collected, and the percentage of larvae non-motile was estimated over 
the course of two years. 
3.8.1.2. IResuOts 
The number of larvae produced by the total amount of faeces collected per 
rat over the two years for the three parasites is shown in Figs.2:1, 2:2 and 2:3 
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Mesenteric lymph  node cells obtained from different rats were exposed to 
various concentrations of rnitogen (Fj.3:4a) or serum-free medium 
(unstimulated controls, Fj.3:4b)in order to find the concentration which would 
produce a high level of blastogenesis. 
Fig. 3: 1 
E4ect of varying concanav11in A concentr a tion, Enpt 10 
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The effect of varying the time at which the mesenteric lymph node cells were 
harvested was investigated to find out what effect it had on the level of 










day S vo. day 4 P- 005 
Fig. 3:  
E4ct of harv e sting on dierent d a ys, Ept U 












day S Va.- day 4 P0.00I 
2 s 	I 
rot nucabor 
4 
day of £a,00V 
 
b) undhuIogod coDa 
I 	2 	 I 	2 
rat nuobor 
4 
day of harvocl 
74 
Cells exposed to either concanavalin A (Fig.3:6a) or serum-free medium 
(unstimulated controls, Fgj.3:6b)were harvested on days 3, 4 and 5 of culture, 
to discover what effect the length of time spent on culture had on the level of 
stimulation obtained. 
Fig 36 
E4fQct of harvesting on di+4rent days Etpt 12 
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(Appendix 2, page:303). 	Although there are some gaps in the data there did 
not seem to be any consistent parern in the seasonal variation in the output 
of infective larvae, since the peak recoveries occurred at different times each 
year for each parasite. (Other data from this study are shown in TabOcas 2:6(ñ), 
2:6(u) and 2:6(öii), Appendix 2, page 294). 
3.. Section 3:8 
Properties of some of the data 
The properties of the type of data collected routinely in this study have 
been explored by Wilson and Simpson (1981). The statistical methods adopted 
in this context are those recommended by these authors. Two types of data 
were new, however, and it was necessary to establish the correct procedure 
for their analysis. The number of eggs in the uteri of worms proved to be an 
important criterion in assessing resistance. On the face of it, such data, being 
discontinuous and having a low mean, could well have a frequency distribution 
significantly divergent from normal. It was nessary to test this possibility 
before they were analysed according to the principles of parametric statistics. 
In addition, the data obtained from the lymphocyte blastogenesis assays 
presented another problem in that the variances of the original observations 
from different treatments were quite obviously proportional to their means. 
This property violates a condition necessary for the application of analysis of 
variance. The standard procedure to overcome this difficulty is to convert the 
individual variates to their logarithms. Samples of the relevant data were 
transformed in this way and inspected to see whether the offending 
relationship between mean and variance had disappeared. The frequency 
distribution of the transformed numbers was also tested to confirm that it 
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matched the normal curve. 
L VJehod 
Differential counts per minute obtained from different treatments within the 
lymphocyte blastogenesis assays were converted to their natural logarithms. 
These were scrutinised for any obvious relationship between mean and 
variance. Samples of the transformed results with similar means, as well as 
samples of control and experimental observations of eggs in utero, were 
tested using the "Minitab" computer package (Edinburgh Regional Computing 
Centre). This generates a new set of data which are normally distributed and 
have the same mean and standard deviation as the test data. The two sets of 
data are compared for correlation and a P value is obtained from tables using 
the program's calculated correlation coefficient and the number of replicates 
per treatment. This shows how well the test data fitted a normal distribution. 
2. Resufts 
The variances of samples of log transformed counts from blastogensis 
assays were not proportional to their means. Neither type of data under test 
had frequency distributions significantly different from normal (TabBes 2:7(i) 
an 2:7(öi), Appendix 2, page 306). On these grounds it is feasible to apply 
parametric techniques of analysis to both. 
The general methods used in this Chapter can be found in the relevant 
section of Chapter 2 given below:- 
i) method for infecting rats by subcutaneous injection or skin-application 
Section 2:10, page 47. 
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method for counting the number of worms and the number of eggs in 
utero per worm Section 2:10, page 50. 
method for estimating the number of third-stage larvae Section 2:1, 
page 30. 
statistical analysis of results, Section 2:11, page 51. 
All results are shown in Appendix 2, pages 290-306). 
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3.. Sunuvarv 
Housing rats either singly, or in pairs, did not affect the proportion of the 
dose of S.ratti (homogonic strain) recovered on day 20 post-infection, when 
differences in the immune response would have been detected. 
Rats carrying S.ratti (homogonic strain) seemed to be incapable of 
re-infecting themselves from their own contaminated faeces. 
Results following surgical transfer of adult Strongylo/des spp. suggested 
that a donor: recipient ratio of 1:4 should be possible; that worms should be 
transferred within two hours of the donor's death to ensure maximum survival; 
and that the viability of female worms taken from different donors was 
homogeneous. 
"Auto-infection" of rats by Strong/oides spp. was unlikely in this 
experimental framework. 
Cell transfer medium did not affect the proportion of S.ratti (homogoriic 
strain) recovered from rats post-infection and a 1:3 donor to recipient ratio 
should be feasible in cell transfer experiments if rats are to receive 2.500 8 
cells each. 
Conditions for lymphocyte transformation assays would include 15% 
human serum in the cell medium, concanavalin A at a concentration of 
2.5pg/ml for stimulation, and cells would be harvested on day 4 of culture. 
No apparent seasonal variation in the production of infective 
Strongyloides spp. from faecal cultures was detected. 
viii) The data from counting eggs in the uterus of parasitic worms and the 
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transformed lymphocyte blastogenesis data could be legitimately analysed by 
parametric statistical techniques. 
MI 
CHAPTIER 13  
COURSE OF INFECTIOM OF AM EXACT DOSE OF LESS THM 100 THORD-STAGE 
LARVAE OF STR&IGYLOIOES SPP. 
41. Dnoduction 
In order to ensure that any cross-immunity demonstrated in reciprocal 
challenge experiments using the various parasites was specific in origin, it 
would be necessary to challenge rats when all the responses against the 
primary infection had subsided. In that case, at challenge, it would be the 
presence of immunological memory against the priming agent that would be 
investigated, and any cross-protection found after homologous and 
heterologous challenge would be because the two parasites shared common 
functional antigens. Therefore initially it was nessary to know:- 
the course of a primary infection for each strain of S.ratti and 
S. venezue/ensis 
whether there was any strain or species-specific type  of primary 
infection. In the experiments rats were infected with an exact dose of less 
than 100 third-stage larvae. Previous workers (Sheldon, 1937; Moqbel and 
Denham, 1977;1978; and Moqbel and McLaren, 1980) had found that the 
majority of S.ratti adults were expelled between days 25-30 post-infection, 
however the doses used in their experiments were a factor of ten greater than 
those planned. Therefore it was possible that such a small infection may have 
elicited a less potent anti-worm response and thus be able to survive much 
longer in the host. 
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4.2. Moed&Gs and methods 
Three experiments were carried out using the protocol shown in Fgj.41, 
page 83. 
4.2.1. Expts. ii and 2, Course of infection of an exact dose of <100 homogjonc 
S.ratti third-stage Oarvae 
There were three amendments to the general protocol in experiment 1:- 
Day 8 injection controls were omitted and the experimental day 8 rats 
were also used as the "cosmic controls" (page 51). 
Results for day 32 post-infection came from 8 rats. A day 38 sample 
time was intended but 3 rats did not recover from the effects of the 
anaesthetic, and one rat was found to be pregnant; therefore the remaining 
two rats were included in the day 32 treatment. 
Only worm numbers were counted. Experiment 2 was a repeat of 
experiment 1, carried out to confirm results and also to ascertain the worm 
distribution within the intestine, and the number of eggs in utero per worm 
during the course of infection. The general protocol shown in Fig.4:1 was 
followed with no alterations. The mean exact dose at priming was 97.5 
third-stage larvae in experiment 1, 92.5 for skin-application rats and 89.0 for 
injection control animals in experiment 2. 
4.2.2. Ext. 3, Course of infection of an exact dose of <100 third-stage 
heterogonic S.rtti larvae 
The protocol used was identical to that shown in Fig 4:11. The mean exact 
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F&g.4: ii 
Thirty-six rats (Gps.A and Cl) were infected with an exact dose of <100 
infective S.ratti larvae; Gp.A by skin-application and Gp.C1 by subcutaneous 
injection. Eight days later six rats from Gp.A and the primary controls, Gp.C1 
(used to assess the viability of the larvae) were killed. The remaining animals 
in Gp.A were killed in batches of six on days 14, 20, 26 and 32 so that the 
course of a primary infection of the parasite could be followed. The number 
of parasitic female worms present, their distribution along the intestine and 
the number of eggs in utero per worm was recorded for each rat. 
!9 04:1 
General protocol used in experiments to study course of a primary infection 
DAY 0 	Gp0A - experimentals, 30 rats 
Gp0C1 primary controls, 6 rats 
1 
DAY 8 	6 experimentals (Gp0A) 
Gp0C1 primary controls 
1. 
DAY 14 6 experimentals (Gp0A) 
1. 
DAY 20 6 experinentals (Gp0A) 
I 
DAY 26 6 experimentals (Gp0A) 
1. 
DAY 32 6 experimentals (Gp0A) 
infected with an exact dose of 








dose was 95.1 for skin-application rats and 95.2 for injection control animals. 
4.2.3. Ept. 4, Proportion of the dose recovered on day 8 post-infection, in rats 
infected with S.venezuelensis 
Since S.venezuelensis was a new parasite to this laboratory there was no 
background information on its worm burden post-infection. Therefore this 
initial experiment was carried out to find what proportion of an exact dose of 
less than 100 third-stage larvae would be recovered on day 8 post-infection in 
Wistar rats of the Edinburgh colony. 
Eight rats were infected with an exact dose of <100 third-stage 
S.venezuelensis larvae, four by skin-application (mean exact dose 97.8 larvae) 
and four by subcutaneous injection without an anaesthetic (mean exact dose 
94.8 larvae). Rats were killed on day 8 post-infection and their worm burden 
found. 
The modes of infection, methods used to count worm numbers, their 
distribution within the intestine and the mean number of eggs in utero per 
worm are given in Section 2:10, Chapter 2, page 47. Statistical analyses were 
as described in Section 2:11, page 51. 
4.3. Results JExpts 'U, 2, 3 and 41 
'U. Proportion of the exact dose recovered 
In both the homogonic and heterogonic strain of S.ratti there was a 
reduction in the number of adults recovered over the course of infection. By 
day 26 post-infection the majority of adults had been lost (results of Expts. 
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1-3, shown in FLg.4:2, pages 86-88). Results for days 8, 14 and 20 post-
infection, only, were analysed since the mean proportion of the dose 
recovered on days 26 and 32 was much smaller. Surprisingly, in experiment 3 
(Fñg.4:2(iü), page 88), there was a significant difference in the proportion of the 
dose recovered from day 8 experimental rats and controls (P<0.01), the cause 
of which is unknown. Comparison of all three experiments showed there was 
a difference in the pattern of worm loss, since a two-way analysis of variance 
of "experiments" versus "days" revealed a significant variance attributable to 
interaction (P<0.025, Appendix 3:3a, page 309. If experiment three was 
omitted from the analysis, so that data for the homogonic strain only was 
analysed, this interaction disappeared, implying similar dynamics in those 
experiments. The significant differences in the proportion of the dose 
recovered between Expts 1 and 2 for each sample time (P<0.001, Appendix 
3:3a, page 309) were consistent and not surprising, because the different 
infective larvae employed could have had a different potential for development 
(Wilson and Simpson, 1981). Only a very small proportion of the dose was 
recovered from rats infected with S.venezue/ensi, regardless of the method of 
infection used (mean 0.056 t 0.033 injection; 0.020 t 0.005 skin-application). 
The reason for this was unclear, but it seemed pointless to study the course 
of infection of such a small number of adults. 
2. The number of eggs in utero per worm 
There was a reduction in the number of eggs in ufero per worm for both 
S.rarti strains over the course of infection, until day 20 post-infection for the 
heterogonic strain, and day 26 post-infection for the homogonic strain, when 
it reached a minimum of approximately 2 eggs in utero per worm (Ag4:2(UU)b 
and 4:2(M)b, pages 87 and 88). Eggs in utero at the outset were approximately 
[:I;1 
Fj.4:2 
Rats were infected with an exact dose of <100 third-stage S.ratti larvae and 
killed at various intervals post-infection to discover the length of the infection. 
Resuts for the Giomogoffic strain (Expts 1 and 2) are shown in 5g.4:2G) an 
42c55, whereas those for the heterogonic strain (Expt 3) are given in g.4:2(5G). 
Fig. 4:2 
Egg and worm data over the course of infection of an exact dose of <100 
third-stage S.rattj larvae, Eupts 1 	2 and 3 
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Fig. 4:2 (continued) 
ii) Expt 2 homoonIc S.ri1H 
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Fig.4:2 (continued) 
III) Expt 3 hetorogonlc S.retI 
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8 and 6 for the homogonic and heterogonic strains respectively. 
3. Distribution of adults along the intestine 
It was difficult to determine whether a posterior migration of adults had 
occurred late post-primary infection since results are based on the location of 
a maximum of 8 worms (Tables 3:2(i), (ii) and (iii), Appendix 3, page 308). 
There was a possible movement towards the rear of adult homogonic S.ratti 
worms on day 32 post-infection, since a greater proportion of the parasites 
was recovered from section 8, but further studies would be necessary to 
confirm this. There was a more plausible posterior migration of adult 
heterogonic S.ratti; since a greater proportion of the worms was recovered 
from section 8 on day 20 post-infection, and on days 26 and 32 post-infection 
the majority of parasites were recovered from section 4 of the intestine 
instead of the more usual site of section 1. Further studies using a greater 
number of replicates per treatment for the later sample times are necessary to 
show whether this posterior movement of worms is a reality. 
There did seem to be a difference in the distribution of adult 
S.venezue/ensis and S.ratt,, since on day 8 post-infection adult S.ratti were 
recovered as far as section 7 of the intestine (Tables 3:2(i), (ii) and (iii), 
Appendix 3, page 308), whereas adult S.venezuelensis were only recovered 
from sections 1 and 2. Further studies are necessary to confirm this 
observation. 
4. Rate of reduction in the proportion of the dose recovered and in the 
number of eggs in utero per worm over the course of primary infection 
Exponential coefficients were calculated from the data in order to follow 
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the rate of worm loss and the reduction in the number of eggs in utero per 
worm over the course of S.rafti infection using the 
equation 
Pt = P0e 
where:- 
= 	proportion of the dose recovered at time "t" 
P0 	= proportion of the dose recovered on day 8 post-infection 
t = 	time in days 
x 	 = exponential coefficient 
The coefficients varied greatly at each sample time when the rate of 
reduction in the proportion of the dose was considered, whereas the rate of 
reduction in the number of eggs in utero per worm seemed to be more 
constant (Fçj.4:3, page 91). Thus the force responsible for the reduction in the 
proportion of dose recovered was either a single unit which varied in intensity 
over the course of infection, or a number of units, which acted together to 
cause the observed reduction. Whereas if the reduction in the number of 
eggs in utero per worm is considered the factor responsible for its changes 
seemed to be constant over the course of infection (see General Discussion, 
Chapter 10). However further experimentation would be necessary to confirm 
these findings. 
The results obtained in this section are shown in Appendix 3, which 
includes statistical analyses of the data (page 307 ). 
Fig.4:3 
The figure shows the rate of reduction in the worm and egg data over the 
course of infection with S.ratti (homogonic and heterogonic strains), using 
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4.4. Suar 
The results of experiments described in this section showed that the 
majority of adult worms from a primary infection of S.ratti (homogonic and 
heterogonic strains), initiated with an exact dose of <100 third-stage larvae, 
were expelled by day 26 post-infection in Edinburgh colony Wistar rats. There 
seemed to be a difference in the pattern of worm loss for the two strains of 
S.ratti Calculation of exponential coefficients suggested that the rate of 
reduction in the number of eggs in utero per worm seemed to be fairly 
constant over the course of infection, whereas the rate of reduction in the 
proportion of the dose recovered varied over the course of infection. Infection 
of Edinburgh colony Wistar rats with an exact dose of <100 third-stage 
S.venezue/ensis larvae led to the recovery of an insignificant worm burden on 
day 8 post-infection, regardless of the mode of infection used; and there 
seemed to be a difference in the distribution of adult S.ratti and 
S. venezuelensis worms. 
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CHAPTER 5 
THE AMOUNT OF RECIPROCAL CROSS-IP4MUNITY BETWEEN THE TWO STRAINS OF 
SJ?A 771 AD S. (EJ!EZUELE1JSIS 
5.1. Introduction 
The experiments carried Out in this section had two main aims:- 
to discover whether small exact doses of less than 100 third-stage 
larvae of the three parasites would stimulate an effective resistance to 
homologous challenge infection with a similar small dose. 
to investigate the amount of reciprocal inter-specific and intra-specific 
cross-immunity between the two strains of S.ratti and S.venezuelensi& 
For reasons which will appear later in this chapter and also in "The course 
of primary infection" (Chapter 4, page 81) some of the possible 
cross-reactions could not be studied comparatively. 
In order to make clear decisions about the immunological relationship of 
the three parasites, rats were not re-infected until four weeks post-priming. 
Previous results had shown that, by then, the majority of worms from a 
priming dose were expelled from the intestine (results of Expts 1-3, Chapter 4, 
page 84). Thus any non-specific inflammatory response against the primary 
infection should have subsided by this time. 
Previous workers have shown that a strong resistance to S.ratti challenge 
infection can be induced in rats (Sheldon, 1937; Moqbel and Denham, 1977; 
Murrell, 1980), and mice (Dawkins and Grove, 1980, 1982). None of these 
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studies has involved the use of more than one strain and all have been based 
on the use of doses 5-10 times larger than those used in this study, which 
were less likely to pick up subtle differences in the host's immune response 
for a number of reasons (see Discussion). 
Very little work has been carried out on the level of cross-resistance 
between Strong v/aides species. Dawkins and Grove (1982) found that priming 
with S.stercora/is (infective larvae) protected mice against heterologous 
challenge with S.ratti, measured as a suppression in the number of larvae 
produced per gm faeces in comparison to control mice. This is a very 
artificial system since neither S.ratti nor S.stercora/is occur naturally in the 
mouse. Moreover, reciprocal challenge experiments were impossible because 
S.stercoralis is unable to complete its life cycle in this host. A major 
advantage of the experimental system used in this investigation was that all 
three parasites were in their natural host. 
5.2. Materials and methods 
The general protocol shown in Fög.51 (page 96) was followed, with various 
amendments for individual experiments. 36 rats were divided into 5 main 
groups: - 
Gps.A and B - 20 rats, infected by skin-application with an exact dose of 
<100 third-stage Strongyloides spp. larvae. Four weeks later ten animals 
(Gp.A) were challenged by the same method with a similar small dose of the 
homologous parasite (X), and the remainder (Gp.B) with the heterologous 
parasite ('1). 
Gp.C1 - 6 rats, primary controls - infected with an exact dose of <100 
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third-stage larvae of the same parasite (X) used at priming. 
Gp.C2 - 5 rats, secondary controls - infected at challenge with an exact 
dose of <100 third-stage larvae of the homologous parasite (X) used at 
priming. 
Gp.C3 - 5 rats, secondary controls - infected at challenge with an exact 
dose of <100 infective larvae of the heterologous parasite (Y). 
Controls were infected either by skin-application with anaesthesia or by 
subcutaneous injection without anaesthesia. All rats were killed either on day 
8 post-primary infection or day 8 post-challenge. The number of adult worms 
present, their distribution within the intestine, and the mean number of eggs in 
utero per worm for each rat was found. Detailed descriptions of the methods 
used are given in Section 2:10 and 2:11, Chapter 2, pages 47 and 51 
respectively). 
5.2.1. Eipts 1, 2 and 3, Homologous challenge with homogonic strain of S.ratti 
The same procedure described in the general protocol (page 94) was 
followed with a few ammendments (Figj.5:2 for Expt 1; page 97, Fig.5:3 for 
Expts 2 and 3, page 98) since rats were only challenged with the homologous 
parasite. Expts. 2 and 3 were run in conjunction to confirm the results of Expt 
1. To economise on the number of animals used, rats were primed together 
with larvae from the same pool, and shared priming controls. However at 
challenge each experiment had its own controls and animals were challenged 
with larvae from different pools. Controls from all three experiments were 
infected by subcutaneous injection. 
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Fg.5: 11 
Rats in Gps.A, B and Cl were infected with an exact dose of <100 infective 
S.ratti larvae of the homogonic strain. The larvae were administered by  
skin-application to animals in Gps.A and B whereas they were either injected 
subcutaneously or applied by skin-application to those in Gp.C1. To check the 
viability of the larvae used the priming controls (Gp.C1) were killed on day 8 
post-infection. The challenge was administered on day 28 of the primary 
infection when Gp.A were infected wih the homologous parasite (X) and Gp.B 
with the heterologous strain of S.ratti or species (parasite Y). Corresponding 
controls were infected at the same time (Gps.C2 and C3). Rats in all 
treatments were infected with an exact dose of <100 infective larvae given by 
skin-application to the experimentals, and either by skin-application or 
subcutaneous injection to the challenge controls. Animals were killed 8 days 
later and the proportion of the dose recovered, the distribution of worms 




DAY 0 f Gps0C2 and C3 	 untreated 
Gps0A and B - experimentals 	 primed with 
Gp0Cl 	- priming controls parasite X 
DAY 8 Gp0Cl 	- priming controls 	 killed 
DAY 28 	 challenge 
' Gp0A 	- homologous challenge 	 infected with parasite X 
Gp0B - heterologous challenge infected with parasite Y 
Gp0C2 	- secondary controls 	 infected with parasite X 
. Gp0C3 - secondary controls infected with parasite Y 
DAY 36 ----------- ALL RATS -------------------- 	killed 
Rat numbers used 
Group Expt 
4 5 6 7 8 9 
Gp0A 	= 10 10 9 10 9 10 
Gp0B = 10 9 10 10 10 10 
GpCl= 5 6 5 4 5 5 
Gp0C2= 5 5 5 4 5 5 
Gp0C3= 6 4 5 5 5 5 
Fig.5:2 
On day 0 rats in Gps.A and Cl were infected with an exact dose of <100 
infective homogonic strain S.ratfi larvae, given by skin-application to rats in 
Gp.A and injected subcutaneously to rats in Gp.Cl. Eight days later the 
priming controls (Gp.C1) were killed to assess the viability of the larvae used. 
On day 28 post-infection rats in Gps.A, C2 (skin-application controls) and C3 
(injection controls) were infected with an exact dose of <100 third-stage 
homogonic strain S.ratti larvae. Animals were killed 8 days later and the 
proportion of the dose recovered from the homologous challenge treatment 
(Gp.B) and its corresponding controls (Gps.C1 and C2) compared to find if any 
resistance to S.ratt/infection was induced with such a small priming dose. 
Fig 5g2 
Protocol for Expt 5:1 
TREMu1'1' 
DAY 0 (18  rats untreated (Gps0C2 and C3) 	 priming with an 
Gp0A - homologous challenge r 12 rats 	 exact dose of <100 
Gp0C1 priming controls, 6 rats 	 third-stage homogor 
strain S0ratti lar 
DAY 8 	Gp0C1 priming controls 	 killed 
DAY 28 	 challenge with an 
exact dose of <100 
infective homogonic 
S0ratti larvae 
GPeA - homologous challenge 
Cp0C2 - challenge controls (skin-application) 12 rats 
Cp0C3 - challenge controls (injection) 6 rats 
DAY 36 ------- ALL RATS 	 killed 
Figj.5:3 
Animals in Gps.A1, A2 and Cl were infected with an exact dose of <100 
third-stage homogonic S.ratti larvae by skin-application (Gps.A1 and A2) or 
subcutaneous injection (Gp.C1). The priming controls (Gp.C1) were killed 8 
days later to give an estimate of the viability of the larvae used. On day 28 
post-infection animals were challenged with an exact dose of <100 infective 
larvae of the homologous parasite with a different larval pool being used to 
challenge animals in Expts 2 and '3. The experimental animals in each 
experiment were infected by skin-application of the larvae whereas controls 
were injected subcutaneously with them. Eight days later all the rats were 
killed and the amount of resistance expressed in each experiment was found 
by comparing the proportion of the dose recovered and the number of eggs in 
utero per worm of the challenged treatments (Gps.A1 and A2) with their 
corresponding controls (Gps.C2 and C3). 
Protocol for experiments 5:2/3 
TREATMENT 
DAY 9 [10rats untreated (Gps0C2 and C3) 	 priming with 
 Gps0Al and A2 - homologous challenge, 24 rats 	homogonic strain 
Gp0C1 	priming controls, 6 rats 	 of S0ratti 
DAY 8 Gp0C1 	- priming controls 	 killed 
DAY 28 	 challenge with 
Gp0A1 	- homologous challenge 9 Expt 2, 12 rats hcxinogonic strain 
GpA2 - homologous challenge, Expt 3, 12 rats 	of S0ratti 
GpC2 	- challenge controls, Expt 2, 5 rats 
Gp0C3 - challenge controls, Expt 3, 5 rats 
DAY 36 --------------- ALL RATS ------------ 	killed 
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5.2.2. Ezpts 4 and 5, Homologous vs hsterologjous chaOlenge: homogonc strain 
of S.ratti priming animals 
There was one changes to the general protocol described on page 95, and 
shown in (Fg.5:L page 96). In Expt 4 the number of third-stage larvae 
produced per gm of faeces by the challenge treatments and their 
corresponding controls was found on days 6-8 post-challenge. Three rats 
were randomly chosen from each group and placed in individual grid cages on 
day 5 post-challenge. Faecal collections were made every day and individual 
cultures for each rat were set up on days 6,7 and 8 post-challenge. The 
number of third-stage larvae produced per gm of faeces and the theoretical 
number of larvae which could have been produced from the total amount of 
faeces collected was noted. The method of culture is given in Chapter 2 
(Section 2:1, page 30). 
Controls in Expt 4 were infected by subcutaneous injection of infective 
larvae whereas those in Expt 5 were infected by skin-application of larvae. 
5.2.3. Expts 6 and 7, Homologous vs heterologous challenge: heterogonic strain 
of S.rittiprflming animals 
The reciprocal challenge infection to that described in Expts 4 and 5 was 
carried out with no adjustments to the general protocol (given on page 95, 
and shown in Fig.5:1, page 96). Controls in Expt 6 were infected by 
subcutaneous injection of third-stage larvae, whereas those in Expt 7 were 
infected by skin-application. 
5.2.4. 1Ezps 8 and 9, Hom00090us vs hGIGITOB090us challenge: S.venezuIensis 
oving animals 
There were no adjustments to the general protocol described on page 95 
and shown in Fig.5:1, page 95 In experiment 8 the homogonic strain of S.ratti 
was used as the heterologous parasite whereas in Expt 9 the heterogonic 
strain was utilised. Controls in both experiments were infected by 
skin-application of infective larvae of the relevant parasite. 
The doses used in each experiment are shown Appendix 4, pages 312 -318. 
5.3. Results 
1. Worm data 
In all experiments where S.ratt/ was used to immunise and challenge rats, 
there was a significant reduction in the proportion of the dose recovered 
(P<0.001), and in the number of eggs in utero per worm (P<0.001) after 
homologous and heterologous challenge compared with the corresponding 
controls, regardless of the strain used to prime or challenge animals (Fig.5:4, 
Table 5:1a and Table Sib, pages 101 and 102). 
However, if S.venezue/ensis was used to prime rats either no immunity was 
elicited or there seemed to be a degree of immunosuppression since a 
significantly greater proportion of the dose was recovered from heterologous 
challenged rats in Expt 8 and 9 (P<0.001), and from homologous challenged 
rats in Expt 9 (0.01<P<0.05, Table Sic, page 1103) compared with 
corresponding controls. Adult S.venezue/ensis were recovered on day 36 
post-primary infection from the heterologous challenged groups in Expts 8 and 
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Figj.5:4 
Rats were primed with an exact dose of <100 third-stage homogonic strain 
S.rarri larvae and then challenged on day 28 post-primary infection with a 
similar small dose. The amount of resistance produced was found by 
comparing the proportion of the dose recovered (Expts 1, 2 and 3) and the 
number of eggs in utero per worm (Expts 2 and 3) from immunised rats (Gp.A 
in Expt 1; Gp.A1 in Expt 2; and Gp.A2 in Expt 3) and their corresponding 
challenge controls (Gps.C2 and C3; Gp.C2; Gp.C3: respectively). 
Fig. 5:4 
Effect of homologous challenge with the homogonic strain of S.ratti 
Expts l 2 and 3 
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TaIIe 5:1 
Rats were infected with an exact dose of <100 infective larvae of either the 
homogonic strain of S.ratfi, the heterogonic strain of S.ratti or S.venezue/ensjs 
Four weeks later the animals were challenged with a similar small dose of the 
homologous (Gp.A) or heterologous (Gp.B) parasite. The amount of resistance 
elicited in the primed animals was found by comparing the proportion of the 
dose recovered and the number of eggs in ufero of the experimentals (Gps.A 
and B) with their corresponding controls (Gp.C2 and C3, respectively). Table 
5:1(a) homogonic strain of S.ratti priming rats, challenge with the homologous 
and heterologous strain. Table 5:1(b) heterogonic strain of S.ratti priming 
animals, challenge with the homologous and heterologous strain. Table 5:1(c) 
S.venezue/ensis immunising animals, challenge with the homologous parasite 
and either homogonic strain of S.ratti (Expt 8) or heterogonic strain of S.ratt/ 
(Expt 9). 
Table 5:1 
a) Homologous vs heterologous challenge: homogonic strain of S.ratti 
priming rats 
ltpt 	Troabe2nt Group 	?lean prop. 	n 	SD 	Man no. 	n SD 
of the doom of agga 
recovarcxd 	 in utero/ 
voraVrot 
'3 	homologous challenge C.A 	0.124 	10 	0.110 	1.402 	10 1.111 
heteroloqous challenge (.B 	0.066 	10 	0.086 	1.616 	1 0.846 
priming controls (.Cl 	0.565 	S 	0.318 	8.311 	5 0.905 
challenge controls C.C2 	0.401 	S 	0.022 	1.566 	5 8.586 
homogonic S.ratti 
challenge controls Gp.C3 	0.534 	6 	0.208 	5.815 	6 0.331 
heterogonic S.ratti 
mean exact dose priming 	homoqonic $.ratti 	skin-application 91.10 
injection 81.60 
challenge 	homogonic S.ratti 	skin-application 97.10 
injection 89.40 
heterogonic S.ratti 	skin-application 95.50 
injection 81.67 
P values 	worm data 	egg data 
c.Cl vs C2 0.25>P0.10 0.0100.05 
c.C2 vs C3 	0.25P0.10 	P0.001 
.C2 vs A <0.081 K0.001 
.C3 vs B 	P<0.001 	P<0.e01 
5 	homologous challenge (.A 	0.079 	10 	0.069 	0.901 	8 0.556 
heterologous challenge (.B 	0.030 	9 	0.036 	0.801 	6 1.102 
priming controls Gp.Cl 	0.541 	6 	0.069 	7.300 	6 0.441 
challenge controls (.C2 	0.568 	5 	0.156 	6.319 	5 0.565 
homogonic S.ratti 
challenge controls Cp.C3 	0.438 	4 	0.055 	4.803 	4 0.434 
heteroqonic S.ratti 
mean exact dose priming 	homagonic $.ratti 	skin-application 95.62 
challenge 	homogonic $.tatti 	skin-application 95.65 
heterogonic $.ratti 	skin-application 94.08 
P values 	worm dita 	egg data 
c.Cl vs C2 P)0.05 0.01<P<0.05 
c.C2 vs C3 	0.25P)0.10 	P0.001 
,.C2 vs A P(0.001 P0.001 
.C3 vs B 	P<0.e01 	P0.901 
Table 5:1 
b) Homologous vs heteroloqous challenge: heterogonic strain of S.ratti 
priming rats 
Expt 	Treatment Group Kean prop. n SD lean no. n SD 
of the dose of agga 
recovorcd in uttzro/ 
won/rot 
6 	homologous challenge (.A 0.034 9 0.043 1.208 S 0.633 
heterologous challenge Gp.B 0.320 10 0.061 2.259 10 0.650 
priming controls Qp.Cl 0.492 5 0.358 6.038 5 1.199 
challenge controls GP-C2 0.540 5 0.116 6.180 S 0.629 
heteroqonic S.ratti 
challenge controls Gp.C3 0.663 5 0.133 7.408 5 0.875 
\-omoqonic S.ratti 
iiomn exact dose 	priming heter000nic S.ratti skin-application 95.55 
injection 84.67 
challenge heterogonic S.ratti skin-application 94.89 
injection 95.40 
homogonic S.ratti skin-application 94.80 
injection 98.40 
P values two data eggdata 
vs C2 P. We 79 P)0.25 
c.C2 vs C3 0.25<<0.10 (f3.00l 
(.C2 vs A P<0.00l 
(.C3.vs B P<0.001 N0.001 
1 	homologous challenge 	C,.A 	0.010 10 	0.013 	0.000 	S 0.167 
heteroloqous challenge 	(.B 	0.159 10 	0.085 	2.233 	10 0.700 
priming controls (.Cl 	0.471 4 	0.159 	6.363 	4 0.350 
challenge controls (.C2 	0.368 4 	0.063 	5.118 	4 0.586 
heterogonic S. ratti 
challenge controls Cp.C3 	0.524 5 	0.063 	6.602 	S 0.274 
homogonic S.ratti 
mean exact dose priming heterogonic S.ratti skin-application 97.52 
challenge heterogonic S.ratti skin-application 06.61 
homoqonic S.ratti skin-application 96.40 
P values worm data egg data 
.Cl vs C2 0.10>P0.05 0.10P>0.05 
.C2 vs C) 0.25>>0.10 P(0.001 
vs A <0.801 P<0.001 
.C3 vs 8 P(8.001 P<0.001 
Table 5:1 
C) HomologUV8  heterologous challenge: S,verbezueleflSiS priming rote 
Expt 	Treatment 	Group Mean prop. 	n SD 	Mean no. 	
n SD 
of the dose of eggs 
recovered in uterO/ 
worm/rat 
8 	homologous challenge Cp.A 0.060 	9 0.042 
heterologous challenge Gp.B 0.458 	10 0.140 	6.807 	10 1.109 
residual S.venezuelensis Gp.D 0.057 	8 0.058 
priming controls Gp.C1 0.047 	5 0.062 
challenge controls Gp.C2 0.023 	5 0.023 
S. venezuelertSiS 
challenge controls Gp.C3 0.247 	5 0.156 	6.638 	5 0.603 
homogoniC S.ratti 
mean exact dose 	priming S.venezuelensis skin-application 96.65 
injection 98.40 
challenge s.venezuelensls skin-application 95.22 
injection 93.20 
homogonic S,rattl 	skin-application 97.10 
injection 88.80 
P values worm data 	egg data 
vs C2 	P>0.25 
Gp.C1 vs D P>0.25 
Gp.C2 vs A 	0.25>P)0.10 
Gp.C3 vs B P<0.001 	P>0.25 
9 	homologous challenge Gp.A 0.098 	10 0.051 
heterologous challenge Gp.B 0.690 	10 0.122 	3.455 	10 0.596 
residual S.venezuelensis Gp.D 0.048 	9 0.032 
priming controls Gp.Cl 0.023 	5 0.018 
challenge contols Gp.C2 0,041 	5 0.021 
S .venezuelensis 
challenge controls Cp.C3 0.359 	5 0.100 	5.125 	5 0.354 
heterogonic S. ratti 
mean exact dose priming S.venezuelensis skin-application 96.15 
Injection 97.20 
challenge S.venezuelensis skin-application 97.20 
injection 92,60 
heterogonic S.raj 	skin-application 92.70 
injection 93.00 
P values worm data 	qqq data 
Gp.Cl vs C2 o 
c.Cl vs D 
c,.C2 vs A 
Gp.C3 vs B <0.001 
N .B. 
S. venezuelens is adults from the primary infection were recovered from the 
heterologous challenged rats (Gp.B), The proportion of the primary infection 
dose recovered from these animals is shown separately as Gp.D in this table. 
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9 (shown as the residual S.venezue/ensis treatment, Gp.D, Table 51c, page 
103). They were distinguished from adult S.ratti worms using a morphological 
criterion (Section 2:1, Chapter 2, page 23). Therefore adults recovered from 
homologous challenged rats in Expts 8 and 9 could be derived from the 
primary or challenge infection. Thus the significant increase in the proportion 
of the dose recovered from the homologous challenge group compared to 
controls in Expt 9 could be the result of challenge worms simply adding to the 
adults already present from the primary infection. However, this does not 
explain why more adult S.ratti worms were recovered from heterologous 
challenged rats compared to their controls in Expts 8 and 9. It should be 
noted that the proportion of the dose recovered from the secondary controls 
was lower than that obtained in previous experiments (Expts 1, 2, 3, 4 and 5 
for the homogonic strain; and Expts 6 and 7, for the heterogonic strain; shown 
in Fig.5:4 and Table 5:1a and b, pages 101 and 102) but there is no logical 
reason to believe that this had a fundamental impact on the outcome. If 
immunosuppression had occurred in these experiments no anti-worm 
response would have been expected but in Expt 9 there was a significant 
reduction in the number of eggs in utero per worm for the heterologous 
challenged treatment compared to its control (P<0.001, Table 51c, page 103). 
A corresponding reduction was not found in Expt 8 but this could be related to 
the use of different strains in the two experiments. 
2. Quantitative comparison of homologous and heterologous challenge 
The degree of protection resulting from homologous and heterologous 
challenge was compared by calculating resistance quotients for the two 
treatments within each experiment (Fig.5:5, pages 105 and 10. These gave a 
clear indication of the effectiveness of each treatment since the height of the 
bar is directly proportional to the level of resistance produced. If homogonic 
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The amount of resistance expressed against homologous and heterologous 
challenge infection was found by calculating the resistance quotients from the 
egg and worm data collected. The height of the bar for both treatments is 
directly proportional to the amount of protection produced. In Expts 4 and 5 
the homogonic strain of S.ratt/ was used at priming and rats were challenged 
with either the homologous (Gp.A) or heterologous strain (Gp.B). The reciprocal 
experiment was carried out in Expts 6 and 7 and the heterogonic strain was 
used to immunise animals. S.venezuelensis was the priming agent in Expts 8 
and 9, animals were challenged with the homologous parasite (Gp.A) and 
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Fig.5:5 (continued) 
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S.ratti was used to prime rats there was no significant difference in the level 
of immunity elicited by homologous or heterologous challenge (F:5(i) and 
(ii), Expts 4 and 5, pages 105 and 106). However, in the reciprocal challenge 
experiment, homologous challenge with heterogonic S.ratti produced a 
significantly greater level of immunity expressed as a greater reduction in the 
proportion of the dose recovered (P<0.001), and a greater reduction in the 
number of eggs in utero per worm [0.025<P<0.05, Expt 6; 0.01 <P<0.025, Expt 
7, see Fig.5:5 (iUi) and (iv), page 105 and 106). These results contrast with 
those obtained when S.venezue/ensis was used to prime rats since there was 
no reduction in the worm data in either experiment (shown by the negative 
Resistance Quotient, "ReOw", in Fig.5:5(v) and (vi), Expts 8 and 9, page 10. 
3. Worm fecundity posit-challenge 
In one of the experiments information was collected in an attempt to 
answer the question "does a reduction in the number of eggs in utero per 
worm reflect a reduction in worm fecundity ?" It was feasible that female 
worms succumbing to the host's immune response may have laid eggs at a 
faster rate to offset any reduction in the number they produced. Thus fewer 
eggs in utero could actually be consistent with an increase in fecundity as 
much as the reverse. Therefore data was collected to discover if there was 
any relationship between the number of third-stage larvae produced per gram 
of faeces per worm (used as a measure of worm fecundity) with the number 
of eggs in utero per worm (used as a measure of the host's antiworm 
response throughout the study) post-challenge. 
There did seem to be both a reduction in the number of third-stage larvae 
produced per gram of faeces per worm and in worm fecundity (Table 5:2, page 
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109 for the challenged treatments compared with their corresponding 
controls. But the high variability within the results, possibly because of the 
low number of replicates per treatment, did not allow firm conclusions to be 
made. The estimated relative reduction in the number of eggs in utero per 
worm was not proportional to the number of third-stage larvae produced per 
gram of faeces per worm (compare "Ratio 1 " and "Rati02", Table 5:2, page 109) 
since, after homologous challenge there was a greater reduction in the 
number of eggs compared to the reduction in the number of third-stage larvae 
produced; and the reverse was found after heterologous challenge. Thus the 
observed change in the number of eggs in utero per worm is possibly not 
entirely accounted for in terms of a reduction in worm fecundity. 
4. Worm distribution post-challenge 
There may have been a posterior migration of adult S.ratti worms after 
homologous and heterologous challenge (regardless of strain used at priming) 
but since results are based on the relative position of 15 worms or less 
(minimum 1), it was impossible to make any firm conclusions (Tables 4:20)-(vi), 
Appendix 4, page 313). In experiments 8 and 9 where results were based on 
the relative position of forty, or more adults, there was a posterior migration 
of adult S.ratti worms in the heterologous challenge treatments compared with 
control data (Tables 4:2(vii) and 4:2(viii), Appendix 4, page. 316 ). However, 
other criteria had shown that no measureable resistance was induced in these 
experiments (see above). These results suggest there was a difference in the 
longitudinal distribution of the two Strongy/oides spp. within the intestine. 
Adult S.ratti worms were recovered from up to section 6 of the gut whereas 
S.venezuelensis worms were only recovered from sections 1 and 2, even in 
the heterologous challenge treatments. However this judgement was only 
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Table 5:2 
Ratios 1 and 2 were calculated to discover whether there was any relationship 
between the the reduction in the number of eggs in utero per worm obtained 
in challenged treatments and worm fecundity. 
Table 5g2 
Ocniparison of worm fecundity, measured as number of third-stage S.ratti 
larvae produced per gin0 of faeces per adult and number of eggs in utero 
Per worm on day 8 postchallenqe 
Treatment Group mean no0L3 	n SD mean no0 	ratiol 	ratio2 
/gm faeces/ eggs in a C 
worm utero/worm/ b 	d 
rat 
challenge controls Gp0C2 761 	(b) 	3 431 6.319 	(d) 
homogonic S0ratti 
homologous challenge GOA 531 	(a) 	3 4.35 0901 (c) Oo698 	0.143 
(with homogonic 
S0ratti) 
challenge controls Gp0C3 267 	(b) 	3 139 4.803 	(d) 
heterogonic S0ratti 
heterologous 	Gp0B 	ØOØØ (a) 3 0.00 	0.801 (c) ØOØØ 	0167 
challenge (with 
heterogonic S0 ratti) 
Where- 
ratiol = 	a 
S 
ratio2 = 	C 
U 
Data in this table is taken from Expt 5 
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based on the location of a maximum of 10 S.venezue/ensis worms. Results for 
each experiment in this Chapter are shown in Appendix 4, pages 32-38. 
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5.4. Summary 
Priming with an exact dose of <100 turd-stage S.ratt/ larvae elicited a 
strong protective response against challenge with a similar small dose, 
regardless of the strain used at either infection. This was demonstrated as a 
reduction in the proportion of the dose recovered, and a reduction in the 
number of eggs in utero per worm compared with corresponding controls. 
Quantitative comparison of the level of resistance produced in rats after 
homologous and heterologous challenge showed that homologous challenge 
with heterogonic S.ratti produced a significantly greater level of immunity than 
heterologous challenge with homogonic S.ratt assessed as a greater relative 
reduction in the proportion of the dose recovered, and in the number of eggs 
in utero per worm. However in the reciprocal challenge experiment there was 
no difference in the level of protection against either challenge treatment. 
Priming rats with an exact dose of <100 third-stage S.venezue/ensis 
larvae failed to immunise them against homologous challenge, or heterologous 
challenge with the homogonic strain of S.ratti since there was no significant 
difference in the proportion of the dose recovered, or in the number of eggs 
in utero per worm, compared with corresponding controls. When heterogonic 
S.ratti was used at challenge a response could be detected in terms of a 
significant reduction in the number of eggs in utero per worm compared to 
the controls (P<0.001), even though there was no adverse effect on 
establishment of these same worms. 
Data collected from one experiment suggested that the reduction in the 
number of eggs in utero per worm of S.ratti parasites obtained from 
challenged animals compared with corresponding controls may not be related 
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to a reduction in worm fecundity. 
5. Measurements made on the distribution of adult worms along the 
intestine suggested that S.ratti worms were found in a more distal position in 
the intestines of challenged rats (irrespective of the strain used at priming) 
compared with corresponding controls; and that S.venezuelens/s parasitic 
female worms had a more restricted distribution in the intestine compared 
with S.ratti However, in both cases the observation was based on the 
location of only a few parasites so it may have no real significance. 
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CHAPTER 6 
STUDIES ON STRONG YLO/DES VENEZUEL ENS/S 
6.1. Introduction 
The aim of this series of experiments was to discover why only a few adult 
worms of this species developed from an exact dose in fully grown rats of the 
Edinburgh Wistar colony (see results of Expt 4, Chapter 4, page 84). The 
source of the problem could have been any of a number of factors including 
the age, sex , weight or strain of host, or the biology of the parasite, or simply 
bad luck at a first attempt in this laboratory. 
The findings of Wertheim (1970a and b) suggested, however, that the strain 
of the host, mode of infection and the size of the dose could all be involved. 
Wertheim obtained 44% recovery of S.venezue/ensis from young male rats of 
the "Subra" strain infected by intra-peritoneal injection with 250 third-stage 
larvae, but only 8% if rats were similarly infected with 1000 infective larvae. 
However in both cases there was a huge variation in her data (a range of 
82-218 adults in rats infected with 250 third-stage larvae, and 14-180 
following doses of 1000). In a study by Nolan and Katz (1981), a similar low 
parasite take was obtained in adult rats since only 3% of an inoculum of 4000 
third-stage S.venezuelens/s larvae was recovered from control rats. 
In the light of Wertheim's report and from other considerations the 
following experiments were designed to investigate four parameters,namely; 
the effect of the age of the host, the size of dose, the mode of infection, and 
the use of different types of anaesthesia. The fate of third-stage larvae 
administered was also investigated, using radio-labelled infective larvae, in an 
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attempt to discover if S.venezue/ensis larvae reached the host's intestine. 
6.2. Materiags and methods 
6.21. Expt ii, Skin-application vs subcutaneous injection 
Two groups of 4 adult rats were infected with an exact dose of less than 
100 third-stage S.venezuelensis larvae, half the animals were infected by 
subcutaneous injection without anaesthesia, the remainder were infected by 
skin-application of the larvae whilst under Sagatal anaesthesia. Worm burdens 
were determined in the intestines of rats killed 8 days post-infection. 
6.2.2. Expt 2, Ether vs Sagatal anaesthesia 
Experiment 1 was repeated with one alteration, all rats were infected by 
skin-application of third-stage S.venezuelensis larvae, half the animals were 
under Sagatal anaesthesia, the others were maintained under ether anaesthesia 
for 10 minutes. 
6.2.3. Expt 3, Size of dose 
Six rats were infected by skin-application with 2000 third-stage 
S.venezuelensis larvae, i.e. a dose approximately 20 times larger than before. 
The number of adults present in the intestine on day 8 post-infection was 
recorded. 
6.2.4. Expt 4, Age of host 
Four three-week old and 4 adult rats were infected by skin-application of 
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an exact dose of <100 (mean 96.00) third-stage S.venezuelensis larvae. On 
day 8 post-infection the number of adults present in their intestines was 
recorded. 
6.2.5. Ezpt 5, The effect of the age of the host on larval migration to the 
intestine 
17 rats were divided into four groups:- 
A - 5 adult rats (12 weeks old) - infected with S.venezue/ensis 
B - 5 adult rats (12 weeks old) - infected with S.ratti 
C - 3 three-week old rats - infected with S.venezuelens/s 
G o. 0 - 4 three-week old rats - infected with S.ratti 
All rats were infected by skin-application with an estimated dose of 2500 
( 75Se)-selenomethionine labelled infective larvae (see materials and methods, 
page 33) contained in approximately 0.3ml distilled water. The number of 
counts per minute per larva were 2.9 ± 0.4, for S.venezue/ensi. and 2.0 . 0.2, 
for S.ratti. Rats were killed 72 hours post-infection, at which time the 
proportion of the dose in their intestines was estimated. 
6.2.6. Expt 6, Survival of worms and 
75  Se label over 8 days in a rat's intestine 
Fifteen adult (12 weeks old) rats were infected by skin-application with an 
estimated dose of 2030 ( 75Se)-selenomethionine labelled infective 
S.venezueleiisis larvae (cpm per larva 3.7 ± 0.3). Seven of the rats were killed 
at 72 hours post-infection and the remainder were killed on day 8. The 
proportion of the labelled dose recovered at both times was calculated, but on 
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day 8 post-infection the number of adult worms present in the rats' intestines 
was also counted after measuring the level of radio-activity present. This 
would give an indication of the amount of attached label lost over the course 
of infection. 
When rats were killed, the number of adults present, their distribution 
along the intestine, and the number of eggs in utero per worm per rat was 
found. The proportion of the dose in the anterior and posterior halves of the 
intestine was found in experiments using labelled larvae. 
The methods of infection and the method of collecting worm and egg data 
is given in Chapter 2, Section 2:10, page 47. The method of obtaining 
( 75 Se)-selenomethionine labelled infective larvae and estimating the proportion 
of the dose recovered is given in Chapter 2, Section 2:3, page 33. Edinburgh 
colony Wistar rats were used throughout experiments. The method of 
analysing the worm and egg data is given in Chapter 2, Section 2:11, page 51. 
The results from the experiments using labelled infective larvae were analysed 
in the same manner as the worm data using the proportion of the labelled 
dose recovered, in statistical tests. 
6.3. Results 
A low proportion of the exact dose of S.venezue/ensis was recovered in 
Expts 1 and 2 suggesting that neither the mode of infection (mean 
subcutaneous injection 0.091 ± 0.0533; skin-application 0.092 ± 0.0597, Expt 1) 
nor the type of anaesthesia (mean Sagatal 0.034 0.0135, ether 0.090 t 0.0358, 
P>0.10, Expt 2) was responsible for the low adult burdens in the initial 
experiment (Expt 4, Chapter 4, page 84). Increasing the size of the infection 
dose did seem to have an affect, since 29% of the inoculum was recovered 
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from a dose of 2000 (compared with a maximum of 10% in Expts 1 and 2). No 
real conclusion can be drawn from these data since controls infected with an 
exact dose of S.venezue/ensis larvae were omitted from the experimental 
protocol. Moreover, this result is in direct contradiction of those of Wertheim 
(1970a and b). 
There seemed to be an age-related resistance to infection with 
S.venezuelensis since a significantly higher proportion of the dose was 
recovered as worms from three-week old rats compared with adults (12-week 
old rats) on day 8 (mean 0.298 ± 0.0401 three-week old rats, 0.013 ± 0.0080 
adult rats, P<0.001, Expt 4). The results of Expt 5, where 
( 75Se)-selenomethionine labelled larvae were used to infect rats, mirrored this 
effect since a significantly greater level of radio-activity was recovered from 
the intestines of young rats compared with their adult counterparts on day 3 
(P<0.001, Fig 6:1, page 118). An age-related resistance to infection was not 
demonstrated for S.ratti since a similar amount of radio-activity was present in 
the intestines of both young and adult rats (P>0.25, Fig 6:1, page 118 ). 
However, even though a larger proportion of the S.venezue/ens/s dose was 
recovered from three-week old rats in experiment 5, it was still lower than 
that obtained from similarly aged rats infected with S.ratt/ (P<0.001, Fig 6:1, 
page 118). 
The results of experiment 6 (Fig 6:2, page 1119), suggested that third-stage 
Svenezuelensis larvae were still reaching the intestine after 72 hours 
post-infection since a significantly higher proportion of the dose was 
recovered on day 8 post-infection compared with day 3 (P<0.001). This was 
contrary to expectation because attached label was likely to be lost during 
worm development. That label was lost overall in this experiment was clear, 
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Three-week old and adult rats were infected with an estimated dose of 75  Se-
labelled third-stage S.venezuelens/s or S.ratti larvae (mean 2500). The amount 
of label present in their intestines on day 3 post-infection was recorded in 
order to ascertain whether S.venezue/ensis larvae reached the intestine, and to 
find out if the age of the host had an effect. 
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Adult rats were infected with an estimated dose of radio-labelled 
S.venezue/ens/s larvae (mean 2030). The amount of label present in their 
intestines on day 3 and day 8 post-infection was recorded to discover if the 
age of the host had an effect and to find out if larvae were still reaching the 
intestine after 72 hours. On day 8 post-infection the actual numbers of 
worms present (Gp.3) was also counted to show how well the proportion of 
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since the worms at 8 days carried a maximum of approximately a third of what 
was originally attached to the third-stage larvae (Fig 6:2, page 1119). Some of 
this loose label was recovered from the posterior half of the intestine on day 
Crtc.e 
8 post-infection 	no adults were actually found. 
Throughout the 6 experiments adult S.venezue/ensis were recovered from 
the anterior sections of the rats' intestines, mainly from section 1 in Expts 1-4 
(Tabes 5:2 (Q-(hi), Appendix 5, page 3211 ) where the longitudinal distribution 
of adult worms along the intestine was noted. 




The proportion of the S.venezue/ensis dose recovered in adu.t rats was 
unaffected by the mode of infection, or by the use of different anaesthetics. 
Expt 3 suggested that increasing the size of the infection dose may lead to an 
increased recovery. But this finding would have to be confirmed since 
controls, infected with a small exact dose of third-stage S.venezue/ensis 
larvae, were omitted from the protocol. 
There seemed to be an age-related resistance to infection with 
S.venezuelensis since a higher proportion of the dose was recovered from 
three-week old compared with adult (12 week-old) animals on days 3 and 8 
post-infection. 
The age related resistance probably affected the migratory stages of the 
life cycle as well as development in the intestine. 
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CHAPTER 7 
DIFFERENT METHODS FOR STUDYING THE ANTIGENIC RELATIONSHIP OF THE TWO 
STRONG YLO/DES SIP. 
71. Ontroducton 
An unsuspected resistance was demonstrated in Wistar rats of the 
Edinburgh colony infected with S.venezue/ensiS in this study (results of Expts 
4-6, Chapter 6, page 114), so that only a small proportion of an exact dose 
was recovered 8 days post-infection. 	In reciprocal cross-immunity 
experiments no protection 	 \ against any sort of challenge was 
induced in rats primed with this low dose of S.venezue/ens/s (results of Expts 
8 and 9, Chapter 5, page 100). It appeared, therefore, that the number of 
adults of this species present during a primary infection initiated in this way 
was below the threshold necessary to stimulate an immune response. 
In order to circumvent the problem four methods of priming rats against 
S.venezue/ensis were explored in the hope that one or more would provide an 
experimental framework in which cross-immunity using the two Strongyloides 
spp. could be studied. 
7.2. Priming rats with heat-killed larvae [Expt 11 
Some workers, using dead nematode infective larvae to immunise animals 
against re-infection, have had limited success (reviewed by Clegg and Smith, 
1978; and Lloyd, 1981). In contrast, resistance against S.ratti infection has 
been artificially produced in this manner by Sheldon (1937, 1939), and Murrell 
(1980). There seemed to be some specificity in the protection elicited, since 
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priming with S.stercora/is failed to immunise rats against infection with S.ratti 
(Sheldon, 1939). However their experimental design involved serial injections 
of increasing numbers of dead larvae, a total of 13 and 16 injections by 
Sheldon (1937, 1939, respectively), and 17 injections by Murrell (1980); a 
protocol which was too imprecise for the purposes of the present study and 
which necessitates finding a number of injection sites on the animal. 
Therefore the potency of single doses of 10,000 heat-killed third-stage larvae 
was tested followed by challenge 10 days later with an "exact" dose of live 
larvae. An initial study was carried out using homogonic S.ratti as the priming 
agent to see whether the method immunised animals, since previous 
experiments carried out in this study had shown that live infections of this 
parasite were capable of priming rats against re-infection (results of Expts 1, 
2, 3, 4 and 5, Chapter 5, page 95). 
7.21. dJateri&s and methods EExpt fi 
35 rats were divided into 3 groups:- 
Gp.A - 15 rats, immunised 
Gp.B - 15 rats, day 20 challenge controls 
Gp.0 - 5 rats, day 8 secondary controls 
Rats from group "A" were immunised by the subcutaneous injection of 
10,000 heat-killed 	homogonic S.ratt/ larvae in 	0.3m1 	distilled 	water, 	whilst 
under ether anaesthesia, using a 25G needle and a imi Plastipak syringe (see 
Section 2:4, 	Chapter 	2, 	page 36, 	for 	the method 	of 	preparing 	heat-killed 
larvae). A second injection of 0.3m1 	distilled water was given with the same 
syringe to minimise the number of 	larvae left 	in 	the 	needle. 	On 	day 	10 
123 
post-priming all rats were infected by skin-application with an exact dose of 
<100 third-stage homogonic S.ratti larvae. Animals in group "C" were killed 
on day 8 post-infection, and the remainder on day 20. 
7.2.2. Results [Expt 11 
Priming with a single dose of 10,000 third-stage homogonic S.ratti larvae 
failed to produce any protection against homologous challenge infection 
(P>0.25, mean immunised rats 0.179 + 0.018, day 20 challenge controls 0.211 ± 
0.026). Therefore any further studies using this method were abandoned. 
7.3. Priming with transferred adult worms [Expts 2-81 
Introduction of adult S.venezuelensis worms directly into the host's 
intestine may lead to a higher worm recovery than previously obtained in this 
study, since it would circumvent the larval penetration, migration and 
maturation stages of the life cycle, at which points the resistance to 
S.venezuelensis infection in Edinburgh colony Wistar rats may be expressed. 
Thus an amount of antigenic stimulation may be produced by the transferred 
adults sufficient to protect animals against challenge infection to a detectable 
degree. Previous workers have shown that immunising rats with the adult 
stage of S.ratti gave some protection against challenge with either adults or 
third-stage larvae (Murrell, 1980; Bell et al.. 1981, Nawa et at, 1982, and 
Korenaga etal. 1983b). 
Initially it was important to discover if transferred adult S.venezuelensis 
could establish in a new host. If so, it was necessary to know the length of 
time adult worms of all types under study would survive in this system. This 
information was required to be able to give challenge infections when the 
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primary one had been eliminated and any non-specific inflammatory responses 
would have subsided. 
Surgical transfer was studied in experiments 2-8 and since the protocols 
are related they are presented together, before an integrated treatment of the 
results obtained. 
7.3.1. Materiags and methods EExpts 2-81 
The techniques applicable to experiments 2-8 are described in Section 2:9, 
Chapter 2, page 44. 
7.3.1.1. Expt 2. The ability of transferred adult S.venezuelensisto establish in a 
new host 
Four rats were infected with an exact dose of less than 100 adult 
S.venezue/ensis worms and killed on day 4 post-infection (donor: recipient ratio 
1:2). 
7.3.1.2. Expts 3-6. Course of infection of an exact dose of <50 adult 
Strongyloides spp. worms 
The general protocol shown in Fig.7:1, page 127, was followed. The 
parasites used in each experiment were:- 
Expt 3 - S. venezue/ensis 
Expt 4 - heterogonic strain of S.ratti 
Expts 5/6 - homogonic strain of S.ratti 
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In experiments 3, 4 and 6, adult worms were transferred within 2 hours of 
the donor's death (see Expt 4, Chapter 3, page 62). In experiment 5 they were 
transferred later, over a period of approximately 2-3 hours. 
7.31.3. lExpt 7, Homologous challenge with adult homogonic S.ratti 
The experimental design shown in Fig.7:2, page 129, was followed. Five 
rats from Gp.A, and five animals from Gp.C2, were killed on days 4 and 8 
post-challenge. 
7.31.4. Expt 8, Priming rats with adult homogonic S.rattifollowed by 
homologous and heterologous challenge 
The general protocol shown in Fig.7:2, page 129, was followed but in this 
case rats in Gp.A were challenged with either homogonic or heterogonic strain 
adult S.ratti and then killed on day 8 post-infection (Fig.7:3, page 130). 
7.3.2. Results [Expts 2-8 
Adult S.venezue/ensis seemed to be capable of establishing in a new host, 
since 32% of the exact dose of less than 100 adult worms was recovered on 
day 4 post-infection, therefore the progress with time of similar infections for 
the three parasites was studied. 
It appeared from the results of experiments 3, 4, 5, 6 and 7 that infection 
with an exact dose of less than 50 adult Strongyloides spp. worms was falling 
by day 21 post-infection but within treatment variability was extreme (the 
coefficient of variation ranged between 30-118%). In only one case was there 
a significant difference in the proportion of the dose recovered over the 
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Fig.71 
Eighteen rats were infected by surgical transfer with an exact dose of <50 
adult Strong/oides spp. worms. On days 4, 14 and 21 six of the animals 
(randomly chosen) were killed in order to follow the course of infection. 
!9 07:1 
General protocol used to find course of infection of an exact dose of <50 
adult Stongyloidesp0 worms 
DAY 0 18 RATS infected by laporotorny with 
I an exact dose of <50 adult 
Strongyloides spp 	worms 
DAY 4 6 RATS killed 
DAY 14 6 RATS killed 
DAY 21 6 
I 
RATS killed 
The number of eggs in utero per worm for each rat e and the number of worms 
present were recorded. A donor:recipient ratio of 1:6 was used and mortality 
was always 0 
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course of the experiment (Expt 6, Table 7:1, page 131). The high variability 
probably masked the effect in each of the other experiments since there was 
agreement in the trend in all five (Table 7:1, page 131). 
From these results it was clear that rats primed with an adult infection 
should be challenged some time after day 21 post-infection. Challenge was 
therefore initiated on day 28 post-infection. 
Priming rats with adult homogonic S.ratti (Expt 7) did protect against 
homologous challenge, demonstrated as a significant reduction in the number 
of eggs in utero per worm on days 4 and 8 post-challenge; and a significant 
reduction in the proportion of the dose recovered on day 8 compared to the 
relevant controls (Fig.7:4, page 133). A higher proportion of the dose was 
recovered from day 8 controls compared with those for day 4 (0.01<P<0.05). 
This was clearly anomalous. If the day 8 controls were used as a measure of 
the unchallenged state on day 4, then challenged rats had a significantly lower 
worm burden on day 4 (P<0.001). A significantly lower proportion of the dose 
was recovered from the day 8 challenge group compared with day 4, 
consistent with the expectation that the process of worm expulsion was 
cumulative over time. 
Investigation into the specificity of the adult-induced immune response 
proved disappointing since the high variability within the data would have 
masked anything but gross differences in the host's response (Expt 8, 
Fi.7:4(ii), page 133). There did seem to be some immunity against the 
challenge infections since the mean proportion of the dose recovered from 
these groups was consistently lower than their corresponding controls though 
not significantly so. In addition the egg data gave some evidence for 
specificity in the anti-worm response. There was a reduction in this 
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Fig.7:2 
Fourteen rats (Gps.A and Cl) were infected by laporatomy with an exact dose 
of <50 homogonic strain of S.ratti worms. Four days later the priming 
controls (Gp.Cl) were killed to check the viability of the worms used. On day 
28 post-transfer the secondary controls (Gp.C2) and the primed animals (Gp.A) 
were infected using the surgical transfer technique with an exact dose of <50 
worms of the homologous parasite (homogonic strain of S.ratt4. On days 4 
and 8 post-challenge five animals from each group (Gps.C2 and A) were killed. 
The proportion of the dose recovered and the number of eggs in ufero per 
worm were recorded to discover when immunity (if any) was expressed. 
Fjq.7:2 
Protocol used in 
	7 where rats were given an hcitologous challenge with 
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Nineteen rats (Gps.A. B and Cl) were infected by surgical transfer with an 
exact dose of <50 adult homogonic strain S.ratti worms. Four days later the 
priming controls (Gp.Cl) were killed to assess the viability of the worms used. 
On day 28 post-infection half the animals received a homologous challenge 
with an exact dose of <50 adult worms given by laporatomy (Gp.A), the 
remainder were given a heterologous challenge with heterogonic strain of 
S.rafti in the same manner (Gp.B). Corresponding challenge controls (Gps.C2 
and C3) were also infected at the same time and all rats were killed on day 8 
post-challenge. The proportion of the dose recovered and the number of 
eggs in utero per worm of the experimental groups (Gps.A and B) were 
compared with their relevant controls (Gps.C2 and C3 respectively) to discover 
if any immunity had been elicited in the primed animals. 
untreated 9 rats (Gps0C2/3) 
rats infected 
by laporatomy 
with an exact dose 
of <50 adult 
homogonic S0ratti 




DAY 4 3p0C1 	killed 
y controls 
DAY  f Gps0A and B 
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!g 07 3 
Protocol used in cha11erge infections involving adult worms Expt8 
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rats infected by 
laporatomy with 
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Table 7:1J 
Egg and worm data obtained over the course of a primary infection with an 
exact dose of <50 adult worms of S.venezueIens/. Expt 3. (a); heterogonic 
strain of S.ratfi, Expt 4, (b) and homogonic strain of S.ratti, Expts 5 and 6 (c 
and d). 
Table 7:1 
Egg m4 wom data Espts 3-6) on days 4, 14 and 21 of an adult only 
Stronqyloicles app. infection, 
Ompt 3, S.venezu2lensis 
Treatment mean proportion 	n SD 
Of the doss 
rcovorcd 
day 4 0.223 	 6 0.101 
day 14 0.127 	 6 0.151 
day 21 0.152 	 6 0.119 
mean enact dose 48.6 
P values torm data 
day 4 vs 14/21 P>0.95 
Ept 4, heterogoruc strain of S.ratti 
C,) _6 S 
Treatment mean proportion 	n SD mean no. 	n 
of the doss of eggs in 
recovered utero/vormw 
rat 
day 4 0.303 	 6 0.114 6.188 	5 
day 14 0.201 	 6 0.063 3.764 	6 
day 21 0.111 	 6 0.070 2.600 	6 
mean enact doss 48.4 
P values worm data 	egg data 
day 4 vs 14/21 P>0.95 
day 4 vs 14 P(0.001 
day 14 vs 21 0.01p9.95 
c) ExPt S. hasogonic strain of S.ratti 
Treatment mean proportion 	n SD ceen no. n 	SD 
of the dose of eggs in 
recovered utarozc/ 
rat 
day 4 0.299 	 6 0.242 7.291 5 	0.017 
day 14 0.307 	 6 0.154 6.703 6 	1.312 
day 21 0.117 	 6 0.062 6.053 6 	1.301 
mean euect dose 	40.4 
P values worm data 	egg data 
day 4 vs day 14/21 P)0.05 	P>0.05 
d) Expt 6, hosogonic strain of S.retti 
Treatment mean proportion 	n SD mean no. n 	SD 
of the dose of eggs in 
recovered utOro/vora/ 
rat 
day 6 0.435 	 6 0.298 7.024 6 	0.346 SD 
day 14 0.293 	 6 0.111 5.349 6 	1.361 
day 21 0.116 	 6 0.057 5.697 6 	0.027 
1.341 mean enact dose 	45.9 
0.197 
P values vorn data 	egg data 
1.074 
day 6 vs day 14 0.10)P)0.05 	P<0.001 
day 14 vs day 21 0.016M.05 P>0.25 
parameter for both challenge treatments compared with their controls 
(P<0.001, Fig.7:4(ii)b, page 133), and a significantly greater reduction after 
homologous challenge (0.01<P<0.05, Fig.7:5, page 135). 
7.4. Priming with a trickle infection [Expts 8 and 9 
In natural conditions the host is probably infected with small numbers of 
third-stage nematode larvae over an extended period of time. In the previous 
experiments carried out in this study, infections were the result of a single 
dose of larvae, admittedly much smaller than that given by most workers, but 
it may still have produced an abnormal host response. Therefore it was 
decided that the level of infection produced in rats exposed to trickle infection 
would be investigated, that is, repeated doses of a low number of larvae over 
a long period of time. Exposure to S.venezue/ensis in this manner may lead to 
a cumulative worm burden, which could immunise rats against challenge 
infection. 
Rats, exposed to a trickle infection of 5 third-stage S.venezue/ensis larvae 
per week day, were killed after various intervals of trickle infection to find out 
if the worm burden increased as increasing numbers of infective larvae were 
administered. After different times, animals from each experiment were 
challenged with an exact dose of less than 100 third-stage homogonic strain 
S.ratti larvae, to discover if any resistance was induced against heterologous 
challenge, and if so, whether it was related to the length of time the host was 
exposed to a trickle infection. A homologous challenge treatment was not 
included in the experimental protocol, since only a small proportion of a 
similar small dose of S.venezue/ensis would be recovered from secondary 
controls and would therefore constitute an inappropriate comparison to 
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Figj.7:4 
Rats were primed with an exact dose of <50 adult homogonic S.rattiworms. 
Twenty-eight days later the animals were given a homologous or heterologous 
challenge infection with a similar small dose of adult worms. In Expt 7 
animals were only given a homologous challenge [Fig.7:4(i)J; whereas in Expt 8 
rats were given either a homologous challenge with homogonic S.ratti worms 
or a heterologous challenge with heterogonic S.ratti worms [Fj.7:4(öfi)]. Worm 
data [Fj.7:4a] and egg data [Fig.7:41b] are shown for the two experiments. 
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Fig. 7: 4 
Effect of priging .  with adult woras of the hoaogonic strain of S.ratti on 
subsequent challenge infection. Ept 7 and U 
a) vorfa dab 
b) ogo data  
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KEY 
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determine if any immune response had occurred. Experiments 9 and 10 on 
this topic are so similar that they are described together. 
7.41. Materials and methods Expts 9 and 1011 
7.41.1. Ept 9, Six weeks of trickle infection with S.venezuelensis followed by 
heterolo9ous challenge with homogonic S.ritti 
36 rats were divided into 7 groups:- 
Gp.1 - 1 week of trickle infection - 5 rats, total dose planned = 25, mean 
dose given = 23.2 
Gp.2 - 3 weeks of trickle infection - " , total dose planned = 75, mean dose 
given = 72.2 
Gp.3 - 5 weeks of trickle infection - 	, total dose planned = 125, mean 
dose given = 117.6 
Gp.4 - 6 weeks of trickle infection - 	, total dose planned = 150, mean 
dose given = 147.7 
Gp.5 - heterologous challenge - 6 rats 
Gp.6 - secondary sham S.ratti controls - 5 rats 
Gp.7 - secondary S.ratt/controls - 5 rats 
Animals which received trickle infections were injected subcutaneously 
without anaesthetic, every week day for the required number of weeks, with a 
planned number of 5 third-stage S.venezuelens/s larvae in approximately 0.3ml 
distilled water using a 190 needle and a imi Plastipak syringe. Rats were not 
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Figj7:5 
The degree of protection elicited by homologous and heterologous challenge 
infection was compared by calculating the resistance quotients for the egg 
data in Expt 8. Where animals, which had been primed with an infection of 
adult homogonic S.ratfi worms, were challenged 4 weeks later with a similar 
dose of adult worms of the homologous or heterologous parasite (heterogonic 
S.rart. The height of the bar is directly related the amount of protection 
produced. / 
Fig. 7:5 














GpoA vs. GoB 0001<P<0005 
KEY 
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injected in the same site twice to avoid complications due to the production 
of a local inflammatory response. Sham controls received 0.3ml saline in an 
identical manner over the course of trickle injections. Groups 5, 6 and 7 were 
then infected by skin-application of an exact dose of less than 100 third-stage 
homogonic strain S.ratti larvae (mean 97.7) three days after animals in Gp.5 
had received their last trickle infection. Rats in Gps.1-3 were killed 8 days 
after their last injection, allowing all the larvae present to mature to the adult 
stage. Animals in Gps. 5-7 were killed on day 8 post-challenge. 
The planned daily dose for trickle infections was corrected to account for 
losses during administration (see protocol above). After each injection, during 
the first week of both experiments, residual larvae were sought in the syringe, 
hypodermic needle and in the solid watch-glass from which the inoculum was 
drawn. However, larvae were rarely recovered from the syringe and needle 
washings therefore this practice was discontinued. Therefore only the number 
of larvae present in the watch-glass was noted. After challenge infection, in 
accordance with the standard "exact dose" technique (Section 2:10, Chapter 2, 
page 47) the number of larvae recovered from both the watch-glass and the 
syringe washings were found. 
7.4.1.2. lExpt 10, Ten weeks of trickle infection with S.venezuelensis followed by 
heterologons chalenge with homogonic S.ratti 
Experiment 10 was run in conjunction with experiment 9. Thirty-six rats 
were also divided into 7 groups, but trickle infections lasted longer so that :- 
- 5 weeks of trickle infection - 5 rats, total dose planned = 125, mean 
dose given = 119.0 
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Gp.2 - 7 weeks of trickle infection - 	, total dose planned = 175, mean 
dose given = 169.6 
Gp.3 - 9 weeks of trickle infection - " , total dose planned = 225, mean 
dose given = 219.6 
Gp.4 - 10 weeks of trickle infection - , total dose planned = 250, mean 
dose given = 243.9 
Gps. 5-7 were identical treatments to those described in experiment 9 
(page 136) but the mean exact dose given at challenge was 95.8 larvae. 
7.4.2. Results [Expts 9 and 101 
The S.venezuelensis worm burden did not increase in proportion to the 
dose administered over the course of trickle infection (Fg.7:6 and Fig.7:7, 
pages 139 and 140). The mean number of worms recovered were 2, 1, 3, 3 
after 1, 3, 5 and 6 weeks of trickle infection respectively, in Expt 9 and in Expt 
10 a maximum of 1 was recovered. Thus further trickle infection seemed to 
lead to a reduction in the proportion of the dose recovered but since the 
actual number of parasites involved at any time was low, no significance could 
be attached to these changes. 
There may have been a reduction in the number of eggs in utero per worm 
of S.venezuelensiS adults recovered over the course of infection, but since this 
observation was based on few replicates (i.e. worms) per treatment, no real 
judgements could be made. 
Priming rats with a trickle infection of 5 infective S.venezue/ensiS larvae 
per week day for 6 or 10 weeks failed to protect animals against heterologous 
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challenge infection with an exact dose of less than 100 third-stage homogonic 
S.rarri larvae, since there was no reduction in the proportion of the dose 
recovered, or in the number of eggs in utero per worm of the challenged 
group compared with secondary controls (Figs 7:6 and 7:7, pages 139 and 
140). 
Adult 5.venezue/ensis were recovered from the heterologous challenge 
group in both experiments 9 and 10 (shown separately as Gp.8 in Figjs.7:6 and 
7:7, pages 139 and 140). However the number of S.venezue/ensiS adults was 
very small, and clearly quite insufficient to compete with S.rattifor resources. 
7.5. Priming immature rats with S.venezuelensis EExpt 1)1] 
Experiments by previous workers have suggested that young animals have 
a reduced resistance to a number of parasites compared to their adult 
counterparts. For example, young rats are more susceptible to infection with 
N.brasiliensis (Jarrett et al., 1966, 1968, 1969), Plasmodium berghei (Smalley, 
1975), and Fasciola hepatica (Hayes et a/,1974). Similarly, calves are more 
susceptible to Cysticercus boy/s (Soulsby, 1963). These examples are 
consistent with general experience that some component(s) of the immune 
system is(are) not fully functional until the host reaches a certain age. In the 
present study it was found that young rats were more susceptible to infection 
with S.venezuelensis compared with adults (results of Expts 4-6, Chapter 6, 
page 115). Therefore it was decided that the effect of priming three-week old 
animals with an exact dose of less than 200 infective S.venezue/ensiS larvae, 
followed by a challenge infection nine weeks later, would be investigated. If 
some protection was elicited by this regime, it might have offered a 
framework to study cross resistance with the S.ratti varieties. 
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IFig.7:6 
The effect of 5 weeks of trickle infection with S.venezue/ensis on subsequent 
challenge with homogonic S.ratti was investigated to find if any immunity 
against the priming agent had been elicited. The doses given to rats over the 
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Fög.7:7 
Rats were given a trickle infection with S.venezue/ensis for 9 weeks and then 
challenged with homogonic S.ratti to discover if any immunity against the 
priming agent had been produced. The doses administered to animals over 
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7.5. Materiags and methods KFJnpt fl 
The protocol shown in Fig.7:8 (page 142), was followed. 
7.5.2. Results [Expt 111111 
Priming immature rats with S.venezue/ensis elicited a significant protective 
response against both homologous and heterologous challenge, demonstrated 
as a significant reduction in the number of eggs in utero per worm for all 
three treatments compared with their corresponding controls (P<0.001. TaibDe 
7:2, page The host's anti-worm response was also demonstrated as a 
significant reduction in the proportion of the dose recovered for the 
heterologous challenge treatments compared with controls (P<0.01, Table 7:2, 
page 143). A similar reduction was not obtained after homologous challenge 
due to the previously demonstrated age-related resistance to S.venezue/erisiS 
infection in the Edinburgh colony Wistar rats (results of Expts 4-6, page 114) 
therefore only a low proportion of the dose was recovered from secondary 
adult controls making it impossible to determine if a reduction had occurred in 
challenged animals. This age-related resistance was also demonstrated in this 
experiment since a significantly lower proportion of the dose, and a 
significantly lower number of eggs in utero per worm, was recovered from 
secondary, compared with primary, controls (Table 7:2, page 1143). 
Quantitative comparison of the level of immunity elicited by each parasite, 
assessed as the relative reduction in the number of eggs in utero per worm 
revealed significant differences. Maximum immunity was expressed against 
homologous challenge, followed by heterologous challenge using heterogonic 
S.rafti with the minimum produced by heterologous challenge with homogonic 
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Fig.7:8 
Twenty-nine three-week old Wistar rats (Gps.A, B, D and Cl) were infected by 
skin-application with an exact dose of <200 third-stage S.venezuelensis 
larvae. On day 8 post-infection five of the animals (priming controls, Gp.C1) 
were killed to check the viability of the larvae used. Nine weeks later animals 
in Gps.A, B and D were challenged with an exact dose of either the 
homologous (Gp.A), or heterologous parasite (homogonic strain of S.rart Gp.B; 
heterogonic strain of S.raft, Gp.D) in the same manner used at priming and 
corresponding challenge controls were infected at the same time (Gp.C2 for 
Gp.A; Gp.C3 for Gp.B; and Gp.C4 for Gp.D). Eight days later all the rats were 
killed and the proportion of the dose recovered and the number of eggs in 
utero per worm recorded for each rat. The effectiveness of the different types 
of challenge treatments were found by calculating resistance quotients for the 
egg and worm data of each. 
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Table 7:2 
Egg and worm data obtained on day 8 post-challenge from rats which were 
primed with an exact dose of <200 third-stage S.venezuelensis larvae when 
they were 3 weeks old and then challenged with an exact dose of <100 
infective larvae of the relevant parasite 9 weeks later. S.venezue/ensjs adults 
were recovered from rats given a heterologous challenge (Gps.B and D) and 
their results are shown separately as Gps.132 and 02. 
Ii 
Table 7:2 
Komolcqous vs hsteroioqous cha llenge : S. 	2ZU2LGnZI'3 Pcimirg itUQ COt 
Enpt Li 
a) tzim data b) WA data  
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tnIouo c1tollonp 4.A 0.015 	7 	0.02 
homologous ci 1 1n .A 1.730 	4 1.26 
htocoic5ouu dtAloup Cp.B 0.351 	0 	0.00 
1tcocnic strain of h2terologaus chollenp (.0 4.712 	0 0.90 
S,rotti hoo5onic strain of 
S.rctti 
Ptttaro1ogous ctiollen*2 Gp.B2 0.010 	0 	0.02 
toonic strain of Ptttco1oqous ct11ur c.82 1.300 	5 1.32 
S.cittl. i:ogonjc strain of 
-Worts S.catti • $.v?flvAenSiJ 
tZzm 
taroioqous choll=92 Gp.D 0.162 	7 	0.04 
tarcgonic atcOIfl of PttotoLcgozo c4O11On92 Op.0 2.202 	7 o.s, 
Sant htrccnic strain of 
$.rotti 
Ititoro1cqous cohilamp Cp.02 0.004 	7 	0.01 
Pt2torcac strain of lttoro1c5ouz chollerap (.07 1.500 	2 0.71 
cotti. 5.2ouv?J.J1 h2tGrOOnlc strain of 
tD S.rottl. 5.vu1ensjs 
pri.cthtg control Qp.C1 0.436 	5 	0.04 
pximirtg controls Gp.Cl 7.061 	S 0.52 
dl1snqs control C?p.C2 0.023 	6 	0.04 
challenge controls Op.C2 6.125 	2 1.59 
S.vw1snsis 
challengo control Gp.C3 0.477 	6 	0.04 
.%3O .1C S.ratti challengs controls Gp.C3 6.503 	4 0.17 
lcgonic S.ratti 
challenge control (3p.C4 0.466 	5 	0.12 
PtstOCCgsnAC S.rottk th0115i55 controls (.C4 5.467 	5 0.30 
hstercqonic S.tstti 
on esoct do= pcusinq 	5.v2lIn 191.06 
challenge 94.33 
hos.oqonic Sjottj 90.00 
hsterogoniC 	jatj 96.00 P va1us 	 worm data egg data 
.C2 vs 8/02/t2 P>0.25 P(0.90I 
C.C3 vs B 	0.801(P<0.01 <o.eel 
vs <0.00l <0.001 
C?P.C3 vs C4 P>0.25 0.01<<0.05 
.C1 vs C3/C4 P>0.25 - 
.C1 vs 02/C2 P0.001 
S.ra ff1 (Fi.7:, page 145. 
A similar comparison was carried out using the worm data. Initially all 
three treatments were included in the analysis, but because there was a much 
higher variability in the homologous challenge treatment, it was omitted from 
statistical analysis of the data. The outcome of this comparison was 
consistent with that already described for the egg data. A significantly greater 
reduction in the proportion of the dose recovered was produced after 
heterologous challenge with heterogonic S.ratti, compared with that induced 
by homogonic S.ratt/challenge infection (P<0.001, Figj.7:9, page 145). 
Adult S.venezue/ensis were recovered from the heterologous challenge 
treatments (shown as Gps.132 and 02 in Table 7:2, page 143) demonstrating 
that the host's immune response against the primary infection was not fully 
functional in expelling all those worms from the intestine. 
Data on the longitudinal distribution of adult Strongyloides spp. recovered 
from experiments 2-11, are shown in Tables 6:2(i)-(x), Appendix 6, page 326. 
Posterior migration of worms in the challenge treatments seemed to occur in 
Expts 7 and 8; for, compared with controls, adults were recovered further 
down the intestine on day 8 post-challenge in experiment 7, and after 
heterologous challenge in experiment 8 (Tabes 6:2(vã)-(viö), Appendix 6, page 
327 ). However this was based on so few parasites that no real significance 
could be attached to the observation. The distribution of adult S.venezue/ensis 
in Wistar rats seemed to be more restricted than that of S.ratti since worms 
of the former species were only recovered from the first three sections of the 
intestine. For example, worms recovered from primary controls in experiment 
11 were found exclusively from these sections, and this observation was based 
on the relative position of 83 adults (Tabe 6:2(z), Appendix 6, page - 329). 
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Animals, which had been primed with an exact dose of <200 infective 
S.venezuelensis larvae when they were 3 weeks old, were challenged 9 weeks 
later with an exact dose of <100 third-stage larvae of either the homologous 
or heterologous parasite. The amount of protection induced was assessed by 
calculating the resistance quotients for the three treatments. The amount of 
resistance induced by the three treatments can be seen clearly since the 
height of the bar in the figure is directly related to the degree of protection 
induced. 
Fig. 7:9 
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Thus this would seem to be a real feature of the biology of S.venezueIensi 
and the data from these experiments give credence to others carried out in 
the present study, in which a similar distribution was detected, but with too 
few worms to provide concrete evidence (Expts 9 and 10, Tables 6:2(viii) and 
Appendix 6, page. 	328). Adult S.ratti on the other hand, are recovered 
as far as sections 5 and 6 of the intestine (Expts 9, 10 and 11, Tables 6:2(viii)- 
Appendix 6, page. 328). A number of common experimental techniques 
were used throughout this section and they can be found in the relevant 
section of Chapter 2, shown below:- 
infection by skin-application and subcutaneous injection, Section 2:10, 
page 47. 
method of worm counting and counting the number of eggs in utero per 
worm, Section 2:10, page 50. 
c) statistical analysis of results, Section 2:11, page 51. 
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7.6. SwTlary 
Priming with a single dose of 10,000 heat-killed homogonic S.ratt/ larvae 
failed to protect rats against homologous challenge infection with an exact 
dose of less than 100 infective larvae. 
Transferred Strongyloides spp. adults were capable of establishing in a 
new host. The course of a primary infection with an exact dose of less than 
50 transferred worms lasted about 21 days. An exact dose of <50 adult 
homogonic S.ratti worms immunised animals against homologous challenge 
with a similar small adult infection dose, which was expressed as a reduction 
in the number of eggs in utero per worm, and a reduction in the proportion of 
the dose recovered. There appeared to be some specificity in the immune 
response since homologous challenge with homogonic S.ratti produced a 
significantly greater reduction in the number of eggs in utero per worm 
compared with heterologous challenge with heterogonic S.ratfi Unfortunately 
all experiments displayed high variability within the treatments, so clearly there 
were unknown facets of the experimental procedure which were insufficiently 
under control. 
Trickle infection for 6 or 10 weeks with 5 S.venezuelensis infective 
larvae per week day did not lead to the recovery of a large number of adults, 
nor did it protect rats against subsequent heterologous infection with an exact 
dose of less than 100 homogonic S.ratti larvae. 
Immunising immature rats with an exact dose of less than 200 
S.venezuelensis larvae induced a protective immune response against 
subsequent challenge infection with an exact dose of <100 Strongyloides spp. 
infective larvae. This appeared as a reduction in the number of eggs in utero 
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per worm (all treatments) and a reduction in the proportion of the dose 
recovered (heterotogous treatments only). Quantitative comparison of the 
level of immunity produced, as assessed by the relative reduction in the 
number of eggs in utero per worm, suggested there was a graded immune 
response. Using this criterion, homologous challenge produced the maximium 
amount of immunity, followed, in order, by heterologous challenge with 
heterogonic and then homogonic S.ratt,. If the comparison was carried out 
using worm data, there was a significantly greater reduction in the proportion 
of the dose recovered after challenge with heterogonic S.ratti compared with 
the homogonic strain of the species. The homologous challenge treatment 
was not included in this comparison, since the very high variability in this 
particular treatment rendered a pooled estimate of error variance across all 
treatments suspect. With this previso, the data obtained by counting worms 
were consistent with those from eggs in utera 
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CHAPTER 
ADOPTIVE TRANSFER OF IMMUNITY AGAIST STRO&'GYLO!DES SPP. 
8.. llMroduction 
The experiments in Chapter 5 have shown that prior infection with an exact 
dose of less than 100 S.ratti larvae induced a significant resistance to 
challenge infection, and that there was a quantitative difference in the level of 
immunity elicited depending on the strain of S.ratti used to prime rats (see 
results of Expts 4, 5, 6 and 7, Chapter 5, page 9). 
The underlying asymmetry detected by these experiments could have been 
related:- 
a) to antigen differences between the strains (see discussion) 
or b) a quantitative or qualitative difference in the non-specific detrimental 
effect that both strains had on the intestinal enviroment during primary 
infection. 
In order to decide between these alternatives the following adoptive 
transfer experiments were carried out using inbred rats of the PVC strain. 
These experiments had four main aims:- 
to find out if resistance against Strongyloides spp. could be transferred 
from immunised to naive rats with mesenteric lymph node cells, and if so, 
when it was expressed. 
to find out if such cells primed against an exact dose of <100 
Strongyloides spp larvae could protect against a similar small challenge 
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infection. 
to discover whether transferred cells would protect against challenge 
infection with the heterologous parasite. 
to see whether there was any asymmetry in (i), (ii) and (iii) dependent 
on which strain was used for priming and, if so, whether the pattern mimicked 
the one already revealed by earlier, experiments (see above). 
The results 	obtained suggested that infection of rats with a large 
inoculum of third -stage S.venezue/ensis larvae led to a higher proportion of 
the dose recovered than previously, using small exact doses (results of Expt 3, 
shown in Table 5:1I(iii), Appendix 5, page 319). Thus it may be possible to 
immunise rats against the parasite using large doses so that their mesenteric 
lymph node cells could be used in reciprocal cross-immunity studies along 
with the two strains of S.ratti 
The cell transfer method used throughout experiments was similar to that 
of Moqbel and Wakelin (1981), who demonstrated that transfer of immune 
mesenteric lymph node cells taken late post-primary infection, from rats 
infected with 1000 third-stage S.ratti larvae, protected against homologous 
challenge. Ideally 2.5x10 8 cells were administered per rat, but this was not 
always possible, therefore the actual number of cells given is shown for each 
experiment. 
The experiments described in this chapter are divided into three sections 
which contain related studies. 
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8.2. Protection induced by homoOogous chalUenge assessed on day 8 
post-challenge 
It had already been found that rats primed against S.ratti and challenged 28 
days later demonstrated a significant resistance to re-infection on day 8 
post-challenge (Chapter 5, page 3). In a similar experimental framework, 
could animals, primed with immune mesenteric lymph node cells and assayed 
on day 8 post-challenge, be shown to be resistant to infection? 
8.2.L Materials and methods 
8.21.1. Expts 11 and 2, Comparison of the level of immunity induced in rats 
after a secondary infection and homologous challenge sifter adoptive transfer 
The protocol used in Expts 1 and 2 is summarised in Fig-8:1, page 152.. In 
experiment 1, 5x10 7  mesenteric lymph node cells were administered to each 
rat, in experiment 2 the number was increased to 2xl0 8cells per rat. Ideally the 
animals receiving immune cells should have been given 2.5x10 8 cells each but 
the yield from the cell donors was too small, therefore the lower number had 
to suffice. 
8.2.1.2. Expt 3, The effect of increasing the infection dose in the rats which 
suppOy the immune cells 
The protocol used in Expts 1 and 2 was modified since the secondary 
infection and the "normal" cell treatments, Gps. "B", "0" and "F", were omitted. 
Cell donors were infected with a mean of 1000 or 4000 infective homogonic 
S.ratri larvae instead of a small "exact" dose. The procedure followed is 
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Fig-8:1 
On day 0 rats in groups A, B and Cl were infected by skin-application with an 
exact dose of <100 third-stage S.ratti larvae of the homogonic strain. Eight 
days later the priming controls (Gp.C1) were killed to give an estimate of the 
viability of larvae used at priming. The adoptive transfer of mesenteric lymph 
node cells was carried out on day 25 post-infection, animals in Gp.E received 
immune cells, donated by rats in Gp.A, whereas rats in Gp.F received normal 
cells prepared from rats in Gp.D. Thr'ee days later rats in Gps. 3, E. F and C2 
(challenge controls) were infected by skin-application with an exact dose of 
<100 homogonic strain S.rarti larvae. On day 8 post-challenge all rats were 
killed and the efficacy of the immune cells was found by comparing the 
proportion of the dose recovered, and the number of eggs in utero per worm, 
from Gp.E (recipients of immune cells) and secondary controls (Gp.C2). 
Results from Gp.D (which received normal cells) showed whether the 
technique used had any effect on the parasite burden and results from Gp.B 
(secondary infection) demonstrated how effective priming with a full infection 
compared with priming with immune cells only. The numbers in brackets refer 
to the number of animals used in Expt 2. 
Fig. 8 1 
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shown in Fij.8:2, page 154 
When animals were killed at the relevant time the number of adults present 
in their intestines and the number of eggs in utero per worm was counted. 
8.2.2. Results 
From the results of experiments 1 and 2 (Fig.8:3, page 155) it was clear 
that little, or no, immunity was adoptively transferred to rats by the procedure 
under test (Gp.F vs Gp.E) whereas a highly significant resistance was obtained 
after secondary infection (Gp.C2 vs B). In both experiments the low proportion 
of the challenging dose recovered from rats which had a primary infection 
(Gp.B) compared with their controls (Gp.C2) was quite emphatic (P<0.001), as 
also was the reduction in the number of eggs in utero (P<0.001). 
In experiment 1 there was a slight reduction in the proportion of the dose 
recovered from rats which received immune cells compared with controls; 
however, a corresponding reduction was not obtained in experiment 2, where 
more immune cells were given to each rat, and where a greater level of 
protection might therefore be expected. There was a reduction in the number 
of eggs in utero per worm after challenge, for both experiments, compared to 
controls (Gp.E vs Gp.C2, 0.01<P<0.05, in Expt 1; P<0.001, in Expt 2, Fig.8:3(b), 
page 155, suggesting that some anti-worm response had occurred. A 
corresponding reduction in the number of eggs in utero per worm was not 
obtained in rats which received normal cells, inferring that the transfer 
technique was not responsible for this effect. 
There was no obvious difference in the distribution 	of adults recovered 
from secondary controls, challenged animals and donor rats (killed on day 25 
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Fig.8:2 
Rats in groups A, B and Cl were infected by skin-application with third-stage 
S.ratti larvae of the homogonic strain; Gp.C1 (priming controls) received an 
exact dose of <100 larvae, 1000 larvae were administered to rats in Gp. A, 
whilst Gp.B animals received 4000 larvae. The priming controls were killed on 
day 8 post-infection to check the viability of the larvae used at priming and 17 
days later adoptive transfer of immune mesenteric lymph node cells to rats in 
Gps. 0 and E was carried out. Three' days later these animals and challenge 
controls (Gp.C2) were infected by skin-application with an exact dose of less 
than 100 infective S.ratti larvae of the homogonic strain. All rats were killed on 
day 8 post-challenge and comparison of the proportion of the dose recovered 
and the number of eggs in utero per worm from rats in Gps. 0 and E showed 
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Fig.8:3 
The effect of priming rats with either a full infection (Gp.B), or with immune 
mesenteric lymph node cells (Gp.F) (- obtained from donors infected with an 
exact dose of <100 homogonic S.ratti infective larvae), on subsequent 
homologous challenge was investigated. Animals were killed on day 8 of the 
challenge infection. 
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of a primary infection). There was a possible posterior migration of worms 
from the secondary infection group, but this observation was based on the 
relative position of a few worms (Tables 7:2(i) and (ii), Appendix 7, page 335). 
Increasing the level of infection in the cell donors did not have a dramatic 
effect on the results obtained. The cells did transfer some immunity since 
there was a significant reduction in the number of eggs in utero per worm 
compared with controls (Gp.D/E vs Gp.C2, P<0.001), but a corresponding 
reduction in the proportion of the dose recovered did not occur (Fig.8:4, page 
158), reflecting the results of experiments 1 and 2. There was no dose 
response effect demonstrated in the egg data since there was no significant 
difference in this parameter between the challenged groups which received 
cells from rats infected with either 1000, or 4000 homogonic S.ratti infective 
larvae (Gp.D vs Gp.E, P>0.25, Fig 8:4b, page 158). There did not seem to be 
any posterior migration of adults in any treatment, except perhaps the cell 
donors, killed on day 25 post-primary infection (Table 7:2(iii), Appendix 7, page 
33$) but again this observation was based on the relative position of only a 
few worms. 
Since very little immunity was transferred by this protocol, the effect of 
killing rats later post-challenge was investigated. 
8.3. Resistance induced by homologous challenge assessed on day Th 
post-challenge 
Although some protection was demonstrated in Expts 1-3 following the 
transfer of primed cells it was too slight at day 8 post-challenge to allow fine 
distinctions to be drawn between types of parasite. It was possible, however, 
that the response would be more emphatic at day 16 of the infection; 
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therefore the following experiments were designed to examine this question. 
The same general protocol was used throughout experiments 4-7 (Figj.8:5, 
page 160). Rats, at transfer, received cells which had been primed either 
against an exact dose of less than 100 S.ratti infective larvae or against an 
estimated mean dose of 2000. Each recipient should have received a standard 
dose of 2.500 8  immune mesenteric lymph node cells, but in some cases 
where the yield from cell donors was too small a lower dose was 
administered. 
8.3.1. ?deterieis and methods 
83.1.1. Expts 4 and 5 
The homogonic strain of S.ratt/ was used to prime cell donors and 2.5x10 8 
cells were given to each recipient. 
8.3.1.2. Expts 6 and 7 
Donors were primed against the heterogonic strain of S.ratti and 200 8 
cells were administered to every rat in the relevant treatment in Expt 6, and 
1.77008 cells in Expt 7. 
When rats were killed at the appointed time the number of adults present, 
their distribution along the intestine and the number of eggs in utero per 
worm was found. 
8.3.2. ResuOts 
Homologous challenge with either strain of S.ratti at both infection levels, 
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Fig.8:4 
The effect of increasing the infection dose in the cell donors on the amount of 
protection transferred to recipients was investigated. The cell donors (Gps.A 
and B) were infected with either 1000 or 4000 third-stage homogonic S.ratti 
larvae (respectively) . The recipients (Gps.D and E) were challenged with an 
exact dose of <100 third-stage larvae of the homologous parasite and killed 
on day 8 of the challenge infection. 
Fig. 8:4 
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induced a significant resistance to re-infection expressed as a reduction in the 
proportion of the dose recovered (Gp.D/E vs Gp.C3, P<0.001) and a reduction 
in the number of eggs in utero (P<0.001, Table 81, page 61.). 
If the homogonic strain was used to prime the immune cells transferred to 
rats, then those from donors infected with 2000 third-stage larvae transferred 
a greater degree of immunity than those from rats infected with <100 
parasites. This was demonstrated as a greater reduction in the proportion of 
the dose recovered (Gp.D vs Gp.E, P<0.001), as well as in the number of eggs 
in utero per worm (P<0.001, Table 81, page 16). However if the heterogonic 
strain was used to prime cells a dose-response effect of similar intensity was 
absent (Gp.D vs Gp.E, P>0.10, Table 8:1, page 16). There was a significant 
difference in the number of eggs in utero (0.01<P<0.05) for the two 
treatments in experiment 7, but this result was not duplicated in experiment 6. 
In neither of these experiments was there a significant difference in worm 
burden related to the two levels of priming. 
There was a possible posterior migration of parasites in challenged rats 
which received cells primed against the larger infection dose in Expts 4 and 5, 
and in both groups in Expts 6 and 7 (Tables 7:2(iv)-(vii), page 336). 
8.4. Homologous and heterologous challenge of rats given immune mesenteric 
lymph node cells 
Since a significant immunity had been obtained using the protocol in 
Section 2, this procedure was used to carry out cross-resistance studies. Rats 
which supplied immune cells were infected with an estimated dose of 2000 
third-stage Strongy/oides spp. larvae since this dose gave a higher level of 
resistance in the recipients challenged with the homogonic strain of S.ratti 
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Fig.8:5 
On day 0 rats in Gps.A, B and Cl were infected by skin-application with 
infective $.I-att/ larvae of the homogonic or heterogonic strain. An exact dose 
of <100 larvae was administered to rats in Gps.A and Cl, whilst those in Gp.B 
were infected with an estimated dose of 2000 larvae. Eight days later the 
primary controls (Gp.Cl) were killed to give an indication of the efficacy of 
priming. On day 28 post-primary infection both cell transfer and challenge 
infection was carried out and all rats were given an exact dose of <100 
infective larvae of the homologous parasite, administered by skin-application. 
On day 8 post-challenge Gp.C2 rats were killed to check on the viability of 
larvae used at challenge and 8 days later all rats were killed. Group C2 was 
omitted from Expt 7 to economise on the number of rats used. Comparison of 
the proportion of the dose recovered and the number of eggs in utero per 
worm from animals in Gps. D and E showed whether altering the infection 
level in the cell donors affected the amount of immunity transferred. The 
number of rats shown were used in Expts 4, 5 and 6. The numbers shown in 
brackets refer to the numbers used in Expt 7. 
Fig 8:5 
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Tabe 8:1 
Recipients of immune mesenteric lymph node cells (Gps.D and E) from cell 
donors; infected with either an exact dose of <100, or a mean of 2000, S.ratti 
infective larvae, were challenged with an exact dose of <100 third-stage 
larvae of the homologus parasite. Sixteen days later the rats were killed and 
the amount of protection induced found by comparing the worm burden and 
the egg data of the challenged groups (Gps.D and E) and the secondary 
controls (Gp.C3). The viability of the larvae used at both infections was 
assessed from the egg and worm data of day 8 controls (Gp.C1, priming 
infection; Gp.C2, challenge infection). In experiments 4 and 5 (TabiJe 81a) the 
homogonic strain of S.ratti was the parasite used to infect animals whereas in 
Expts.6 and 7 (TabOe 81b) it was the heterogonic strain. 
Teble 8:1 
Table 0:1 
a) Priming cell donors against the pssogonic strain of s.ratti: 	ig 
b) Prloinq call donors rgsinst tha hateroonic strom 	of S.ratti: hoD1ccz3 
Challenge  of cell recipients assay 	on day 16.post-infection 
dl1enge of cefl 	cipienta assayed on day 16 
ixpt 	?roabont 	Grcsp 	n prop. n 	SD Man no 	n 
	SD Empt 	Trasbeant 	Group 	P=n prop 	n 
of tIre doss of eggs of ths doss of oggo 
rccovrcd In uttero/ rcsovsrcd In utoro/ 
torsVrat ossVrot 
4 	homologous challenge 	(?p.E 	0.027 3 	0.021 1.754 	
3 	1.250 6 	hOSOlOgOUS ds11cnge 	(.E 	0.132 6 	0.048 2.422 	6 	0.711 
horolcgous ds11en53 	.D 	0.137 5 	0.058 3.929 	5 	
0.535 hoetologous &011Gnge 	Op.O 	0.172 4 	0.072 2.581 	4 	1.061 
pricing controls 	c.C1 	0.655 3 	0.088 7.283 	3 	0.029 
priming controls 	Gp.Cl 	0.403 3 	0.057 6.201 	3 	0.267 
day 8 dollsnge controls 	(,.C2 	0.567 4 	0.075 7.030 	4 	0.202 
day U do1159e controls 	(.C2 	0.517 4 	0.054 6.304 	4 	0.469 
day 16 challenge controls (7p.C3 	0.292 5 	0.065 6.441 	5 	0.516 
day 16 challenge controls Gp.C3 	0.340 5 	0.009 3.990 	5 	0.594 
n esect doss pricing 	95.20 mean esect doss pricing 	
97.40 
challenge 97.12 challenge 90.42 
P values 	vsrc data egg data 
P values uoos data sqq data 
(.c1 vs C2 0.10P>0.05 P30.25 C7LC1 vs C2 P>0.2S 
P>0.25 
.C2 vs C3 (0.001 0.001<P<0.01 
(.C2 vs C3 ikoxal o.o0l<co.ol 
Gp.C3 vs D/U (0.001 (0.001 
(?p.C3 vs 0/8 P<0.001 0.001 
C.D 	vs S (0.001 P<0.001 
Clp.0 	vs S 0.250.10 
S 	horolcgouo challenge 	Op.E 	0.121 6 	0.069 2.010 	6 	
1.337 7 	hO01cgoei5 dtO11Q5 	().2 	0.090 7 	0.053 3.367 	7 	1.422 
hlcgOus challenge 	(.D 	0.304 5 	0.064 5.025 	5 	0.402 
homologous challenge 	Gp.0 	0.107 4 	0.007 4.500 	4 	1.240 
pricing controls 	C?p.C1 	0.562 3 	0.146 7.933 	4 	0.645 
priming controls 	Gp.CI . 	0.446 4 	0.116 6.050 	4 	0.670 
day 0 dtcillenga controls 	(,.C2 	0.584 4 	0.100 7.220 	4 	0.177 
day 16 challenge controls (?p.C3 	0.277 4 	0.095 7.075 	4 	0.401 
day 16 challenge controls (.C3 	0.441 4 	0.079 1.288 	4 	0.210 




asan esect doss pricing 	93.80 
challenge 96.79 p values uorm data data e
0)
t
> c.C1vsC3 0.091PG.01 .05 
P values worm data egg data C.C3 vs D/E 
P<0.001 ikoxol 
C.D 	vs S )0.25 0.01(PC0.05 
C.C1 vs C2 P30.25 0.10)P>0.05 - - 
Op.C2 vs C3 0.0100.05 p30.25 
.C3 vs D P<0.001 0.0014<0.01 
.C3 vs S P<0.001 P<0.001 
vs S P0.001 P0.001 
This may increase the sensivity of the assay and aid in detecting differences in 
the host's immune response against different types of parasite. 
8.4.11. /sterUslls and methods 
The general protocol shown in Fig.8:6 (page 164) was followed in 
experiments 8-13. 
8.4.1.11. Eps 8 and 9 
The cells used at transfer (2.500 8 cells per rat) were primed against the 
homogonic strain of S.ratti and recipients were infected either with the 
homologous or heterologous S.ratti strain. 
8.4.11.2. ExplIs 10 and 11 
The reciprocal experiment to that carried Out in Expts 8 and 9 was 
undertaken, thus cells were primed against the heterogonic strain of S.ratti. 
The number of cells each animal Ain Expts 10 and 11 were 2.5x10 8 and 2.0x10 8 
respectively. The smaller inoculum had to suffice since the yield from the 
donors in that case was insuffient to provide the standard dose. 
8.4.1.3. Exps 112 and 13 
The cells used at transfer were primed against S.venezue/ensis and rats 
which received the cells were challenged with the homologous parasite or one 
of the two strains of S.ratri In Expt 12 each rat received 1.55x10 8 cells 
whereas in Expt 13 2.5x10 8 cells were administered. 
After killing rats at the appropriate time, the number of adults present, 
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their distribution within the intestine, and the number of eggs in utero per 
worm for each rat was found. 
8.4.2. Results 
A significant resistance to both homologous and heterologous challenge 
was induced in all experiments regardless of the strain or species used to 
prime rats. This was demonstrated in rats given immune mesenteric lymph 
node cells as a significant reduction in the proportion of the dose recovered, 
and, with one exception, a significant reduction in the number of eggs in utero 
per worm, compared with corresponding controls (Table 8:2, pages 166 and 
167). The exception was Expt 12, where there was no difference in the mean 
number of eggs in utero for each worm from secondary homogonic S.ratti 
controls and the corresponding challenge treatment (Gp.D vs Gp.C3, P>0.25). 
In the duplicate experiment a significant difference between the two 
treatments was obtained (0.001<P<0.01). 
In addition, there seemed to be a quantitative difference in the level of 
immunity obtained after challenge with S.ratti, which depended on the strain 
used to prime rats. 
If the homogonic strain was used to prime the transferred immune cells 
there was no significant difference in the level of immunity produced against 
homologous or heterologous challenge in the recipients (Fig.8:7a, page 168). 
However if the heterogonic strain was used to immunise cell donors there was 
significantly greater resistance produced after homologous compared with 
heterologous challenge in Expt 10. This was demonstrated as a greater 
reduction in the proportion of the dose recovered (0.01<P<0.05, Figj.8:7b(i), 
page 169). A corresponding differential reduction in number of eggs in utero 
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Fig.8:6 
Rats in groups A (cell donors) and Cl 	(priming controls) were infected by 
skin-application with the appropriate strain of S.ratti or S.venezue/ens/s 	An 
estimated dose of 2000 infective larvae were administered to Gp.A animals, 
whereas those in Gp.C1 were infected with an exact dose of <100 larvae. 	On 
day 8 post-infection the priming controls were killed to assess the viability of 
the larvae used. 	Challenge infection with an exact dose of <100 third-stage 
larvae of the relevant parasite and adoptive transfer of the immune mesenteric 
lymph node cells (prepared from 	rats in 	Gp.A) was carried 	out on day 28 
post-infection. 	Animals in Gps. B and Cl were infected with the homologous 
strain or species used to prime cell donors whilst those in 	Gps. 0 and C2 
were both infected with the same heterologous parasite. 	In Expts 12 and 13 
there were two heterologous 	challenge 	treatments therefore 	an additional 
experimental group (Gp.E) and its corresponding control (Gp.C4) were included 
in the protocol. 
Fig!! 
Protocol used in Expts 8. 9 Q lO 11 , 12 and 13 




















priming with the 
required number 
third-stage 




GpC2 	cC3 (Gp,C4) 
experimentals------ ----- secondary controls 
recipients of cells from 
GpA 
challenge infection a.m and adoptive transfer of immune mesenteric 
lymph node cells p.m 
DAY 44 
	 ALL RATS----------- 	killed 
Number of rats used 
Group 	 EXPT 
8 9 10 11 12 13 
cOA 16 14 16 16 21 21 
Gp.Cla 4 4 4 3 4 3 
0C2- 5 5 5 5 5 5 
Gp0C3° 5 5 5 5 5 5 
5 5 
6 7 6 6 5 5 
6 7 6 6 5 5 
5 5 
KEY 
indicates progress of the same animals 
indicates transfer of mesenteric lymph node cells 
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per worm was not obtained. In the duplicate experiment (Expt 11) this 
situation was reversed, there was no significant difference in the proportion of 
the dose recovered from the two treatments but there was a significantly 
greater reduction in egg data after homologous challenge (0.01<P<0.02, 
Fig.8:7b(1i), page 169). 
If S.venezuelensis was used to prime cell donors, and worm burdens were 
taken as the criterion, there was no detectable difference in the level of 
immunity produced in the animals which received the cells after homologous 
or heterologous challenge. However, results for the egg data, which seem to 
be a more sensitive test of an anti-worm response, lead to the conclusion that 
the host's immune response could differentiate between the three parasites. 
Thus the greatest reduction in the mean number of eggs in utero occurred 
after homologous challenge. The next most effective treatment was 
heterologous challenge with heterogonic S.ratti, and the least one was 
challenge with homogonic S.ratti (Fig.8:8, page 171). There was an exception 
in Expt 12, where there was no significant difference in the relative reduction 
in the number of eggs in utero for the homologous and heterologous 
(heterogonic) S.ratti treatments, but the resistance quotient for the 
homologous treatment was numerically higher. 
There seemed to be a possible posterior migration of adult S.ratti in both 
challenged groups from experiments 8 and 9, whereas it only seemed to occur 
after homologous challenge in experiments 10 and 11 (Tables 7:2(viii)-(xi), 
Appendix 7, page 33&). There did not seem to be any adjustment in the 
relative location of adults from any treatment in experiments 12 and 13 (Tables 
7:2(ii) an (xiiö), Appendix 7, page 341) where S.venezue/ensis was used to 
prime the cells used at transfer. 
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Table 8:2 
Rats which had received immune mesenteric lymph node cells from donors, 
infected with a mean dose of 2000 third-stage Strogyloides spp. larvae, were 
challenged with an exact dose of <100 infective larvae of the homologous or 
heterologous parasite. Sixteen days later the rats were killed and the amount 
of protection induced assessed by comparing the worm and egg data from the 
challenged rats (Gps.B, D and E) with their corresponding controls (Gps.C2, C3 
and C4 respectively). The parasites used in each experiment were: Expts 8 and 
9, homogonic strain of S.ratti priming cell donors, homogonic or heterogonic 
strain of S.ratti challenging recipients (Table 8:2a); Expts 10 and 11, 
heterogonic strain of S.ratti priming cell donors, heterogonic or homogonic 
strain of S.ratti challenging recipients (Table 8:2b); Expts 12 and 13, 
S.venezue/ensis priming cell donors, S.venezue/ensis or S.ratti (homogonic and 





a) Donors of cello piistsd against the hecotonic Strom of S.rattl: effect of 
hoeologouo and heteroloqcue challenge nth the heterogonic strain on the 
cell recipients 
Oupt 	Treebeent 	Group ram prep. n SD 4&in no. n 	a) 
of the doze of eggs in 
recovercd utero/tortf 
rot 
0 	hosologous challenge (.B 0.165 6 0.106 3.295 6 	2.061 
hetorologoeo challenge (lp.D 0.156 6 0.066 2.425 6 	0.674 
palming controls Gp.Cl 0.647 4 0.074 7.554 4 	0.291 
dcllonge controlo Gp.C2 0.535 5 0.065 6.740 5 	0.232 
hcemgonic $.rctti 
challenge controls Gp.C3 0.311 5 0.096 4.969 S 	0.643 
heterogonic S,ratti 
mean enact does 	priming hoeUgOnic S.rctti 95.25 
challenge hoeogonic S.ratti 95.64 
hetercgcnlc A,KPtU 94.02 
P voluec 
CF.-C1- 02 
(.C2 vs C3 
(?p.C2 Vi) B 
Qp.C3 90 0 
9 	homolcgeeo challenge (.B 	0.152 
hatorologele diollenge (.D 	0.131 
priming controls Gp.Cl 	0.742 
challenge controls C.C2 	0.379 
hosogonic S.Kotti 
challenge controls Op.C3 	0.268 
heterogonlc SKfttti 
mean enact dose 	priming hosogonic S.rattj 95.50  
challenge 	hosogonic S.ratti 96.09 
heterogonic S.rotti 96.75 
P values vsrm data egg data 
(.C1 vs C2 N0.001 0.01(P<0.05 
Qp.C2 vs CS 010))0.05 >0.25 
C2 vs B P(0.001 <0.001 
C3 vs 0 0.00l,7p<0.0l (0.001 
Table 8:2 
b) Priming of- cell donors lmth the heteroonic strain: effect of hosologauS 
and haterologous challenge vith rnnic S.rotti on the cell recipients 
ipt 	Tresbssnt Group 	mean Prop. ii 	So mean no. 	n 	So 
of the dose of egga in 
recovered uteroMrtV 
rot 
10 	homologous challenge 0p.8 	0.077 4 	0.050 3.075 	4 	1.951 
haterologouo chollenge O.D 	0.256 6 	0.077 4.538 	S 	0.035 
priming controls .C1 	0.617 3 	0.084 6.452 	3 	0.253 
challenge controls (?p.C2 	0.338 S 	0.044 5.279 	S 	0.345 
hetarogonic S.rattj 
challenge controls Qp.C3 	0.564 5 	0.024 6.465 	5 	0.150 
homogonic S.rattl 
mean enact dose priming 	heterogonic S.rattt 93.50 
challenge 	heterogonic S.ratti 97.64 
hoiwgonic S.ratti 94.55 
P values uocm data egg data 
.C1 vs C2 N0.001 0.01<P<0.05 
.C2 vs C3 K0.01 0.0l<(0.OS 
(?p.C2 vu B <0.001 <0.O01 
C?p.C3 vs 0 PCO.Wl KO.Col 
11 	hcmologouo diollenge Cp.B 	0.041 3 	0.024 2.627 	5 	0.059 
heterologcuo challenge (.D 	0.037 5 	0.051 4.019 	4 	1.269 
priming controls (.C1 	J.493 3 	0.072 5.362 	3 	0.410 
challenge controls Op.C2 	0.252 4 	0.021 6.137 	4 	0.521 
heterogonic S.ratU 
challenge controls Cp.C3 	0.291 4 	0.063 6.900 	4 	0.745 
homogonic S.ratti 
mean enact dose priming 	heterogonic Sratti 95.33 
challenge 	heterogenic S.ratti 96.67 
hosogonic S,retti 96.67 
P values vorm data egg data 
.C1 vs 02 N0.001 P>0.25 
Cp.C2 vs C3 >0.25 0.10)P)0.0S 
Cp.C2 vs B P<0.001 NO.001 
.C3 vs 0 P<0.001 P<0.001 
	





7 0.059 4.055 	7 	1.093 
7 0.075 3.697 	7 	0.990 
4 	0.110 	7.411 	4 	0.379 
4 0.150 6.538 	4 	0.975 
5 	0.094 	6.128 	5 	0.461 
Table 8:2 
C) S.vnzul6nsis priming cell donors: effect of homologous an 	haterologous 
challenge uith S.ratti on call recipients 
Eq* 	Treatnt 	 Group 	rman prop. n 	SD 	mean no. 	n 	SD 
of the dora of eggs in 
recerd utoro/orW 
rot 
12 	homologous challenge GP.B 	0.111 5 	0.057 4.386 	4 	1.161 
haterologous challenge (.D 	0.307 5 	0.124 6.855 	S 	0.185 
hozegonic S.rattl 
hatoroloqous challenge C.E 	0.103 5 	0.654 4.323 	5 	0.031 
hatorcgonlc S. ratti 
prinirtg controls GP.Cl 	0.269 4 	0.159 6.811 	3 	0.275 
challenge controls (?p.C2 	0.272 5 	0.988 6.211 	5 	0.732 
S.vertazuelensis 
challenge controls (.C3 	0.399 S 	0.079 1.010 	S 	0.412 
homoqonic S.ratti 
challenge controls (.C4 	0.352 S 	0.064 5.266 	5 	0.643 
heterogonic S.ratti 
omen erect dose priming 	,vsneie1erw&o 94.75 
challenge S.venaswelenclo 97.11 
hacgonic S,rattj 95.20 
haterogonic $.rattl 95.11 
P values tzrm date egg data 
c,.ci vs 42 P>0.25 0.10>P>0.05 
c?p.C2 vs l3 0.01((0.05 0.01<<0.05 
c.c2 vs C4 0.10>XJ.0S 0.061C0.01 
.C3 vs C4 >0.25 K0.001 
,.C2 vs 8 <0.001 ike.eul 
Gp.C3 vs 0 0.01<<0.05 >0.25 
4.C4 vs S ikmol 0.001<(0.01 
13 	homologous challenge (.B 	0.143 4 	0.652 3.969 4 	1.117 
hsterologous challenge (.D 	0.336 S 	0.111 6.747 S 	0.461 
homogonic S.rattl 
hetotologous challenge qp.s 	0.101 4 	0.044 4317 4 	0.209 
heterogonic S.rsttl 
prising controls c?p.c1 	0.368 3 	0.096 6.031 3 	6.219 
challenge controls (.C2 	0.326 5 	0.140 6.700 S 	6.331 
S.venezuelcouis 
challenge controls .C3 	0.473 3 	0.010 1.403 3 	0.200 
hcsgonic S.retti 
challenge controls O.C4 	0.316 5 	0.010 6.015 S 	0.273 
tratarogonic S.rotti 
seen caret dose priming 	S.vrnezuulensio 88.33 
challenge 	S.venezuelenelj) 96.70 
hozsgonic 0.rett1 97.67 
ttetorcgonlc S.rottl 90.70 
P values eom data egg data 
c.c1 vs Cl P>0.25 P>0.25 
4.C2 vs C3 0.0160.05 O.c010.01 
.C2 vs C4 fmas (0.001 
(.C3 vs C4 0.016P<0.f15 <0.001 
(.C2 vs 8 0.000k0.01 P40.061 
Op.C3 vs 0 0.01<P<0.05 O.CX)1<(0.01 
Qp.C4 vs 0 0.061(10.01 
Fig.8:7 
The amount of resistance produced in rats after homologous and heterologous 
challenge was compared by calculating resistance quotients for the two 
treatments. In Expts 8 and 9 the homogonic strain of S.ratti was used to prime 
the cell donors, whereas in Expts 10 and 11 the donors were primed against 
the heterogonic strain. 
Fig. 8:7 
Comparison of the amount of protection induced in rats a4ter homologous ar 
heterologous challenge: S.ratti priming cell donors, Expts 8-11 
a) llom000Aic Stahl pqltainO: tiOtOtOgOflic/Nomogonic 3.,l$l choflonglng 
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Fiq.8:7 (continued) 
b) l'olovo0onc 8.,0I11 'isalAØ: 1lomoD,.Icp,0to,00onIc c1iGlIot0Ifl0 
I) EDl 10 
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Details of the methods used are given in the relevant section of Chapter 2 
(section 2:10, for the method of infection and worm counting; section 2:5, for 
the method used at adoptive transfer; and section 2:11, for statistical analysis 
of the results, pages 47, 37, and 51 respectively). 
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Fig.8:8 
The amount of protection induced in rats after homologous and heterolOgOUs 
challenge was assessed by calculating resistance quotients for the egg and 
worm data. The animals had received immune mesenteric lymph node cells, 
from donors infected with S.venezue/ensis and were challenged with an exact 
dose of <100 infective larvae of the relevant parasite. 
o. C0.04 P0.5 
C.0 	G,.o 0.00I0.01 
0.I0PO.o 
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Comparison of the amount o4 resistance induced in animals after homolo g ous 
and heterojogus challenge: S.venezuelensjs priming cell donors. Epts 12 and 
13 
t.000] 
— Ci•0 •O c? . 0 	P0.001 













Gp.8 - homologous challenge 
Gp.Q - hoerotogoue challenge, homogonjc S.rau 
Gp.E - heeroIogote challenge, hoorogon,c S.roi 
S.C. - standard error 
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Fig. 8:8 
Comparison of the amount of resistance induced in animals after homologous 
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KEY 
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8.5. Swvmary 
The immunity adoptively transferred was not firmly expressed until day 
16 	post-infection. If 	rats 	were 	killed 	on day 8, there was 	no consistent 
demonstrable resistance to re-infection, even if the infection dose used to 
infect rats which provided the cells, was increased. 
Immune mesenteric cells primed against an exact dose of less than 100 
third-stage S.ratti larvae are capable of immunising rats against homologous 
challenge. 
A dose-response effect was demonstrated if rats were immunised with 
transferred mesenteric lymph node cells from donors infected with different 
dose levels of S.ratti homogonic strain third-stage larvae (i.e. an exact dose of 
<100 larvae vs 2000 larvae), which was expressed as a greater reduction in 
the proportion of the dose recovered, and a greater reduction in the number 
of eggs in utero per worm, after homologous challenge. A corresponding 
effect was not obtained if the heterogonic strain was used to prime cells. 
There seemed to be an asymmetry in the level of immunity expressed 
against homologous and heterologous challenge in rats immunised with 
immune mesenteric lymph node cells, which depended on the strain of S.ratti 
used to prime the cells. If the heterogonic strain was used homologous 
challenge produced the greater resistance compared with heterologous 
challenge with the homogonic strain; demonstrated as a significantly greater 
reduction in the proportion of the dose recovered in Expt 10, and a 
significantly greater reduction in the egg data in Expt 11. In contrast, if the 
homogonic strain was used to prime the cells there was no significant 
difference in these two parameters after homologous and heterologous 
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challenge. 
Adoptive transfer of mesenteric lymph node cells primed against 
S.venezuelensis protected rats against homologous and heterologous S.ratti 
infection. If the egg data was considered there seemed to be a quantitative 
difference in the level of immunity induced at challenge. Maximum protection 
was elicited after homologous challenge, followed by heterologous challenge 
with the heterogonic strain of S.ratti, and the minimum level of immunity was 
expressed after heterologous challenge with the homogonic strain (assessed 
as the relative reduction in the number of eggs in utero per worm for the 
three groups). If the worm data was considered there was no difference in 
the resistance produced after challenge with any parasite. 
There did not seem to be any clear difference in the longitudinal 




THE AMOUNT OF LYMPHOCYTE STIMULATION PRODUCED BY STRONG YLOIDES SPP. 
ANTIGENS 
91. Introduction 
Lymphocyte stimulation or transformation can be induced either by the 
interaction of lymphocytes with specific antigen, or with certain plant products, 
called lectins, causing the production of blast cells. The mode of activation in 
both cases is thought to be similar, although stimulation by an antigen leads 
to the proliferation of specific clones of lymphocytes, whereas lectin induced 
mitogenesis is non-specific and thus polyclonal. The amount of proliferation 
induced is assumed to be related to DNA synthesis, judged in practice by the 
level of incorporation of a radio-labelled nucleotide, such as tritiated 
thymidine. Thus comparative studies of the relative stimulation induced by 
various antigenic preparations seemed possible. 
Initially the assay was used to investigate four aspects of the cellular 
response to Strongyloides spp. as follows:- 
the amount of cross-reactivity between the three Strongyloides spp. 
parasites by priming the donors of cells against antigens from one of them 
followed by homologous and heterologous challenge. 
the stage-specificity of the response by challenging in vitro cells from 
primed donors using antigenic preparations made from different stages of the 
life-cycle. 
the nature of the antigens involved in eliciting an immune response by 
174 
comparing the response to somatic and excretory/secretory antigen 
preparations. 
d) the dynamics of the cellular response by challenging cells taken at 
different times post-infection with the same antigen preparation. Unfortunately 
the antigens prepared could not be standardised since they were found to 
contain no detectable protein as judged by the Lowry assays carried out (see 
Appendix 8:5, page 357). Rather than abandon these studies altogether the 
preparations jer_ tested to find if they did have antigenic properties. It 
was possible that they might have some specific mitogenic effect on primed 
cells since some protein may have been present but at too low a 
concentration for the Lowry assay to detect it, or that other substances such 
as carbohydrates, whose concentration had not assessed, may elicit a 
response in primed cells. Different dilutions of the antigens were assayed in 
some experiments to find if there was a dose-response effect, which would 
confirm that antigens were present. A similar difficulty in removing protein 
from S.ratt/ has been described by Murrell and Graham (1982) who tried to 
strip epicuticular antigens from the surface of third-stage S.ratti larvae. 
Treatment with a variety of enzymes, including proteases, carbohydrases and 
lipase, as well as detergents, failed to remove any material from the surface of 
the larvae. 
Previous results by Genta et al. (1983) have shown that, among those 
tested, the most responsive cell population to a S.ratti antigen was the 
mesenteric lymph node cells. Therefore this cell population was used 
throughout the experiments. As a positive control, treatment with the T cell 
mitogen, concanavalin A, was also included in the experimental protocol to 
show that cells were capable of responding to stimulation. The response of 
175 
unstimulated cells was also recorded to give an indication of the amount of 
proliferation initiated in viva 
Each experiment carried out in this section is described separately since 
different combinations of antigens were tested. However, the same general 
technique described in Section 2:6, Chapter 2, page 38 was used throughout. 
Other methods common to these experiments used are given on page 213. 
.2. Dynamics of the response 
The timing of the peak cellular response against Strongyloides spp. 
parasites was determined by investigating the response of mesenteric lymph 
node cells, taken at various times during a primary infection, to antigenic 
stimulation. 
9.2.11. Ept 11, Dynamics of the cellular response: hetero9onic strain of S.rtti 
priming cell! donors 
9.2.11.11. Materials and methods 
Eighteen rats were divided into 3 groups:- 
Gp.X - 9 animals - infected by skin-application with 2000 third-stage 
heterogonic strain S.ratti larvae, to provide immune mesenteric lymph node 
cells. 
Gp.Y - 6 rats - uninfected, provided normal mesenteric lymph node cells. 
Gp.Z - 3 rats - controls to assess the viability of the larvae, infected in the 
same manner as Gp A using an exact dose of <100 larvae and killed on day 8 
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post-infection. Three rats from Gp.X and two rats from Gp.Y were killed on 
days 8, 16 and 28 post-infection. The mesenteric lymph node cells obtained 
from them were plated out as shown in Fig.9:1, page 179. Numbers of worms 
and their distribution along the gut were also recorded. 
9L2.1.2. Results 
A significantly higher level of unstimulated activity was obtained in immune 
cells (0.01<P<0.05) obtained on day 8 post-infection (Fg.9:2a, page 180). 
Unstimulated activity of cells from day 16 of a primary infection illustrated a 
feature which recurred throughout these assays: that is to say, cells from 
different rats within treatments were often significantly different in their 
behaviour. Thus, in this case, although the overall difference between cells 
from uninfected rats and those from infected ones at day 16 was not 
significant (Fg.:2e, page 180), 2 of the 3 infected rats did have a significantly 
higher activity than any of the controls (P<0.001). This within-treatment 
variation often presented a problem in interpreting the results (see Discussion). 
On day 28 post-infection there was obviously no difference in the 
unstimulated blastogenesis of the two cell populations (Fg.9:2a, page 180) and 
no idiosyncracy within treatments. 
Cells from infected and uninfected rats on day 8 and 16 post-infection 
expressed a similar level of mitogen-induced activation (Fi.9:2b, page 180). In 
contrast day 28 cells from immune rats expressed a significantly lower 
response to concanavalin A stimulation (0.01<P<0.025), F.9:2b, page 180). 
There was no specific stimulation of day 8 immune cells but day 16 cells 
from one of the three infected rats gave a positive response to homologous 
challenge (EFij.:2c, page 181). On day 28 post-infection there was no 
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response to the neat heterogonic strain S.ratti antigen, therefore a comparison 
of the response of immune cells to the different concentrations of the antigen 
is omitted. 
The worm data (Table 8:2(i), Appendix 8, page 352) showed there was no 
significant difference in the proportion of the dose recovered from rats 
infected either with an exact dose of <100, or 2000, third-stage heterogonic 
strain S.ratti larvae on day 8 post-infection. Over the course of infection the 
worm burden in the cell donors fell, until day 28 post-infection when no 
parasites were recovered. A corresponding reduction in the number of eggs in 
utero per worm was obtained on day 16 post-infection, and there also seemed 
to be a posterior migration of adults compared with the results for day 8 
post-infection (Table 8:3(i), Appendix 8, page 354). 
9.2.2. apt 2, The response of daV 28 immune cells to various treatments: 
heterogjonic strain of S.rtti priming cell donors 
9.2.21. Materials and methods 
Five rats were divided in to two groups:- 
Gp.X - 3 rats - infected by skin-application with 2000 infective S.ratti 
larvae of the heterogonic strain and killed 28 days later to provide immune 
cells. 
Gp.Y - 2 rats - untreated animals which provided normal mesenteric lymph 
node cells. 
On day 28 of Gp.X's infection the rats were killed and the cells obtained 
plated out as shown in Figj.9:3, page 183. The number of adult worms present 
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Fig.:l 
On days 8 and 16 cells obtained from two of any of the five rats were plated 
out together as shown in (i). Therefore there was a possibility that a plate 
could contain cells from an uninfected (Gp.Y) and infected rat (Gp.X). Since 
there was an odd number of animals, a separate plate had to be set up for 
one of the rats. In this case, its cells were added to all wells but columns 
5-12 which contained cells and medium were ignored. On day 28 a separate 
plate was set up for each individual rat (ii). Only results for cells exposed to 
treatments U, C, Al, A2 and A3 were recorded. 
!49 9 g  1 
Appearance of mlcrotitreplate in p .t] 
1) pys 8 and 16 
Column no. 1 2 3 	4 5 6 7 8 9 	18 11 12 
Row no.A in in in 	in in in in in in 	in in in 
B in U C A in 0 C A in m in in 
C in U C 	A in U C A in 	in in in 
D m U C A in U C A in Tn in in 
Em U C 	A in U C A in 	Tn in in 
Fm U C A in U C A in m in in 
G m U 'C 	A in U C A m 	in in in 
H m in in m in in in m in in in in 
<--- cells from a rat —>< cells from another rat ---=> 
Whereg- 
m = medium only added to the cells which were not harvested 
U = unstimulated control treatment (same treatment as cells with medium but the 
cells were harvested) 
C = concanavalin A added to cells (205pgAnl) 
A = cells treated with adult heterogonic strain of S0ratti 
excretory/secretory antigen 
ii) Day 28 
Column no. 1 2 3 4 5 6 7 8 9 18 11 12 
Row no.A in in in in m in in in in in in in 
B in U C Al A2 A3 U C Al A2 A3 in 
C in U C Al A2 A3 U C Al A2 A3 in 
Din U C Al A2 A3 U C Al A2 A3 in 
Em U C Al A2 A3 U C Al A2 A3 in 
F in U C Al A2 A3 U C Al A2 A3 in 
Gin 0 C Al A2 A3 U C Al A2 A3 in 
H in in in in in in m in in in in in 
<--- cells from a rat ----><-- cells from another rat ---> 
Where:- 
in = medium only added to the cells which were not harvested 
U = unstimulated control treatment (same treatment as cells with medium but the 
cells were harvested) 
C = concanavalin A added to cells (205pgJnl) 
A = cells treated with adult heterogonic strain of S0ratti 
excretory/secretory antigen 
1 = neat antigen 
2 = antigen diluted 1:2 
3 = antigen diluted 1:4 
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Fig.9:2 
The effect of addition of medium alone (unstimulated cells, treatment U, 
Fög.9:2a), mitogen (treatment C, Fij.:2b) and homologous excretory/secretory 
worm antigen (treatment A, !Figj.9:2c) on the level of stimulation of cells from 
donors either untreated or primed with the heterogonic strain of S.ratri was 
investigated. Each bar in the figure refers to the results of cells obtained from 
an individual animal, rats A-F were uninfected (Gp.Y) and those numbered 
1-12 were infected (Gp.X). The p vlues shown in the figures refer to the 
overall comparison of the response of cells obtained from uninfected and 
uninfected donors (Gp.X versus Gp.Y, shown as I vs U, where I stands for 
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in the cell donors, their distribution along the intestine and the number of 
eggs in utero per worm was recorded. To economise on the number of rats, 
day 8 controls, which give an indication of the viability of the larvae used at 
priming were omitted. 
9.2.2.2. Results 
There was no significant difference in unstimulated activity of normal and 
immune cells (Fig.9:4a, page 185). The overall treatment difference in the 
amount of concanavalin A induced blastogenesis of cells from normal and 
immune rats was not significant statistically (using the data of cells treated 
with 2.5ug/ml of concanavalin A since this was used throughout other 
experiments) but there were highly significant differences in the results from 
individual animals (P<0.01, Figj.:4b, page 185). If compared on a rat to rat 
basis, and applying the least significant differences between means, the low 
response of immune cells compared with non-immune was highly significant 
(P<0.001). The biggest mean among infected rats was less than half the value 
of the smallest from uninfected animals (Table 8:1(iv), Appendix 8, page 345). 
In regard to the response of normal cells to different concentrations of 
concanavalin A, two-way analysis of variance identified significant interaction 
between rats and coricanavalin A concentration (P<0.05, Fig.9:4, page 185). 
Using one way analyses of variance of the data for each animal, rat A had a 
significantly higher response to 51ug/ml (P<0.001), but there was no difference 
in its response to 2.5 or 10 1ug/ml. Rat B seemed to have a graded response 
to concanavalin A with a significant difference between the two extreme 
concentrations (P<0.05). 
Cells from immune rats showed no overall significant difference in 
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Fij.9:3 
Cells collected from each of the five rats were dispensed into a separate 
microtitre plate and then the relevant sample was added to each well as 
shown. Only results for treatments U, HO, HE, S. Cl, C2 and C3 were 
recorded. 
Fiq. 9 g  3 
earance of microti tre 	inEç 
Column no. 1 2 3 4 5 6 7 8 9 is 11 12 
Row no. A in in in in In in in in in in in in 
B in U HO HE S C1 C2 C3 in m in in 
Cm U HO HE S Cl C2 C3 in in in in 
Din U HO HE S Cl C2 C3 in in in in 
Em U HO HE S Cl C2 C3 in in in in 
F in U HO HE S Cl C2 C3 in in in m 
G in U HO HE S Cl C2. C3 in in in m 
H in in ' in in in in in in in in in in 
Where 
in = medium only added to the cells which were not harvested 
U = unstimulated control treatment (same treatment as cells with medium but the 
cells were harvested) 
Cl = concanavalin A added to cells (205ig/il) 
C2 = concanavalin A added to cells (500pg/xnl) 
C3 = concanavalin A added to cells (1ignl) 
HO = cells treated with adult hcmogonic S0ratti excretory/secretory antigen 
HE = cells treated with adult heterogonic strain of S0ratti 
excretory/secretory antigen 
S = cells treated with adult S0vertezuelensls excretory/secretory antigen 
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response to the mitogen across the concentration range but rat number 3 had 
a much lower reponse at a concentrations 5 and 10.ig/ml (Fig.9:4b, page 185) 
which was probably responsible fcr the highly significant between rat variation 
(P'<O.00l). Least significant differences between treatment means for each rat 
showed that 5pg/ml caused the highest level of stimulation for rat 1 
(0.01'<13 <0.05), 2.5pg/ml for rat 3 (0.01<P<0.05), and there was no difference 
in the response of rat 2 to any of the concentrations. 
Overall, the data from this experiment were strongly influenced by the high 
levels of activity of non-immune cells from rat B in all treatments, including 
the unstimulated controls (Fig.9:4a, page 185). This phenomenon completely 
dominates the differences shown between cells from other rats in response to 
parasite antigens (Fig.9:4c, page 186). Therefore it could only be concluded 
that there was no real difference between any of these treatments although, 
as before, there was a highly significant between rat variation (P<0.001). 
All worms had been expelled from the infected rats by day 28 
post-infection. 
9.2.3. Expt 3, Dynamics of the cellular response: S.venezuelensis priming cell 
donors 
9.2.3.1. Materials and methods 
Eighteen rats were divided into three groups:- 
Gp.X - 9 rats - infected by skin-application with 2000 third-stage 
S.venezue/ensis larvae, to provide immune mesenteric lymph node cells. 
Gp.Y - 6 animals - untreated, provided normal mesenteric lymph node 
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Fig.9:4 
The response of cells obtained from donors, either primed with heterogonic 
strain of S.ratt/ or untreated to various samples was recorded. The cells 
were either exposed to medium alone (unstimulated cells, treatment U, 
Fig.9:4a), concanavalin A (treatment C1-C3, Rg.9:4b) or various worm 
excretory/secretory antigens (treatments HO, HE and S. Fj.:4c). Each bar in 
the histograms refers to results of cells obtained from a particular donor, 
which was either uninfected (rats A and B) or infected (rats 1-3). The p values 
shown refer to the overall comparison of the response of cells from 
uninfected rats (Gp.Y, shown as U) versus infected rats (Gp.X, shown as I) to 
the various additions. 
Fig. 9: 4 
In vitro response of day 28 ieoQntQrjc lyoph nodo co1)c froo cell 
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Gp.Z - 3 rats - priming controls, infected with an exact dose of <100 
infective S.venezue/ens/s larvae in the same way as Gp.X, and killed on day 8 
post-infection to give an estimate of the viability of the larvae used at 
priming. 
Three rats from Gp.X and two from Gp.Y were killed on days 8. 12 and 21 
post-infection and their mesenteric lymph node cells were used in a 
lymphocyte transformation assay. The treatments to which the cells were 
exposed are shown in Fi.9:5, page 189. Worm and egg data from the rats 
were recorded. 
9.2.3.2. Resufts 
On days 8, 12 and 21 post-infection there was no difference in the level of 
unstimulated activity in normal and immune cells (Fig-9:6a, page 190). 
Unfortunately there are no results available for concanavalin A stimulation 
of cells on days 8 and 12 post-infection since the mitogen used had been 
stored at a concentration of 7.5jig/ml which seemed to have abolished its 
effect. A new batch of concanavalin A (sample A) was used on day 21 
post-infection and this was highly active compared to the diluted sample 
(Sample C) used on the previous occasions (Fig9:6d, page 193). On day 21 
there was no significant difference in the level of stimulation in normal and 
immune cells after treatment with the mitogen but there was a significant 
between rat variation (0.001<P<0.01, Fig.:6d, page 193). 
There was no specific response to any concentration of the homologous 
adult homogenate or excretory/secretory antigens on day 8 post-infection 
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(tF.9:6b() and 9:6c(i), pages 190 and 192). However on day 12 post-infection 
immune cells exhibited a significantly greater response to both adult antigens 
(P<0.01, excretory/secretory antigen; P<0.05, homogenate antigen, Fig.9:61b(ii) 
and 9:6c(ii), pages 191 and 192). There was no significant difference in the 
level of stimulation produced in immune cells by the various concentrations of 
the two antigens nor in their response to the two antigen types (using data 
for the neat antigens). A similar specific response was demonstrated in day 
21 immune cells for both antigens (i.e. P<0.05, excretory/secretory antigen; 
P<0.025, homogenate antigen, Fig.9:6b(iii) and Fig.9:6c(iii), pages 191 and 193). 
Again varying the concentration of the antigens had no effect (P>0.05) and a 
similar level of stimulation was produced by them. 
A significantly lower proportion of the dose was recovered from rats 
infected with 2000 third-stage S.venezue/ensis larvae compared with those 
infected with an exact dose of <100 (P<0.01, Table 8:2(iii), Appendix 8, page 
35. There seemed to be a gradual worm loss over the course of infection 
since there was no significant difference in the proportion of the dose 
recovered on adjacent days but there was a reduction in the number of eggs 
in utero per worm (Table 8:2(iii), Appendix 8, page 352) suggesting that an 
anti-worm response was in operation. There was no posterior migration of 
adults throughout the course of infection, with the majority of worms being 
recovered from the first section of the intestine (Table 8:3(u), Appendix 8, page 
354). 
9.3. Homologous vs heterologous challenge 
The peak cellular response to the parasites seemed to occur about day 
12-16 post-infection since there was an increase in unstimulated activity 	in 
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Fij.9:5 
Cells from an individual rat were added to all wells of a microtitre plate before 
the addition of the relevant sample (as shown). Only results of cells in rows 
B-G of columns 2-9 on days 8 and 12, and of columns 2-11 on day 28 were 
recorded. 
11 
!49 9 g  5 
Ngp?arance of microtitreplate in Exp 
i) Days 8 and 12 
Column no. 1 2 3 4 5 6 7 8 9 10 U 12 
Row no. A in in in in in in in in m in in in 
B in U Cc Al A2 A3 H1H2 H3 in in in 
C in U Cc Al A2 A3 Hi H2 F!3 in in in 
D in U Cc Al A2 A3 Hi H2 H3 in in in 
Em Ii Cc Al A2 A3 Hi H2 H3 in in in 
Fm U Cc Al A2 A3 Hi H2 H3 in m in 
C m U Cc Al A2 A3 H1 H2 H3 in in in 
H in in in in in in in in in in in in 
ii) Day 21 
Column no. 1 2 3 4 5 6 7 8 9 10 11 12 
Row no. A in in in in in in in in in in in in 
B in Ii Cc Al A2 A3 Hi H2 H3 Cb Ca in 
C in U Cc Al A2 A3 Hi H2 H3 Cb Ca in 
D in U Cc Al A2 A3 Hi H2 H3 Cb Ca in 
E in U Cc Al A2 A3 Hi H2 H3 Cb Ca in 
F in U Cc Al A2 A3 Hi H2 H3 Cb Ca in 
G in U Cc Al A2 A3 Hi H2 H3 Cb Ca in 
H in in in in in in in in in in in m 
Where: 
in = medium only added to the cells which were not harvested 
U = unstiimiiated control treatment (same treatment as cells with medium bt 
the cells were harvested) 
Ca = concanavalin A added to cells (20igAnl9 freshly made solution from a 
newly recieved batch of powder, Sample A) 
Cb = concanavalin A added to cells (205pgAnl9 solution frozen at a 
concentration of 2ng/ml before use 	same powder as that used to 
prepare Cc, Sample B) 
Cc = concanavalin A added to cells (2 0 5ign1, solution frozen at a 
concentration of 705).]g/ml before use r Sample C) 
A = cells treated with adult S0venezuelensis excretory/secretory antigen 
H = cells treated with adult S0venezuelensis homogenate antigen 
1 = antigen used neat 
2 = antigen diluted 1:2 
3 = antigen diluted 1:4 
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Fig.9:6 
The response of cells obtained from donors either infected with 
S.venezue/ensjs (Gp.X, rats 1-12) or uninfected (Gp.Y, rats A-F) to different 
preparations is shown. Four main types of samples were tested, medium 
alone (unstimulated controls, treatment U, Fig.:6a), homologous worm 
excretory/secretory antigen (treatment A, Fag.:6b), homologous worm somatic 
antigen (treatment H, Fg.:3c) and mitogen (treatment C, Fg.:6d). As before, 
each bar in the figure refers to data collected from one rat and the p values 
show the results of the response of cells from uninfected versus infected 
donors (I vs U) to the different treatments. There are also probability levels 
given which show the overall response of cells from infected donors to 
different concentrations of the antigens or mitogen. 
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immune cells at this time (Expt 1) and a specific response to the antigens 
(Expt 3). Therefore a number of experiments were conducted using mesenteric 
lymph node cells obtained on these days to find out if the response to 
homologous and heterologous challenge varied. In Expts 4-6 antigens 
produced from adult worms were used, whereas, in Expts 7 and 8, adult and 
third-stage larval antigens were tested. 
9.31. Expt 4, Homologous vs heterologous challenge: homogonic strain of 
S.ratti priming cell donors 
9.311. MateriaOs and methods 
Five rats were divided into 2 groups:- Gp.X - 3 rats - infected by 
skin-application with 2000 third-stage homogonic S.ratti larvae, to provide 
immune mesenteric lymph node cells. 
Gp.Y - 2 rats - uninfected, provided normal cells. 
Rats were killed on day 12 post-infection and their cells were plated Out as 
shown in Fig.9:7(i), page 196. The data on worms found in the intestine were 
recorded as before. 
9.3.1.2. Results 
There was no significance overall in the difference An, Ihe unstimulated 
activity of cells from normal and immune rats but again, there was a 
in 
significant between rat variation the infected group (P<0.025). 	Thus, 
application of the least significant difference between individual rat means did 
show that cells from infected rats expressed a higher level of activity than 
either of the controls (P<0.05, Table 9:18, page 197). 
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Comparison of the response of the two cell populations to mitogenic 
stimulation showed that normal cells exhibited a greater response (P<0.05, 
Table 91a, page 197) but there was no significant difference in the response 
of each cell type to the two concanavalin A samples. 
The heterologous antigens (neat) produced a specific stimulation of cells 
from infected rats (P<0.05, S.venezue/ens/s antigen; P<0.01, heterogonic S.ratti 
antigen, Table 9:11a, page 197) whereas the homologous antigen did not 
produce specific stimulation overall of immune cells, but there was a 
significant inter-rat variation (P<0.05). Using the least significant difference 
between means, it was clear that rat 2 had no response, whilst rat 3 had a 
highly significant response to the antigen (P<0.001). Comparison of the 
response of immune cells from rats 2 and 3 to the two concentrations of the 
heterologous antigens showed that they produced a similar response to both 
for the S.venezue/ensiS antigen, but that they deviated in their response to the 
heterogonic S.ratti antigen (in both cases there was a significant difference in 
the results from rats 2 and 3, P<0.05). The least significant difference was 
not exceeded when comparing individual rats in response to different 
concentrations of the S.venezue/ensis antigen, though individual differences 
were greater than the least significant difference in the case of the 
heterogonic S.ratt/ antigen, with the higher concentration producing the 
greater response (0.01<13 <0.05). 
Comparison of the response of immune cells to all three types of adult 
worm excretory/secretory antigens showed that effects of the three 
treatments were not additive, since there was a significant interaction detected 
by the two way analysis of variance (immune rat cells vs antigens P<0.05). 
This interaction was founded on the fact that there was no difference in the 
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Fig.9:7 
Cells from each rat were added to all wells of a single microtitre plate in all 
three experiments and they were exposed to the appropriate treatment as 
shown in (i) for Expt 4; (ii) for Expt 5; and (iii) for Expt 6. 
Fig, 9:7 
Appearance of aicrotitp1atO inptZ 46 
1) Oupt 4 
Column no. 1 2 3 4 5 6 7 0 9 19 11 
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C ía U 1401 1402 HE1 HE2 Si S2 Ca th ía ía 
D Is U 1401 1402 HE1 HE2 Si S2 Ca th ía Is 
E Is U 1401 1402 HE1 HE2 Si S2 Ca th ía ía 
F ía U 1101 1102 HE1 HE2 Si S2 Ca Cb ía 
ía 
G wi U 1401 1102 HE1 HE2 Si S2 Ca Cb ía 
Is 
H ía ía ía ía ía ía ía ía ía ía ía ía 
ii)Expt 5 
Column no. 1 2 3 4 , 5 6 7 3 9 10 ii 12 
Row no. A ía is ía ía ía ía ía in in ía ía ía 
B in U 1101 1402 HE1 HE2 Si 52 Ha Hb Ca P 
C is U 1101 1402 HE1 14E2 Si S2 Ha Hb Ca P 
0 ía U H01 1402 HE1 HE2 Si S2 Ha Ith Ca P 
£ in U 1401 1402 HE1 HE2 Si S2 Ha Hb Ca P 
F is U 1401 1402 HE1 HE2 Si S2 Ha Fib Ca P 
C in U 1101 1402 HEl HE2 Si S2 Ha Hb Ca P 
H ía in ía m m in ía in in m ía in 
iii) 
Column no. 1 2 3 4 5 6 7 8 9 19 ii 12 
Row no 	A ía ía in ía ía is in in ía ía in 
in 
B ía U 1101 1102 HEl HE2 Si S2 Ha P Ca Q 
C is U 1401 1402 HE1 HE2 Si S2 Ha P Ca Q 
0 in U 1401 1402 HE1 HE2 Si S2 Ha P Ca Q 
E in U 1101 1402 HE1 11E2 Si S2 Ha P Ca Q 
F is U 1401 1102 HE1 HE2 Si S2 Ha P Ca Q 
C in U 1401 1102 HE1 HE2 Si S2 Ha P Ca Q 
H in in in in in in is M ga in m in 
Where:- 
in a medium only added to the calls which were not harvested 
U a unstiinuiated control treatment (seine treatment as cells with medium but 
the calls wars harvested) 
Ca concanavalin A added to cells (2.5g/Ml, freshly made) 
Cb a concanavaith A added to cells (24gAitl, solution frozen at a 
concentration of 2ngftil before use) 
HO a adult hcxtnogonic strain of S.ratti excretory/secretory antigen added 
to cells 
HE a adult heterogonic strain of S0ratti excretory/secretory antigen added 
to cells 
S a adult S,,venezuelensis excretory/secretory antigen added to cells 
a antigen used neat 
2 a antigen diluted 1:2 
Ha adult heterogonic strain of S o 
 ratti homogenate antigen added to 
calls, stored overnight at +4 C before use, used neat 
Hb adult heterog3nic strain of S.ratti homogenate antigen added to cells, 
stored at -29 C overnight before use, used neat, same batch as Ha 
P a combination of Ca + Ha added to cells (concentration of the mitogen was 
adjusted to remain at 2.ug/m1 but the antigen was diluted 1:2) 
Q a combination of Ca + HE added to cells (concentration of the mitogen was 
adjusted to remain at 24ig/ini but the antigen was diluted 1:2) 
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Table 9:1 
Results for mesenteric lymph node cells in Expts 4-6, which were obtained 
from either uninfected (A and B), or infected (1-3), donors. The effect of the 
mitogen treatments only are shown for Expt 6 (iii) since there was no specific 
response to the other treatments but their data can be found in Table 8:1th, 
Appendix 8, page 348 
th10 9:1 
1oo1ccc vo htoro1oqouc co11c, roculto of Eto 4, 5 td 6 1 
doto 1ooncforoad 
orpt 4 0 horcqoiic strain of S.rotti pjpirg 0211 donoro 
ct 
oit no. 	U 	Co 	th 	)CO2 	)C01 	HM 	ml 	$2 	Si 
thtfctoi 
A 	ci 4.6 9.70 9.64 -0.07 -0.54 -1.17 -1.14 -1.65 -0.05 
SD 0.50 0.13 0.15 2.77 3.40 3.60 3.09 3.40 4.27 
ft 5 5 5 6 6 6 6 6 6 
0 4.54 10.00 10.16 -2.63 0.72 0.65 -0.93 -1.43 1.02 
50 0.33 0.09 0.14 2.33 3.31 3.01 2.40 3.27 2.75 
n 5 5 5 6 6 6 6 6 6 
Rntcctc 
2 	can 6.01 7.99 0.06 -1.63 -1.59 
50 	0.66 1.53 0.09 	4.62 	5.67 
	
ft 5 	5 	5 6 6 
3 	=m 5.07 0.47 0.96 	0.17 	4.54 
SD 	0.16 0.76 0.23 4.45 1.00 
ft 5 	5 	5 	6 	6 
b) loupt 5, butorcarttc strain of S.rotti ptciIr 
?rcnt 
3t Ito. U 	Co. 	K02 	ICOI K2 	HEl 
I0tiitfcctc 
A ti 5.39 9.06 4.34 -0.97 0.05 -0.60 
SD 0.32 	0.33 	1.24 	5.13 5.23 	5.49 
ft 	5 5 5 5 	5 5 
S cl 6.24 	0.39 -0.35 	1.06 5.16 0.95 
50 1.23 0.21 	6.29 5.93 3.04 . 5.17 
ft 	5 	5 5 	5 	5 	5 
lnfcctcd  
1 cait 0.40 7.66 0.77 	6.03 7.95 7.80 
SD 0.59 0.31 0.15 7.97 0.70 0.90 
It 	5 	5 	5 	5 	5 	5 
2 	on 0.43 7.31 	4.63 	9.14 51 23 	0.53 
50 0.04 0.60 6.75 0.30 7.50 0.50 
ft 	5 	5 	5 	5 	5 	5 
3 roan 0.13 	9.12 	7.09 	5.20 3.17 . 2.17 
nan 	cia, c7U C 1 
CD 
4.36 	7.00 	5.09 	6.20 
4.05 0.52 0.04 0.03 
6 	6 	6 	6 
5.15 	6.07 	5.06 	5.36 
0.55 0.97 LOS 1.04 
6 	6 	6 	6 
CL-11 dooro 
52 	Si ICo lOt 
2.70 -1.00 1.37 5.03 9.00 
5.29 4.17 5.32 1.11 0.21 
5 	6 	5 	5 	5 
1.00 0.56 0.75 1. 30 1.94 
5.12 6.57 5.71 5.75 0.43 
S 	6 	5 	S 	5 
5.71 	0.48 0.17 8.41 2.26 
5.01 	0.46 0.90 0.76 7.07 
5 6 	5 	5. 	5 
7.57 	7.91 0.37 0.30 -7.14 
0.70 0.99 0.65 0.60 1.61 
5 	6 	5 	5 	5 
2.14 	0.60 8.56 4.40 8.58 
, 1 	I 11 ft 	c nt 01 
C) aupt 6, S.tiozzt1anoio pximim 0211 d000zo 
t 140. 
U 03 0 P 
Uniltfcctc 
P. 	oan 5.52 7.74 7.17 0.04 
50 0.46 0.34 0.23 0.22 
ft 5 S 5 5 
San 4.04 0.51 0.39 0.39 
SD 0.43 0.25 0.17 0.17 
A 5 5 5 5 
Xnfccd 
1 	roan 	7.46 	6.00 	0.40 	0.43 
50 0.37 0.64 0.31 0.31 
ft 	 5 	5 	5 	5 
2 	con 	7.07 	-3.19 	0.60 	5.21 
50 0.93 5.56 7.25 5.06 
ft 	 5 	5 	5 	S 
3 	==n 	7.69 	0.50 	0.99 	0.49 
SD 0.66 0.13 0.17 0.27 
n 	 5 	5' 	5 	5 
U = wtjtkulatcd crntrol tzront 
Co = 0:3110 txcotcd t,ith caho=emlin A (2.5xJt3L, 2roc2tly cD) 
Cb o  0:3110 oticulot8 u1th croc moi,ctlin A (2.5)Z0Jt31, coiut*cfl fro 	at a 
ccmontrotict of 2.0 bforo uc3) 
140 o  ha=g=ic otroin of S.ratti cult oocratory/ccrOtOty cntiçn tdc 
to 03110 
HE h3tQrco1ic strain of S.ratti adult ocretory/cCrQtOry cnei5cI c4 
to 0:3110 
S o S.vangroloqtoto cult 000tatory/c3ctatOcy ontiç2t c 	to 02110 
1 	antigen *zd rtmot 
2 antigen di1utc 1:2 
Ho h2torcc2IiC strain of .rotti 	it h0203noto antiçt Cd 	to 02110, 
stored overnight at +4 C, ucd root 
140 hatorogonic strain of S4rottt cult h oqanato anttç3tt c3t) to 02110, 
stored overnight at -20 C baforo t, u03d root 
P = crobinotian of. Co+ No LdtIOd to 02110 (ccmcantraticn of tha oltcan t30 
odjuctod to rrooin at 24u.ki1, but the antiçt ea dilutad 1:2) 
Q ° oambinatim of Ca + HE 	to 02110 (ccmontraticft of tho oitcn tZ30 
adjusted to rrooin at 2.5oJo1, but tha cntiçat o dilutcO  1:2) 
response of rat 3 to all three antigens, whereas, while rat 2 exhibited no 
response to the homogonic S.ratti antigen, it had a positive response to the 
other two (Table 9:la, page 197). 
9.3.2. apt 5, Homologous vs heteroOogous chalenge: heterogonic strain of 
S.rtti priming cell donors 
9.3.2.11. Materials and methods 
Five rats were divided into two groups:- 
Gp.X - 3 rats - infected by skin-application with 2000 infective heterogonic 
strain S.ratti larvae, provided immune mesenteric lymph node cells. 
Gp.Y - 2 rats - untreated, provided non-immune cells. 
All the rats were killed on day 12 of Gp.X's infection and their cells were 
used in a transformation assay (see Fig.9:7(ii), page 196). Egg and worm data 
were collected from the rats. 
9.3.2.2. Results 
Immune cells expressed a significantly higher level of unstimulated activity 
compared with normal cells (0.001<P<0.01, Table 9:1(b), page 197) but there 
was no difference in the level of mitogen-induced blastogenesis of the two 
cell populations, although there was a significant between rat variation within 
treatments (P<0.001, Table 9:1b, page 197). 
The response to antigenic stimulation was variable (Table 9:1b, page 197). 
A positive specific response was induced by heterologous challenge with the 
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homogonic S.ratti excretory/secretory worm antigen (P<0.05) but challenge 
with similar preparations from S.venezue/ensis or the homologous heterogonic 
S.ratti worms produced no effect. A pcstive response was however, produced 
by the homologous heterogonic S.ratt/ homogenate antigen (P<0.001). 
Inspection of the results (Table 91b, page 197) shows that the results from rat 
3 probably had a strong influence on the overall outcome of any analysis since 
its cells expressed a very depressed response to two of the three adult worm 
excretory/secretory antigens compared with those from rats 1 and 2. 
There was no difference in the response of cells from infected rats to 
treatment with the two samples of heterogonic S.ratti homogenate antigen 
suggesting that freezing does not affect the ability of the antigenic preparation 
to stimulate cells. Treatment of cells with a mixture of heterogonic S.ratfi 
homogenate antigen and concanavalin A did not increase the level of 
stimulation of the immune cells above that already obtained after treatment 
with mitogen only (Table 9:11b, page 197). 
9.3.3. Ept 6, Homologous vs heterologous Challenge: S.venezuelensis priming 
cell donors 
9.3.31. Materials and methods 
Five rats were divided into two groups:- 
Gp.X - 3 rats - infected by skin-application with 2000 infective 
S.venezuelens/s larvae, provided immune mesenteric lymph node cells. 
Gp.Y - 2 rats - uninfected, provided normal cells 
On day 12 of the infection animals in both groups were killed and their 
hI1!] 
cells were used in an assay to assess their response to various treatments 
(Fj.9:7(ii), page 196). Egg and worm data were also collected. 
9.3.3.2. Results 
There was a significantly greater level of unstimulated activity obtained in 
immune cells (P<0.01, Tabe 91c, page 197) but the response of the two cell 
populations to mitogenic stimulation was similar, although there was a 
significant between rat variation (P<0.001). There was no response to any 
antigen preparation (Table 81(ix), Appendix 8, page 348)and comparison of the 
results obtained from immune cells treated with concanavalin A on its own 
versus mixtures of coricanavalin A with either heterogonic excretory/secretory 
or homogenate worm antigen, showed there was no significant difference in 
the level of stimulation produced (Table 91c, page 197). 
9.3.3.3. Results of worm data for Expts 4-6 
Comparison of the worm burdens obtained on day 12 post-infection in 
experiments 4, 5 and 6 showed there was a significant difference in the results 
(P<0.001, Tables 8:2(iv)-(vi), Appendix 8, page 352). Application of least 
significant differences between treatment means demonstrated that the 
highest proportion of the dose was recovered from rats infected with the 
homogonic strain of S.ratt/ (P<O.05, compared to heterogonic strain of S.ratti 
P<0.001, compared with S.venezue/ensis. The lowest proportion of the dose 
was recovered from rats infected with S.venezuelensis (P<O.O1, compared with 
both S.ratti strains). 
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9.3.4. Epts 7 and 8, Homologous vs hGW09090us challenge, aduft and 
third-stage larval antigens: hrog)onic S.ratti prming cell donors 
93.4.1. Materials and methods 
Essentially the same protocol was used in both experiments. Ten rats were 
divided into 2 groups:- 
Gp.X - 6 rats - infected by skin-application with 2000 infective heterogonic 
strain S.rattilarvae, provided immune mesenteric lymph node cells. 
Gp.Y - 4 rats - uninfected, provided normal cells. 
Three rats from Gp.X and two from Gp.Y were killed on days 12 and 16 
post-infection, their cells were plated out as shown in Fig.9:8(i), Expt 7, and 
Fig.9:8(ii), Expt 8, page 203. Egg and worm data were recorded for each rat. 
9.3.4.2. Results 
There was no difference in the unstimulated activity of normal and immune 
cells in Expt 7 on days 12 and 16 post-infection, but there was a significant 
between rat variation within treatments in both cases (P<0.001, Figj.9:9a, page 
204). Calculation of the least significant difference between individual rat 
means at day 12 and day 16 showed that immune cells demonstrated a higher 
level of stimulation (P(O.05, day 12; P<0.001, day 16) which could have been 
masked by the between rat variation. However, in Expt 8 immune cells 
exhibited a significantly greater level of overall unstimulated activity on day 12 
post-infection (P<0.05, Fig.910a, page 20 despite a significant between rat 
variation within treatments (P<0.001). A similar higher activity in immune 
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cells was not demonstrated on day 16 post-infection in Expt 8 (F.10a, page 
2O7. 
Initial analysis showed there was no difference in the level of 
mitogen-induced stimultion exhibited by normal and day 12 immune cells in 
Expt 7 but it was obvious from the data that the results from rat 1 were 
affecting the outcome since cells from rats 2 and 5 had a depressed response 
(Fig.9:99, page 206, results for stimulation with sample A of concanavalin A 
only are shown for days 12 and 16 since there was no significant difference in 
the response of individual rat cells to both). Day 16 immune cells from Expt 7 
express a significantly lower level of blastogeneseis (P<0.001) despite the fact 
that there was, as usual, a significant between rat variation within treatments 
(P<0.001). In Expt 8 there was no difference in the level of mitogen-induced 
blastogenesis of cells from infected and uninfected rats on both day 12 and 16 
post-infection (Fij.9:10b, page 207). These results are confused by the 
anomalous results of rat 4. 
In Expt 7 none of the adult excretory/secretory antigens produced 
significant specific stimulation of day 12 immune cells (Fig.9:9b, page 204) 
whereas the S.ratti larval antigens did (P<0.01, Fig.9:9d, page . 205) but there 
was also a significant between rat variation within treatments (P<0.001). 
Direct comparison of the effect of antigens from larvae and adult S.ratti 
confirmed that the larval antigens were more potent in this particular assay 
(P<0.001). Consistent with results from day 12 cells, none of the adult 
excretory/secretory antigens caused specific stimulation of those from day 16, 
but inspectation of the data shows that overall, the means for individual rats 
were higher for infected animals, but that the high variation in the data was 
probably masking any effect (Fi.9:9c, page 205). There was no significant 
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Cells from an each rat were dispensed into a separate microtitre plate in both 
experiments and the appropriate sample added to each well as shown in (i) for 
Expt 7 and (ii) for Expt 8. Because of doubts about the potency of the 
concanavalin A in previous assays, 2 different sources of the mitogen were 
used in experiment 7. 
Fiq.9g8 
AS?parance of microtitre plate in $pts 7 and 8 
i) 
Columnno0 1 2 3 4 5 6 7 8 9 10 U. 12 
Row no.A in in in in in in in in in in in in 
B in U HE HO S HEL HOL SL Ca Cb m in 
C in U HE HO S HEL HOL SL Ca Cb m in 
D in U HE HO S HEL HOL SL Ca Cb in in 
E in U HE HO S HEL HOL SL Ca Cb m m 
F in U HE HO S HEL HOL SL Ca Cb m in 
G in U HE HO S HEL HOL SL Ca Cb in in 
H in in in in in in in in in in in m 
ii) 
Column no. 1 2 3 4 5 6 7 8 9 10 11 12 
Row no. A in in in m in in m in in in m in 
B in U HE HO S HEL HOL Ca in m in m 
C in U HE HO S HEL HOL Ca in in in in 
D in U HE HO S HEL HOL Ca in in in in 
E in U HE HO S HEL HOL Ca in in in in 
F in U HE HO S HEL HOL Ca in in in in 
G in Ii HE HO S MEL HOL Ca in in in in 
H in in in in in in in in in in in m 
Where: 
in = medium only added to the cells which were not harvested 
U = unstimulated control treatment (same treatment as cells with ntediuni but 
the cells were harvested) 
Ca = concanavalin A added to cells (20ig/in1 freshly made from the powder) 
Cb = concanavalin A added to cells (24igAnl7 solution frozen at a 
concentration of 2mg,4n1 before use) 
HE = cells treated with adult heterogonic strain of S0ratti 
excretory/secretory antigen 
HO = cells treated with adult homogonic strain of S0ratti excretory/secretory 
antigen 
S = cells treated with adult S0venezuelensis excretory/secretory antigen 
L = larval homogenate antigen added to cells (of the species or strain shown 
e0g0 SL 0 S0vertezuelensis larval homogenate antigen used) 
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Fig.9:9 
The response of cells obtained from uninfected (rats A-D) and infected donors 
(rats 1-6) to four main treatments is shown. That is, addition of medium alone 
(unstimulated controls, treatment U, Fg.9:e), homologous and heterologous 
worm excretory/secretory antigens (treatments HE, HO and S. Fpj9:9b and 
FLj.1:9c), homologous and heterologous somatic third-stage larval antigens 
(treatments 	HEL, 	HOL and 	SL, 	F.9:9d 	and F.9:9e) and 	concanavalin 	4 
(treatment Ca,F.:9f). As before, the P values show the results of the overall 
comparions and each bar shows the results of cells from one rat. 
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The effect of stimulation of cells obtained from uninfected (rats A-E) and 
infected donors (rats 1-6) with various preparations is shown. Namely, 
addition of medium alone (unstimulated controls, treatment U, Fãg.9:10e), 
concanavalin A (treatment Ca, Fig.:10b), homologous and heterologous worm 
excretory/secretori., antigens (treatments HE, HO and S. Füg.9:1Oc and Fg.:1Od) 
and S.ratti third-stage somatic antigens (treatments HEL and HOL, Fij.:We 
and Fig.:1Of). The probability valdes given show the results of overall 
comparisons and each bar in the histograms shows the results of one rat. 
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specific stimulation by the heterogonic S.ratti and S.venezue/ensis larval 
antigens on day 16 but the homogonic S.ratti antigen had an effect (Fig.9:9e, 
page 206). 
In Expt 8 none of the antigen preparations caused a significant specific 
stimulation of day 12 cells from two of the three infected rats (Fig.9:10c and 
9:10e, pages 208 and 209). With regard to day 16 and adult antigens, the data 
at first sight (Fg.910d and Fig.9:10f, pages 208 and 209) indicated that the 
response of cells from infected rats was not uniform across antigen types. 
Two-way analysis of variance confirmed this to be the case, the interaction 
between individual rats on the one hand, and parasite antigens on the other, 
being significant at P<0.05. A series of one-way analysis of the same data 
showed that cells responded in a consistent pattern to S.ratti antigens, but rat 
4 behaved anomolously with respect to S.venezue/ensis antigen. Treatment 
with larval antigens produced a specific response in day 16 immune cells 
(P<0.05) which was similar for homologous and heterologous challenge. 
Comparison of the level of blastogenesis produced by adult and larval antigens 
in immune cells showed that both were equally ineffective (day 12) or effective 
(day 16), bearing in mind that S.venezuelensis antigens were not tested. 
The worm burdens obtained in experiments 7 and 8 were compared using 
a two-way analysis of variance. There was no significant difference in the 
proportion of the dose recovered on days 12 or 16 for either experiment, but a 
significantly lower proportion of the dose recovered on day 16 compared with 
day 12 post-infection (P<0.05, Table 8:2(vii) and (vfii), Appendix 8, page 353). 
There was a possible posterior migration of adults on day 16 compared with 
day 12 post-infection in both experiments (TabDe 8:3(vi), Appendix 8, page 355). 
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9.4. Effect of ceOO density on the amount of stimuPation produced [Expt 91 
From the foregoing it can be seen that specific responses to parasite 
antigens of cells from primed rats did occur under some conditions. 
However, throughout these assays, it was impossible to demonstrate the 
difference between homologous and heterologous challenge that might have 
been expected from the present studies of cross resistance and adoptive 
immunity (Chapters 5 and 8). Several features of the experimental system may 
have made it insensitive to detect a difference, supposing one to exist. One 
obvious test of the method was to see whether it could discriminate between 
different numbers of cells responding, since the assumption being made was 
that it could. 
1]. Materials and methods 
Cell suspensions were prepared from the mesenteric lymph nodes of three 
uninfected rats and the cell concentrations estimated. Aliquots of the original 
cell suspension from each rat were made up to lOmI with cell medium to give 
a final concentration of 1x10 6, 2x10 6 and 4x10 6 cells/mi. These cells were 
plated out as shown in Figj.9:111, page 212, and one plate was prepared for 
each rat. The cells were cultured as described in Chapter 2, Section 2:6, page 
38, with addition of tritiated-thymidine on day 3. Seventeen hours later the 
cells were harvested and the level of radio-activity present per treatment 
found. 
2. Results 
There was a significant difference in the pattern of response of individual 
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Fg091l 
Appearance of inicrotatreplate in Ex 
Column no. 1 2 3 16 5 6 7 8 9 18 11 
12 
Row no. A in in in in in in in in in in in in 
B in 01 Cl Cl 02 C2 C2 03 C3 C3 i in 
C in 01 Cl Cl 02 C2 C2 03 C3 C3 in m 
D in 01 Cl Cl 02 C2 C2 03 C3 C3 in in 
E in 01 Cl Cl 02 C2 C2 03 C3 C3 in in 
F in 01 Cl Cl 02 C2 C2 03 C3 C3 in in 
G in 01 Cl Cl 02 02 C2 03 C3 C3 in in 
H in in in in in in In in in in in m 
Where:- 
in = mediimi only added to the cells which were not harvested 
U = unstimulated control treatment (saute treatment as cells with medium but 
the cells were harvested) 
C = concanavalin A added to cells (2u/Inl) 
1 = cells at a concentration of lxl85/Ml 
2 = cells at a concentration of 2xlø 5Anl 
3 = cells at a concentration of 4x18 ,inl 
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rats to mitogenic stimulation over the range of cell densities, since a 
significant interaction was present in the results (P<0.001, TWO 9:2, page 
214). A series of one-way analyses of variance showed that cells of rat 
number 3 expressed a similar level of blastogenesis at each cell concentration. 
Those of rat number 1 exhibited the highest level of triated-thymidine 
incorporation at a density of 1x10 5 and the lowest at 4x10 5cells/well. There 
was no difference in the proliferation of cells from rat number 2 incubated at a 
concentration of 1x10 5 or 2x10 5celIs/well, but incubation at a concentration of 
4x10 5  produced a lower response. Overall the level of unstimulated 
blastogenesis obtained at all cell concentrations seemed to be the same 
(P>0.05), although there was a significant between rat variation (P<0.025, 
Table 9:2, page 214). 
3. Common techniques used througout aID experiments 
The methods used to infect rats, to count the number of adults present, 
and the number of eggs in utero per worm throughout these experiments are 
described in Chapter 2, Section 2:10, page 47. The method of assessing the 
level of radio-activity present is described in Chapter 2, Section 2:6, page 38 
and the method of analysing the data is given in Section 2:11:3, page 53. The 
antigen pools used in each experiment are given in Appendix 8, Section 8:4, 
page. 356.. Actual results obtained in this section are given in Tables 
8:1(i)-(xv), Appendix 8, pages 344-364 
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Table 9 .- 2 
Effect of vapling cell densityçpt 9 ( data 12q_ transformed) 
Rat no0 	 Treatment 
03 	C3 	02 	C2 	Ui 	Cl 
1 	mean 529 8.3,6 4080 927 4.87 9055 
SD 065 032 0,30 0.33 9.35 018 
n 6 10 6 10 6 11 
2 	mean 523 839 459 852 526 904 
SD 072 063 0,30 129 056 022 
n 6 11 6 11 6 11 
3 	mean 499 908 484 9,50 551 920 
SD 033 038 031 0,15 028 L16 
n 6 11 6 11 6 10 
Where - 
o = unstimulated control treatment 
C = cells treated with cgncanavalin A (24ig/ml) 
1 = cell density of 1x10 5 cells/Ml 
2 = cell density of 2x105 calls/Ml 
3 = cell density of 4x10 cells/ml 
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B.S. Summary 
A higher level of unstimulated blastogenesis occurred in immune cells 
taken from rats at days 12-16 of an with Strongyloides sppinfection compared 
with their normal counterparts. Early in infection (day 8), there was no 
consistent increase in increased activity in immune cells though individual rats 
showed the effect. By day 21-28 post-infection the disparity had disappeared. 
The response of cells taken during the later stages of infection with 
Strongyloides spp, from day 12 onwards, showed a depressed response to 
mitogenic stimulation compared with cells taken from uninfected controls. The 
most consistent depression occurred on day 	 28 post-infection. 
The response of immune cells taken from donors infected with 
Strongyloides spp. to antigenic stimulation , although not consistent, seemed 
to follow the course of infection. On day 8 there was no increased 
blastogenesis initiated by specific stimulation, peak stimulation occurred on 
days 12-16, and by day 28, at the end of infection, no specific response was 
obtained. 
Wherever antigenic stimulation occurred there was no consistent 
difference in the degree of stimulation obtained after homologous or 
heterologous challenge. No stage-specificity was expressed by the cellular 
response, nor did the nature of the antigen presented, that is, whether 
excretory/secretory or somatic, effect the response obtained. 
One of the major consistent features of all experiments carried out was 
a high between rat variance in the response of cells from individuals to the 
same treatment. This occurred even with cells from uninfected controls. 
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f) The system could not detect a fourfold difference in numbers of cells 




The aim of this study was to investigate the inter-specific and 
intra-specific cross-immunity between three parasites within the genus 
Strongyloides The essential criteria recorded to measure the effect of the 
host's immune response in this context were: 
The proportion of the dose recovered post-infection. In the majority of 
cases rats were infected with an "exact" dose of <100 third-stage larvae of 
the relevant species/strain. 
The distribution of adults along the intestine. 
The number of eggs in utero per worm. 
Change in the proportion of the dose recovered was a clear cut measure 
of the host's anti-worm response but the most sensitive criterion proved to be 
changes in the egg data. In some cases a reduction in the number of eggs 
per worm was obtained either before, or without, an effect on the number of 
worms. For example, in Expt 7, Chapter 7 (page 126) a reduction in terms of 
eggs in utero was obtained in the group given a homologous challenge of 
adult homogonic S.ratti worms on day 4 post-challenge, whereas a 
corresponding reduction in worms was not present until day 8. Similarly, in 
the adoptive transfer experiments, a reduction in egg numbers was present on 
day 8 post-challenge but a reduction in worms was not obtained until day 16 
(page 151). 
An attempt was made to discover whether the reduction in the number of 
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eggs in utero per worm of challenged rats compared with controls was, 
indeed, a true reflection of reduced fecundity. This was done by measuring 
the number of third-stage larvae produced per gm of faeces per worm in one 
of the experiments (page 109). It was possible that worms could lay eggs at a 
faster rate in immune animals with the result that they spent a shorter time in 
the uteri. At any one instant, therefore eggs in utero would be fewer in 
number, even though there was no change in egg production (i.e. fecundity). 
Rats from both homologous and heterologous challenge treatments did 
produce fewer infective larvae per gm of faeces per adult parasite compared 
with their respective controls, but there was a high variability within each 
treatment. Comparison of the extent to which eggs in utero and third-stage 
larvae in faeces were fewer in challenged animals compared with controls 
showed no precise correspondence, though the data are too scanty to draw 
firm conclusions (see ratios RE and  RL3,  page  109).  In practice, the number of 
third-stage larvae produced per gm of faeces was probably not the best 
measure of worm fecundity since there is a high variability in larval production 
under apparently identical culture conditions (page 72 ). Had it been possible, 
it would have been better to measure the actual egg production in the faeces 
of rats, but, in the case of S.ratti a proportion of the eggs hatches in the 
intestine, so the numbers of first-stage larvae produced would also have had 
to be counted. Many workers do relate a reduction in the number of eggs in 
utero per worm with a reduction in worm fecundity with no supporting 
evidence. Moqbel and Wakelin (1979), Moqbel and McLaren (1980), and Moqbel 
et at. (1980), all refer to a reduction in this parameter as a reduction in the 
fecundity of S.ratti but they do not include results to show that there has 
been a corresponding reduction in the number of eggs or larvae produced per 
worm to confirm the statement. Therefore, lacking firm evidence on the matter 
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from this study, a change in the number of eggs in utaro per worm will be 
referred to without any implication that it is directly related to worm fecundity. 
This constraint in no way diminishes the value of the parameter as a measure 
of the host's anti-worm reaction. 
Throughout this study, the location of adults within the intestine was 
noted, since some workers have found that a longitudinal migration within the 
intestine was associated with a developing host immune response which 
resulted in worm expulsion. An anterior migration has been found for 
N.brasi/iensiS ( Brambell, 1965; Alphey, 1970), and a posterior migration for 
T.spira/is (McCoy, 1931; Kennedy, 1980), and S.ratt/(Moqbel and Denham, 1977; 
Moqbel and McLaren, 1980; Moqbel and Wakelin, 1981). There seemed to be 
little evidence for a similar posterior migration of S.ratti or S.venezue/ensis 
from my results. In a few cases there may have been posterior movement of 
S.ratti worms, but the majority were normally recovered from the first section 
of the intestine; for example, worms recovered from challenged treatments in 
Expts 2, 3, 5 and 7 (Chapter 5), seemed to be located more distally in the 
intestine compared with corresponding controls (page 313 ). However, in 
immune animals this observation was based on the relative position of only a 
few adults (generally less than 10), therefore it may have no general 
applicability. The apparent contradiction between present results and those of 
Moqbel and co-workers may be related to the size of dose, since an infection 
dose twenty-times smallefthan that of those researchers was used. The fewer 
adults present in the experiments reported in this study may have sensitized a 
comparatively small area of local foci in the anterior intestine, and were thus 
able to move to a new site within the same region to escape any detrimental 
effects inflicted by the host's immune response. If there were many worms 
present, a large area of the anterior intestine may become sensitized and adult 
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parasites may have to move posteriorly to find a more hospitable site. 
There seemed to be a difference in the distribution of S.ratti and 
S.venezue/ensis in Edinburgh colony Wistar rats, but the two species did 
overlap. Adult S.venezuelensis parasites were apparently restricted to the first 
three sections of the intestine whereas S.rattiworms were recovered as far as 
section five (e.g. controls of Expts. 8 and 9, Chapter 5, page 316). This may 
be related to the small number of adult S.venezue/ensis found post-infection, 
but 85 worms recovered from primary controls in Expt 11, Chapter 7, still 
exhibited a similar distribution (page 329). It would not be surprising if the 
two species had a different distribution since if they are to co-exist they must 
not exhibit total niche overlap (Schad, 1963). The fact that the longitudinal 
distribution of the two species overlaps to some extent does not mean they 
would be competing directly in that zone. Wertheim (1970b) suggested that 
the two species have a different radial distribution, and in the experience of 
this researcher, S.venezuelensis parasites are located nearer to the gut lumen 
than S.ratti 
10.1. Preliminary studies 
One of the most vital of the preliminary experiments was to ensure that 
skin-penetrating third-stage Strongy/oldes spp, which could have developed 
from the faeces of rats carrying a worm burden, did not re-infect the animals. 
If this had occurred it would have complicated all the long term experiments. 
It was reassuring therefore, that, even when rats were not regularly cleaned 
out, the in-contact control animals did not become infected (page 60). 
Nevertheless, throughout this study the cleaning regime tested in the 
alternative treatment in this experiment was adopted, to ensure that there was 
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no possibility of rats re-infecting themselves. 
It has been suggested by Moqbel and Denham (1978) that auto-infection 
occurs in S.ratti whereby first-stage larvae which have hatched in the host's 
intestine could develop directly to the adult in an immunosuppressed host. 
There was no reason to suggest that rats in the experiments reported here 
were immunosuppressed, but it was necessary to devise some test to see 
whether auto-infection was a common event, because it could have had 
profound effects on the results. Therefore the surgical transfer technique was 
used to introduce first-stage S.ratti larvae directing into the host's intestine 
(page 64). As no worms were recovered from any of the rats thus infected, it 
was assumed that auto-infection, if it occurs at all, is a rare phenomenon 
which can be safely excluded as a complicating factor in the interpretation of 
experimental results. 
Graham (1939) thought that there was a seasonal variation in the 
production of free-living adults from faecal cultures of his heterogonic strain 
of S.ratti, which reflected subliminal changes in the environmental conditions 
to which the host was exposed. If there was a similar seasonal variation in 
the number of third-stage larvae produced in cultures, it could reflect changes 
in the egg production of parasitic females in the gut. This would have meant 
that measurements of the number of eggs in utero per worm, one of the 
criteria used to record an anti-worm response, could have been suspect. 
Therefore the output of infective larvae from faecal cultures of the three types 
of parasite used in this study over the course of two years was studied. 
Fortunately, no regular pattern of the sort in question emerged (page 72). In 
this experimenter's experience variations in the number produced were due to 
random changes in the uncontrolled conditions of faecal culture. Few larvae 
221 
were collected if the paper towel on which the faecal pellets were collected 
was either too wet or too dry: if faecal cultures were made too wet at the 
beginning, or during incubation, very few larvae emerged. These parameters 
were a matter of personal judgement and only a very detailed study would 
identify the optimum conditions to ensure that the majority of larvae from a 
given faecal sample was obtained. Even if such optima could be defined, it 
would probably be impossible to conform to them under routine culture 
conditions. 
Most of the experiments in this study ran for 5-6 weeks and, in order to 
accommodate all the animals necessary, rats had to be housed together. 
Bailenger and Cabannes (1976) have shown that changes in the blood 
corticosteroid levels can have an antagonistic effect on the non-specific 
inflammatory response, leading to a higher S.ratti worm burden. Stressful 
situations are among the factors which cause alterations in the hormone 
levels; so it had to be established that a method of housing rats which might 
create stress due to an increase in the social interactions between animals, 
would not result in higher worm burdens. The results of experiment 1, 
Chapter 3 (page 58) provide firm evidence that this possibility could also be 
disregarded in the interpretation of results. 
A major problem encountered in this study was a resistance to infection 
with S.venezuelensis in Edinburgh colony Wistar rats. A potential way of 
overcoming this was to introduce adult S.venezuelensis worms directly into 
the intestine of the host, since it was possible that the innate resistance was 
expressed during the parasite's migration and development. Before 
comprehensive, comparative studies of surgical transfers using adult worms of 
all three types of parasite to prime rats were attempted, a number of 
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preliminary experiments were undertaken to determine the optimum technique 
to apply. It was found that worms had to be transferred within two hours of 
the donor's death, since the time adults spent in the extra-intestinal 
environment could have a detrimental effect on their survival post-transfer 
(page 62). Kennedy (1980) found a similarly depressed worm survival if adult 
Tsp/rails were transferred later than two hours after the donor's death. To 
avoid such damage, the deaths of the rats which supplied the worms to be 
transferred were sequential, since one rat could only supply enough adults to 
infect 4-6 rats with an exact dose of <50 worms (page (51). In order for this 
to be valid experimentally, it was necessary to show that worms from different 
donors were not significantly different in terms of viability. It was reassuring 
therefore to find that adults aquired from different hosts had equal capabilities 
of establishing in a new rat (page 63). 
Another method used to carry out reciprocal challenge experiments with 
both strains of S.rattf and S.venezuelensiS was adoptive transfer of mesenteric 
lymph node cells between rats of the PVG inbred line (page 149). Initially it 
had to be ensured that injection of the medium in which the cells were 
suspended had no effect on the worms which might have been interpreted as 
immunological. It was found that the medium had no such effects, therefore 
any changes following the transfer of immune cells could be attributed to the 
influence of the cells themselves (page 66). 
In preliminary studies of the lymphocyte transformation assay, the effect of 
three factors on the level of stimulation obtained was investigated as follows: 
serum concentration in the cell medium, mitogen concentration, and the day of 
harvesting the cells. Human serum at a concentration of 15% was used to 
supplement the cell medium since this produced the highest level of 
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mitogen-induced stimulation of the three concentrations tested (page 7). 
Paradoxically, this also caused the maximum suppression of unstimulated cell 
activity, implying that it may be blocking some response at this concentration; 
but since the most important aspect in these experiments was the amount of 
specific stimulation produced, this was disregarded. A high level of 
stimulation was produced using concanavalin A at a concentration of 2.5pg/ml 
so it was decided that this concentration would be used throughout 
experiments (page 68). The results of Expts 11 and 12 showed that peak 
mitogenic response was demonstrated if cells were harvested on day 3 of 
culture (page 70). However, the response to antigenic stimulation may not 
occur as early as this. Genta et a/. (1983) did not harvest rat cells stimulated 
with an S.ratti antigen until at least 79 hours post-stimulation. and Bloch et al. 
(1977) harvested theirs, treated with a N.bras/Iiens/s antigen, after 90-96 hours 
of culture. Taking all things into consideration, it was decided that cells would 
be harvested on day 4 of culture, when a good response to mitogenic 
stimulation was still obtained, and cells would have been exposed to the 
antigen for a prolonged period. 
The preliminary experiments on lymphocyte transformation were carried 
out using cells from uninfected rats. Ideally they should have been repeated 
with cells from individuals infected with Strongyloides spp, to ensure that 
conditions were equally suitable in this context. Due to financial restrictions 
this was not possible. The experimental protocol used was based on that of 
Genta et al. (1983), who investigated the effect of stimulation of mesenteric 
lymph node cells with a S.ratti antigen, therefore it seemed unlikely that the 
conditions would be unfavourable. In conformity with this protocol, a 
concentration of 2x10 5  cells per well was adopted as standard since, with it, a 
good level of mitogen-induced stimulation had been obtained (but see later). 
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Before reciprocal challenge experiments using full infections of all three 
Strongyloides spp. parasites to prime animals could be carried out, it was 
necessary to discover how long a primary infection with an exact dose of 
<100 infective larvae would last. It was essential to know this in order to 
challenge rats when the effects of the host's inflammatory response against 
the priming infection had subsided. Unfortunately it was only possible to 
investigate this aspect for the two S.ratti parasites, because infection of 
Edinburgh colony Wistars rats with a similar small dose of S.venezue/ensis led 
to an insignificant adult worm burden (page 84). Results showed that the 
majority of adult worms from a primary infection of an exact dose of less than 
100 third-stage S.ratti had been expelled by day 28 post-infection (page 84). 
Previous workers, using infection doses 10-40 times larger, found that the 
duration of a primary infection of S.ratti had a similar time span (Moqbel and 
Denham, 1977; Moqbel and Wakelin, 1981). 
There seemed to be a difference in the pattern of worm loss exhibited by 
the two strains. Two replicate experiments (Expts 1 and 2), using the 
homogonic strain revealed similar rates of loss. This was in spite of a 
significant difference in the proportion of the dose obtained at each sampling 
time. In the single relevant experiment (Expt 3), the heterogonic strain 
suffered progressively greater losses than the homogonic strain, illustrated by 
the higher exponential coefficient in that case (page 9 1 ). Whether this was 
due to a more severe specific anti-worm response against the heterogonic 
strain, or to a non-specific innate resistance, could be debated. The former 
would be consistent with results from some of the adoptive transfer 
experiments carried out, since no dose-response effect was exhibited in 
homologous adoptive resistance of rats primed with immune cells obtained 
from donors infected with two widely different levels of the heterogonic strain. 
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From this it was apparent that <100 larvae produced just as potent an 
immune response in cell donors as infection with 2000 (page 157). In contrast, 
a dose-response effect was expressed if the homogonic strain of S.ratti was 
used in the same protocol, demonstrating that an exact dose of <100 larvae 
produced a less severe immune response in cell donors (page 157). Thus the 
heterogonic strain of S.rarti might be a more potent stimulator of the host's 
specific immune response. On the other hand, the host may express a higher 
level of innate resistance against the heterogonic strain, since a consistently 
lower worm burden was obtained for this parasite, compared with the 
homogonic strain, in naive Wistar and PVG strain animals (Table page 
227). Therefore a more severe innate response against the parasite, coupled 
with specific events, may explain the phenomenon. Further experimentation 
would be necessary to decide between these alternatives. 
There was also a reduction in the number of eggs in utero per worm over 
the course of infection with S.ratti but, as no measurement of the egg or 
third-stage larval production was taken, it was not known if this reflected a 
reduction in worm fecundity. The data of Moqbel and Denham (1977) can be 
used to show that worm fecundity did decrease over the course of their 
infections, since one can calculate that the number of third-stages produced 
per gm of faeces per adult worm fell from 12.7 on day 10 to 3.4 on day 32 
post-infection. Unfortunately they did not refer to this specifically or measure 
the number of eggs in utero per worm. Had they done so, it could have 
settled the question of the relationship of the two parameters. There seemed 
to be an equilibrium level of two eggs in utero per worm in the present 
experiments, reached on day 26 for the homogonic strain, and on day 20 
post-infection for the heterogonic. This contrasts with the results of Moqbel 
and McLaren (1980) and Moqbel and Wakelin (1981), who recorded a value of 
Table 10:1 
g and worm data collected throughout this sthdy 
Parasite proportion of the mean number of 
dose recoverered eggs in utero 
S/A I 	S/A day 16 per worm per worm 
per ra 
yeneZUeleRij X 0.045 





(PVG rats) Y 0,353 6841 6.821 
3 2 2 
SD 008 0,01 0,,01 
0.296 6.522 6.500 
n 2 2 2 
SD 0,03 046 029 
homogonic Y 0,562 7.224 7.246 
n 25 22 15 
(Wistar rats) SD 008 039 042 
0.501 7.210 7178 
n 15 13 13 
SD 012 084 083 
(PVC rats) Y 9.423 6.883 6.859 
n 8 8 8 
SD 0010 036 0,39 
heterogonic Y 0,482 5982 5.898 
$,rattj n 10 9 9 
(Wistar rats) SD 0,11 0,,55 0..54 
0.473 5.967 5.744 
n 6 6 6 
SD 007 003 0039 
(PVC rats) R 0,307 5.781 5.732 
n 8 8 8 




0.0, and less that 0.5, eggs in utero per worm, respectively, on day 26 
post-infection with S.ratti This difference could be related to the use of 
different sized doses to infect rats, perhaps implying that a dose-dependent 
anti-worm response exists which could be demonstrated as changes in the 
egg data. Beyond the likelihood that they are immunologically mediated (see 
later), the actual mechanism or mechanisms responsible for the reduction in 
the egg and worm numbers in these experiments are unknown, but it is 
improbable that both are manifestations of the same isolated process for 
reasons to be discussed (page 243, et seq.). 
10.2. Studies on S.venezuelensiS 
A number of experiments were carried out in an attempt to explain why 
only a few adults were recovered from Edinburgh colony Wistar rats infected 
with an exact dose of <100 third-stage S.venezuelensis larvae. Two of the 
factors investigated were found to have an effect; the age of the host and the 
size of the infection dose. 
Increasing the size of the dose to 2000 third-stage S.venezuelensis seemed 
to increase the proportion recovered as adults, but it must be noted that no 
controls infected with small exact doses were included in the experimental 
protocol (page 114). This was the reverse of what was found by Wertheim 
(1970b), for, in her experiments, a dose of 2000 led to an 82% reduction in the 
proportion recovered compared with one of 250. The only difference between 
this study and that of Wertheim would appear to be the strain of rat involved. 
There was a definite age-related resistance to infection demonstrated in 
Edinburgh colony Wistar rats, since a significantly greater proportion of the 
dose was recovered from three-week old, compared to adult, rats at 72 hours 
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using labelled larvae, (page 1115), and on day 8 post-infection, when worms 
were counted directly (page 114). However, the proportion recovered from 
three-week old rats was still significantly lower than that obtained from 
similarly aged animals infected with S.ratti (page 115). 
The basis of the age-related resistance is unknown, but it could be due to 
a number of factors: either physical, physiological or associated with 
fundamental differences in the ecology of this parasite compared with S.ratti 
(see later). 
Lewert and Lee (1957) found that susceptibility of the host to infection with 
S.ratti decreased with age and that, at the same time, the ability of infective 
larvae to penetrate the skin was reduced. The physiology of the host can 
have an effect since the immune response of rats against N.brasiliensis was 
shown not to be fully developed until they were 7-9 weeks old (Ogilvie and 
Love, 1974), implying that some component involved in the expulsion of the 
parasite is not fully developed until the rats reach a certain age. This does 
not seem to be the case for S.venezuelensis since 3 week old rats, primed 
with an exact dose of <200 infective S.venezuelensis larvae, express a 
significant immune response against heterologous challenge with both strains 
of S.rattigiven 9 weeks later (page 1411). 
A similar age-related resistance was demonstrated for S.ratti by Zamirdin 
(1974) who worked in this laboratory. He obtained a significantly higher 
proportion of an exact dose of less than 100 infective S.ratti (homogonic 
strain) from three-week old rats compared with that obtained from 9 or 12 
week olds. However, the same effect was not demonstrated with this 
particular parasite in this study (page 11. 
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It was not fully appreciated until experiments using PVG rats were started 
what a profound effect the strain of the host could have in this context. Higher 
adult S.venezue/enSiS recoveries were obtained from this strain of rat 
compared to that obtained in Wistars (Tabe 10:1, page 227). For example, a 
proportion of 0.421 of an exact dose of <100 larvae was recovered on day 8 
post-infection from PVG animals (page 352); whereas a proportion of only 
0.013 was obtained from Wistars (page 32), infected with a similar small dose. 
This may explain why these results contrast with those of other workers. 
Wertheim (1970b) recovered 44% of a dose of 250 infective larvae in "Sabra" 
strain rats, and Nolan and Katz (1981) recovered 3.16% of an inoculum of 4000 
third-stage larvae from "Sprague-Dawley" animals, both on day 7 
post-infection. 
The experiments carried out using radio-labelled larvae led to some 
important conclusions. First, the results showed that S.venezue/ens/s infective 
larvae lost a third of their attached label during their development (page 15). 
Seaton (personal communication) has found that 50% of the same radio-active 
label attached to Ostertagia circumc/ncta third-stage larvae was lost during 
exsheathment. Thirty-seven percent could be accounted for on the sheath, 
the remaining 13% was probably metabolised away. Similarly, Georgi and Le 
Jambre (1983), who also used 
75  Se, found that 40% of label attached to 
infective Haemonchus contortus larvae was lost during chemically-induced 
ecdysis, 17-32% being lost in a soluble form. Therefore, in order to carry out 
critical studies using this method, it would be useful to obtain some sort of 
correction factor for all three Strongyloides spp. which would take into 
account the amount of label lost during their development. 
Assuming that the homogonic strain of S.ratti and S.venezue/ensis lose a 
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similar proportion of their attached radio-label, the results of Expt 5 (page 115) 
would indicate that the migration of S.venezue/ensis took longer, since 
third-stage S.venezuelensis larvae were apparently still reaching the intestine 
after 72 hours post-infection. Seaton (1983), who worked in this laboratory 
with 755e labelled larvae, found that the migration of S.ratti was completed 
after 40 hours, but results of other workers using traditional methods have 
implied that it has not terminated until after 96 hours post-infection (Abadie, 
1963; Wertheim and Lengy, 1965; Tada et al., 1979). The report of Wertheim 
(1970a) is at least in agreement with the data collected in this study in so far 
as the migration of S.venezuelensis took longer that that of S.ratt/ Wilson et 
al. (1986) have discussed the reasons why traditional methods may lead to an 
over-estimate of such periods of migration. 
Piecing together various bits of information collected about the biology of 
5.venezue/ensis in this study, one can put forward some reasons for the low 
worm burden obtained in Edinburgh colony Wistar rats. First, a higher 
proportion of the dose was recovered from three-week old rats compared with 
their adult counterparts (pages 114, 115 and 141). Second, a significantly 
higher proportion of the dose was recovered from 3 week old rats compared 
with adults at three days post-infection, implying that in adult rats infective 
larvae were not reaching the intestine (page 115). Third, a cumulative 
S.venezuelensis worm burden was not obtained in rats exposed to a trickle 
infection (page 13. 
One way to interpret these results would be to assume that the 
transmammary route of infection, which has been demonstrated in a number 
of Strongyloides spp, for example, S.ratti in rats (Zamirdin and Wilson, 1974; 
Wilson et a!, 1976a, 1976b, 1978, 1981, 1982), S.westeri in equines (Lyons et 
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at 1973, 1977), and S.ransomi (Moncol and Batte, 1966; Stewart at at, 1969, 
1976); predominates in S.venezuelens/s Let us assume that the majority of 
third-stage S.venezue/ensis larvae which infect adult rats form a larval tissue 
pool available for milk-borne infection. Therefore, if the rat is female and 
becomes pregnant, physiological triggers, induced by hormonal changes in the 
host, activate the larvae to migrate to the mammary gland for passage into 
the pups. Once transferred to a susceptible host all the larvae pass to the 
intestine and develop into parasitic female worms. These produce eggs which 
pass into the external enviroment and develop into the skin-penetrating 
infective larval stage and so the cycle begins again. It would be relatively 
simple to discover if this theory applies since treatment of rats with 
corticosteroids should be able to demonstrate if infective larvae of 
S.venezuelensis do undergo an arrested development in the adult host. So far, 
apart from the fact that milk-borne infection does occur (Nolan and Katz, 
1981), insufficient is known about it in S.venezue/ensis Comparative studies in 
this laboratory of transmammary infection by S.ratt/ leads to the conclusion 
that hypobiosis is not involved in that case (Wilson, personal communication). 
There is an anomaly in that S.veneueIensis develops well in adults of the 
"Sabra" (Wertheim, 1971) and PVG (Table 10:1, page 227) strains of rat. 
However, it is common to find specificities according to the strain of host 
associated with unnatural host/parasite combinations, and, possibly, the adult 
rat is equivalent to an unnatural host in this case. 
110.3. Framework for the study of cross-immunity between S.ratti and 
S. venezuelans/s 
From the preliminary experiments it emerged that it was impossible to 
prime adult Edinburgh colony Wistar rats against S.venezue/ensis using a full 
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infection, so that other methods to carry out reciprocal cross-challenge 
experiments in vivo were investigated, in the hope that one or more would 
provide a suitable experimental system. Four methods were tested and of 
these, priming with adult worms, and full infections in immature rats, showed 
some promise of success. 
No protective response was obtained in homologously challenged rats 
primed with a single dose of 10,000 heat-killed third-stage homogonic strain 
S.ratti larvae (page 122). As it had already been found that S.ratti was a 
potent stimulator of the host's immune response following the normal 
sequence of infection (page 93), it seemed pointless to continue further 
studies using this protocol. Recent experiments by Conder and Williams (1983), 
where rats were also immunised with a single injection of dead infective S.ratti 
larvae, suggest that the immune response thus initiated does not affect the 
ability of worms to establish, but that their egg production and the mean 
number of eggs in utero per worm are reduced. Unfortunately, this parameter 
was not measured in this experiment. It might be interesting to carry out 
further studies, using the present protocol, or that of Conder and Williams, to 
discover if strain and / or species specificity is reflected in differences in eggs 
in utero in response to priming with dead larvae. 
Exposing rats to a trickle infection of S.venezue/ensis for 6 or 10 weeks did 
not immunise animals against subsequent challenge infection with an exact 
dose of less than 100 infective homogonic S.ratti larvae, nor did it lead to 
cumulative S.venezue/ensis worm burdens over the course of the experiments 
(page 132). In contrast, Jenkins and Phillipson (1970) were able to protect rats, 
primed using a trickle infection of N.brasi/iensis against homologous 
challenge; and they also obtained a cumulative worm burden. However, they 
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used very young rats in their experiments, which have been shown to have a 
reduced ability to expel adult N.brasi/iensis worms (Jarrett et a/, 1966, 1968), 
and it has also been shown that the rat's immune response against 
N.brasiiensis does not become fully competent until animals reach 7-9 weeks 
of age (Ogilvie and Love, 1974); therefore the difference could be due to the 
use of different aged rats in the two studies. 
Priming rats with surgically transferred worms seemed to offer a method 
for investigating the antigenic relationship of the three Strongyloides spp., but, 
unfortunately, the high variability obtained within treatments reduced the 
sensitivity of the assay, so that only gross changes in the host's immune 
response would be identified (page 126). Therefore, this method of 
comparison was abandoned since it was very unlikely that the assay would 
have detected small differences in the host's immune response against the 
parasites. The egg data seemed less affected by this overall variability 
because, in both of the relevant experiments (see above), there was a 
significant reduction in the number of eggs in utero per worm in challenged 
treatments compared to their respective controls. The host was also 
expressing some specificity in Expt 8 since homologous challenge produced a 
significantly greater relative reduction in uterine eggs compared with its 
control (page 135). It may be rewarding to carry out comparative studies 
which concentrate wholly on this measurement of the host's anti-worm 
response, but, unfortunately, it was impossible to embark on a new framework 
of experimentation midway through this project. 
The most promising results came from immature rats primed against a full 
infection of S.venezuelensis Three-week old animals, given an exact dose of 
<200 third-stage S.venezue/ensis larvae, produced a significant resistance 
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against homologous and heterologous S.ratti challenge 9 weeks later, which 
appeared as a reduction in the number of eggs in utero per worm for all 
treatments as well as a reduction in the proportion of the dose recovered after 
heterologous challenge, compared with the respective controls (page 141). 
Taking the analysis further, quantitative comparison of the immunity 
induced using the worm data revealed no significant difference in the degree 
of protection obtained after challenge when all three parasites were 
considered. This outcome was not surprising because there was a high 
variability within the data for homologous challenge (coefficient of variation for 
this was 127%, whereas it was only 21% for homogonic S.ratti challenge, and 
27% for heterogonic S.ratt,). If the homologous challenge group was omitted 
from the analysis, it became apparent that heterologous challenge with the 
heterogonic strain of S.ratti produced a significantly greater level of immunity 
in the rats (page 145). The data for eggs in utero from this experiment were 
more homogeneous. Comparison of the level of resistance produced by all 
three treatments, on this basis, demonstrated the existence of a graded 
immune response against the parasites (page 145). Homologous challenge 
elicited the maximum level of immunity, followed by heterologous challenge 
with heterogonic S.ratt,, and the minimum amount was produced by 
homogonic S.ratti challenge . This confirms the results of the worm data and it 
also implies that there is some antigenic diversity between the two S.ratti 
strains (see later) 
The high variability within the homologous challenge treatment implied that 
"responder" and "non-responder" rats may exist within the rat population, 
which vary in their ability to expel S.venezuelensis Three of the seven rats 
within the homologous treatment expelled all their worms, whilst adults were 
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recovered from the remaining four animals. The existence of "responders" and 
"non-responders" within the host population has been identified for other 
parasites: T.muris in mice; Wakelin, 19'5; Tsp/rails in mice; Bell et a!, 1982a 
and 1982b; (also see review by Wakelin, 1978). 
The previously described age-related resistance to infection of Wistar rats 
with S.venezuelensis was also demonstrated in this experiment, since a 
significantly higher proportion of the dose was recovered from primary 
compared with secondary controls (page 14. Adult S.venezue/ensis parasites 
were recovered from the heterologous challenge treatments, and these worms 
must have been exposed to an immune response since rats harbouring this 
infection, when challenged, were resistant to re-infection with S.ratt,. 
Therefore, the adult S.venezue/ens/s had somehow managed to survive despite 
being in a hostile environment. There was no significant difference in the 
proportion of the dose recovered of this species from any of the challenged 
groups, or the secondary controls. It is posible, therefore, that there is a 
constant proportion of S.venezue/ensis worms within the population which is 
specially adapted to mature in older hosts and to evade the rejection 
mechanism of the immune response. 
Further studies with young rats were not pursued, because information on 
the amount of cross-immunity between the two strains of S.ratt/ had already 
been collected using adult hosts. The results of reciprocal challenge 
experiments with S.ratti primed animals would have been difficult to interpret, 
because of the age-related resistance to S.venezuelensis 
The antigenic relationship of the three parasites was also studied using an 
in vitro assay of immune lymphocytes, with variable results. Nevertheless, 
some very interesting results did come out of these experiments which, for 
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simplicity will be discussed in the order of the three main types of treatment 
used; i.e. the behaviour of unstimulated controls, the response of cells 
exposed to concanavalin A, and their response after treatment with antigens. 
There seemed to be a higher level of unstimulated activity in immune cells, 
compared to their normal counterparts, which followed the course of infection 
(Table 0:2, page 239). Although technically "non-specific", the increased 
activity could indicate that the cellular response against Strongyloides spp. did 
not begin until after day 8, that it peaked on days 12-16, and then dropped 
back to control levels by day 21 post-infection. This increase in non-specific 
blastogenesis may be a general feature of parasitic infection, since it has been 
reported in other systems; for example, in Trypanosoma bruce/in mice (Corsini 
et al., 1977); Plasmodium fa/ciparum in mice (Greenwood and Vick, 1975); 
Plasmodium berghe/in mice (Golsener et a/., 1975); Toxoplasma gondiiin mice 
(Strickland et al., 1975), and N.brasi/iensis in rats (Bloch et 8/., 1977); and it is 
often related to the course of the infection. The effect may be restricted to 
cells present in the lymphatic organ draining the site occupied by the worms, 
since Bloch et at (1977, see above) only obtained an increased activity in 
mesenteric lymph node cells: spleen cells from the same individuals did not 
exhibit the phenomenon. 
The mitotic activity initiated in viva was still high after 80 hours of culture 
in vitro in the present experiments, so that it was likely that cells went 
through more than one cycle of DNA replication. A similar observation 
probably applies to cells obtained from rats infected with N.brasi/iensis in 
experiments by 810th et a!, since they still incorporated label between 73-96 
hours after the start of in vitro culture. However, in rats infected with 
P.berghei increased unstimulated activity of spleen cells was restricted to the 
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first 8 hours of culture. Possibly in that case, therefore, in vivo stimulation 
initiated just one cycle of DNA multiplication (Golsener of al. 1975). It would 
be interesting to characterise the increased unstimulated response in immune 
cells from rats infected with Strongy/oides spp, to discover how long it could 
be sustained in vitro, when the peak activity occurred, what the products of 
the cells were, and whether there was any strain or species-specificity 
demonstrated by the response. 
The activity of cells treated with concanavalin A was intended as a positive 
control to check that they were capable of responding to stimulation, but 
these results also yielded some information on the events which may have 
been occurring in viva On day 8 post-infection there was no difference in the 
response of immune and normal cells to mitogenic stimulation; on days 12 
and 16 an apparently depressed response was sometimes obtained, but on 
days 21 and 28 post-infection there was a definite reduced response by 
immune cells (TabOo 10:3, page 240). When the depressed response was 
obtained on days 12 and 16, it was generally an artifact inherent in the 
method of analysing the data, since a relatively higher level of unstimulated 
activity present in immune compared with normal cells at this time (see 
earlier) meant that a lower differential count was obtained for them. The 
actual number of counts per minute obtained for the two cell populations in 
response to mitogenic stimulation was similar. Thus cells from infected 
individuals were probably expressing a near maximal response to stimulation 
before they were placed in culture. 
A depression in the response to concanavalin A stimulation was elicited in 
immune cells taken from rats infected with Strongyloides spp. on day 12 
post-infection in Expt 4, .. . .... and on day 28 in Expts 1 and 2 
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Table 12 
Unstimulated blastogenesis inmune vs normal mesenteric lyh node cells 
Parasite used 	Day post Expt Activity compared with normal cells 
to prime cell infection elevated 	depressed no change 
donors 
heterogonic 	5-rot 	8 1 
3 






S0 ratt i 
heterogonic 	16 1 
S0ratti 7 
8 
S0venezuelensis 	21 	3 
heterogonic 	28 	1 
S0ratti 	 2 
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Table Igo 3 
concanavafln A stimulation: normal vs intinune cells 
Parasite used 
to prime cell 
Day post= 
Infection 
Expt Activity relative to normal cells 
donors 
elevated 	depressed 	no change 
heterogonic 8 1 
S0rattj 






heterogonic 	16 1 
S0rattj 7 
8 
S0venezuelensis 	21 3 
heterogonjc 	28 1 
S0ratti 2 
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(chapter 9). In Expt 	, 4 a specific response occurred to antigenic 
stimulation whereas in Expts 1 and 2 there was no response (Table 10:4, page 
242) suggesting that cells with specifiities for Strongy/oldes spp. antigens 
were "switched off" during the later stages of infection, when a fully effective 
immune response had been completed. It would seem logical for the host to 
dampen its reaction against the parasites at a time when all the worms had 
been expelled in Expts 1 and 2, but a high number of adults was recovered 
from rats which supplied the immune cells for Expts 3 and 4. A similar 
depressed response to the mitogen phytohaemaglutinnin was not obtained by 
Dobson and Soulsby (1974), who studied the response of peripheral blood 
leukocytes from guinea pigs infected with the sheep parasite Trichostrongy/us 
colt/br/form/s This could be due to the use of different cell populations in the 
two studies, since it has already been shown that an increase in the 
unstimulated non-specific activity of immune cells can be restricted to the site 
occupied by the worms (see earlier). 
One of the problems associated with analysing the lymphocyte 
transformation data is differences in the unstimulated non-specific activity of 
different cell populations. A method commonly used in the belief that it 
overcomes this difficulty is to calculate the stimulation index for different 
treatments (i.e. "experimental" divided by "unstimulated control"). 
Unfortunately, as found in this study, this can lead to misleading results. For 
example, if the response of immune and normal cells to concanavalin A 
stimulation is considered then, if the unstimulated activity of immune cells is 
quantitatively much higher than that obtained for their normal counterparts, it 
would lead to a much lower stimulation index for treatment with the mitogen 
even though the actual number of counts per minute for the two cell 
populations may be very similar. The apparent depression in response is an 
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Tabe 10:4 
Cells from uninfected and infected animals were exposed to various antigenic 
preparations. A significantly greater response in the cells from infected rats 
was taken as an indication of a specific response to the antigen. This table 
summarises the data collected from my studies and shows which antigens 
produced a positive response in a particular test. Thus the effect of 
homologous and heterologous challenge of the cells can be compared. 
Table Igo 4 
§R121fic response to antigenic stimulation 
Parasite used 	Day post- 	Expt 	 Antigen added to cells 
to prixte cell infection Adult 	 Larval 
donors 	 E/S 	hctogenate 
HO HE S HE 	HE HO S ! 
heterogonic 	8 	1 
S0ratti 
S0veneuelensis 	 3 
heterogonic 	12 	5 	+ 
S,ratti 	 7 + 	 + 	+ + 
8 	+ + 	+ 	 + - 
S0venezuelensis 	 3 	+ 	 + 
6 
homogonic 	 4 	+ 	+ 
S0ratti 
heterogonic 	16 	1 
S0ratti 	 7 	 _ 
8 + 	+ 	+ 	 + 
S0venezuelensis 	21 	3 	 + 	+ 
heterogonic 	28 	1 
S0ratti 	 2 
Where.--- 
HO = homogonic S0ratti antigen 
HE = heterogonic S0ratti antigen 
S = $venezuelensis antigen 
E/S = excretory/secretory antigen 
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artifact of the method of analysis. As already pointed out, the "differential 
count" method adopted in the present work, if viewed uncritically, could lead 
to false conclusions in some cases; but the parameters in the equation can be 
identified with greater clarity. Suffice it to say that no study of this sort 
should be reported without a full record of the unstimulated control values. 
The "switching off' of cells at the end of infection may explain why a time 
lag occurred between administering immune cells, and the effects they 
brought about, in homologous challenged rats in the adoptive transfer 
experiments reported here (see later). Taking these experiments into 
consideration, if the worm data was used to assess resistance then the 
recipients of cells killed on day 16 post-challenge expressed a significant 
immunity whereas those killed on day 8 did not, even if the number of 
immune cells transferred was increased four-fold (page 151), or if the infection 
level in the donors was increased (page 151). However, if the transferred 
immunity was assessed as a reduction in the number of eggs in utero per 
worm compared with secondary controls, then a significant immunity was 
expressed on both days 8 and 16 post-challenge (page 1511). Thus it could be 
thought that an anti-worm response had been initiated by day 8, but it could 
only be detected as changes in the number of eggs in utero per worm, which 
seems the more sensitive of the two measures of the host's anti-parasitic 
response used in this study. 
Moqbel and Wakelin (1981) also found that a reduction in the S.ratti worm 
burden, after adoptive transfer of immune cells, did not occur until day 16 
post-challenge. Moreover, they showed that if cells were given on day 6 
post-infection worm loss still began on day 16, when cells had only been 
present for 10 days. It appeared from this that it was not the length of time 
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that the cells were present which was important, but the length of time the 
host was exposed to enteral stimulation. Moqbel and Wakelin (1981) also 
obtained a reduction in uterine eggs before worm expulsion, but, surprisingly, 
they found that it did not occur until day 14 post-challenge, even though their 
experimental protocol was similar to the one used in these experiments. The 
decrease they described was 6 days later than that obtained in the present 
study, even though the doses they used to prime cell donors and to challenge 
recipients were twenty times larger. This difference in results could not be 
due to the use of different strains of parasite because the stock homogonic 
variety was common to our laboratories (Wilson, personal communication), or 
to the use of different strains of rat, since PVG animals were used in both 
studies, although the source was not the same. 
Moqbel and Wakelin (1981), suggested two theories to explain their 
results:- 
the reduction in the worm burden and the reduction in the number of 
eggs in utero per worm was brought about by cells with the same specifities, 
but that their effects had different quantitative cellular requirements. 
the reduction in the two parameters was caused by qualitatively 
different mechanisms, and there was a relatively greater proportion of cells 
which caused changes in egg content compared with those which led to worm 
expulsion. 
However, there is another way in which the results of Moqbel and Wakelin 
and those obtained in the present study could be interpreted. If one assumes 
that cells with the same specificities cause a spectrum of effects on several 
organ systems, which vary in susceptibility; then effects which are related to 
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different sensitivities, independent of cell numbers, could be temporally 
separated purely because the rates at which they are brought about are 
different. Which parameter is recorded is a subjective matter, and usually the 
most easily measured effect, such as changes in worm length or changes in 
the number of eggs in utero is chosen. Not surprisingly, these all occur 
before worm expulsion, which is the result of an accumulation of processes 
having a variety of underlying causes. Thus just because events are 
temporally separated does not mean that they are caused by different 
mechanisms, or by different numbers of cells with the same specificity. 
Results from the studies of lymphocyte transformation show that such 
cells are suppressed by day 28 of an infection, presumably by the activity of 
the T-suppressor subset. Therefore they may not be able to respond to 
antigenic stimulation by the challenge infection until a primary immune 
response (starting about day 8 post-infection) had been elicited in the 
recipient. Mediators produced by responding T-helper cells from the recipient's 
cell population would be able to reverse the suppressive effect of the 
transferred T-suppressor cells so that the host now had available a population 
of primed lymphocytes with specificites for the parasite to aid in its immune 
response. Armed in this way, it would be able to mount a quicker and more 
severe anti- worm response than would have been possible had it not been 
immunised. This theory would explain why Moqbel and Wakelin found that 
cells given either on day 1 or on day 6 post-infection caused a reduction in 
worms at the same time, i.e. day 16. It would be interesting to investigate the 
effect on homologous challenge of transferring a mixed cell population of day 
16 immune cells (which are actively responding to the parasite) and day 28 
immune cells (containing an enriched population of memory cells with 
specificities for the parasite). Prediction from this theory is that an effect 
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would be present by day 8 post-challenge. 
The results obtained after antigenic stimulation of cells in vitro express 
one main feature, that is, inconsistancy (Table 10:4, page 24. Wherever 
specific stimulation did occur there was no difference in the level obtained 
after homologous or heterologous challenge; no dose-response effect was 
demonstrated for any antigen preparation; nor did the nature of the antigen, 
that is, whether it was of somatic or excretory/secretory origin, seem to have 
an effect; and no stage-specificity emerged. The results were consistent with 
the idea that the cellular response against Strongyloides spp. did not begin 
until day 12, that it peaked on days 12-16, and had terminated by day 28 
post-primary infection. Overall it appeared that, if antigenic stimulation 
occurred, then its intensity was similar for all antigenic preparations. 
One of the major reasons for this result was probably because the 
antigens were used at too dilute a concentration. No protein seemed to be 
extracted from the parasites, either by homogenization or in vitro culture, even 
though the amount of raw material was increased and different techniques like 
freeze-thawing and sonication were tried. Perhaps the only method of 
ensuring that protein is stripped from the parasites is to use some detergent 
such as CTAB but, unfortunately, there was no time to start intensive studies 
to find the best detergent and the conditions for its application. Genta et a! 
(1983) were obviously able to extract some protein, and the only difference 
between their method and the one used in this study was that they used 
sodium hypochlorite to sterilise S.ratt/third-stage larvae, which possibly could 
have made it easier to remove protein. It was found in the present study that 
there was a limit to the sensitivity of the Lowry assay used to standardise the 
protein concentration of the antigens, since it was only possible to detect 
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protein if it was above a concentration of lOQug/mi. Genta et al. also used 
this method to standardise their antigens. It would be interesting to see the 
sort of standard curves they obtained and the initial concentration of their 
antigens before dilution. There may also have been some fundamental defect 
in the experimental design used throughout the lymphocyte transformation 
described. Altering the cell density could improve the sensitivity of the assay, 
since the results of Expt 9 (page 211) gave cause to think that the one used 
(2.5x10 6/ml) was not suitable to detect small changes in antigen-induced 
proliferation. The experiment revealed that the method could not identify a 
4-fold dilution in the density of cells stimulated by concanavalin A. However, 
lectin-induced blastogenesis involves complex cell interactions, and such a 
dilution may not lead to a reduction in the amount of blastogenesis obtained, 
since the degree of tritiated-thymidifle incorporation need not be a linear 
function of the density of cells even under ideal conditions. Whatever the 
reason for the insensitivity of the assay, the fact that it is insensitive vitiated 
its use for the purpose intended. 
A possible explanation for the inconsistency in my results with antigen 
may be the existence of "non-responders" and "responders" within the inbred 
PVG rat population, since a common feature of all experiments was a 
significant between-rat-within-treatment variation. On the other hand, this 
variability also occurred among the uninfected rats. The obvious way to 
overcome this problem would be to use more rats per experiment but, 
logistically, this was not a realistic alternative. The comparative study of 
lymphocyte transformation originally planned proved to be impossible, but the 
experiments performed did indicate a number of areas where this assay could 
be exploited to provide further information on the general properties of the 
cellular response to Strongyloides spp. 
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10.4. Homologous vs heterologous challenge 
Results of the cross-challenge infections, where rats were primed with 
either a full infection or immune cells, gave information on the antigenic 
relationship of the two strains of S.ratti and S.venezuelensis For reasons 
already explained it was not possible to test all the parasite combinations 
intended. The outcome of-these experiments is discussed as follows:- 
the results of challenge using full infections to prime animals 
the results of the adoptive transfer experiments 
an integrated view showing how the results of (a) and (b) can fit into a 
theory on the antigenic relationship of the three parasites. 
Initial studies showed that priming rats with an exact dose of 91-98 
third-stage S.ratt/ larvae elicited a strong protective response against 
homologous challenge with a similar small dose. This response was 
expressed as a reduction in the proportion of the challenge dose recovered, 
and a reduction in the number of eggs in utero per worm, compared with 
secondary controls (page 93). The reduction in both parameters over the 
course of a primary infection of S.ratt/(see earlier) may well have been due to 
an anti-worm response by the host. Previous workers, using a priming and 
challenge dose 10 times higher than that used in these experiments, have also 
demonstrated a resistance to re-infection with S.ratti (Sheldon, 1937a, 1937b; 
Moqbel and Denham, 1977, 1978; Moqbel and McLaren, 1980). Dawkins and 
Grove (1982) found that prior infection with as few as 6 third-stage larvae of a 
homogonic strain of S.ratti could protect mice against homologous challenge 
infection with 500 infective larvae. The criteria of these workers were 
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reduction in the number of third-stage larvae produced per gm faeces, and a 
97% reduction in the worm burden, compared with controls. 
The present results of reciprocal cross-immunity experiments involving 
both strains of S.ratt/ showed an asymmetry, since, if the heterogonic strain 
was used to prime rats, homologous challenge produced a significantly greater 
relative reduction in the proportion of the dose recovered as well as in the 
number of eggs in urero per worm (page 105). However, if the homogoniC 
strain was the priming agent, there was no difference in the level of immunity 
elicited by homologous and heterologous challenge. 
Prior infection with an exact dose of less than 100 third-stage 
S.venezue/ensis larvae failed to immunise adult rats against homologous, or 
heterologous challenge with S.ratti (page 100) probably because the number of 
S.venezuelensiS adults present post-primary infection was below the threshold 
necessary to elicit an immune response. It has been demonstrated in other 
systems that a threshold to the immune response does exist. Wortis et a/. 
(1969), investigating the antibody response of mice primed against sheep 
erythrocytes, found that they were unable to detect any immunoglobulin A 
plaque forming cells in the spleen cells of mice immunised with less than 
4xl0 8cells. Similarly, Askonas and Rhodes (1965) found that the minimum 
amount of haemocyanin necessary to give a significant antibody response 
above control levels was 0.001ig/mouSe in primed mice. The "threshold" 
theory is supported by the fact that adult S.venezue/ensis worms were 
recovered from the heterologous challenged rats (page 103) showing that a 
protective response was not expressed against the primary infection with this 
species. Thus challenging S.ratti worms simply augmented the 
S. venezuelensis already present. Primary infection S. venezuelensis were 
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probably also present in the homologous challenge treatment in both 
experiments but, with my experimental protocol, it was impossible to 
distinguish adults from the primary and secondary infection. It should be 
emphasized that this problem arose only in the few cases discussed. In the 
general framework of this study remnants of the primary infection did not 
complicate the interpretataion of results after challenge. 
Although rats were not challenged until day 28 post-infection, it was still 
not shown that the immunity revealed by such experiments was of a specific 
or non-specific origin, since it was quite possible that the inflammatory 
response against the primary infection had not totally subsided. However, it 
was possible to transfer immunity against homologous and heterologous 
challenge using immune mesenteric lymph node cells primed against any one 
of the three parasites; demonstrated as a reduction in the proportion of the 
dose recovered and in the number of eggs in utero per worm of the 
challenged treatments compared with their relevant controls (page 166 and 
167). The one exception to this pattern was the heterologous treatment with 
homogonic S.ratti in Expt 12 for, in that case, the difference in eggs in utero, 
though consistent with other results, was not significant (page 167). In a 
replicate experiment, however, a significant reduction in this parameter did 
occur in the relevant treatment (page 167). The small discrepancy cannot 
outweigh the general conclusion from these experiments that the 
cross-protection found previously had a specific origin. 
Quantitative comparison of the level of protection produced after 
homologous and heterologous challenge showed that the results of the cell 
transfer experiments mirrored those carried out using full infections (see 
earlier). There was an asymmetery in the resistance expressed against 
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homologous and heterologous challenge with S.ratt/ which depended on the 
strain used to prime rats. If the homogonic strain was used, there was no 
significant difference in the level of immunity expressed against homologous 
and heterologous challenge. In contrast, if the heterogonic strain was used a 
greater immunity was expressed against homologous challenge. This emerged 
as a significantly greater relative reduction in the worms in ExptlO and eggs in 
Expt 11 (page 18 and 169 
The results of the experiments where S.venezue/ens/S was used to prime 
cell donors confirmed that there was an antigenic difference between the two 
S.ratti strains. If the egg data were used to assess the level of protection, 
then there seemed to be a graded immune response against the three 
parasites (page 171). Homologous challenge produced the greatest level of 
immunity, followed by heterologous challenge with the heterogonic strain of 
S.ratti and minimum immunity was expressed after challenge with homogonic 
S. ratti. 
From these results it is apparent that the three parasites possess common 
functional antigens, and that there is more cross-reaction between 
heterogonic S.ratti and S.venezue/ens/s than between homogonic S.ratti and 
S.venezue/ensis Results following the challenge of rats primed at three weeks 
of age with third-stage larvae of S.venezue/ensiS are in agreement (see 
earlier). 
Hypotheses 
The asymmetry in the host's immune response against S.ratti could be 
explained by one of two theories:- 
a) Antigenic polymorphism within the populations of both strains 
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Taking the simplest model, we. might suppose that the same antigen locus 
exists as two mutually exclusive polymorphs "x" and "y" (Fig.10:5, page 253). If 
populations of worms of the homogonic strain had a ratio of "x worms" to "y 
worms" of 4:1, priming with this strain could feasibly give enough stimulation 
for the host to produce a protective response against both "x" and "y" worms. 
The imbalance could then reside in the possibility that virtually all the 
heterogonic strain individuals expressed the "x" determinant. Thus, priming 
with the homogonic strain would protect against "x worms" from either strain 
(i.e. all heterogonic and 80% of the homogonic worms), as well as "y worms" 
within the homogonic strain itself (the remaining 20% of that population). 
Priming with the heterogonic strain would only protect the host against the "x 
worms", with the result that 20% of the homogonic strain expressing the "y" 
polymorph would escape the host's immune response. 
b) Existence of a strain-specific antigen 
If a strain-specific antigen was responsible for the asymmetry of the host's 
immune response (Fg.10:5, page 253) various assumptions would have to be 
made to explain the imbalance. i) worms of both strains must express common 
functional antigens in order to obtain a cross-protective response in reciprocal 
challenge experiments 
the proportion of strain-specific functional antigen(s) must be low 
compared to the common antigens, or there would be no asymmetry. 
the locus of the strain-specific antigen must be either on a common 
organ system or in excretory/secretory products. 
this model would have to assume that the two strain-specific antigen(s) 
either varied in their relative immunogenicity, perhaps due to a different size, 
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Fig. 1 0:5 
Theories to enpWn results of cro shvmulty studies using two 
strains o1_lli 
a) Antlgsric polymorphism among Individuals 
homogonic strain primes: 
-0 - 
homogonic strain 	heterogonic strain , 	recognised 
heterogonic strain primes: 
recognised 
eg. 	80% 	20% 	majority of 
population 
b) Strain-specific antigen 






-=-Q more vulnerable to attack 
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charge or configuration; or that the attack of one had a more debilitating 
effect on the worms' survival. 
v) the heterogonic strain would have to be more vulnerable to attack. 
If rats were primed with either strain the host would recognise the 
common functional antigens and produce an immune response against both 
parasites. If the homogonic strain was used to prime rats the host would also 
recognise the homogonic strain-specific antigen, but since a response directed 
against the antigen had little detrimental effect, both parasites would be 
equally affected. In contrast, priming with the heterogonic strain, would 
produce a more severe response against heterogonic worms compared with 
that directed against homogonic adults and thus a greater immunity would be 
demonstrated after homologous challenge. 
One way to test these theories would be to culture homogonic strain 
infective larvae from successive generations of challenge infections of animals 
primed with the heterogonic strain. If the first theory applies this should 
select for a population of homogonic worms containing proportionally more 
adults expressing the "y" polymorph. One would expect a stepwise decline in 
reciprocal cross-immunity between the two strains after each passage. If the 
second theory applies then the proportion of the worms recovered from 
heterologous challenged rats should remain constant. Another method which 
could be used would be to try and characterize the antigenic differences 
between the strains. If the second theory applied the two strains could be 
separated on the basis of the strain-specific antigen they expressed. However, 
if the first theory applies, the heterogeneity would be between individuals of 
the homogonic strain and not between the strains. 
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One of the difficulties with the first theory is explaining how the 
polymorphism is maintained within the parasite population. From present 
knowledge, the conventional mechanism for selection based on genetic change 
seems to be lacking in Strongy/oideS spp. In particular, genetic recombination 
of the classical kind is probably absent since, in those species investigated 
sufficiently well, both parasitic and free-living females reproduce 
parthenogenetically (Zaffagnini, 1973; Bolla and Roberts, 1968; Albertson et al, 
1979). Despite this, the genome clearly possesses some flexibility, since 
strains with completely homogonic development can be artificially selected 
from heterogoriic varieties (Sandground, 1926). It is possible that a high 
mutation rate, or extra-nuclear events (since the sperm does enter the egg in 
the free-living cycle, even though nuclear fusion fails), maintain the diversity. It 
is relatively simple to visualise an underlying mechanism in support of the 
second theory, since a chance mutation in one individual could introduce the 
strain-specific antigen into the population. This would initiate a new clone of 
parasites in the absence of the normal, sexual, means of maintaining the gene 
pool. The only way to answer this question would be to carry out an in depth 
study of the genetic structure of the two strains. 
10.5. Conclusions 
Most workers studying nematode immunology use large doses, which may 
create an atypical immune response whose very intensity could complicate an 
analysis of contributing processes, specific and non-specific. Among the 
former, large doses may lead to abnormal ratios of T cell subsets, and thus 
seriously distort the outcome compared with infections of more "natural" 
proportions. The present results clearly showed that specific immunological 
events are important in directing the responses which cause parasite 
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expulsion, since resistance could be transferred with immune cells and 
specificity was expressed by the host's immune response elicited at challenge. 
It may be worthwhile to carry out in depth investigations on the contribution 
of specific components of the host's immune system in parasite rejection 
since, at present, most of the effort in laboratories devoted to experimental 
immunology of nematode infection is concentrated on the role of non-specific 
mechanisms (see Introduction). Moreover, the experimental system developed 
in this work, particularly in regard to the asymmetry it reveals, could be 
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Radio-active labels used in this stud 
I) 	
75-Se) Selenomethionine 
Concentration: 37MBq/ml. 	 (Amersham International Ltd.) 
Stored at +4 0C 
tl/2 =118.5 days 	decays at 100% electron capture to stable arsenic 
Working Concentration = 74k3q/ml, made up with distilled water 
II).[methyl-3H] thymidine 
Concentration: 37Mbq/ml. 	 (Amersham International Ltd.) 
Stored at +4°C 
tl/2 = 12.26 years 
Working Concentration = 925kBg/ml, made up with serum-free medium (see 
Appendix 1:2, page 
Appendix 1:2 
cgpounds for adoptive transfer 
I)Cell medium 
penicillin/streptomycin 	10,000 units/rnl, (Gibco) 
human serum 	 15% heat-inactivated 
RPMI-1640 with 25mM hepes with L-glutarnine 	(Gibco) (see below) 
L-glutamine 	 20mM(x200) (Gibco) 
heparin 
100 ml medium 
Solution A was made by adding 5m1 of penicillin/streptomycin and 5m1 of 
L-glutamine to 500m1 of RPMI-1640. lOOml of cell medium was prepared 
by adding 85m1 of A to 15 of human serum, which had been heat-inactivated 
for 45 minutes. 
II)Ethidium bromide/acridine orange 
lOOx stock solution 
50mg. ethidiurn bromide 	 (Sigma) 
15mg. acridine orange (BDH) 
The above powders were dissolved oi lml. of 95% ethanol and 491 of distilled 
water was added. The solution was mixed well and stored at -20 C in ]iiil 
aliquots 
lx solution 
imi was made up 1:100 with phosphate buffered saline (see Appendix i:L) 
and stored in an amber bottle at +4 0C, The solution was active 
for one month. 
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Appendix 1:3 
Solutions for lymphocyte transformation assay 
I)Cell medium 
The medium was essentially the same as that used for adoptive transfer 
(see AgPendix 1:2) 	with the addition of beta-mercaptoethanol 
(5x10 M, Sigma ) ,50).il/lOOml of medium,and the exclusion of heparin. 
II)Concanavalin A (Sigma, type 5, lyophilised) 
Normally 2.5pg/ml. concentration was used, which was made up with serum-free 
medium (from above), and then filter sterilised by passing through a 0.22pm. 
filter (Millipore) It was made up x3 the final concentration needed to allow 
for the 1:3 dilution in the well of the micro-titre plate. 
III) Scintillant 
Toluene 	 (Mackay and Lynn) 
PPO [2,5 -diphenyloxazole] 	6gm./litre 	(Sigma) 
POPOP [(1,4 bis <2-(5 	eny1ozozo1yl)) benzene)] 
0.05gm/litre (Sigma) 
These powders were dissolved in 1 litre of toluene. 
IV)Giensa stain 
Giemsa (Gurr) was made up to 10% with Giemsa buffer,pH 7.3 (Gibco) 
Ag?end 1:4 
I) .Compounds for antigen production 
Adult culture medium 
RPMI-1640 with 25mM hepes with L-glutamine 	 (Gibco) 
penicillin/streptomycin(10,000 units/ml) 2m1/100ml of medium (Gibco) 
L-glutamine 	20mM (x200) 	 lrnl/100m1 of medium (Gibco) 
sodium pyuvate 	 10% volume 	 (Gibco) 
Furigizone lyophilized (250mcg/ml) 	2m1/100ml of medium (Gibco) 
lOOml of the medium was made using the above onstituents, made up to 
lOOml with RPMI-1640, and it was stored at +4 C until needed. 
II).Phosphate buffered saline 	pH 7.3 Dulbecco A 	(Oxoid Ltd.) 
disodium hydrogen phosphate 1.15gm/litre 
sodium chloride 	 8gm/litre 
potassium dihydrogen phosphate 	0.2gm/litre 
potassium chloride 	 0.2gm/litre 
,Supplemented phosphate buffered saline 
lml. of penicillin/streptomycin(10,000 units/ml, Gibco) was added to lOOrnl 
of phospate buffered saline 
.Polyethylene glycol 6000 	(BDH) 
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III) RPMI-1640 
Inorganic salts 	 mg/Ml 
hydrated calcium nitrate 	 100 
potassium chloride 	 400 
hydrated magnesium sulphate 	100 
sodium chloride 	 6000 
sodium hydrogen carbonate 	 2000 
hydrated sodium hydrogen phospate 1512 
Other compounds 
glucose 
glutathione (reduced) 	 5 
Amino-acids 
L-arginine hydrogen chloride 50 
L-asparagine 20 
L-cystine 50 
L-glutamic acid 20 
L-glütamine 300 
glycine 10 
L-histidine hydrogen chloride H 2O 15 
L-hydroxyproline 20 
L-isoleucine(allo free) 50 
L-leucine(methionine free) 50 
L-lycine hydrogen chloride 40 
L-methionine 15 
L-phenylalanine 15 
L-proline(hydroxy L-proline free) 20 
L-serine 80 





D-calcium pantothenate 0.200 
choline chloride 3.000 
folic acid 1.000 
i-inositol 35.000 
nicotinamide 1.000 
para-aminobenzoic acid 1.000 
pyridoxine hydrogen chloride 1.000 
riboflavin 0.200 





Compounds for Micro-Lowry 
Solutions 
2% sodium carbonate 	 (Analar, BDH Chemicals) 	"A" 
0.5% hydrated copper sulphate 	(Sigma) 	 "B" 
1% sodium/potassium tartrate (Sigma) "D" 
I).Solution D 
192ml of "A" was added to 0.4ml of "B" and 0.4m1 of "C" 
II).Solution E 
Folin and Ciocalteu's phenol reagent (Fisons) 1:1 with water 
.Trichloroacetic acid 
	
25% (Sigma) Stored at +40C 
.Sodium hydroxide (Sigma) 
	
1M Stored at room-temperature 
,Albumin, bovine(Fraction 5,Sigma) 
BSA was made up to various concentratios using phosphate buffered saline 
(see Appendix 1:4, part II, 
pendix 1:6 
Background counts over the course of lymphocyte transformation tests 
Date measured Mean counts/min n SD 
19.6.84 15 5 3.0 
24.7.84 16 5 3.8 
1.11,84 16 5 2.1 
20.1.85 18 20 2.5 
19.2.85 16 5 2.7 
28,7.85 14 5 2.8 
5.8.85 15 14 2.4 
9.8.85 15 5 2,3 
overall mean: 
	
16 	64 	3.0 
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.Appendix 1:7 
Correcting two-level nested anova tables used to analysis egg data for 
unequal sample sizes 
Initially coefficients of variance were calculated from quantities 1-4. 
Quantity 1 =E aE bi nlJ 
Quantity 2 = a bi 2 n ij 
Quantity 3 = E a 	bi 	2 niji 
Quantity 4 = E a bi n  2. ij] 
Zbi nij 
n ' o =Quantity 4 - [ Quantity 2 / Quantity 1 1 
df. Groups 
no = Quantity 1 - Quantity 
df Subgroups 
(nb) = Quantity 1 - [ Quantity 3 / Quantity 1 3 
df0 Groups 
Using these coefficients of variance the new MS'gps, and MS' subgps,, could 
be calculated:- 
MS gps,, = s 2 + n'o S 2BcA + 	S2  
MS subgps. = s2 + n0 s2 BcA 
Thus:- 
S = MS within, the error variance from the two-level nested ariova 
S2BcA = MS subgps 	within 
n  




For an approximate test of significance a new denominator mean square 
MS' subgps can be calculated. 
F5 =MS gp = s 2 + g'o S 2BcA+ (nb) 0 S 2  A 
MS 'subgps S' + n' o S'BcA 
Now a new critical value of F against which to test F5 is needed. The 
degrees of freedom for MS gps are unchanged but the denominator is a new 
mean square with new degrees of freedom, df' subgps. To compute these a 
new MS' subgps. is calculated in terms of the original mean square. 
MS' subgps =2  + n '0 S2BcA 
= MS within + n'o [MS subgps 
n 
0 
n'o I MS within + n'o MS subgps 
n 	 n 
0 0 
A general formula for the new df' of a reconstituted mean square MS' is:- 
df' = 	(MS') 2 
i( wi MSi )2 
dfi 
where "wi" are the coefficients of the mean squares, dft are the original 
degrees of freedom of the mean squares MSi, and i indicates summation 
over all the constituent mean squares. Thus for df' subgps. :- 
df' subgps = 	 ( Ms subqpj 2 
[(1 - n'o x MS within) J + [(n'ox MS subgp )'] 
n 	 n 
0 0 
df error 	 df subgps 
This is obviouly quite a complicated process and very time consuming. A 
few examples were carried out to find out how much of a difference there 
was between the original MS gps and MS subgps and the newly calculated 
MS' gps and MS' subgps, and to the original F ratio obtained and the newly 
calculated Ft ratio. In both cases there was little difference, therefore 
the results were not corrected for unequal sample sizes ( see examples 
1 and 2 below ), 
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Example 1 
Expt. 6(Chapter 5) 
Original ariova table 
















Newly calculated anova table(correcting for unequal sample sizes) 





F (420) =7.10 0.1% 










The method of calculating the new MS' and df' is shown below:-
Quantity 1 =lDnij = 13+12+14+ ....,. +20+6 = 262 
Quantity 2 EaZbi2 = 13 2+122+ . ,. 62 = 3324 
Quantity 3 = Za,zbiJ2 = 5420+322+,,.1012 = 18578 
Quantity 4 a 	
bi 2. 	= 132+ 122+. ,, +15 2 =  
2 ni j 54 
= 52.24 
n'o = Quantity 4 - [Quantity 2 / Quantity 11 
df gps 
= 52.24 - [ 3324 / 262 1 
4 
= 9.89 
no = Quantity 1 - Quantity  
df subgps 




(nb) = Quantity 1 - [Quantity 3/Quantity 11  
° 	 df 
= 262 - [18578/262] 
4 
=47.77 
s 2 = MS within = 1.66 
S 2BCA = MS subgps - MS within = 2,38 - 1.66 = 0.08 
no 	 9.12 
s 2i = MS yp - MS within - n'o S 2BcA 
(nb) 
0 
= 267.07 - 1.66 - (9.89) (0.08) 
47,77 
= 5,91 
F = MS gp = S2 +..n'o S 2 BgA + ( nb) 	2 A 
S 	45 subgps S' + n'o S' BcA 
= 1.66 + 9.89(0.08) + 47.77 (5.91) 




MS' subgps = (1 - n'o )MS within + n'o MS subgp 
n 	 n 
0 0 
= -0.08(1.66) + 1.08 (2.38) 
= 2.39 
df' subgp = 	 2 . 92 
[(-0.08 x 1.66) - 1 + [( 1.08 x 2,38)] 





Example 2 (Expt. 8, Ch 3.pter 5, page 
Original anova table 
Source Of Variation df SS 	MS F 
Among Gps 
	
1 - 102.,T5 12,,145 20,91 
Among Subgps 13 	63.487 	4,884 	2.50 
Within 
	
225 439,102 1,952 
Total 239 	604.733 
Newly calculated anova table (corrected for unequal sample sizes 
Sources Of Variation df SS 	MS' F 
Among Gps 	 1 102.145 T.38 	23.37 
Among Subgps 14 	63,487 	4.41 2.26 
Within 	 225 439.102 1.952 
Total 239 	604.733 
F (1114 ) =17.14 0.1% 	F(12 ) =2,18 1% 
The new mean squares and df' were calculated as shown below:- 
Quantity 1 = 240 
Quantity 2 = 4204 
Quantity 3 = 38,322 
Quantity 4 = 31.02 
n'o = 31.02 - [ 4204 / 240 J = 13.50 
1 
(nb) 	= 240 - ( 38,322 / 240 ) 	= 80.33 
0 1 
n240 - 31,02 	=16.08 
13 
MS Within = 2 = 1.952 
BcA = 4.884 - 1.952 	= 0.18 
16.08 
A 	= 102.145 - 1.952 - 13.5(0.18) 
80.33 
= 1.22 
F 	= 1.952 + 13.5(0.18) + 80.33(l.22)  
S 1,952 + 13.5(0,18) 
= 23.37 





df' subgps = 	 (4.41)' 
[(ø16 x 1952)'] 	+ 	[(ø84 x 4,884)'] 




The method of calculating the resistance ratios and resistance quotients 
For simplicity the method for calculating the resistance ratios and the 
resistance quotients for the worm data only is shown, the method is identical 
for the egg data, but " the mean number of eggs in utero/worm It  should be 
substituted for the mean proportion of the dose recovered". Data from 
experiment 7, chapter 4 , (see page ), was used in this example, where rats 
were primed with an exact dose of less than 100 third-stage heterogonic 
S.ratti larvae, and challenged with a similar small dose of the homologous 
or heterologous strain, 
a) Homologous Challenge 
Proportion Of the Mean Proportion Of Resistance Resistance 
Dose Recovered the Dose Recovered Ratio Quotient 
from Each Exptl. from Controls *1 ReQw*2 
Rat 
0.000 0.368 0.000 1.000 
0.000 0.368 0.000 1.000 
0.000 0.368 0.000 1.000 
0.000 0.368 0.000 1.000 
0.020 0.368 0,054 0,946 
0,010 0.368 0.027 0.973 
0.031 0.368 0.084 0.916 
0.030 0.368 0.082 0.918 
0.000 0.368 0.000 1.000 
0,010 0,368 0,027 0.973 
12. 10 10 
Mean 0.027 0.973 
SD 0,034 0.034 
re: - 
*1 Resistance Ratio, R = a 
E 
a = proportion of the dose recovered for each experimental rat 
b = mean proportion of the dose recovered from the relevant control 
*2 Resistance Quotient, ReQ = 1 - R 
For example, for observation 4, where the proportion of the dose recovered 
for the experimental rat was 0,020 then:- 
Resistance Ratio = 0.020 	= 0,054 
0.368 
Resistance Quotient = 1 - 0.054 	= 0.946 
ReQw 
This procedure was followed for each individual observation within the 
treatment and then repeated for the results of the heterologous challenged 
group in (b) 
am 
b) Heterologous Challenge 
Proportion Of the 	Mean Proportion Of 	Resistance 	Resistance 
Dose Recovered the Dose Recovered Ratio Quotient 
for Each Exptl 
	
for Controls 	 ReQw 
Rat 
0.020 0,524 0,038 0.962 
0.168 0.524 0.321 0.679 
0.265 0.524 0.506 0.494 
0,168 0,524 0.321 0.679 
0.167 0.524 0,319 0,681 
0,040 0.524 0,076 0.924 
0.237 0.524 0.452 0.548 
0.177 0.524 0.338 0,662 
0.265 0.524 0.506 0.494 
0.085 0.524 0.162 0.838 
fl 	10 10 
Mean 0.304 0.696 
SD 	0,166 0.166 
Two things become apparent from (a) and (b) 
the mean resistance ratio and the mean resistance quotient have the 
same "n" and standard deviation, and thus the same standard error. 
the mean resistance qoutient can be calculated directly from the 
mean resistance ratio, i.e.:- 
Mean Resistance Quotient = 1 - [ Mean Resistance Ratio] 
for example, if the results given in (a) are considered then:- 
	
Mean Resistance Ratio 	= 0.027 
thus Mean Resistance Quotient 	= 1 - 0.027 = 0.973 
from (a) Mean Resistance Quotient = 0.973 
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2:lSwimary of results for Section 3:1 
Table 2:1(i) 
The effect of pairing rats on the proportion of the hcmsgonic S.ratti dose 
recovered, Expt 1 
Treatment 	Mean proportion 	n 	SD 	Mean exact 
of the dose 	 dose 
recovered 
single 0.247 	 14 	0.116 
92.53 
paired 0.223 	 16 	0.156 




Distribution of homegonic S.ratti worms along the intestine in Expt 1 
Treatment Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 6 	7 8 
single 	Mean 0.37 	0.33 	0.16 	0.99 	0.92 0.92 	0.01 	8.01 	15 
SD 0.08 	0.11 	0.08 	0.06 	0.03 0.03 	0.02 	0.02 
NS 	 mean no. of worms per rat 22 
0 
paired 	Mean 0.40 	0.36 	0.17 	0.03 	0.02 0.00 	0.001 0.003 	15 
SD 0.25 	0.16 	0.13 	0.05 	0.05 0.00 	0.004 0.011 
mean no. of worms per rat 20 
injection 	Mean 0.35 	0.35 	0.20 	0.09 	0.02 0.004 0.00 	0.00 	6 
controls SD 0.94 	0.03 	0.03 	0.04 	8.02 0.010 0.00 	0.00 
mean no. worms of per rat 48 
2:2Sunmary of results Section 3:2 
Table 2:2(1) 
An attempt to demonstrate "self-infection" in Rats, hcmegonic S.ratti 
Treatment 	Mean proportion 	n 	SD 
of the Dose 
recovered 
infected "A" 0.340 7 0.119 
infected "B" 0.403 7 0.177 
uninfected "A" 0.000 7 0.000 
uninfected "B" 0.000 6 0.000 
injection 0.543 6 0.104 
controls 





- rats clenaed Out every two days 
- rats cleaned out once on day 10 post-infection 
Table 2:2(u) 
Distribution of hanogonic S.ratti worms in Expt 2 
Treatment Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 6 	7 	8 
injection Mean 	0.31 	0.32 	0.16 	0.16 	0.04 0.01 	0.093 9.00 	6 
controls SD 0.06 	0.04 	0.08 	0.07 	0.07 0.92 	0.010 0.00 
mean no. of worms per rat 47 
infected Mean 	0.36 	0.37 	0.18 	0.08 	0.03 0.094 0.80 	0.001 	14 
rats SD 0.16 	0.11 	0.09 	0.05 	0.05 0.010 0.00 	0.004 
(pooled) mean no. of worms per rat 33 
r" 
Table 2:3111) 
2:3Sunmary of results from Section 3:3 The effect of varying the donor of adult worms on their ability to survive 
post-transfer, S.venezuelensis, Expt 5 
Table 2:3(i) 
Husber of worms recoveredduring Incubation of Intestine, Expt 3 Treatment 	Mean proportion 	n SD Mean exact 
Parasite 	Day post- Time in saline digest*  Total no. 	Mean prop. St) 
of the dose dose 
infection in minutes worms 	of the 
90 	120 	180 	240 	300 recovered 	dose Donor A 0.311 	 4 0.213 recovered 
S.venezuelensis 	7 0 	290 	65 	48 	14 417 	0.321 9.13 
Donor B 0.151 	 3 0.117 47.75 
73 83 	44 	30 0 230 Donor C 0.380 	 4 9.116 
honogonic 	 7 22 	160 	60 	145 	0 387 	0.378 0.01 Donor 0 9.249 	 4 0.112 
S.ratti 15 	240 	80 	34 0 369 
heterogonic 	7 56 	220 	41 	61 	0 378 	0.347 0.04 
overall mean 	0.281 	 15 0.165 
S.ratti 0 	140 	110 5 	60 315 
Table 2:3(iv) 
Distribution of S.venezuelensis worms along the intestine in Expt 4 
Table 23(ii) 
The 	t of time spent in the extra-intestinal enviroment on the ability effec 
Treatment Proportion of worms in each gut section Rat n 
of worms to establish in a new host, hcsegonlc S.ratti, Expt 4 
1 	2 	3 	4 5 6 	7 8 
1 Hour Mean 	0.69 	0.28 	0.04 	0.90 0.00 0.00 	0.00 0.00 	4 
Treatment 	Mean prop. n 	SD 	Mean no. 	n SD 	Mean no. 	n SD SD 0.39 	0.26 	0.04 	0.00 0.00 0.00 	0.00 0.00 
of the eggs in eggs in mean no. of worms per rat 25 
dose utero/ utero/ 
Recovered worm/rat worm 2 Hours Mean 	0.93 	0.07 	0.00 	0.00 0.00 0.00 	0.00 0.00 	3 
1 Hour 	0.516 4 	0.156 	6.875 	4 0.66 	6.734 	37 1.561 
SO 0.12 	0.12 	0.90 	0.90 0.00 0.08 	0.00 0.00 
mean no. of worms per rat 2 
2 Hours 	0.050 4 	0.942 	5.331 	1 0.00 	5.333 	3 1.155 3 Hours Mean 	0.78 	0.22 	0.00 	0.00 9.00 0.00 	0.00 0.90 	3 
SD 0.20 	0.20 	0.09 	0.00 0.00 0.00 	0.00 0.00 
3 Hours 	0.182 4 	0.158 	6.565 	3 9.44 	6.375 	16 1.028 mean no. of worms per rat 8 
4 Hours 	8.1.74 4 	0.149 	7.417 	2 9.83 	7.222 	9 1.641 4 Hours Mean 	0.65 	0.31 	0.03 	0.02 0.00 0.00 	0.00 0.00 	4 
SD 0.47 	0.47 	0.06 	0.03 0.00 0.00 	0.00 0.00 
mean exact dose 49.13 mean no. of worms per rat 8 
2:4 SuTimary of results from Section 3:5 
Table 2:4(1) 
Rat n We nuither of mesenteric licth node cells recovered per rat, Expt 8 
• Rat No. 	No. Cells,knl. 	Total No. Cells 	% Dead 
1 	 3.7x108 1.11x1 26.7 




Mean 	 1.44x10 8 8 9.7s10 8 
SD 1.96x10 8 1.23x10 
Table 2:4(u) 
The effect of cell transfer medium on the proportion of the hcxnogonic S.ratti 
dose recovered, Expt 7 
4 
Treatment 	Mean prop. 	n 	SD Mean no. 	fl SD 	Mean exact 
of the dose of Eggs dose 
recovered in utero/ 
15 worm 
No Medium 	0.541 	6 	0.113 7.229 	97 1.245 
98.25 
Medium 	0.542 	6 	0.086 7.129 	106 1.137 
Table 2:3(v) 
Distribution of S.venezuelensis worms along the intestine in Expt 5 
Treatment Proportion of worms in each gut section 
1 	2 	3 4 5 .6 7 8 
Donor A Mean 0.89 	0.04 	0.06 0.00 0.90 0.00 0.00 0.00 
SD 0.29 	0.08 	0.12 0.00 000 0.00 0.00 0.09 
mean no. of worms per rat 15 
Donor B Mean L0O 	9.90 	0.09 0.90 0.00, 0.00 0.90 0.00 
SD 0.00 	0.00 	0.00 0.00 0.90 0.00 0.00 0.00 
mean no. of worms per rat 7 
Donor C Mean 0.90 	0.09 	0.01 0.00 0.00 0.08 9.00 0.00 
SD 0.10 	0.12 	0.04 0.00 0.00 0.00 0.00 0.00 
mean no. of worms per rat 18 
Donor D Mean 0.90 	0.07 	0.03 0.00 0.00 0.00 0.00 0.00 
SD 0.15 	0.10 	0.05 0.90 0.00 9.00 0.00 0.00 
mean no. of worms per rat 11 
Overall Mean 9.92 	0.05 	0.03 0.09 9.00 0.00 0.00 0.00 
SD 0.17 	0.09 	0.07 9.00 0.00 0.00 9.00 0.00 
mean no. of worms per rat 13 
'0 
Table 2.i ii' 
Distribution of hcrinogonic S.ratti worms along the Intestine in Expt 7 
Treatment 	 Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 	6 	7 	8 
Medium 	Mean 0.42 0.26 0.18 0.10 0.03 0.003 0.00 0.00 	6 
SD 	0.13 0.09 0.05 0.04 0.02 9.010 0.00 0.00 
mean no. of worms per rat 	53 
No Medium Mean 0.36 0.33 0.18 0.09 0.03 0.004 9.00 9.00 	6 
SD 	0.07 0.08 0.06 0.04 0.04 0.019 0.00 E00 
mean no. of worms per rat 	53 
Table 2:5(iii) 
The effect of varying the day of harvesting ce lls on the level of 
stimulati on obtained, Expt 11 
Rat No. Day Of 	Harvest 
Day Day  
Unstim. linstim. 
- Control Exptl. 01ff. Control Exptl. Oiff. 
cpu cpu Counts cpu cpu Counts 
1 	Mean 507 69754 69247 760 25775 25015 
SO 153 20896 766 8231 
n 5 11 5 11 
2 	Mean 380 81151 80851 377 24798 24421 
SD 117 14364 227 1665 
n S 	- 11 5 10 
3 	Mean 490 71552 71062 692 19251 18559 
SD 192 16329 299 1136 
n 5 11 5 10 
Table 2:5(iv) 
The effect of varying the day of harvesti ng cells on the level 
Of stimulation obtained, Cxpt 12 
Rat No. 	 Day Of Harvest 
Day 	 Day 	 Day  
Unstim. 	 tJnstim. 	 tJnStim. 
Control Exptl. Diff. Control Exptl. Diff. Control Exptl. Diff. 
cpu 	cpu Counts cpu 	cpu Counts cpu 	cpu 	Counts 
1 	Mean 437 90121 	89964 237 33417 	33180 361 22974 	22613 
SD 294 15517 79 9280 305 6835 
n 5 10 5 11 5 10 
2 	Mean 342 125777 	125435 222 41824 	41602 223 28231 	28014 
SD 107 14017 44 7177 33 5410 
n 6 10 5 11 5 10 
3 	Mean 473 96710 	96237 188 39541 	39353 261 24623 	24362 
SD 90 12449 80 11535 67 5715 
n 6 11 5 11 S 9 
* Note 
Unstim. = unstimulated 
01ff. count = differential count 
2:5 Summary of results from section 3:6 
Table 2:5(i) 
The effect of serum concentration in the cell medium on the level of 
stimulation obtained, Expt 9 
Pat No. 	 Serum Concentration 
5% 	 igI 	 15% 
Unstim. 	 Unstim. 	 ljnstim. 
Control Exptl. Diff. Control Exptl. Diff. Control Expti. D. 
cpu 	cpu Counts cpucpu Counts cpu 	cpu C 
I 	Mean 1534 19762 	18228 1364 100906 	99560 274 107647 	10 
SO 395 3818 399 18732 108 31633 
n 5 10 5 Il 6 11 
2 	Mean 2482 25478 	22996 1952 75924 	73972 378 99548 	9 
SD 1318 3927 459 23992 181 10201 
n S U 6 12 6 11 
3 	Mean 489 32287 	31798 438 19457 	19019 240 32916 	3 
SO 206 7722 76 4919 92 1089 
n 6 12 6 12 6 11 
Table 2:5(u) 
The effect of Concanavalin A concentration on the level of stimulation 
obtained, Expt 10 
"C 	 Rat No. Unstim. Concanavalin A Concentration pg/mi 
Control 
cpu 20 10 5 2.5 
I 	Mean 1158 12724 12020 42120 123782 
SD 834 5712 1388 4481 14267 
n 9 11 11 5 11 
01ff. Counts 11566 10862 40962 122624 
2 	Mean 1728 15677 16936 59877 140755 
SD 760 3228 4285 7391 23054 
n 9 8 9 7 1 
01ff. Counts 13949 15208 58149 139027 
3 	Mean 852 14197 14199 24978 107030 
SD 265 9855 3781 3268 3713 
n 11 11 .7 5 11 
01ff. Counts 12469 12471 23250 185302 
Note 
01ff. Count = differential count 
IJnstim. 	= uistimulated 
2:6 	SurrunaryOf Results Of Section 3:7 
Table 2:6(i) 
Results For homogonic S.ratti 
Week no. Date Rats 	Total no., £3 No, £3/gm. 	Estimated No, 	% Non- 
Infected Recovered 	Faeces £3 which 	Motile 
theoretically 
could be produced 
from all faeces 
collected 
YEAR 1 1983-1984 
1 15-8-83 60670 3315 60670 - 
2 22-8-83 - - - - 
3 29-8-83 201700 10903 201700 14,8 
4 5-9-83 79000 4158 90226 - 
5 12-9-83 25000 1225 32966 7.4 
6 19-9-83 3125 144 4472 3.4 
7 26-9-83 58000 2566 91619 14,9 
8 3-10-83 6000 256 7256 5.3 
9 10-10-83 33000 1284 36724 14.7 
10 17-10-83 4833 241 4833 0.0 
11 24-10-83 25840 1298 25840 5.0 
12 31-10-83 4667 200 4667 0,0 
13 7-11-83 62000 3229 62000 10.1 
14 14-11-83 21670 1223 21670 0,7 
15 21-11-83 42670 1855 42670 0.0 
16 28-11-83 3670 232 3670 12.0 
17 5-12-83 64830 3325 81453 26.0 
18 12-12-83 19500 990 24251 1.7 
19 19-12-83 - - - - 
20 26-12-83 - - - - 
21 2-1-84 - - - - 
22 9-1-84 7905 462 7905 9.3 
23 16-1-84 5000 394 5000 0.0 
24 23-1=84 9900 550 9900 0,0 
25 30-1-84 12677 689 20669 7,6 
26 6-2-84 69670 3537 106450 3.5 
27 13-2-84 25998 1870 25998 16,0 
28 20-2-84 95400 5747 95400 2.5 
29 27-2-84 21650 2303 21650 6.4 
30 5-3-84 4902 299 9535 3,9 
31 12-3-84 16170 893 16170 5,8 
32 19-3-84 - - - - 
33 26-3-84 68830 3845 81904 5.1 
34 2-4-84 47670 2563 65364 18.3 
35 9-2-84 23170 1363 28758 1,4 
36 16-4-84 33500 4085 33500 0,9 
37 23-4-84 - - - - 
38 30-4-84 36500 2310 36500 1.8 
39 7-5-84 44331 3534 59592 6.4 
40 14-5-84 48330 2860 93800 13,4 
41 21-5-84 35330 2091 53309 5.7 
42 28-5-84 27915 1813 54561 0.6 
43 4-6-84 135000 14835 135000 23,3 
44 11-6-84 31300 1910 54063 6,0 
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45 18-6-84 23680 1894 28984 1.8 
46 25-6-84 33336 3788 54174 0.0 
47 2-7-84 31370 2070 31370 11.2 
48 9-7-84 56700 5611 56700 6.3 
49 16-7-84 - - - - 
50 23-7-84 - - - - 
51 30-7-84 - - - - 
52 6-8-84 
YEAR 2 	1984-1985 
1 13-8-84 - - - - 
2 20-8-84 8869 785 25665 0.0 
3 27-8-84 6300 643 14657 0.0 
4 3-9-84 41250 3198 103605 3,8 
5 10-9-84 5070 367 9773 2.5 
6 17-9-84 43830 3879 98133 11.3 
7 24-9-84 17900 1642 26768 0,0 
8 1-10-84 118500 10128 162051 9.0 
9 8-10-84 11500 855 11500 21,0 
10 15-10-84 22050 1542 27138 23.0 
11 22-10-84 - - - - 
12 29-10-84 10536 667 17004 0.0 
13 5-11-84 22264 1700 25663 1,0 
14 12-11-84 - - - - 
15 19-11-84 - - - - 
16 26-11-84 - - - - 
17 3-12-84 5719 397 9254 3,9 
18 10-12-84 - - - - 
19 17-12-84 - - - - 
20 24-12-84 - - - - 
21 31-12-84 - - - - 
22 7-1-85 52000 3314 60719 - 4,9 
23 14-1-85 54000 3064 81307 6.0 
24 21-1-85 - - - - 
25 28-1-85 26264 1811 30611 4,0 
26 4-2-85 29064 2004 33073 0.0 
27 11-2-84 60631 4394 60631 15,0 
28 18-2-85 15000 2000 15000 0.0 
29 25-2-85 36670 3006 50496 14.4 
30 4-3-85 36730 2340 36730 22.7 
31 11-3-85 35330 2236 35330 21.5 
32 18-3-85 - - - - 
33 25-3-85 - - - - 
34 1-4-85 8598 632 8598 0.0 
35 8-4-85 - - - - 
36 15-4-85 18900 1196 18900 6,0 
37 22-4-85 42704 1906 42704 14.0 
38 29-4-85 46800 2218 46800 5.4 
39 6-5-85 1000 68 1156 3.0 
40 13-5-85 26000 1421 26000 12.2 
41 20-5-85 3068 323 3068 2.5 
42 27-5-85 27799 1418 32621 2,1 
43 3-6-85 18396 1057 20616 11,5 
44 10-6-85 26670 1657 26670 29.0 
45 17-6-85 26136 1098 26136 000 
46 24-6-85 - - - - 
47 1-7-85 - - - - 
48 8-7-85 - - - - 
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49 	15-7-85 	54396 	 3073 	 54396 	 9,3 
50 22-7-85 10268 723 10268 0,0 
51 	29-7-85 	 - 	 - 	 - 	 - 
52 5-8-85 - - - - 
296 
Table 2:6(u) 
Results For heterogonic S.ratti 
Week No. 	Total No, L3 
Recovered 
YEAR 1 1983-1984 
No. L3/Gii. 	Estithated No. 	% Non- 
Faeces L3 which 	 Motile 
theoretically 
could be produced 
from all faeces 
collected 
1 640 36 828 8.0 
2 - - - - 
3 25800 2505 25800 11.9 
4 13170 766 17917 1,3 
5 2000 110 2670 7.4 
6 11563 480 14154 2.7 
7 - - - - 
8 7762 317 9346 21,2 
9 8170 339 10001 21,2 
10 4500 210 5788 50,0 
11 4600 245 6677 50,0 
12 13325 595 13325 3.2 
13 4800 208 4800 2,0 
14 6175 330 6175 20,4 
15 20670 975 20670 3.8 
16 10925 9518 12323 6.6 
17 15170 712 19657 6,2 
18 - - - - 
19 - - - - 
20 - - - - 
21 - - - - 
22 5225 307 5225 1.8 
23 9668 424 14417 0,0 
24 16775 937 21836 4.2 
25 6782 6315 8990 2,7 
26 - - - - 
27 6438 562 6438 4,9 
28 6932 381 6932 3,7 
29 14898 645 20057 6,3 
30 13650 794 17618 7.4 
31 5833 310 6857 0,0 
32 - - - - 
33 13500 754 13500 2.4 
34 25830 1510 43503 21.3 
35 8000 575 10008 18,6 
36 13064 1306 13064 5.8 
37 8335 583 18127 6.6 
38 15670 1178 16613 2.1 
39 32170 2401 35051 8.4 
40 17225 1083 39000 15.0 
41 - - - - 
42 16790 1235 35307 8.8 
43 3600 316 3600 2.3 
44 16800 1209 36740 2.7 
45 15631 1797 15631 19.8 
46 7098 703 12017 0.0 
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47 7096 1223 7096 0.0 
48 5732 630 5732 0.0 
49 - - - - 
50 - - - - 
51 - - - - 
52 - - - - 
YEAR 2 1984-1985 
1 5367 511 5367 0.0 
2 0 0 
3 28025 2260 56502 0.0 
4 3198 305 7736 0.0 
5 8500 696 15442 1.9 
6 6300 594 14969 0,0 
7 1750 173 3327 5.0 
8 17025 2702 24051 3,5 
9 - - - - 
10 31330 2589 31330 0.0 
11 - - - - 
12 4550 251 3570 19,0 
13 0 0 
14 - - - - 
15 12800 1143 21257 0,0 
16 - - - - 
17 - - - - 
18 9149 257 9149 2.4 
19 - - - - 
20 - - - - 
21 - - - - 
22 - - - - 
23 1000 76 3412 10.0 
24 - - - - 
25 13080 998 26460 0.0 
26 0 0 
27 30133 1826 48578 0.0 
28 6332 1213 6332 0.0 
29 95000 5864 106780 0,0 
30 5670 332 5670 0.0 
31 35000 2652 35000 0.0 
32 - - - - 
33 - - - - 
34 36000 2083 36000 12.0 
35 1000 61 1000 1.0 
36 45330 3170 45330 0.0 
37 15812 742 19895 0.0 
38 46800 2463 46800 0.0 
39 - - - - 
40 28800 1565 39757 1.8 
41 15000 1456 15000 8.2 
42 10330 733 10330 0.0 
43 39330 2537 39330 0.0 
44 30000 2326 30000 2.0 
45 46379 2710 46379 1.0 
46 53660 3650 53660 0,0 
47 - - - - 
48 - - - - 
49 31330 1958 39163 5.1 
50 4835 361 4835 5,0 
51 - - - - 
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52 




Results For S.venezuelensis 
Week No. 	Date Rats 	Total No. L3 No.L3/Qrt. 	Estimated No. % Non- 
Infected Recovered 	Faeces L3 which 	Motile 
theoretically 
could be produced 
from all faeces 
collected 
YEAR 1 1983-1984 
1 26-8-83 43670 3580 43670 11.2 
2 2-9-83 - - - - 
3 9-9-83 5670 336 5670 5.6 
4 16-9-83 15170 632 17066 6,0 
5 23-9-83 81000 8265 81000 22.4 
6 30-9-83 12170 1512 12170 17,3 
7 7-10-83 2670 102 2670 30,5 
8 14-10-83 1025 58 1025 4.1 
9 21-10-83 75500 6235 75500 27.6 
10 28-10-83 400 26 400 27.3 
11 4-11-83 7761 342 7761 49.3 
12 11-11-83 1650 146 1650 50.0 
13 18-11-83 8883 584 8883 48.8 
14 25-11-83 400 48 400 000 
15 2-12-83 4000 131 4000 22.6 
16 9-12-83 15932 1099 15932 5.0 
17 16-12-83 - - - - 
18 23-12-83 - - - - 
19 30-12-83 - - - - 
20 6-1-84 9972 669 9972 9.3 
21 13-1-84 32830 2027 32830 33.4 
22 20-1-84 11670 627 11670 1.4 
23 27-1-84 6300 325 11334 35.7 
24 3-2-84 0 0 
25 10-2-84 - - - - 
26 17-2-84 0 0 
27 24-2-84 7534 638 7534 6.5 
28 2-3-84 80000 5556 80000 6.6 
29 9-3-84 19750 1056 29150 50.0 
30 16-3-84 33830 1911 60588 26.7 
31 23-3-84 33857 1743 35923 2,9 
32 30-3-84 2060 121 2872 13.4 
33 6-4-84 18932 1372 18932 33.8 
34 13-4-84 14500 868 15455 2.5 
35 20-4-84 - - - - 
36 27-4-84 - - - - 
37 4-5-84 32704 2031 36360 5.2 
38 11-5-84 - - - - 
39 18-5-84 115375 6631 145876 15.0 
40 25-5-84 12532 915 18752 10.0 
41 1-6-84 91800 9663 91800 13,1 
42 8-6-84 25330 2093 41651 2,6 
43 15-6-84 8085 735 8600 3.0 
44 22-6-84 10540 811 12243 16,8 
45 29-6-84 - - - - 
46 6-7-84 6915 1032 6915 9,8 
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47 13-7-84 5 
48 20-7-84 - - - - 
49 27-7-84 - - - - 
50 3-8-84 - - - - 
51 10-8-84 - - - - 
52 17-8-84 9332 735 18370 5.0 
YEAR 2 1984-1985 
1 24-8-84 41800 6967 41800 1.3 
2 31-8-84 - - - - 
3 7-9-84 5831 435 11923 0,0 
4 14-9-84 11328 1287 24072 2,3 
5 21-9-84 16128 3934 16128 0.0 
6 28-9-84 40330 4859 52963 6.0 
7 5-10-84 12652 1278 16869 22.0 
8 12-10-84 - - - - 
9 19-10-84 28280 1964 52239 7.1 
10 26-10-84 16500 6346 16500 10.8 
11 2-11-84 9830 806 19660 20,0 
12 9-11-84 30500 2500 45750 50.0 
13 16-11-84 - - - - 
14 23-11-84 - - - - 
15 30-11-84 14123 1130 17738 4,2 
16 7-12-84 - - - - 
17 14-12-84 - - - - 
18 21-12-84 - - - - 
19 28-12-84 - - - - 
20 4-1-85 - - - - 
21 11-1-85 15867 912 23983 16.7 
22 18-1-85 - - - - 
23 25-1-85 8169 529 9359 3.5 
24 1-2-85 11250 787 11250 6.3 
25 8-2-85 - - - - 
26 15-2-85 15950 1173 16888 0.0 
27 22-2-85 8633 3197 8633 60,0 
28 1-3-85 - - - - 
29 8-3-85 88000 5207 88000 12.0 
30 15-3-85 - - - - 
31 22-3-85 - - - - 
32 29-3-85 - - - - 
33 5-4-85 - - - - 
34 12-4-85 - - - - 
35 19-4-85 - - - - 
36 26-4-85 35000 1913 35000 5,4 
37 3-5-85 32704 1869 37189 6.0 
38 10-5-85 31500 1898 31500 11.9 
39 17-5-85 31330 2034 37026 4,1 
40 24-5-85 10330 684 10330 0.0 
41 31-5-84 - - - - 
42 7-6-85 1333 106 1333 1.0 
43 14-6-85 1666 85 1905 5.0 
44 21-6-85 - - - - 
45 28-6-85 - - - - 
46 5-7-85 - - - - 
47 12-7-85 - - - - 
48 19-7-85 12503 817 19694 4,0 
49 26-7-85 - - - - 
50 2-8-85 - - - - 
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Fig.2:2 
Third-stage larvae output of cultures heterogonic 3.ratti over 1983-1985 
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Fig.2:3 
ThIrd-stage larvae output of cultures of S.venezuelensls over 1983-1985 
0 
year I 	 week number 	 year 2 
0 
0 
2:7 	Statistical analysis of results from Section 3:8 
Table 2:7(i) 
Egg Data 
Expt 	Treatment Mean No. Dgs Total No. 	Correlation 	P 
	
in Uterol%lorm Worms Assayed Coefficient Value 
- -- /Rat 	 /Treatnmnt 
Cxpt 3 Day 8 6.000 120 0.998 0.01 
Chapter heterogonic 5.500 




Expt 5 Day 8 6.007 54 9.998 0.01 
Chapter heterogonic 6.500 
5 S.ratti 6.143 
Priming 6.800 
Controls 





Expt S Day 8 7.277 65 0.995 0.01 
Chapter hcmvgonic 7.421 
9 S.ratti 7.290 
Challenge 7.009 
Controls 





Eapt 6 Day 8 6.588 43 0.999 0.01 
Chapter heterogonic 6.111 
9 S.ratti 6.143 
Priming 
Controls 








Lyrrçhocyte transformation data 






Expt 	9 	Rat 1 	5% Serum 9.791 10 0.989 0.01 
Chapter 
3 	 10% Serum 11.486 11 0.791 ) 	0.10 
15% Serum 11.477 11 0.641 I 	0.19 
Rat 2 	5% Serum 10.028 II 0.981 0.01 
10% Serum 11.164 12 9.982 0.01 
15% Serum 11.501 11 9.963 0.01 
Rat 3 	5% Serum 10.340 12 9.966 0.01 
10% Serum 9.815 12 0.925 0.05 
15% Serum 10.375 11 0.923 0.05 
Overall 15% Serum Controls 5.480 
5.775 18 0.975 0.01 
5.323 
3:lSuimiary Of Results Table 3:1(iii) 
Table proportion of the heterogonic S.ratti dose recovered over the course The proportion of the bcinogonic S.ratti dose recovered over the course of - 	 of infection in Expt 3 
infection in Cxpt 1 
Day 	Mean proportion 	n 	SD 	?lean no. 	n 	SD Mean no. n SD Day post-infection 	Mean proportion of n SD Post- of the dose of eggs of eggs the dose recovered infection 	recovered 	 in utero/ in utero/ 
8 0.538 6 0.102 
worm worm/rat 
8 	0.445 	6 	0.320 	5.962 	78 	1.55 5.800 6 0.918 14 0.349 6 0.093 (controls) 
20 0.224 6 0.114 8 	0.681 	6 	0.101 	5.508 	120 	1.52 5.508 6 0.301 
26 0.073 6 0.068 14 	0.353 	6 	0.046 	3.576 	118 	1.73 3.590 6 0.636 
32 0.014 8 0.023 20 	0.080 	6 	0.047 	2.227 	44 	1.55 1.983 6 0.788 
mean exact dose at priming 	97.5 26 	0.007 	6 	0.009 	3.000 	4 	1.15 3.000 3 1.000 
32 	0.007 	6 	0.012 	2.250 	4 	1.26 2.165 2 0.233 
mean exact dose 	subcutaneous injection 95.2 Table 3:1(u) 
S.ratti dose recovered over the course 
 skin-application 95.1 The proportion of the haiogonic 
of Infection in Expt 2 
Day 	Mean proportion n 	5)) 	Mean no. 	n SD Mean no. 	n SD 
post- of the dose of eggs of eggs Table 3:1(iv) 
infection 	recovered in utero/ in utero/ Proportion of the S.venezuelensis dose recovered on day 8 post-infection worm worm/rat in Expt 4 
8 	 0.726 6 	0.165 	7.817 	120 1.361 7.908 	6 0.591 Treatment 	Mean proportion of the 	n 	SD 	mean exact (controls) dose recovered dose 
8 	 0.703 6 	0.090 	7.908 	120 1.595 7.817 	6 0.380 subcutaneous 	0.056 	 4 	0.066 94.8 
injection 
14 	 0.459 6 	0.084 	5.683 	120 1.243 5.683 	6 0.342 
skin-application 	0.020 	 4 	0.008 20 	 0.234 6 	0.095 	4.547 	86 1.752 4.413 	6 0.869 
97.8 
26 	 0.079 6 	0.043 	1.977 	43 1.928 2.202 	6 1.301 
32 	 0.045 6 	0.050 	2.391 	23 2.488 2.197 	4 2.356 
mean exact dose subcutaneous injection 89.0 
skin-application 92.5 
3:2 Distribution data 
Table 3:2(i) 
Distribution of adult haKgonic S.ratti worms along the 
intestine in Expt. 2 
Treatment Proportion of worms in each gut section Rat n 
1 	2 	3 4 	5 6 7 8 
Day 8 Mean 0.41 	0.32 	0.16 0.07 	0.02 0.002 0.00 0.00 6 
SD 0.04 	0.06 	0.04 0.04 	0.02 0.004 0.00 0.00 
mean no. of worms per rat 65 
Day 8 Mean 0.40 	0.36 	0.16 0.06 	0.03 0.01 0.00 0.00 6 
(controls) SD 0.13 	0.06 	0.07 0.04 	0.03 0.01 0.00 0.00 
mean no. of worms per rat 65 
Day 14 Mean 0.45 	0.29 	0.14 0.10 	0.01 0.01 0.00 0.01 6 
SD 0.06 	0.14 	0.06 0.08 	0.01 0.03 0.00 0.02 
mean no. of worms per rat 42 
Day 20 Mean 0.45 	0.27 	0.16 0.09 	0.02 0.01 0.00 0.00 6 
SD 0.08 	0.09 	0.06 0.07 	0.04 0.01 0.00 0.00 
mean no. of worms per rat 22 
Day 26 Mean 0.29 	0.41 	0.17 0.01 	0.04 0.07 0.00 0.02 6 
SD 0.27 	0.31 	0.20 0.03 	0.09 0.13 0.00 0.05 
mean no. of worms per rat 7 
Day 32 Mean 0.32 	0.24 	0.30 0.00 	0.00 0.00 0.00 0.12 4 
SD 0.47 	0.28 	0.32 0.00 	0.00 0.00 0.00 0.15 
mean no. of worms per rat 4 
Table 3:2(u) 
Distribution of adult hetonic S.ratti worms along 
the intestine in Expt 3 
Treatment Proportion of worms in each gut section Rat n 
1 	2 	3 	4 5 6 7 8 
Day 8 Mean 0.26 	0.44 	0.23 	0.03 0.02 0.01 0.002 0.00 6 
SD 0.13 	0.17 	0.09 	0.03 0.02 0.02 0.004 0.00 
mean no. of worms per rat 	65 
Day 8 Mean 0.40 	0.43 	0.11 	0.03 0.01 0.01 0.00 0.00 6 
(controls) SD 0.08 	0.09 	0.06 	0.02 0.02 0.01 0.00 0.00 
mean no. of worms per rat 	42 
Day 14 Mean 0.35 	0.37 	0.18 	0.07 0.02 0.01 0.00 0.01 6 
SD 0.08 	0.08 	0.06 	0.07 0.03 0.01 0.00 0.02 
mean no. of worms per rat 	34 
Day 20 Mean 0.25 	0.10 	0.03 	0.06 0.08 0.04 0.05 0.40 6 
SD 0.16 	0.09 	0.05 	0.10 0.12 0.06 0.08 0.35 
mean no. of worms per rat 8 
Day 26 Mean 0.17 	0.17 	0.00 	0.67 0.00 0.00 0.00 0.00 4 
SD 0.29 	0.29 	0.00 	0.58 0.00 0.00 0.00 0.00 
mean no. of worms per rat 1 
Day 32 Mean 0.00 	0.00 	0.34 	0.67 0.00 0.00 0.00 0.00 2 
SD 0.00 	0.00 	0.47 	0.47 0.00 0.00 0.00 0.00 
mean no. of worms per rat 1 
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Table 3:2(iii) 
Distribution of adult S.venezuelensis along the intestine 
in Expt 4 
Treatment 	 Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 	6 	7 	8 
sub- 	Mean 	0.57 0.43 0.00 0.00 0.02 0.00 0.00 0.00 	3 
cutaneous SD 0.51 0.53 0.00 0.00 0.04 0.00 0.00 0.00 
injection 	mean no. of worms per rat 	5 
skin- 	Mean 	0.67 0.33 0.00 0.00 0.00 0.00 0.00 0.00 	4 
application SD 0.47 0.47 0.00 0.00 0.00 0.00 0.00 0.00 
mean no. of worms per rat 	2 
3:3 Statistical analysis of data 
The results of the analyses carried out on data in Chapter 4 are given as 
an example of the type of tests used to analyse data throughout this study. 
3:3a Worm data 
Table 3:3a(i) 
Single classification anova on data in Expt 1 
Source Of Variation 	df 	SS 	MS 	F 
Among Gps. 	 4 7817.296 19T.824 	13.37 
Within 	 27 	1221.267 	45.232 
Total 9068.563 
F (427 ) =6.33 	0.1% 
Table 3:3a(ii) 
Single classification anova on data in Expt 1, days 8, 
14 and 20 only 
Source Of Variation 	df 	SS 	MS 	F 
Among Gps. 	 118T598 591299 1.96 
Within 	 15 	745.700 	49.713 
Total 1934.298 
F 2,15 ) = 11.96 	0.1% 
Table 3:3a(iii) 
Single classification anova on data in Expt 2, days 8, 
14 and 20 only 
Source Of Variation 	df 	SS 	MS 	F 
Among Gps. 	 T 369T367 123-2.789 -29.17 
Within 	 20 	1222.700 	61.135 
Total 4921.068 
=8. 10. 0.1% 
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Table 3:3a(iv) 
Single classification anova on data in Expt 3, days 8, 
14 and 29 only 
Source Of Variation 	df 	SS 	MS 	F 
Among (s. 	 T 498t801 16.600 1160 
Within 	 20 	2636.179 	131.809 
Total 7617.989 
F(320) = 810 	0.11  
Table 3:3a(vii) 
Two-ay anova comparing the proportion of the dose recovered on 
days 8, 14 and 20, in Expts 1, 2 and 3 
Source Of Variation 	df 	SS 	MS 	F 
Among Cols. 	i 824T453 41.727 	.24 
M,OQg Rows 2 	586.931 	293.726 6.06 
Interaction 	4 635.286 158.821 	3.28 
Among (s. 8 	9468.769 	1183.596 
Within 	 45 2176.972 48.317 
Total 11645.741 
F (445 ) = 3 . 10 	2.5% 
Table 3:3a(viii) 
Two-way anova comparing the proportion of the dose recovered on 
all days for Expts 1 and 2 
Source Of Variation 	df 	SS 	MS 	F 
Among Cols. 	i 1695T150 42T8.288 	.70 
PJeDng Rows 1 	454.889 	454.889 8.45 
Interaction 	4 249.792 62.448 	1.16 
Among Cps. 9 	17657.831 1961.981 
Within 	 50 2692.653 	53.853 
Total 20350.484 
Table 33a(v) 
t-test comparing the two treatments in Expt 4 
Source Of Variation 	df 	SS 	MS 	t-value 
Among s. 	 T 1554 T.554 0.55 




) = 1.21 25% 
1 (459 ) 	0.1% 	1(150) = LA. 1% 1(459) 	iZ 
b)E5g data 
Table 3:3b(i) 
Two-level nested anova on egg data in Expt 2 
Source Of Variation df SS 	MS 	F 
Among (s. 5 202775 	4.155 	4-9.87 
Among Subgps. 28 276.891 9.889 	4.78 
Within 478 988.803 	2.069 
Total 511 3286.469 
0.1% F124 	iL 
Table 3:3a(vi) 
0 
Car,arison of the proportion of the dose recovered for c ontrols 
in Expts 1, 2 and 3, using a single classification anova 
Source Of Variation 	df 	SS 	MS 	F 
Among Gs. 	 t 140536 3.884 1.60 
Within 	 25 	3411.600 136.464 
Total 4831.140 
= 2 . 76 	5% 
Table 3:3b(ii) 
Sinqle classification anova on eqq data in ExDt 2 
Source Of Variation 	df 	SS 	MS 
Among Gps. 	 5 178.227 35.645 
Within(Error) 28 	31,035 	1.108 
Total 	 209.261 
F (528 )=5 0 66 
Table 3:3b(iii) 
Two-level nested ariova on egg data in Expt 3 
Source Of Variation df SS MS 	F 
Among Gps, 5 589.830 117.966 
Among Subgps. 23 107.966 4.685 	1,95 
Within(error) 339 814,146 2.402 
Total 367 1511,728 
F (523 )=6008 0.1% 	F(12.&=1.75 5% 
17 
Table 3:3b(iv) 
Single classification anova on egg data in Expt 3 
Source Of Variation 	df 	SS 	MS 	F 
Among Gps. 	 5 68.634 13.634 	.47 
Within 	 23 	11.847 	0,515 
Total 80,017 
F (523 )=6.08 0.1% 
F 
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4:1 	Suninary of results 
Table 4:1(i) 
Homologous challenge with hanoqonic S.ratti, Expt 1 
TreatrTent Mean proportion 	n SD 
of the dose 
recovered 
homologous 0.054 12 0.056 
challenge 
Cp. 
day 8 secondary 0.546 12 0.102 
skin-application 
controls, Gp.C2 
day 8 priming 0.539 6 0.164 
injection 
controls, Gp.Cl 
day 8 secondary 0.547 6 0.138 
injection 
controls, Gp.C3 
mean exact dose priming skin-application 97.08 
injection 95.17 
challenge skin-application 95.70 
injection 90.71 
Table 4:1(u) 
Homologous challenge with haigonic S.ratti, Expts 1 and 2 
Treatment 	Mean prop. n SD 	Mean no. n SD 
	
Mean no. n SD 
of the dose 	 of eggs 	 of eggs 
recovered in utero/ in utero 
worm/rat 
	
0.065 	10 	0.114 	2.776 	47 	1.658 	2.358 	4 	0.917 
0.031 	11 	0.065 	1.516 	31 	1.264 	1.325 	6 	0.429 
0.500 	5 	0.237 	8.607 	83 	1.585 	8.624 	5 	0.414 
0.417 6 0.236 6.943 88 1.193 1.050 6 0.616 
0.632 5 0.396 7.770 74 1.641 7.782 4 0.289 
priming skin-application 96.36 
Expts 2 and 3 injection 96.20 
challenge skin-application 96.73 
Expt 2 injection 97.80 
challenge skin-application 98.50 












and 3, Gp.Cl 
challenge 
controls 
Expt 2, Gp.C2 
challenge 
controls 
Expt 3, Gp.C3 
mean exact dose 
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4:2 Worm distribution data 
Table 4:2(i) 
Distribution of worms alonq the intestine in Expt 1 
Treatment Proportion of worms 









homologous Mean 0.34 	0.29 	0.10 0.07 0.08 0.09 0.01 0.03 	8 
challenge SD 0.35 	0.32 	0.10 0.10 0.11 0.14 0.04 0.07 
Gp. mean no. of worms per rat 5 
day 8 Mean 0.46 	0.31 	0.18 0.06 0.003 0.00 0.00 0.00 	12 
secondary SD 0.10 	0.07 	0.07 0.05 0.009 0.00 0.00 0.00 
controls mean no. of worms per rat 52 
Gp.C2 
day 8 Mean 0.37 	0.37 	0.17 0.10 	0.01 0.003 0.00 0.00 	6 
priming SD 0.12 	0.06 	0.07 0.06 	0.02 0.010 0.00 0.00 
controls mean no. of worms per rat 51 
Gp .C1 
day 8 Mean 0.46 	0.32 	0.14 0.07 	0.01 0.01 0.00 0.00 	6 
challenge SD 0.12 	0.08 	0.07 0.04 	0.02 0.02 0.00 0.00 
controls mean no. od worms per rat 50 
Gp.C3  
Table 4:2(u) 
Distribution of worms along the intestine in Expts 2 and 3 
Treatment 	 Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 	6 	7 	8 
homologous 	Mean 	0.83 0.06 0.10 0.01 0.00 0.01 0.00 0.00 	6 
challenge SD 0.27 0.10 0.16 0.02 0.00 0.02 0.00 0.00 
Expt 2 	mean no. of worms per rat 	6 
Gp.. A 
homologous 	Mean 	0.54 0.06 0.12 0.11 0.00 8.04 0.03 0.02 	4 
challenge SD 0.36 0.11 0.18 0.15 0.00 0.06 8.07 0.03 
Expt 3 	mean no. of worms per rat 	3 
Gp.ci2 
priming 	Mean 	0.46 0.34 0.10 0.06 0.03 0.004 0.00 0.004 	5 
controls SD 0.17 0.09 0.08 0.03 0.02 0.01 0.00 0.01 
Gp.Cl 	mean no. of worms per rat 	48 
challenge Mean 0.36 	0.42 	0.17 8.04 	0.004 0.002 0.002 0.00 	5 
controls SD 0.08 	0.15 	0.07 0.05 	0.01 8.004 0.004 0.00 
Expt 2 mean no. of worms per rat 41 
Gp .C2 
challenge Mean 0.31 	0.43 	0.22 0.03 	0.008 0.00 0.00 0.003 	6 
controls SD 0.08 	0.18 	8.12 0.05 	0.02 0.00 0.00 0.008 




Distribution of worms along the intestine in Expt 4 
Treatment Proportion of worms 








homologous Mean 0.41 	0.23 	0.22 0.06 0.04 0.03 0.00 0.00 10 
challenge SD 0.36 	0.21 	0.30 0.09 0.07 0.05 0.00 0.00 
Gp.B mean no. of worms per rat 12 
heterologous Mean 0.15 	0.44 	0.14 0.18 0.02 0.03 0.02 0.01 7 
challenge SD 0.13 	0.36 	0.14 0.37 0.03 0.07 0.03 0.02 
Gp.D mean no. of worms per rat 6 
priming Mean 0.41 	0.36 	0.13 0.07 0.03 0.01 0.00 0.00 5 
controls SD 0.16 	0.03 	0.08 0.04 0.03 0.01 0.00 0.00 
Gp.Cl mean no. of worms per rat 49 
challenge Mean 0.29 	0.35 	0.21 0.12 0.02 0.00 0.00 0.00 5 
homogonic SD 0.13 	0.12 	0.08 0.11 0.02 0.00 0.00 0.00 
S.ratti mean no. of worms per rat 36 
controls 
Gp .C2 
challenge Mean 0.24 	0.38 	0.24 0.11 0.03 0.01 0.00 0.00 6 
heterogonic SD 0.06 	0.07 	0.04 0.04 0.03 0.03 0.00 0.00 




Distribution of worms alonq the intestine in Expt 5 
Treatment Proportion of worms in each gut section Rat n 
1 2 	3 	4 5 6 7 8 
homologous Mean 0.50 0.06 	0.10 	0.15 0.04 0.07 0.02 0.05 9 
challenge SD 0.33 0.09 	0.13 	0.17 0.06 0.17 0.05 0.10 
Gp.B mean no. of worms per rat 8 
heterologous Mean 0.32 0.05 	0.05 	0.18 0.00 0.06 0.04 0.18 8 
challenge SD 0.33 0.10 	0.10 	0.36 0.00 0.08 0.06 0.35 
Gp.D mean no. of worms per rat 3 
priming Mean 0.35 0.39 	0.14 	0.11 0.02 0.00 0.00 0.00 6 
controls SD 0.06 0.04 	0.07 	0.08 0.02 0.00 0.00 0.00 
Gp.Cl mean no. of worms per rat 52 
challenge Mean 0.37 0.27 	0.21 	0.13 0.01 0.00 0.00 0.00 5 
homogonic SD 0.11 0.10 	0.05 	0.04 0.02 0.00 0.00 0.00 
S.ratti mean no. of worms per rat 54 
controls 
Gp.C2 
challenge 	Mean 0.44 0.30 0.16 0.10 0.02 0.004 0.00 0.00 
	
5 
heterogonic SD 	0.11 0.10 0.02 0.04 0.03 0.010 0.00 0.00 
S.ratti 	mean no. of worms per rat 	41 
controls 
Gp .C3 
-51 1 1.  
Table 4:2(v) 
Distribution of worms alon_g the intestine in Expt 6 
Treatment Proportion of worms in each gut section 
1 	2 	3 	4 	5 	6 	7 
Rat n 
8. 
homologous Mean 0.21 	0.31 	0.25 0.15 	0.01 0.03 0.03 0.00 6 
challenge SD 0.27 	0.40 	0.18 0.21 	0.03 0.09 0.09 0.00 
Gp.B mean no. of worms per rat 3 
heterologous Mean 0.57 	0.27 	0.12 0.03 	0.003 0.00 0.00 0.00 10 
challenge SD 0.09 	0.10 	0.08 0.03 	0.010 0.00 0.00 0.00 
Gp.D mean no. of worms per rat 30 
priming Mean 0.57 	0.33 	0.10 0.02 	0.01 0.00 0.00 0.00 5 
controls SD 0.06 	0.05 	0.10 0.02 	0.01 0.00 0.00 0.00 
Gp.Cl mean no. of worms per rat 42 
challenge Mean 0.51 	0.32 	0.11 0.05 	0.01 0.004 0.00 0.00 5 
heterogonic SD 0.09 	0.04 	0.05 0.03 	0.02 0.01 0.00 0.00 
S.ratti mean no. of worms per rat 52 
controls 
Gp.C2 
challenge Mean 0.38 	0.33 	0.20 0.08 	0.00 0.01 0.00 0.00 5 
homogonic SD 0.07 	0.05 	0.07 0.07 	0.00 0.01 0.00 0.00 




Distribution of worms along the intestine in Expt 7 
Treatment 	 Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 	6 	7 8 
homologous 	Mean 	0.62 0.10 0.09 0.12 0.00 0.00 0.00 0.07 	7 
challenge SD 0.49 0.25 0.16 0.21 0.00 0.00 0.00 0.19 
Gp.B 	 mean no. of worms per rat 	1 
heterologous Mean 	0.64 0.18 0.11 0.04 0.02 0.00 0.04 0.004 	10 
challenge 	SD 0.23 0.16 0.09 0.05 0.07 0.00 0.02 0.01 
Gp.D 	 mean no. of worms per rat 	15 
priming 	Mean 	0.42 0.39 0.12 0.06 0.02 0.00 0.00 0.00 	4 
controls SD 0.08 0.16 0.06 0.06 0.03 0.00 0.00 0.00 
Gp.C1 	mean no. of worms per rat 	41 
challenge 	Mean 	0.33 0.46 0.14 0.07 0.00 0.00 0.00 0.00 	4 
heterogonic SD 0.02 0.10 0.10 0.05 0.00 0.00 0.00 0.00 
S.ratti 	mean no. of worms per rat 	36 
controls 
Gp .C2 
challenge 	Mean 	0.38 0.31 0.14 0.12 0.06 0.00 0.00 0.00 	5 
homogonic SD 0.07 0.10 0.05 0.06 0.07 0.00 0.00 0.00 





Distribution of worms along the intestine in Expt 8 
Treatment Proportion of worms in each gut section Rat n 
1 2 	3 	4 5 6 7 8 
homologous Mean 0.86 0.14 	0.00 	0.00 0.00 0.00 0.00 0.00 8 
challenge SD 0.14 0.14 	0.00 	0.00 0.00 0.00 0.00 0.00 
Gp.B mean no. of worms per rat 6 
heterologous Mean 0.36 0.35 	0.19 	0.05 0.01 0.002 0.00 0.00 12 
challenge SD 0.11 0.11 	0.08 	0.05 0.02 0.010 0.00 0.00 
Gp.D mean no. of worms per rat 44 
residual Mean 0.91 0.09 	0.00 	0.00 0.00 0.00 0.00 0.00 8 
S.venezuelensis SD 0.13 0.13 	0.00 	0.00 0.00 0.00 0.00 0.00 
Gp.E mean no. of worms per rat 6 
priming Mean 0.87 0.13 	0.00 	0.00 0.00 0.00 0.00 0.00 5 
controls SD 0.19 0.19 	0.00 	0.00 0.00 0.00 0.00 0.00 
Gp.C1 mean no. of worms per rat 5 
challenge Mean 0.87 0.13 	0.00 	0.00 0.00 0.00 0.00 0.00 4 
S.venezuelensjs SD 0.25 0.25 	0.00 	0.00 0.00 0.00 0.00 0.00 
controls, Gp.C2 mean no. of worms per rat 2 
challenge Mean 0.55 0.30 	0.09 	0.06 0.01 0.00 0.00 0.00 5 
homogonic SD 0.23 0.21 	0.06 	0.08 0.02 0.00 0.00 0.00 
S.ratti mean no. of worms per rat 22 
controls, Gp.C3  
Table 4:2(viii) 
Distribution of worms along the intestine in Expt 9 
Treatment Proportion of worms in each 





homologous Mean 0.89 	0.11 	0.00 0.00 0.00 0.00 0.00 0.00 10 
challenge SD 0.10 	0.10 	0.00 0.00 0.00 0.00 0.00 0.00 
Gp.B mean no. of worms per rat 10 
heterologous Mean 0.34 	0.40 	0.18 0.06 0.01 0.01 0.00 0.00 10 
challenge SD 0.07 	0.09 	0.09 0.03 0.01 0.02 0.00 0.00 
Gp.D mean no. of worms per rat 64 
residual Mean 0.79 	0.21 	0.00 0.00 0.00 0.00 0.00 0.00 9 
S.venezuelensis SD 0.31 	0.31 	0.00 0.00 0.00 0.00 0.00 0.00 
Gp. E mean no. of worms per rat 5 
priming Mean 0.72 	0.28 	0.00 0.00 0.00 0.00 0.00 0.00 5 
controls SD 0.44 	0.44 	0.00 0.00 0.00 0.00 0.00 0.00 
Gp.Cl mean no. of worms per rat 2 
challenge Mean 0.97 	0.03 	0.00 0.00 0.00 0.00 0.00 0.00 5 
S.venezuelensis SD 0.08 	0.08 	0.00 0.00 0.00 0.00 0.00 0.00 
controls, Gp.C2 mean no. of worms per rat 4 
challenge Mean 0.33 	0.38 	0.16 0.08 0.02 0.004 0.00 0.00 5 
heterogonic SD 0.09 	0.17 	0.05 0.07 0.02 0.010 0.00 0.00 
S.ratti mean no. of worms per rat 33 
controls, Gp.C3 
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4:3 Third-stage larval output post-challenge for Expt 5 
Table 4:3(i) 
Treatment Day L3 output/gm. faeces Theoretical number Of L3 
which could be produced 
by all faeces collected 
Mean L3/gm. n 	SD Total no. L3 	n 	SD 
faeces produced 
hornogonic 6 193.6 3 	92.6 2056.2 	3 	1350.9 
S,ratti 7 133.6 3 104.8 1200.6 3 1006.9 
challenge 8 197.8 3 	203.6 314,6 	3 	398.8 
controls 
heterogonic 6 82.3 3 46,5 895,2 3 465.3 
S,ratti 7 209.3 3 180.5 2410.8 3 2159.3 
challenge 8 65.4 3 51.8 150.5 3 34.2 
controls 
homologous 6 	- 0,7 3 1.0 11.0 3 17,0 
challenge 7 31.4 3 39.8 320,3 3 510,5 
8 21.0 3 17.9 90,0 3 85.4 
heterologous 6 0,0 3 0.0 
challenge 7 0,0 3 0,0 
8 0.2 3 0,3 0,7 3 1,2 
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4:4 Resistance quotients for Expts 4-9 
Table 4:4(i) 
Resistance ouotients 





ReQ n SE 
4 homologous 0.70 10 0,09 0.81 80 0.03 
challenge 
heterologous 0.88 10 0,05 0.73 50 0.04 
challenge 
5 homologous 0.84 10 0.04 0.83 61 0.02 
challenge 
heterologous 0,93 9 0,03 0.76 22 0.07 
challenge 
6 homologous 0,93 9 0.03 0.81 20 0,04 
challenge 
heterologous 0,52 10 0,03 0,66 154 0.02 
challenge 
7 homologous 0.97 10 0,01 0,89 10 0004 
challenge 
heterologous 0.70 10 0.05 0.63 100 0,02 
challenge 
8 homologous -1.59 9 0,61 
challenge 
heterologous -0,85 10 0.18 
challenge 
9 homologous -1.39 9 0044 
challenge 





Mode Of Infection. Exot 1  
Treatment 	mean proportion n SD age of rats mean exact 
of the dose dose 
recovered 
subcutaneous 	9.091 4 0.197 Adult 94.75 
injection 
skin-application 	0.092 4 0.119 Adult 97.75. 
Table 5:1(u) 
Mode of anaesthertizing rats, Expt 2 
Treatnmnt 	mean proportion n SD age of rats 	mean exact 
of the dose dose 
recovered 
Sagatal 	0.034 4 0.023 Adult 97.00 
ether 	 0.090 4 0.072 Adult 94.75 
Table 5:1(iii) 
Increasing infection dose, Expt 3 
Treatment 	mean proportion 	n SD age of rats 	mean no. n 	SD 
of the dose of eggs 
recovered in utero/ 
worm 





Age -of host, Expt 4 
Treatment mean proportion 	n 	SD 	mean exact 
of the dose 	 dose 
recovered 
3 week old 0.298 	 4 	0.089 
rats 96.00 
adult rats 0.013 	 4 	0.019 
Table 5:1(v) 
Age of host: using labelled larvae, 72 hours post-infection, Expt S 
Treatment 	mean prop. 	n SD 	mean prop. 	SD mean prop. 	SD 
of the dose of the dose of the dose 
recovered in the in the 
anterior posterior 
Intestine Intestine 
hosoqonic 	0.321 	4 0.059 	0.274 	0.041 0.047 	0.920 
S.ratti 
adult rats 
hasegonic 	0.326 	3 	0.062 	0.275 	0.036 	0.054 	9.029 
S,ratti 
3 week old 
rats 
S.venezuelensis 0.093 	5 	0.004 	0.0998 	0.002 	9.003 	0.003 
adult rats 
S.venezuelensis 0.180 	4 	0.048 	0.175 	0.044 	0.004 	0.004 
3 week old 
rats 
S.ratti 	 25000 5090cmi 	thus 2.OcpnVL3 	Background 238cps 
S.venezue lens is 2500I3 4745ce thus 2.9cpiVl.3 Background 219cpn 
Table 5:l(vi) 
Age of host: using labelled larvae, days 3 and 8 post-infection, Expt 6 
Treatment 	mean prop, n 	SD 	mean prop 	SD 	mean props SD 
of the dose of the dose of the dose 
recovered 	 in the 	 in the 
anterior posterior 
intestine 	intestine 
S0venezuelensis 	0.,016 	7 	0,007 	0,,012 	0,005 	0,004 	0,002 
adult rats 
72 hours 
Svenezuelensis 	0.031 	8 	0 . 007 	0.029 	0.,007 	0,,002 	0,,001 
adult rats 
day 8 




S.venezuelensis 2030L3 7511c 	thus 3.7cprrVL3 Background 227cpm 
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Table 5:2(i) 
Distribution of worms along the intestine in Expt 1 
Treatment Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 5 6 7 8 
subcutaneous Mean 	0.82 	0.13 	0.05 	0.00 0.00 0.00 0.00 	0.00 	4 
injection SD 0.29 	0.19 	0.10 	0.00 0.00 0.00 0.00 	0.00 
mean no. of worms per rat 9 
skin-application Mean 	0.93 0.04 0.03 0.00 0.00 0.00 0.00 0.00 	3 
SD 0.06 0.08 0.06 0.00 0.00 0.00 0.00 0.00 
	
mean no. of worms per rat 	9 
Table 5:2(u) 
Distribution of worms along the intestine in Expt 2 
Treatment 	 Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 	6 	7 8 
Sagatal 	Mean 	0.76 0.22 0.00 0.00 0.00 0.00 0.00 0.00 	3 
anaesthesia SD 0.16 0.19 0.00 0.00 0.00 0.00 0.00 0.00 
mean no. of worms per rat 	3 
ether 	Mean 	0.92 0.08 0.00 0.00 0.00 0.00 0.00 0.00 	4 
anaesthesia SD 0.12 0.12 0.00 0.00 0.00 0.00 0.00 0.00 
mean no. of worms per rat 	9 	 - 
Table 5:2(iii) 
Distribution of worms along the intestine in Exp 
Treatment 	 Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 	6 	7 8 
dose Of 	Mean 	0.59 0.30 0.10 0.01 0.003 0.002 0.00 0.00 	6 
2000L3 SD 0.06 0.03 0.03 0.01 0.004 0.004 0.00 0.00 
mean no. of worms per rat 	580 	 -- 
Table 5:1(w) 
Distribution of worms along the intestine in Expt 4 
Treatment 	 Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 	6 	7 8 
3 week old 	Mean 	0.69 0.28 0.02 0.02 0.00 0.00 0.00 0.00 	4 
rats 	SD 0.10 0.06 0.03 0.03 0.00 0.00 0.00 0.00 
mean no. of worms per rat 	29 
adult rats 	Mean 	0.75 0.00 0.25 0.00 0.00 0.00 0.00 0.00 	2 
SD 0.18 0.00 0.35 0.00 0.00 0.00 0.00 0.00 
mean no. of worms per rat 	1 
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6:1 	Summary 	of egg and worm data 
Table 6:1(i) 
Priming rats with heat-killed third-stage homogonic S,ratti larvae, Expt 1 
Treatment 	Mean proportion 	n 	SD 
of the dose 
recovered 










mean exact dose 
0.211 	 15 	0.112 
0,436 	 5 	0.089 
skin-application 	95.47 
injection 	 80.00 
Table 6:1(u) 
Day  post-infection with transferred S.venezuelensis worms, Expt 2 
Treatment 	mean proportion 	n 	SD 	mean exact 
of the dose 	 dose 
recovered 




Haim3logous vs heterologous challenge: hatgonic S.ratti worms priming rats, 
Expt 8 
Treatment mean prop. 
of the dose 
recovered 









homologous 0.093 7 0.063 	1.740 	6 0.838 2.526 19 4.384 
challenge 
heterologous 0.092 7 0.039 	2.417 	6 1.191 2.385 26 2.041 
challenge 














mean exact dose 	priming haTogonic Sratti 44.32 
challenge hcxnogonic S.ratti 47.00 
heterogonic S,ratti 46.50 
mortality 0% 
Table 6:1(iii) 
HOznoloqous challenge: haTogonic S.ratti worms priming rats, Expt 7 
Treatment mean prop. n SD mean no. n SD mean no. n SD 
of the dose of eggs of eggs 
recovered in utero/ in utero/ 
worm/rat worm 
homologous 0.229 5 0.102 2.947 5 1.699 3.656 32 1.945 
challenge 
day 4 
homologous 0.065 5 0.052 1.367 4 0.427 1.444 9 0.882 
challenge 
day 8 
day 4 0.359 4 0.173 7.521 4 0.625 7.500 26 1.068 
priming 
control 
day 4 0.237 5 0.198 6.387 4 0.592 6.607 28 1.367 
challenge 
control 
day 8 0.397 5 0.224 6.870 5 0.912 7.267 30 1.337 
challenge 
control 






priming with a trickle infection of S.venezuelensis: homologous vs 
heterologous challenge, Expt 9 
Table 6:1(vill)a 
Adult recoveries, Expt 9 
Treatment 	 S.venezuelensjs 	 S.ratti 
Mean proportion n 	SD 	Mean proportion n 	SD 
of the dose 	 of the dose 
recovered recovered  
1 week of 0.068 
trickle 
infection 
3 weeks of 0.017 
trickle 
infection 
5 weeks of 0.022 
trickle 
infection 














E)gq 	S.venezuelensis, Expt 9 
Treatment 	mean no. eggs 	n 	SD 	mean no. eggs 	n 	SD 
in Utero/ 	 in utero/ 
worm/rat worm 
1 week of 5.500 2 0.709 5.500 2 0.707 
trickle 
infection 
3 weeks of 6.778 3 1.072 6.600 5 1.342 
trickle 
infection 
5 weeks of 4.100 4 1.070 3.667 6 1.633 
trickle 
infection 
6 weeks of 4.400 5 2.278 4.300 10 1.767 
trickle 
infection 
heterologous 5.083 4 0.484 5.111 9 1.274 
challenge 
heterologous 	6.024 	 5 	0.613 	6.000 	51 	1.223 
challenge 
challenge 	6.028 	 5 	0.506 	6.109 	55 	1.208 
controls 








mean exact dose S.venezuelensjs 
S. ratti 
1 week of trickle 	23.2 
3 weeks of trickle 72.2. 
5 weeks of trickle 	117.6 
6 weeks of trickle 	147.7 
skin-application 	97.7 
0.416 	5 	0.105 
Table6:I(v)c 
0.448 	5 	0.061 	 Eggta, honogonic S.ratti, Expt 9 
Treatment 	mean no. eggs 	n 	SD 	mean no. eggs 	n 	SO 
in utero/ 	 in utero/ 
0.466 	5 	0.183 	 wornv'rat - 	worm 
"-p 
Table 6:1(vi) 
Priming with a trickle infection of S.venezuelensis: honoloqous vs 
heterologous challenge, Expt 10 
Table 6:1(vi)a 
Adult recoveries, Expt 10 
Treatment 	 S.venezuelensis 	 S.ratti 
mean proportion n 	SD 	mean proportion 	n 	SD 
of the dose 	 of the dose 
recovered recovered 
5 weeks of 0.010 5 0.007 
trickle 
infection 
7 weeks of 0.001 5 0.003 
trickle 
infection 
9 weeks of 0.000 5 0.000 
trickle 
infection 
10 weeks of 0.003 5 0.003 
trickle 
infection 
heterologous 0.002 6 0.003 	0.422 6 	0.418 
challenge 








mean exact dose S.venezuelensjs S weeks of trickle 119.0 
7 weeks of trickle 169.6 
9 weeks of trickle. 219.6 
10 weeks of trickle 243.9 
S.rattl skin-application 95.8 
Table 6:1(vi)b 
Dg data, S.venezuelensis, Expt 10 
Treatment mean no. eggs 	n 	SD mean no. eggs 	n 	SD 
in utero/ in utero/ 
worm/rat worm 
5 weeks of 6.700 	1 	- 6.700 	1 	- 
trickle 
infection 
7 weeks of - 	 - 	 - - 	 - 	 - 
trickle 
infection 
9 weeks of - 	 - 	 - - 	 - 	 - 
trickle 
infection 
heterologous 5.000 	1 	- 5.000 	1 	- 
challenge 
Table 6:1(vi)c 
Dg data, S.ratti, Expt 10 
Treatment mean no. eggs n SD mean no.eggs n SD 
in utero/ in utero/ 
worm/rat worm 
heterologous 5.950 6 0.740 6.056 36 1.604 
challenge 
'challenge 6.323 5 0.303 6.393 28 1.068 
controls 




6:2 Distribution of worms along the intestine in Expts2-U 
Table 6:2(1) 
Ex2L 
Treatment 	 Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 	6 	7 	8 
day 4 	Mean 	0.50 0.39 0.03 0.00 0.00 0. 09 0.00 0.00 	4 
S.venezuelensls SD 0.43 0.39 9.06 0.00 0.00 0.00 0.00 0.00 
mean no. of worms per rat 	29 
Table 6:2(11) 
pt 3, S.venezuelensis 
Treatment 	 Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 	6 	7 	8 
day 4 	Mean 	0.69 0.24 0.07 0.00 0.00 0.00 0.00 0.09 	6 
SD 0.31 0.20 0.13 0.00 0.00 0.00 0.00 0.00 
mean no. of worms per rat 	11 
day 14 	Mean 	0.72 9.08 0.15 0.05 0.00 0.00 0.00 0.00 	5 
SD 0.41 0.11 0.34 0.11 0.00 0.00 0.00 0.00 
mean no. of worms per rat 	6 
day 21 	Mean 	0.91 0.07 0.02 0.00 0.00 0.00 0.00 0.00 	6 
SD 0.22 0.11 0.05 0.00 0.00 0.00 0.00 0.00 
mean no. of worms per rat 	7 
Table 6:2(iii) 
Expt 4, heterogonic S.ratti 
Treatment 	 Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 	6 	7 	8  
day 4 	Mean 	0.33 	0.35 	0.14 0.17 0.008 0.00 0.00 0.00 	6 
SD 0.34 	0.35 	0.11 0.41 0.002 0.00 0.00 0.00 
mean no. of worms per rat 14 
day 14 	Mean 	0.47 	0.19 	0.16 0.09 0.07 	0.03 0.00 0.00 	6 
SD 0.28 	0.18 	0.15 0.17 0.12 	0.04 0.00 0.90 
mean no. of worms per rat 9 
day 21 	Mean 	0.24 	0.35 	0.29 0.04 0.09 	0.00 0.00 0.00 	6 
SD 0.27 	0.22 	9.46 0.10 0.14 	0.00 0.00 0.00 
mean no. of worms per rat 5 
Table 6:2(iv) 
Expt 5, hrmogonic S.ratti 
Treatment 	 Proportion of worms in each out section 	Rat n 
1 	2 	3 	4 	5 	6 	7 	8 
day 4 
	
Mean 	0.45 0.31 0.18 0.06 0.00 0.00 0.80 0.00 	6 
SD 0.36 0.19 0.25 0.15 0.00 0.00 0.00 0.00 
mean no. of worse per rat 	14 
day 14 
	
Mean 	0.69 0.25 0.06 0.01 0.00 0.00 0.00 0.00 	6 
SD 0.32 0.25 0.14 0.02 0.00 0.00 0.00 0.00 
mean no. of worms per rat 	15 
day 21 
	
Mean 	0.76 0.20 0.04 0.00 9.00 9.00 0.00 0.00 	6 
SD 0.29 0.23 0.07 0.00 0.00 0.00 0.00 0.00 
mean no. of worms per rat 	6 
Table 6:2(v) 
Expt 6, hrmoqonic S.ratti 
Treatment 	 Proportion of worse in each gut section 	Rat n 
1 	2 	3 	4 	5 	6 	7 	8 
day 4 	Mean 	0.81 0.12 0.03 0.03 0.00 0.00 0.00 0.00 	6 
SD 0.25 0.24 0.05 0.05 0.00 0.00 0.00 0.00 
mean no. of worms per rat 	20 
day 14 	Mean 	0.82 0.12 0.04 0.02 0.90 0.00 0.00 0.00 	6 
SD 0.27 0.19 0.06 0.03 0.00 0.00 0.00 0.00 
mean no. of worms per rat 	13 
day 21 	Mean 0.96 0.92 0.02 0.00 0.00 0.00 0.00 0.00 	6 
SD 	0.10 0.05 0.05 0.00 9.00 0.00 0.00 0.00 
mean no. of worms per rat 	5 
Table 6:2(vi) 
Expt 7, Homologous challenge with hcgonic S.ratti 
Treatment Proportion of worms in each gut section Rat n 
1 	2 	3 	4 5 6 7 8 
homologous Mean 	0.69 	0.16 	0.07 	0.08 0.00 0.00 0.00 0.00 5 
challenge SD 0.18 	0.16 	0.07 	0.11 0.00 0.00 0.00 0.00 
day 4 mean no. of worms per rat 11 
homologous Mean 	0.44 	0.15 	0.14 	0.05 0.13 0.05 0.00 0.05 4 
challenge SD 0.52 	0.17 	0.19 	0.10 0.25 0.10 0.00 0.10 
day 8 mean no. of worms per rat 3 
priming Mean 	0.78 	0.09 	0.13 	0.00 0.00 0.00 0.00 0.00 5 
controls SD 0.44 	0.14 	0.30 	0.00 0.00 0.00 0.00 0.00 
Gp.C1 mean no. of worms per rat 17 
challenge Mean 	0.90 	0.07 	0.00 	0.03 0.00 0.00 0.00 0.00 5 
controls SD 0.22 	0.16 	0.00 	0.06 0.00 0.00 0.00 0.00 
day 4, Gp.C2 mean no. of worms per rat 11 
challenge 	Mean 	0.78 0.22 0.00 0.00 0.00 0.00 0.00 0.00 	5 
controls SD 0.22 0.22 0.00 0.00 0.00 0.00 0.00 0.00 
day 8, Gp.C2 mean no. of worms per rat 	19 
Table 6:2(vii) 
pt8 
Treatment 	 Proportion of worms in each gut section 	Rat r 
1 	2 	3 	4 	5 	6 	7 8 
homologous 	Mean 	0.68 0.20 0.12 0.00 0.00 0.00 0.00 0.00 	6 
challenge SD 0.32 0.24 0.19 0.00 0.00 0.00 0.00 0.00 
Gp.S 	 mean no. of worms per rat 	4 
heterologous Mean 	0.51 0.09 0.24 0.09 0.03 0.00 0.04 0.00 	7 
challenge 	SD 0.38 0.16 0.38 0.12 0.08 0.00 0.09 0.00 
Gp.D 	 mean no. of worms per rat 	4 
priming 	Mean 	0.85 0.10 0.05 0.00 0.00 0.00 0.00 0.00 	5 
homomgonic SD 0.31 0.19 0.12 0.00 0.00 0.00 0.00 0.00 
S.ratti 	mean no. of worms per rat 	15 
controls 
Gp. Cl 
challenge Mean 0.73 	0.23 	0.07 	0.02 0.02 0.00 0.00 0.00 	5 
homogonic SD 0.32 	0.23 	0.11 	0.05 0.05 0.00 0.00 0.00 
S.ratti mean no. of worms per rat 12 
controls 
Gp.C2 
challenge Mean 0.63 	0.37 	0.00 	0.00 0.00 0.00 0.00 0.00 	3 
heterogoriic SD 0.44 	0.44 	0.00 	0.00 0.00 0.00 0.00 0.00 




Treatment Proportion of worms in each gut section 
1 	2 	3 	4 	5 6 7 8 
1 week of Mean 	0.75 	0.25 	0.09 	0.00 	0.00 0.00 0.00 0.00 
trickle SD 0.25 	0.25 	0.00 	0.00 	0.00 0.00 0.00 0.00 
Infection sean no. of worms per rat 2 
3 weeks of Mean 	0.92 	0.00 	0.08 	0.00 	0.00 0.00 0.00 0.00 
trickle SD 0.17 	0.00 	0.17 	0.00 	0.00 0.00 0.00 0.00 
infection mean no. of worms per rat 1 
5 weeks of Mean 	1.00 	0.00 	0.00 	0.00 	0.00 0.00 0.00 0.00 
trickle SD 0.00 	0.00 	0.00 	0.00 	0.00 0.00 0.00 0.00 
infection mean no. of worms per rat 3 
6 weeks of Mean 	0.96 	0.04 	0.00 	0.00 	0.00 0.00 0.00 0.09 
trickle SD 0.10 	0.10 	0.00 	0.00 	0.00 0.00 0.00 0.00 
infection mean no. of worms per rat 3 
heterologous Mean 	1.00 	0.00 	0.00 	0.00 	0.00 0.00 0.00 0.00 
challenge so 9.90 	0.00 	0.00 	0.00 	0.00 0.00 0.00 0.00 
residual mean no. of worms per rat 3 
S.venezuelensis 
heterologous Mean 	0.49 	0.35 	0.12 	0.03 	0.01 0.00 0.00 0.00 
challenge so 0.07 	0.04 	0.05 	0.03 	0.02 0.00 0.00 0.00 
hanogonic mean no. of worms per rat 41 
S.ratti 
challenge Mean 	0.53 	9.36 	0.08 	0.02 	0.01 0.00 0.00 0.00 
homogonic SD 0.03 	0.11 	0.08 	0.03 	0.02 0.90 0.00 0.00 
S.ratti mean no. of worms per rat 44 
controls 
challenge Mean 	0.64 	0.28 	0.08 	0.007 0.00 0.90 0.00 0.00 
hanogonic SD 0.10 	0.07 	0.04 	0.180 0.00 0.00 0.00 0.00 
S.ratti mean no. of worms per rat 46 
sham controls 
Rat n Treatment Proportion of the worms in each gut section 
1 	2 	3 	4 	5 	6 	7 	8 
3 5 weeks of Mean 	0.88 	0.98 	0.12 	0.00 0.00 9.00 	0.00 0.00 
trickle SD 0.25 	0.00 	0.25 	0.00 0.00 0.09 	0.00 0.00 
infection mean no. of worms per rat 1 
4 7 weeks of Mean 	1.00 	0.00 	0.00 	0.00 0.00 0.09 	0.00 0.00 
trickle SD 0.00 	0.00 	0.00 	9.08 9.00 0.00 	0.90 0.00 
infection mean no. of worms per rat 1 
4 10 weeks of Mean 	0.83 	0.00 	0.17 	0.00 0.00 0.09 	0.00 0.00 
trickle SD 0.29 	0.00 	0.29 	0.00 9.00 0.00 	0.00 0.09 
infection mean no. of worms per rat 1 
heterologous Mean 	1.00 	0.00 	0.90 	9.00 0.00 9.00 	9.00 0.09 
challenge SD 9.00 	0.00 	0.00 	9.09 9.99 9.89 	9.90 0.00 
residual mean no. of worms per rat 1 
S.veneuelensis 
heterologous Mean 	0.45 	0.39 	0.12 	0.02 0.01 0.905 0.00 0.90 
challenge SD 0.08 	0.98 	0.04 	0.02 9.02 0.010 0.90 9.00 
hctnogonic mean no. of worms per rat 40 
S.ratti 
S 
challenge Mean 	0.42 	0.36 	9.16 	0.04 0.92 9.904 0.00 0.09 
homogonic SD 0.19 	9.98 	0.08 	0.93 0.02 0.010 9.00 0.99 
S.ratti mean no. of worms per rat 49 
controls 
5 
challenge Mean 	0.49 	9.38 	0.11 	0.03 9.09 9.00 	0.00 0.09 
hanogonic SD 9.94 	0.09 	0.07 	9.03 0.99 0.99 	0.90 0.09 


















Treatirent Proportion of worms 









homologous Mean 0.75 0.25 0000 0.00 0,00 0.00 0,00 0,00 	3 
challenge SD 0,37 0,37 0,00 0,00 0,00 0,00 0.00 0.00 
Gp,B mean no, of worms per rat 1 
heterologous Mean 0,20 0,39 0,29 0,11 0,02 0,00 0,00 0,00 	8 
challenge SD 0,09 0,11 0,15 0,06 0,03 0,00 0,00 0,00 
homogonic mean no, of worms per rat 34 
S,ratti, Gp.D 
S,venezuelerisis Mean 1,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 	6 
present in SD 0.00 0,00 0,00 0,00 0,00 0000 0,00 0,00 




heterologous Mean 0,24 0,23 0,28 	0,22 0,04 0,01 0,00 0.00 	7 
challenge SD 0,14 0,08 0,13 0,14 0,06 0,02 0,00 0,00 
heterogonic mean no, of worms per rat 33 
S,ratti, Gp,E 
S,venezuelensis Mean 1,00 0,00 0,00 	0,00 0,00 0,00 0,00 0,00 	3 
present in SD 0,00 0,00 0,00 0.00 0,00 0,00 0,00 0,00 




priming Mean 0,72 0,26 0,02 0,00 0,00 0.00 0.00 0,00 	5 
controls SD 0.21 0,19 0003 0,00 0,00 0,00 0,00 0,00 
Gp,Cl mean no, of worms per rat 83 
challenge Mean 1,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00 	6 
controls SD 0.00 0,00 0,00 0,00 0.00 0,00 0,00 0,00 
S. venezuelens is 
Gp . C2 
challenge Mean 0,33 0,34 0.22 0,12 0,01 0,00 0.00 0.00 	4 
homogonic SD 0,18 0,09 0,15 0,08 0.01 0,00 0,00 0,00 
S,ratti mean no, of worms per rat 47 
controls, Gp,C3 
challenge 	Mean 	0,21 0.47 0,16 0,12 0,04 0,01 0.00 0,00 	5 
heterogonic SD 0,07 0,05 0,04 0,05 0,04 0,01 0,00 0,00 
S,ratti 	 mean no, of worms per rat 	44 
controls, Gp,C4 
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6:3 Resistance ratios for worm and egg data 
Table 6:3(i) 
Expt 8, Egg data 
Treatment 	Group 	ReQe 	n 	SD 
homologous challenge 	A 0771 	6 	0,045 
heterologous challenge 	B 
	
0506 	6 	02092 
Table 6:3(u) 
Expt 11, Worm data 
Treatment 
	
Group 	ReQw 	n 	SD 
homologous challenge A 0.366 7 0805 
heterologous challenge B 0.265 8 0.157 
homogonic S.ratti 
heterologous challenge .D 0.652 7 0.093 
heterogonic S.ratti 
Table 6:3(iii) 
Expt 11, Egg data 
Treatment Group ReQe n Sb 
homologous challenge A 0.718 4 0.242 
heterologous challenge B 0.363 7 0,1202 
homogonic S.ratti 
heterologous challenge D 0,665 7 0.1403 
















mean exact dose 
5 	0.13 7.134 97 1.20 7.144 5 9.34 
6 	0.02 5.053 95 1.95 5.152 6 0.83 
4 	0.10 7.688 80 1.01 7.688 4 9.25 
5 	0.10 7.113 80 1.68 7.210 5 0.39 
priming 	 97.81 
challenge 	97.48 
7:1 Summary of worm data 
Table 7:1(1) 
Hasoloqous challenge, !xmegonic strain of S.ratti: kill day 8. Expt 1 
Treatment mean prop. n 	SD 	mean no. 	n 	SD Sean no. 	n 	SD 
of the dose of eggs in of eggs in 
recovered utero/worm utero/woruV 
rat 
secondary 0.163 6 	0.09 	1.188 	69 	1.82 3.100 	5 	0.93 
challenge 
immune 	- 0.443 S 	0.10 	6.543 	92 	1.14 6.528 	5 	0.31 
Table 7:10) 
Haimloqous challenqe, harmonic strain of S.ratti; kill day 8, Exp 
Treatment mean prop. 
of the dose 
recovered 
n SD mean no. 
of eggs in 
utero/worm 
n SD mean no. 




secondary 0.141 5 0.06 1.958 48 1.14 1.749 5 	0.99 
infection 








day 25 0.174 5 9.06 4.045 66 1.69 4.190 S 	0.70 
post-primary 
infection 
primary 0.582 3 0.03 7.719 57 0.96 7.725 3 	0.24 
controls 
challenge 0.653 7 0.18 6.975 119 1.27 7.058 7 	0.54 
controls 




Homologous challenge, hcxsgonic strain of S.ratti, kill day 16, Expt 4 
Treatment 	mean prop. n 	SD mean no. 	n SD mean no. 	n 	SD 
of the dose 	 of eggs in of eggs in 
recovered utero/wonn 	 utero/worn/ 
at  










priming 0.655 3 	0.09 7.283 60 1.29 7.283 3 0.03 
controls 
challenge 0.567 4 	0.08 7.038 59 1.32 7.030 4 9.20 
day 8 
controls 
challenge 0.292 5 	0.07 6.494 85 1.65 6.441 5 0.52 
day 16 
controls 
mean exact dose priming 95.20 
challenge 97.12 
Table 7:1(iii) 
Increasing infection dose in donors of immune cells: homeloqous chall 
nunogonic S.ratti, kill day 8, Expt 3 
Treatment 	mean prop. n 	SD mean no. 	n 	SD mean no. 	n 	SO 
of the dose 	 of eggs in of eggs in 
recovered utero/worin 	 utero/wornV 
rat 


















priming 0.648 5 0.06 7.380 100 1.18 7.380 5 0.14 
control 
challenge 0.516 5 0.12 6.972 72 1.13 6.970 5 0.37 
controls 




Homologous challenge, hanogonic strain of S.ratti, kill day 16, Expt 5 
Treatment 	mean prop. 	n SD mean no. 	n SD mean no. 	n 	SD 
of the dose of eggs in of eggs in 
recovered 	 utero/worm 	 utero/wornV 
tat 










priming 0.562 3 0.15 	7.980 50 1.15 7.933 4 	0.18 
controls 
challenge 0.584 4 0.10 	1.231 65 1.04 7.220 4 	0.18 
day 8 
controls 
challenge 0.441 4 0.08 	1.288 80 1.25 7.288 4 	0.21 
day 16 
controls 
mean exact dose priming 93.80 
challenge 	96.19 
Table 
Homologous challenge, heterogonic strain of S.ratti, kill day 16, Expt 6 
Treatment 	mean prop. 	n Si) mean no. 	n SD mean no. 	n SD 
of the dose of eggs in of eggs in 
recovered 	 utero/worm 	 utero/woruV 
rat 










priming 0.483 3 0.06 6.286 49 1.21 6.281 3 9.27 
controls 
challenge 0.517 4 0.05 6.333 45 1.40 6.304 4 0.47 
day 8 
controls 
challenge 0.349 5 0.09 5.212 113 1.40 4.990 5 0.59 
day 16 
controls 
mean exact dose priming 97.40 
challenge 98.42 
Table 7:1(vii) 
Homologous challenge, heterogonic strain of S.ratti, kill day 16, Expt 7 
Treatment 	mean prop. n SD mean no. 	n SD mean no. 	ri SD 
of the dose 	 of eggs in of Eggs in 
recovered utero/worm 	 utero/worm/ 
rat 










priming 0,446 4 0.12 6.093 43 1.25 6.050 4 0,68 
controls 
challenge 0.277 4 0.10 7.235 34 1.08 7.075 4 0,40 
controls 
mean exact dose 	priming 	97,64 
challenge 93.88 
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7:2 Distribution of adults along the intestine in Expts 1-13 
Table 7:2(i) 
pt 1, hpngnic S.ratti 
Treatment Proportion of worms in each gut section Rat n 
1. 	2 	3 	4 	5 6 	7 8 
secondary Mean 	0.35 	0.11 	0.08 	0.11 	0.17 0.12 	0.03 0.03 6 
infection SD 0.38 	0.09 	0.08 	0.13 	0.11 0.10 	0.06 0.06 
Gp.B mean no. 'of worms per rat 16 
irmiune Mean 	0.45 	0.31 	0.16 	0.06 	0.004 0.006 0.00 0.00 5 
cells SD 0.08 	0.08 	0.03 	0.04 	0.010 0.010 0.00 0.00 
Gp.E mean no. of worms per rat 43 
normal Mean 	0.39 	0.35 	0.17 	0.07 	0.02 0.002 0.00 0.00 5 
cells SD 0.08 	0.05 	0.05 	0.04 	0.03 0.004 0.00 0.00 
Gp.F mean no. of worms per rat 51 
day 25 Mean 	0.46 	0.26 	0.13 	0.13 	0.01 0.01 	0.00 0.00 6 
primary SD 0.08 	0.11 	0.10 	0.08 	0.02 0.02 	0.00 0.00 
infection mean no. of worms per rat 18 
Gp.A 
priming Mean 	0.39 	0.34 	0.16 	0.10 	0.00 0.00 	0.00 0.00 4 
controls SD 0.12 	0.14 	0.09 	0.01 	0.00 0.00 	0.00 0.00 
Gp.C1 mean no. of worms per rat 59 
challenge Mean 	0.36 0.37 0.18 0.08 0.01 0.00 0.00 0.00 	5 
controls 	SD 0.14 0.05 0.11 0.03 0.01 0.00 0.00 0.00 
Gp.C2 mean no. of worms per rat 	54 
Table 7:2(u) 
phonogonic S.rattj 
Treatment Proportion of worms in each gut section 
1 	2 	3 	4 	5 	6 	7 8 
Rat n 
secondary Mean 0.13 	0.09 	0.05 	0.23 	0.17 0.10 	0.09 0.15 5 infection SD 0.12 	0.13 	0.08 	0.21 	0.17 0.14 	0.08 0.11 Gp . B mean no. of worms per rat 13 
immune Mean 0.40 	0.36 	0.16 	0.07 	0.01 0.00 	0.00 0.00 6 cells SD 0.05 	0.09 	0.02 	0.04 	0.01 0.00 	0.00 0.00 Gp.E mean no. of worms per rat 61 
normal Mean 0.38 	0.35 	0.16 	0.12 	0.01 0.003 0.00 0.00 4 cells SD 0.06 	0.07 	0.04 	0.04 	0.02 0.005 0.00 0.00 Gp.F mean no. of worms per rat 67 
day 25 Mean 0.39 	0.26 	0.18 	0.10 	0.06 0.02 	0.00 0.008 5 primary SD 0.11 	0.17 	0.02 	0.14 	0.11 0.03 	0.00 0.020 infection mean no. of worms per rat 17 
Gp .A 
priming Mean 	0.53 	0.34 	0.11 	0.00 	0.00 	0.00 0.00 0.00 	3 controls SD 0.14 	0.01 	0.11 	0.00 	0.00 	0.00 0.00 0.00 Gp.C1 mean no. of worms per rat 57 
challenge Mean 	0.45 	0.30 	0.15 	0.05 	0.002 0.00 0.00 0.00 	5 controls SD 0.12 	0.05 	0.08 	0.06 	0.004 0.00 0.00 0.00 Gp.C2 mean no. of worms per rat 58 
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Table 7:2(iii) 
Ept 3, hanogonic S.ratti 
Treatment Proportion of worms in each gut section Rat n 
1 2 	3 	4 5 6 7 8 
jitrnune Mean 0.35 0.30 	0.17 	0.12 0.04 0.01 0.00 0.00 	7 
cells SD 0.10 0.08 	0.07 	0.04 0.05 0.01 0.00 0.00 
40001.3 mean no. of worms per rat 44 
donors 
Gp.E 
immune Mean 0.36 0.34 	0.18 	0.09 0.03 0.006 0.00 0.00 	6 
cells SD 0.13 0.13 	0.08 	0.08 0.03 0.020 0.00 0.00 
10001.3 mean no. of worms per rat 41 
donors 
Gp. D 
day 25 Mean 0.00 0.00 	0.00 	0.00 0.00 0.00 0.00 1.00 	1 
primary SD 0.00 0.00 	0.00 	0.00 0.00 0.00 0.00 0.00 
infection mean no. of worms per rat 3 
10001.3 
Gp.A 
day 25 Mean 0.00 0.00 	0.00 	0.00 0.00 0.00 0.00 1.00 	1 
primary SD 0.00 0.00 	0.00 	0.00 0.00 0.00 0.00 0.00 
infection mean no. of worms per rat 2 
40001.3 
Gp.B 
priming Mean 0.44 0.35 	0.11 	0.09 0.02 0.004 0.00 0.00 	5 
controls SD 0.14 0.06 	0.04 	0.06 0.03 0.010 0.00 0.00 
Gp.C1 mean no. of worms per rat 60 
challenge Mean 0.33 0.32 	0.16 	0.12 0.05 0.01 0.00 0.00 	5 
controls SD 0.14 0.09 	0.09 	0.06 0.06 0.01 0.00 0.00 
.C2 mean no. of worms per rat 49 
Table 7:2(iv) 
pt 4, hQ'rogonic S.ratti 
Treatment 	 Proportion of worms in each gut section 
	
Rat n 
1 	2 	3 	4 	5 	6 	7 	8 
immune Mean 0.00 	0.13 	0.07 	0.17 0.40 0.17 0.07 0.00 3 
cells SD 0.00 	0.23 	0.12 	0.29 0.53 0.29 0.12 0.00 
20001.3 mean no. of worms per rat 3 
donors 
Gp.E 
iTnnune Mean 0.43 	0.22 	0.08 	0.10 0.12 0.06 0.00 0.00 5 
cells SD 0.23 	0.12 	0.09 	0.14 0.14 0.10 0.00 0.00 
<1001.3 mean no. of worms per rat 13 
donors 
Gp.D 
priming Mean 0.40 	0.28 	0.16 	0.13 0.03 0.00 0.00 0.00 3 
controls SD 0.12 	0.06 	0.03 	0.06 0.03 0.00 0.00 0.00 
Gp.Cl mean no. of worms per rat 64 
challenge Mean 0.31 	0.34 	0.16 	0.10 0.08 0.01 0.00 0.00 4 
controls SD 0.11 	0.06 	0.03 	0.06 0.04 0.03 0.00 0.00 
day 8 mean no. of worms per rat 55 
Gp.C2 
challenge Mean 0.50 	0.24 	0.12 	0.09 0.02 0.008 0.00 0.00 5 
controls SD 0.17 	0.12 	0.07 	0.06 0.05 0.020 0.00 0.00 




Expt 5, hcxnogonjc S.ratti 
Treatment 	 Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 	6 	7. 8 
immune Mean 	0.19 	0.12 	0.11 	0.10 	0.22 0.10 0.06 0.10 
cells SD 0.18 	0.14 	0.10 	0.09 	0.39 0.11 0.13 0.08 
2000L3 mean no. of worms per rat 12 
donors 
Gp. E 
imnune Mean 	0.45 	0.26 	0.02 	0.05 	0.02 0.01 0.00 0.00 
cells SD 0.06 	0.03 	0.08 	0.04 	0.02 0.02 0.00 0.00 
<100L3 mean no. of worms per rat 29 
donors 
Gp.D 
priming Mean 	0.42 	0.27 	0.21 	0.09 	0.02 0.07 0.00 0.00 
controls SD 0.16 	0.12 	0.02 	0.04 	0.02 0.12 0.00 0.00 
Gp.Cl mean no. of worms per rat 53 
challenge Mean 	0.32 	0.30 	0.19 	0.09 	0.09 0.02 0.00 0.0 
controls SD 0.09 	0.02 	0.04 	0.01 	0.04 0.02 0.00 0.00 
day 8 mean no. of worms per rat 57 
Gp.C2 
challenge 	Mean 	0.38 0.29 0.17 0.13 0.05 0.00 0.00 0.00 	4 
controls SD 0.09 0.05 0.06 0.05 0.02 0.00 0.00 0.00 
day 16 	mean no. of worms per rat 	43 
Gp .C2 
Table 7-:2 (vi) 
pt 6, heterogonic S.ratti 
Treatment Proportion of worms in each gut section 	Rat n 
1 	.2 	3 	4 	5 6 7 8 
immune Mean 	0.26 	0.27 	0.24 	0.11 	0.03 0.04 0.04 	0.00 	6 
cells SD 0.21 	0.15 	0.10 	0.10 	0.04 0.07 0.05 	0.00 
2000E.3 mean no. of worms per rat 12 
donors 
. E 
immune Mean 0.31 	0.38 	0.13 	0.08 0.11 0.01 0.00 0.03 	4 
cells SD 0.14 	0.10 	0.10 	0.06 0.09 0.02 0.00 0.07 
<100L3 mean no. of worms per rat 17 
donors 
Gp.D 
priming Mean 0.30 	0.38 	0.18 	0.11 0.02 0.01 0.00 0.00 	3 
controls SD 0.08 	0.03 	0.08 	0.05 0.02 0.01 0.00 0.00 
Gp.Cl mean no. of worms per rat 47 
challenge Mean 0.36 	0.33 	0.16 	0.11 0.04 0.02 0.00 0.00 	4 
controls SD 0.08 	0.03 	0.06 	0.05 0.02 0.02 0.00 0.00 
day 8 mean no. of worms per rat 51 
Gp. C2 
challenge Mean 0.29 	0.30 	0.25 	0.15 0.03 0.02 0.00 0.00 	5 
controls SD 0.07 	0.14 	0.04 	0.06 0.03 0.02 0.00 0.00 








Expt 7, heterogonic S.ratti 
Treatment Proportion of worms in each gut section 	Rat 
1 	2 	3 	4 	5 6 7 	8 
immune Mean 	0.33 	0.32 	0.16 	0.13 	0.01 0.04 0.00 	0.00 	7 cells SD 0.25 	0.24 	0.22 	0.14 	0.02 0.09 0.00 	0.00 
2000L3 mean no. of worms per rat 8 
donors 
Gp. E 
inrnune Mean 	0.40 	0.27 	0.19 	0.06 0.03 0.00 0.05 0.01 	4 cells SD 0.43 	0.27 	0.19 	0.12 0.05 0.00 0.06 0.02 
<100L3 mean no. of worms per rat 	10 
donors 
Gp. D 
priming Mean 	0.32 	0.32 	0.19 	0.10 0.07 0.00 0.00 0.00 	4 controls SD 0.10 	0.07 	0.11 	0.05 0.11 0.00 0.00 0.00 
Gp.Cl mean no. of worms per rat 	44 
challenge Mean 	0.38 	0.40 	0.16 	0.03 0.02 0.01 0.00 0.00 	4 controls SD 0.13 	0.27 	0.11 	0.04 0.02 0.02 0.00 0.00 
Gp.C3 mean no. of worms per rat 	26 
Table 7:2 (viii) 
pt8 
Treatment Proportion of worms in each gut section 
1 	2 	3 	4 	5 6 7 8 
Rat n 
homologous Mean 	0.26 	0.19 	0.11 	0.11 	0.14 0.02 0.05 0.14 6 challenge SD 0.26 	0.18 	0.10 	0.15 	0.21 0.04 0.06 0.18 Gp.B mean no. of worms per rat 	16 
heterologous Mean 	0.19 	0.17 	0.14 	0.21 	0.07 0.07 0.08 0.09 4 challenge SD 0.12 	0.12 	0.07 	0.04 	0.06 0.08 0.10 0.11 Gp.D mean no. of worms per rat 	15 
priming Mean 	0.34 	0.39 	0.18 	0.11 	0.02 0.00 0.00 0.00 4 homogonic SD 0.14 	0.04 	0.06 	0.08 	0.02 0.00 0.00 0.00 S.ratti mean no. of worms per rat 	62 
controls 
Gp.Cl 
challenge Mean 	0.25 	0.44 	0.22 	0.11 	0.01 0.00 0.00 0.00 5 homogorije SD 0.06 	0.09 	0.09 	0.06 	0.02 0.00 0.00 0.00 S.ratti mean no. of worms per rat 	51 
controls 
Gp.C2 





Treatment 	 Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 	6 	7 	8 
homologous Mean 	0.27 	0.13 	0.15 	0.24 0.07 0.06 0.04 0.03 7 
challenge SD 0.20 	0.16 	0.12 	0.22 0.05 0.06 0.06 0.06 
Gp.B mean no. of worms per rat 	15 
heterologous Mean 	0.17 	0.43 	0.14 	0.15 0.09 0.01 0.00 0.00 7 
challenge SD 0.14 	0.28 	0.07 	0.15 0.22 0.03 0.00 0.00 
Gp.D mean no. of worms per rat 	13 
priming Mean 	0.35 	0.38 	0.16 	0.09 0.02 0.00 0.00 0.00 4 
homogonic SD 0.03 	0.06 	0.06 	0.02 0.02 0.00 0.00 0.00 
S.ratti mean no. of worms per rat 	71 
controls 
Gp.Cl 
challenge Mean 	0.38 	0.44 	0.12 	0.05 0.005 0.00 0.00 0.00 4 
homogonic SD 0.19 	0.12 	0.02 	0.06 0.01 0.00 0.00 0.00 
S.ratti mean no. of worms per rat 	36 
controls 
Gp.C2 
challenge Mean 	0.32 	0.44 	0.16 	0.05 0.01 0.00 0.00 0.00 5 
heterogonic SD 0.14 	0.08 	0.06 	0.07 0.03 0.00 0.00 0.00 





Treatment Proportion of worms in each gut section Rat r 
1 	2 	3 	4 	5 6 7 8 
homologous Mean 	0.15 	0.22 	0.36 	0.07 	0.04 0.03 0.05 0.07 4 challenge SD 0.21 	0.27 	0.44 	0.14 	0.07 0.07 0.07 0.14 Gp.B mean no. of worms per rat 8 
heterologous Mean 	0.36 	0.31 	0.21 	0.07 	0.03 0.01 0.00 0.005 6 challenge SD 0.06 	0.05 	0.05 	0.05 	0.04 0.02 0.00 0.010 Gp.D mean no. of worms per rat 	24 
priming Mean 	0.20 	0.41 	0.23 	0.10 	0.05 0.01 0.00 0.00 3 heterogonic SD 0.07 	0.10 	0.06 	0.03 	0.04 0.02 0.00 0.00 S.ratti mean no. of worms per rat 	58 
controls 
Gp .Cl 
challenge Mean 	0.32 	0.42 	0.10 	0.13 	0.03 0.00 0.00 0.00 5 heterogonic SD 0.10 	0.06 	0.05 	0.08 	0.04 0.00 0.00 0.00 S.ratti mean no. of worms per rat 	33 
controls 
Gp . C2 
challenge Mean 	0.37 	0.34 	0.17 	0.09 	0.03 0.00 0.00 0.00 5 homogonic SD 0.09 	0.06 	0.07 	0.02 	0.02 0.00 0.00 0.00 S.ratti mean no. of worms per rat 	53 
controls 




Treatment Proportion of worms 









homologous Mean 0,42 0,16 0,13 	0000 0,27 0,00 0003 0.00 	5 
challenge SD 0,25 0,23 0,22 0000 0,25 0,00 0,06 0,00 
Gp.B mean no. of worms per rat 4 
heterologous Mean 0049 0.39 0,06 	0,06 0000 0.00 0.00 0.00 	4 
challenge SD 0.34 0,28 0.08 0,13 0.00 0000 0000 0.00 
Gp.D mean no, of worms per rat 8 
priming Mean 0,33 0.36 0,14 0,10 0,04 0,03 0.00 0000 	3 
heterogoriic SD 0,04 0,14 0,02 0,07 0001 0,04 0,00 0,00 
S0ratti mean no, of worms per rat 47 
controls 
Gp,Cl 
challenge Mean 0,46 0,31 011 0,15 0,02 0,00 0,00 0000 	4 
heterogonic SD 0,18 0,10 0,11 0.10 0,02 0,00 0,00 0,00 
S0ratti mean no, of worms per rat 29 
controls 
Gp0 C2 
challenge Mean 0,46 0.31 0,13 0,06 0,04 0.00 0.00 0,00 	4 
hnogonic SD 0.14 0.09 0.07 0.03 0,06 0,00 0.00 0.00 




Table 7:2 (xi i) 
Expt 12 
Treatment 	 Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 	6 	7 8 
homologous Mean 0.51 0.41 0.07 0001 	0000 0.00 0.00 0000 
challenge SD 0.24 0.20 0.08 0.03 0.00 0000 0000 0000 
Gp.B mean no. of worms per rat 	11 
heterologous Mean 0039 0.27 0.15 0.13 	0.05 0001 0.00 0.00 
challenge SD 0.08 0.17 0016 0.08 0.06 0.01 0000 0.00 
homogonic mean no. of worms per rat 	29 
S.ratti 
Gp.D 
heterologous 	Mean 0.20 0.39 0.13 0.20 0.07 0.03 0.00 0.00 
challenge SD 	0007 0010 0.05 0.09 0.08 0.06 0.00 0.00 




priming 	Mean 0.74 0.24 0.02 0,00 0,00 0000 0.00 0.00 
S.,venezuelensis SD 	0.10 0.06 0.04 0000 0.00 0.00 0.00 0000 
controls mean no. of worms per rat 	25 
Gp,C1 
challenge Mean 0.65 0.27 0.06 0.005 0.01 0.00 0.00 0.00 
S.venezuelensis SD 0.31 0.16 0.13 0.01 0.02 0.00 0.00 0,00 
controls mean no. of worms per rat 	26 
Gpo C2 
challenge Mean 0.39 0.34 0.17 0.07 0.03 0.01 0000 0000 
homogonic SD 0.11 0.12 0.06 0,04 0,04 0,01 0.00 0.00 
S,ratti mean no. of worms per rat 	38 
controls 
Gp. C3 
challenge Mean 0.40 0.24 0.22 0.12 0001 0.01 0.005 0.00 
heterogoriic SD 0.24 0.04 0.12 0,07 0.02 0,01 0.010 0.00 











Treatment Proportion of worms in each gut section Rat n 
1 2 3 4 5 6 7 8 
homologous Mean 0,78 0,22 0.00 0.00 0,00 0000 0.00 0,00 	4 
challenge SD 0.15 0,15 0,00 0000 0,00 0,00 0,00 0000 
Gp.B mean no0 of worms per rat 14 
heterologous Mean 0,45 0,28 0,18 0.07 0.02 0.006 0.00 0.00 	5 
homogonic SD 0.10 0,05 0,11 0.05 0.03 0.010 0000 0.00 
S,ratti mean no. of worms per rat 33 
challenge 
Gp,D 
heterolgous 	Mean 	0.45 0.24 0,16 0.10 0.03 0.02 0,00 0,00 	4 
heterogonic SD 0.15 0.15 0.11 0.05 0.03 0.04 0000 0.00 
S,ratti 	mean no. of worms per rat 	31 
challenge 
Gp.E 
priming Mean 0.66 0.23 0009 0,02 0.00 0,00 0.00 0.00 	3 
S,venezuelensis SD 0,07 0.02 0.07 0,02 0,00 0.00 0.00 0,00 
controls mean no, of worms per rat 33 
Gp. Cl 
challenge Mean 0.85 0,14 0.00 0.004 0,00 0,00 0,00 0,00 	5 
S,venezuelensis SD 0,06 0.06 0.00 0.01 0.00 0000 0,00 0,00 
controls mean no, of worms per rat 31 
Gp. C2 
challenge Mean 0.34 0.44 0.16 0,04 0.01 0.00 0,00 0.00 	3 
homogonic SD 0.07 0,09 0.05 0.04 0.02 0000 0,00 0,00 
S.ratti mean no, of worms per rat 46 
controls 
Gp . C3 
challenge Mean 0,49 0.31 0,12 0.03 0,03 0.01 0,00 0.00 	5 
heterogonic SD 0,09 0.08 0.04 0,03 0,03 0,02 0.00 0,00 




7:3 Resistance quotients for Expts 8-13 
Table 7:3(i) 
Worm data. ExOts 8-13 
Expt Treatment Resistance quotient n SD 
8 homologous 	challenge 0.691 6 0.18 
heterologous challenge 0.499 6 0.19 
9 homologous 	challenge 0.598 7 0.14 
heteroloqous challenge 9.512 7 0.26 
10 homologous 	challenge 0.772 4 0.13 
heterologous challenge 0.545 6 0.13 
11 homologous 	challenge 0.837 5 0.99 
heterologous challenge 0.708 5 0.15 
12 homologous 	challenge 0.592 5 0.19 
heterologous challenge 0.231 5 0.28 
honogonic S.rattl 
heterologous challenge 9.480 5 0.14 
heterogonic S.rattl 
13 homologous 	challenge 0.552 4 0.14 
heterologous challenge 0.291 5 0.21 
hanogonic S.ratti 
heterologous challenge 0.426 4 0.12 
heterogonic S.ratti 
Table 7:3(u) 
Bq data, Expts 8-13 
Expt 	Treatment Resistance quotient 
based on no.eggs/worni 	based on no. eggs/worm/rat 
ReQe 	n 	SD 	ReQe 	n 	SD 
8 homologous 0.395 52 0.32 0.512 6 	9.31 
challenge 
heterologous 0.523 45 0.34 0.499 6 	0.12 
challenge 
9 homologous 0.358 59 0.27 0.389 8 	0.61 
challenge 
heterologous 0.424 49 0.23 0.404 7 	0.15 
challenge 
10 homologous 0.570 22 0.27 0.416 4 	0.32 
challenge 
heterologous 9.285 96 0.29 0.300 6 	0.11 
challenge 
11 homologous 0.556 14 0.20 0.571 5 	9.13 
challenge 
heterologous 0.314 30 9.27 9.296 4 	0.16 
challenge 
12 homologous 0.354 24 0.25 0.292 4 	0.18 
challenge 
heterologous 0.007 81 0.23 0.021 5 	0.11 
hanogonic S.ratti 
challenge 
heterologous 0.198 45 0.33 0.183 5 	0.15 
heterogonic S.ratti 
challenge 
13 homologous 0.396 22 0.20 0.420 4 	0.14 
challenge 
heterologous 0.087 84 0.21 0.099 5 	0.05 
honogonic S.ratti 
challenge 
heterologous 0.194 39 0.22 0.190 4 	8.04 
heterogonic S.ratti 
challenge 
8:1 Number of cpm per treatment for Expts 1-9 
Table 8:1(i) 
Expt 1, day 8, heterogonic S.ratti priming cells 
Rat no. 	Unstimulated 	 heterogonic S.ratti 
control excretory/secretory 
cpn 	concanavalin A 	antigen 
cpm 	differential 	cpm 	differential 
count 	 count 
Uninfected 
A 	Mean 307 7310 	7003 120 	-187 
SD 216 3100 110 
n 7 6 5 
B 	Mean 371 4138 	3767 320 	-51 
SD 178 5204 189 
n 6 6 6 
Infected 
12 Mean 1167 12989 11822 792 	-375 
SD 889 1701 340 
n 6 6 5 
1 Mean 514 9835 9321 711 	197 
SD 232 5905 448 
n 6 6 5 
4 Mean 727 10310 9583 2010 	1283 
SD 83 5229 1723 
n 6 6 5 
Table 8:1(u) - 
pt 1, day 16, heterogonic S.ratti priming cells 
Rat no. Unstimulated heterogonic 	ratti 
control excretory/secretory 
cpm concanavalin A antigen 
CPM differential cpm 	differential 
count count 
Uninfected 
C 	Mean 107 1443 	1336 57 	-50 
SD 101 230 27 
n 6 6 6 
D 	 Mean 99 1008 	909 24 	-75 
SD 80 222 6 
n 6 6 6 
Infected 
2 Mean 1138 2034 869 1059 	-79 
SD 322 640 363 
n 6 6 6 
5 Mean 1804 3696 1892 1161 	-643 
SD 478 393 228 
n 6 6 6 
11 Mean 170 1904 1734 2283 	2113 
SD 101 274 760 
n 6 6 6 
1Lf 
Table 8:1(111) 
Expt 1, day 28, heterogonic S.ratti priming cells 
Pat no. 	Unstimulated concanavalin A 	heterogonic Lratti excretory/ 
control 	 secretory antigen 
Ix 	0.5x 	0.25x 
cpa 	cpa 	diff. cpa diff. cpa diff. cpa diff. 
count 	count 	count 	count  
Uninfected 
E 	Mean 265 19808 19543 	126 -139 	87 	-178 94 	-171 
SD 322 3257 75 28 65 
n 5 5 5 5 5 
F 	Mean 82 23990 23908 	117 35 	75 	-7 68 	-14 
SD 38 9483 87 44 51 
n 5 5 5 5 5 
9 	Mean 167 10943 10776 	392 225 	262 	95 194 	27 
SD 60 1203 210 148 87 
o 5 6 6 6 6 
6 	Mean 237 8017 7780 	894 657 	129 	-108 97 	-140 
SD 125 616 692 69 55 
o 6 5 6 6 6 
8 	Mean 546 7398 6852 	1564 1018 1320 	744 625 	79 
SD 230 1044 666 809 220 
n 6 5 6 6 6 
* Note 
diff. count = differential count 
Table 8:1(iv) 
Expt 2, day 28, heteroqonic S.ratti priming cells 
Rat no. 	Unstimulated Adult excretory! 	concanavatin A 
control 	secretory antigen 
- 	cpa in ug/mi 
hcao 	bet 	S.ven 	2.5 	5 	10 
Uninfected 
A 	Mean 244 183 
SD 116 69 
n 6 6 
DIff. -61 
Count 
B 	Mean 1077 1364 
SD 989 1149 




Mean 	132 	138 	134 	123 
SD 100 120 127 96 
n 	6 	6 	6 	6 
Diff. 6 2 -9 
Count 
2 	Mean 	53 	68 	91 	114 
SD 15 20 26 105 
n 	6 	6 	6 	6 
Diff. 15 38 61 
Count 
3 	Mean 	44 	65 	84 	334 
SD 15 26 56 453 
n 	6 	6 	6 	6 
Diff. 21 40 290 
Count 
Note 
S.ven = S.venezuelensis 
bet 	heterogonic S.ratti 
homo = homogonic S.ratti 
Diff. Count 	differential count 
198 139 13314 23927 12721 
119 61 4751 5140 6254 
6 6 6 6 6 
-46 -105 13070 23683 12477 
1259 1439 45711 59220 55993 
1197 1437 11360 13534 8412 
6 6 6 6 6 
182 362 44634 49143 54916 
6110 9142 4975 
2376 5205 2974 
6 6 6 
5978 9010 4843 
6406 6805 5943 
1674 2410 3954 
6 6 6 
6353 6752 5890 
1185 691 641 
597 416 462 
6 6 6 
1141 647 597 
Table 8:1(vi) 
Expt 3,.day 12, S.venezulenals priming cells 
	
Rat no. Unstimulated Con A 	£.veomzulensis adult antigen 
control 	cpu excretory! 	homogenate 
-cpu 	 secretory 
ix 0.5x 0.25x 	is 	0.5x 0.25x 
Uninfected 





I) 	Mean 45 
SD 	61 
n 6 
Di C C. 
Count 
Infected 















150 129 144 79 136 90 134 
59 41 77 22 48 29 60 
5 6 6 6 6 6 5 
124 103 118 53 110 64 108 
18 110 137 92 136 88 191 
8 50 57 27 63 33 101 
5 5 6 6 6 6 6 
-27 65 92 47 91 43 146 
20 696 851 592 516 551 571 
4 144 527 341 367 274 144 
5 6 6 5 6 6 6 
-13 663 818 559 483 518 538 
61 1165 1284 843 1318 916 1005 
95 338 498 279 642 450 331 
5 6 6 5 6 6 6 
37 1141 1260 819 1294 892 981 
47 1606 1294 610 1495 1517 789 
48 803 598 133 451 306 279 
4 5 6 6 5 6 5 
-1 1558 1248 562 1447 1469. 741 
Note 
Con A = concanavalin A 
01ff. Count = differential count 
-C- 
Table 8:1(v) 
Expt 3, day 8, S.venezulensjs priming cells 
Rat no. 	Unstimulated Con A 	S.venezuelensis adult antigen 
control 	cpu excretory/ 	homogenate 
cpu secretory 
Ix 	0.5x 0.25x lx 	0.5x 	0.25x 
Uninfected 
A Mean 37 34 40 56 44 45 59 56 
SD 29 38 29 16 13 6 17 22 
n 6 5 6 6 6 6 6 6 
Diff. -3 3 19 7 8 21 19 
Count 
B Mean 28 15 203 179 138 135 114 165 
SD 18 4 81 66 56 76 80 132 
n 6 5 6 6 6 6 6 6 
01ff. -13 175 151 110 107 146 137 
Count 
Infected 
7 Mean 86 30 82 97 218 279 261 205 
SD 149 27 32 45 77 163 107 149 
n 5 5 6 5 5 6 6 6 
Diff. -56 -4 11 132 193 175 119 
Count 
Mean 18 20 90 102 91 115 128 112 
SD 3 8 12 25 51 22 116 25 
n 5 4 5 4 5 5 5 5 
Diff. 2 72 84 73 97 110 94 
Count 
6 Mean 27 16 14 257 134 184 180 206 
SD 6 3 38 262 65 120 94 162 
n 6 5 6 5 6 6 5 -6 
Diff. -11 47 230 107 157 153 179 
Count 
*Note 
Con A = concanavalin A 
Diff. Count = differential count 
Uninfected 





















16574 15388 68 85 70 77 90 107 
2060 2118 25 21 36 51 81 107 
5 6 6 6 6 6 6 6 16491 15305 -15 2 -13 -6 7 24 
25265 25965 59 108 106 88 77 108 3596 3358 30 34 40 18 32 33 
6 5 6 6 6 6 6 6 25175 25875 -31 18 16 -2 -13 18 
5859 1119 411 439 1019 1796 980 1170 
1207 643 118 269 769 651 553 529 
6 5 6 6 6 6 6 6 
5388 6648 -60 -32 548 1325 509 699 
5991 8864 197 325 356 789 397 484 
2305 1419 108 211 96 577 197 297 
6 6 6 6 6 6 6 6 
5839 1912 45 173 204 637 245 3322 
Mete 
hono honogonic S.ratti 
bet heterogonic S. ratti 
S.ven S.venezuelenjj 
Con A concanava]j 
Diff. Count a differential count 
Ca = solution made up fresh fr(xn powder 
(3 solution stored at -200C at a concentration of 
2m3/m1 before use 
Table 8: 
Expt 4, day 12, honogonic S.ratti 	 l ls  
S.venezuelengj5 adult antigen 	 Pat no. 	Unstimuiat:ed 	Con A 	Adult excretory/secretory antigens 
2.5pg,nI excretory/ 	homogenate 	
control 
•cpn 	Sample 	 hcxno 	het 	S.ven secretory 
Ca 	lb 0.55 	ix 0.Sx ix 0.Sx lx IX 	0.5x 0.25x lx 0.5x 0.25x  
Table 8: 1 (vil  
pt 3, day 21, S.venezuelensjs priminq cells 
Rat no. 	Unstimulated 	Con A 
control 	2.pgIlnl 
sample 
cFn 	A 	B 	C 
Uninfected 
E 	Mean 95 29079 29239 243 81 80 84 53 83 102 SD 53 4148 3847 314 37 23 33 12 30 65 n 6 6 5 6 6 6 6 6 6 6 Diff. 28984 29144 148 -14 -15 -11 -42 -12 7 Count 





















11 	Mean 191 8675 12239 494 504 348 246 430 415 467 SD 100 5758 412 244 299 44 151 207 143 234 n 6 6 5 6 5 6 6 6 6 6 Diff. 8484 12048 303 313 157 55 239 224 276 Count 




















4 	Mean 180 12174 10438 1089 971 856 925 1134 865 592 SD 85 1298 681 750 371 507 268 542 307 220 n 6 6 5 6 6 6 6 6 6 6 Diff. 11994 10258 839 791 676 145 954 685 412 Count 
* Mete 
	
Con A 	= concanavaljn A 
Diff. Count = differential count 
Table 8:1(vlii) 
Expt 5, day 12, heterogonic S.ratti 	 cel ls  
Rat no. Unstim. 	 Adult antigen 
control Con A 	excretory/secretory 	hanogena te 
Cpu 	cpu homo 	bet 	S.ven 	bet 
	
0.55 	lx 	0.5x 	lx 	0.5x 	lx 	Ha 	Fib 	X 
Uninfected 
A Mean 234 	8449 317 204 247 281 572 190 623 374 9179 
SD 	133 1562 	165 	120 	181 	192 	571 	92 	441 	224 2743 n 6 	5 6 6 6 6 6 6 6 6 	5 Diff. 	 8215 	83 	-30 	13 	47 	338 	-44 	389 140 8945 Count 
B Mean 696 	5167 1159 965 1479 783 	878 947 	744 826 3545 
SD 	463 962 856 676 810 318 	300 591 	272 491 1040 
n 6 	5 	6 	6 	6 	6 6 	6 6 	6 	6 Diff. 	 4471 	454 	269 	783 87 	182 	251 	48 	130 2849 Count 
Infected 
2 Mean 6110 	7789 7508 16420 11024 11750 8136 9836 10704 11465 4460 
SD 	3350 795 2159 3143 5756 2393 1916 2422 2798 2798 1455 
CO 
n 6 	5 	6 	6 	6 	5 	6 	6 	6 	6 	6 Diff. 	 1679 1398 10310 4914 5640 2026 3726 4594 5355 -1650 
Count 
1 Mean 4910 	7231 10901 16658 9037 8862 8805 10298 9478 9984 7678 
SD 	2502 666 1694 9967 2301 2493 2468 2882 3870 2593 4971 
n S 	5 	6 	5 	6 	6 	6 	6 	6 	6 	6 01ff. 	 2411 5991 11748 4127 3952 3895 5388 4568 5078 2768 
Count 
3 Mean 3684 	13699 4971 5689 4031 5682 4745 3983 9639 5898 10266 
SD 	1284 4660 1515 1460 1017 2402 2237 1266 2792 2122 4038 
n 5 	5 	6 	5 	6 	6 	6 	6 	66 	6 Diff. 	 10015 1287 2005 	347 1998 1061 	299 5955 2214 6582 Count 
* Note 
hose = houogonicS.ratti 
bet = heterogonic S.ratti 
S.ven S.venezuelensjs 
Ha 	= ad1t heteroqonic S.ratti homogenate antigen stored at 
+4 C before use 
Hb 	x adut heterogonic S.ratti homogenate antigen stored at 
-20 C before use 
X 	= combination of mitogen and heterogonic S.ratti 
excretory/secretory antigen added to cells 
Con A - concanavalin A 
Diff. Count = differential count 
(Jnstiin. = unstlriijlated  
Table 
Ept 6, day 12. S.venezuelensix priming ce l ls  









bet 	S.ven 	Y 




A 	Mean 271 2667 325 228 193 334 353 	178 479 3150 1593 
SD 119 763 255 176 95 240 195 64 280 967 289 
n 5 5 6 6 6 6 6 	6 5. 6 6 
Count' 
2396 54 -43 -78 63 82 	-93 208 2879 1322 
B 	Mean 136 5216 154 122 98 349 276 	145 415 4795 4415 
SD 59 1242 101 63 16 356 242 84 340 909 1532 
n 5 5 6 6 6 6 6 	6 6 6 6 
Diff. 5980 18 -12 -38 213 140 9 279 4659 4279 
Count 
Infected 
Mean 1835 2962 	775 1008 1988 1364 1533 2251 2722 6384 7223 
SD 	709 	599 	521 	616 1355 1025 	968 1090 1073 1371 2423 
n 5 5 6 6 	6 	6 6 	6 	6 	6 	6 
01ff. 	 1127 -1060 -827 	153 -471 -302 	416 	887 4549 5388 
Count 
2 	Mean 1642 1485 	950 1007 1316 1012 1159 	578 1874 3077 1260 
SD 1515 	585 	507 479 1303 710 	581 	429 1648 1429 1079 
n 	5 5 6 	6 	6 	6 6 6 	6 	6 	6 
Diff. -157 -692 -635 -326 -630 -483 -1064 	232 1435 -382 
Count 
3 	Mean 2547 	9933 3118 2823 2145 1663 3028 1748 2843 7356 10241 
SD 	1363 923 1724 1310 1528 826 2899 554 1368 1245 1585 
o 5 	5 	5 	4 	6 	5 	6 	6 	6 	6 	6 Diff. 	 7386 	571 276 -402 -884 481 -799 	296 4809 7694 
Count 
* Note 
haio = homogonic S.ratti 
bet = heterogonjc S.ratti 
S.ven = S.venezuelensjs 
X 	= beterogonic S.ratti breeqenate antigen and mitogen 
added to cells 
Y 	= heterogonic S.ratti excretory/secretory antigen and 
mitogen added to cells 
Con A = concanavaljn A 
unstim. = unstimulated 
Diff. Count = differential count 
n 
Table 0:1(511) 
Cspt 7, day 16, 4mterogonlc S.rattl priming cells 
Pat no. 	Unstim. 	Adult antigen 	(.3 antigen 	Con A 
control is 	 is 	 sample 
	
cra 	bet 	hcmo Sven homo ht S.ven Co 	Co 
Uninfected 
C 	Mean 5952 4120 4919 2918 3589 	3040 3860 0564 8663 
SD 	2149 2457 2120 	911 	993 1862 2295 1958 	975 
n 5 	6 	6 6 6 	6 	6 	5 6 Diff. 	-1832 -1033 -3034 -2364 -1912 -1892 2612 	2711 
Count 
0 	Mean 701 	540 	760 	278 	96 	613 	482 3924 	3842 
SD 	381 258 417 241 56 238 188 	559 670 
n 5 	6 	6 	6 	6 	6 	6 6 	4 
01ff. 	 -161 59 -423 -615 -98 -219 	3223 3141 
Count 
Note 
boon homogonic S. ratti 
hot heterogonic S.ratti 
S.ven S.venezuelensis 
unstim. unatinuilated 
ConA concanavalin A 
Ca initogen solution made up fresh from powder 
Co mitogen soultion was stored at -20 C at a 
concentration of 	before use 
01ff. Count - differential count 
• 	Note 
hare homogonic S.ratti 
bet heterogonic S.rstti 
S.ven S.venezuelensis 
CouP. concanavalin A 
Ca mitoqen made up fresh from powder 
Co mitogen solution had been stored at -20°C at a 
concentration of 2rqAnl before use 
unstim. • unstin.ulated 
01ff. Count differential count 
(.3 third-stage larval hanogenate antigen 
Table 9:1(sl) 
pt 7, day 12, heterogonlc S.ratti priming calls 
Pat no. Unstim. Adult antigen (.3 £ntigen Con P. 
control is is Sample 
cpu het 	boon Sven haw hat 	S.ven Co 	Co 
Uninfected 
P. 	Mean 122 149 	109 195 74 222 233 842 	8026 
SD 67 102 45 30 32 226 81 1408 967 
n 5 6 	6 6 6 6 6 5 	6 
Diff. 27 -13 -11 -48 100 111 9340 7984 
Count 
B 	Mean 1152 	625 	999 	470 	507 	147 	641 3119 4548 
SD 	529 335 508 1 198 308 266 290 	482 	971 
n S 	6 	6 	6 	6 	6 	6 5 6 





Mean 4981 8365 7669 9581 9546 7683 9905 5014 6342 
SD 	1611 	3224 2467 4910 1847 1590 1948 	903 	699 
n 5 5 	6 	5 	6 	6 	6 6 5 
Diff. 	 3384 	2687 	3600 4565 2702 	4924 	33 	1361 
count 
2 	Mean 8212 10903 15533 10619 14807 11979 11324 7585 	- 
SD 	5355 3678 3672 4936 6569 3220 3553 1252 - 
n 5 	6 	6 	6 	6 	6 	6 	5 
01ff. 	 2691 7321 2399 6595 3767 3112 -627 
Count 
3 	Mean 39027 38005 42488 41387 45682 39201 44240 8842 16093 
SD 18444 	3860 5680 4832 5383 13215 4747 2635 14921 
n 	5 6 	6 	6 	6 	6 	6 	6 	5 
01ff. -1022 3461 2368 6655 174 5213 -30195 -22934 
Count  
3 	Mean 8179 10564 18354 13149 13345 22850 15308 6734 	6672 
SD 	2279 5132 2907 3849 4976 4782 4717 	452 736 
n 5 	6 	6 	5 	6 	6 	6 5 	6 
Diff. 	 2395 10175 	4910 	5166 14671 	7129 -1445 -1507 
Count 
4 	Mean 10069 10984 10726 8027 11573 16094 9260 7211 	7166 
SD 	1917 2268 	3046 2378 4717 	3955 2740 	999 1489 
n 5 	6 6 	6 	6 6 	6 6 	5 Diff. 	 915 	657 -2042 1504 	6925 -809 -2858 -2983 
Count 
6 	Mean 14510 17291 23866 17224 19896 22094 22138 9261 8828 
SD 	4173 	4186 4016 	2672 	1764 	2662 	3479 	1154 	689 





Expt 8, day 12, heterogonic S.ratti priming cells 
Rat no. 	Unstim. 	Adult antigen 	(.3 antigen 	Con A 
control lx 	 lx 
cpa 	hetero hoino Sven 	hetero 	how  
Uninfected 
P. 	Mean 664 612 	737 	983 355 111 12849 
SD 409 613 731 554 311 66 1691 
n 6 6 	6 	6 6 6 6 
Diff. -52 73 319 -309 -553 12185 
Count 
B 	Mean 295 338 	304 	309 112 - 11541 
SD 180 164 242 253 45 - 1523 
n 6 6 	6 	6 6 6 
Diff. 43 9 14 -183 11246 
Count 
Infected 
Mean 4425 3474 	4085 	3941 3351 1811 16111 
SD 1384 1870 1439 	1219 1066 1049 2689 
n 6 6 	6 6 6 6 6 
Diff. -951 -340 	-484 -1074 -2611 11686 
Count 
3 	Mean 2064 678 	1893 	1023 1487 1787 14412 
SD 1892 644 1308 568 802 1420 1742 
n 6 6 	6 	6 6 3 6 
Diff. -678 -171 	-1041 -577 -277 12348 
Count 
5 	Mean 7963 9299 	10080 	8003 7119 10335 19469 
SD 2175 3247 3818 	1562 4453 2181 3079 
n 6 6 	6 6 6 6 6 
DuE. 1336 2117 	48 -844 2372 11506 
Count 
* 	Note 
honto Pionogonic S. ratti 
het heterogonic S.ratti 
S.ven S.venezuelensis 
ConA = conclnavalin A 
unstim. = unstiinulated 
Diff. Count differential count 
(.3 third-stage larval homogenate antigen 
Table 8:1(xiv) 
Expt 8, day 16, heteroqonlc S.ratti primlnq cells 











C 	Mean 5373 4240 	4097 3923 4448 6198 25531 
SD 1632 978 491 654 1660 1717 8961 
n 6 6 	6 6 6 6 6 
Dill. -1133 	-1276 -1450 -925 825 20185 
Count 
0 	Mean 4095 3085 	3875 3555 4045 5798 22810 
SD 1082 683 961 926 699 1999 3897 
n 6 6 	6 6 6 6 
Diff. -920 -130 -450 40 1793 18805 
Count 
E 	Mean 7366 8317 	7586 7132 4433 8283 17118 
SD 1505 3042 2560 2077 1755 3843 3205 
n 6 6 	6 6 4 4 6 
Dill. 951 220 -234 -2933 917 9752 
Count 
Infected 
2 	Mean 19428 20752 	25655 24426 30625 35526 47060 
SD 4200 3017 5433 4052 3213 5519 6975 
o 6 6 	6 6 6 3 6 
Diff. 1324 6227 4998 11197 16098 27632 
Count 
4 	Mean 32815 37708 	33869 28633 45341 47467 25507 
SD 1799 7505 3511 5915 9037 5225 2886 
n 6 6 	6 6 6 3 6 
Dill. 4893 1054 -4182 12526 14652 -7308 
Count 
6 	Mean 6887 11531 	9898 11057 17213 18845 27773 
SD 2596 4640 2355 1884 1049 3018 3579 
o 6 6 	6 6 6 6 6 
Diff. 4644 3011 4110 10326 11958 • 	20886 
Count 
* 	Note 
hano = homogonic S.ratti 
Pint = heterogonic S.ratti 
S.ven S.venezuelensis 
ConA = concanavaliri A 
unstim. = unstimulated 
DiEt. Count = differential count 
0 = third-stage larval homogenate antigen 
Table 8:1(xv) 
Effect of cell density on amount of lymphocyte stimulation, Expt 9 
Rat no 	 cell density 
A 	 B 	 C 
Unstim. Con A Diff. Unstim. Con A Diff. tinstim, Con A Diff. 
control 	Count control 	Count control 	Count 
Mean 	262 	4646 	4384 	118 	11407 11289 	140 	14427 144317 
SD 171 1518 39 5057 	 55 2699 
n 	5 	10 	 5 	10 5 	11 
2 	Mean 155 	5194 5039 	105 
SD 	66 2209 	 35 
n 5 	11 5 
3 	Mean 142 9252 	9110 135 
SD 42 2550 51 
n 5 10 5 
Where:- 	
5 A 	 = 4x10 5 cells per well 
B = 2x105 cells per well 
C 	 = 1x10 cells per well 
Diff, count = differential count 
Con.A 	= concanavalin A 
	
7602 	7497 	229 	8850 	8621 
1097 162 1911 
11 	 5 	11 
13005 	12869 	244 	10245 	10001 
3654 68 1493 
11 	 5 	10 
351 
rj 
8:2 Sunmary of worm data 
Table 8:2(1) 
Expt 1, heterogonlc S.rattl 
Treatment 	mean prop. 0 SD mean no. 	n SD mean no. 	0 SD 
of the dose 	of eggs In of eggs In 
recovered utero/wornV 	utero/worm 
rat 
day 8 	0.302 3 	0.06 	5.333 	3 	0.95 	5.357 	14 	1.21. 
<lOOr..3 
day 8 	0.330 3 	0.03 	5.183 	3 	0.38 	5.183 	60 	1.42 
2000(3 
day 16 	0.165 3 	0.10 	1.883 	3 	0.43 	1.883 	60 	1.04 
2000(3 
day 28 	0.000 3 	0.00 
20801,3 
mean exact dose 	98.33 
Table 8:2(u) 
Expt 2, heterogontc S.ratti, Day 28 
Treatment 	mean proportion n 	SD 
of the dose 
recovered 	 - 
2000(3 	0.00 	 3 	0.80 
Table 8:2(iii) 
Expt 3, S.venezuelensls 
Treatment 	mean prop. n 	SD mean no. n 	SD mean no. n SD 
of the dose of eggs In of eggs in 
recovered utero/wornV utero/worm 
rat 
day 8 	0.421 2 	0.10 7.192 3 	0.38 7.278 36 1.21 
<100(3 
day 8 	0.244 3 	0.05 6.750 3 	0.22 6.750 60 1.13 
2000(3 
day 12 	0.220 3 	0.04 3.100 3 	1.16 3.100 60 1.54 
2000(3 
day 21 	0.184 3 	0.04 3.217 3 	0.60 3.217 60 1.43 
2000(3 
mean exact dose 	96.00 
Table 8:2(iv) 
Expt 4, baTeqonic S.ratti 
Treatment mean prop. 	n SD 	mean no. 	n SD 	Sean no. 	n 	SD 
of the dose of eggs in of eggs in 
recovered utero/wornl/ utero/worm 
rat 
day 12 0.301 	3 0.03 	7.250 	3 0.61 	7.250 	60 	1.47 
2000(3 
Table 8:2(v) 
Expt 5, heterogonic S.ratti 
Treatment mean prop. 	n SD mean no. 
of the dose of eggs in 
recovered 	 utero/worn/ 
rat 
n SD mean no. 	n SD 
of eggs in 
utero/worm 
day 12 	0.227 	3 	0.01 	4.917 	3 	0.20 	4.917 	60 	1.23 
2000L3 
Table 8:2(vi) 
Expt 6, S.venezuelensis 
Treatment mean prop. 	n SD mean no. 	n SD mean no. 	n SD 
of the dose of eggs in of eggs in 
recovered 	 utero/worn/ 	utero/worm 
rat 
day 12 	0.117 	3 0.05 	4.400 	3 	0.13 	4.400 	60 	1.20 2000L3 
Table 8:2(vii) 
çpt 7, heterogonic S.ratti 
	
Treatment mean prop. 	n SD mean no. 	n SD mean no. 	n SD 
of the dose of eggs in of eggs in 
recovered 	 utero/worn/ 	utero/worm 
rat 
day 12 	0.432 	3 	0.11 	3.533 	3 0.81 	3.533 	0 1.48 2000L3 
day 16 	0.059 	3 	0.02 	2.065 	3 0.20 	2.050 	60 1.27 2000L3 
Table 8:2(vijj) 
çt 8, heterqgonjc S.rattj 
Treatment mean prop. 	n SD mean no. 	n SD mean no. 	n SD of the dose of eggs in of eggs in recovered 	 utero/worm/ 	utero/worm 
rat 
day 12 	0.289 	3 0.05 	4.533 	3 	0.51 	4.533 2000 60 0.08 L.3 
day 16 	0.101 	3 0.06 	2.050 	3 	0.20 	2.350 	60 1.53 200 0L3 
8:3 Summary of adults distribution along the intestine in Expts 1-8 
Table 8:3(i) 
Expt 1, heterogoriic S,ratti 
Treatment 	Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 	6 	7 8 
day 8 	Mean 	0.33 0.44 0.17 0,04 0.02 0.00 0,00 0.00 	3 
<100L3 SD 0.10 0,02 0.08 0,04 0,02 0.00 0,00 0.00 
mean no, of worms per rat 	30 
day 8 	Mean 	0.42 0.27 0.17 0.09 0.04 0,01 0,004 0.001 	3 
2000L3 SD 0.03 0.02 0.01 0.01 0,01 0.01 0.004 0.002 
mean no, of worms per rat 660 
day 16 	Mean 	0.24 0.19 0.18 0,10 0,08 0.05 0.06 0.13 	3 
2000L3 SD 0.09 0.12 0.01 0.04 0,03 0.01 0.03 0.03 
mean no, of worms per rat 	0 
Table 8:3(u) 
Expt 3, S.venezuelensis 
Treatment 	Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 	6 	7 8 
day 8 	Mean 0.76 0.23 0.01 0,00 0.00 0.00 0,00 0,00 	3 
<100L3 SD 	0,05 0.06 0,01 0,00 0.00 0,00 0,00 0.00 
mean no, of worms per rat 40 
day 8 	Mean 0,64 0.34 0.02 0,01 0,00 0,00 0.00 0,00 	3 
2000L3 SD 	0.08 0.07 0,01 0,001 0,00 0.00 0,00 0,00 
mean no, of worms per rat 488 
day 12 	Mean 0,66 0,29 0,04 0.01 0.003 0.00 0,00 0.00 	3 
2000L3 SD 	0.10 0.08 0.02 0,01 0,004 0.00 0,00 0,00 
mean no, of worms per rat 440 
day 21 	Mean 0,61 0.35 0.03 0.003 0.001 0,00 	0,00 	0,00 	3 
2000L3 SD 0.02 0,03 0,02 '0,003 0,003 0.00 0,00 0,00 






Proportion of worms in each gut section 	Rat n 
1. 	2 	3 	4 	5 	6 	7 8 
hcnogonic S.ratti 
day 12 Mean 	0.27 	0.24 	0.23 	0.12 0.07 	0.05 0.01 	0.001 	3 
2000E.3 SD 0.09 	0.03 	0.06 	0.02 0.05 	0.06 0.02 	0.001 
mean no. of worms per rat 602 
heterogpnic S.ratti 
day 12 Mean 	0.47 	0.03 	0.15 	0.05 0.02 	0.01 0.004 0.001 	3 
2000L3 SD 0.02 	0.03 	0.03 	0.03 0.02 	0.01 0.004 0.001 
mean no. of worms per rat 454 
S.venezuelensis 
day 12 Mean 	0.65 	0.30 	0.04 	0.01 0.001 0.00 0.00 	0.00 	3 
2000L3 SD 0.05 	0.04 	0.02 	0.01 0.002 0.00 0.00 	0.00 
mean no. of worms per rat 234 
Table 8:2 (iv) 
pts 7 and 9, heteroqonic S.ratti 
Treatment 	 Proportion of worms in each gut section 	Rat n 
1 	2 	3 	4 	5 	6 	7 8 
Ent 7 
day 12 	Mean 	0.38 0.26 0.14 0.12 0.06 0.04 0.010 0.001 	3 
2000L3 SD 0.07 0.04 0.03 0.03 0.02 0.02 0.002 0.001 
mean no. of worms per rat 864 
day 16 	Mean 	0.26 0.14 0.07 0.08 0.08 0.07 0.06 0.23 	3 
2000L3 SD 0.19 0.05 0.02 0.07 0.01 0.05 0.07 0.12 
mean no. of worms per rat 118 
Expt 8 
day 12 Mean 0.31 0.31 	0.19 0.11 	0.05 0.03 0.010 0.001 	3 
20001.3 SD 0.11 0.06 	0.02 0.03 	0.01 0.01 0.001 0.002 
mean no. of worms per rat 578 
day 16 Mean 0.29 0.28 	0.16 0.10 	0.07 0.02 0.02 0.06 	3 
2000L3 SD 0.20 0.05 	0.02 0.09 	0.07 0.02 0.02 0.07 
mean no. of worms per rat 202 
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8:4 Antigens used throughout Expts 1-8 
a) adult heterogonic S.ratti homogenate antigen pool 1 
Expt2 
adult heterogonic S..ratti excretory/secretory antigen pool 1 
adult homogonic S.ratti excretory/secretory antigen pool 1 
C) adult S.venezuelensis excretory/secretory antigen pool 2 
adult S.venezuelensis homogenate antigen pool 1 
adult S.venezuelensis excretory/secretory antigen pool 1 
Expt 4 
adult heterogonic S.ratti excretory/secretory antigen pool 2 
adult homogonic S.ratti excretory/secretory antigen pool 2 
adult S.venezuelensis excretory/secretory antigen pool 2 
adult heterogonic S.ratti excretory/secretory antigen pool 1 
adult homogonic S.ratti excretory/secretory antigen pool 2 
adult S.venezuelensis excretory/secretory antigen pool 3 
adult heterogonic S.ratti homogenate antigen pool 2 
Excpt  
adult heterogonic S.ratti excretory/secretory antigen pool 1 
adult homogonic S.ratti excretory/secretory antigen pool 2 
adult S.venezuelerisis excretory/secretory antigen pool 3 
adult heterogonic S.ratti homogenate antigen pool 2 
adult heterogonic S.ratti excretory/secretory antigen pool 1 
adult homogonic S.ratti excretory/secretory antigen pool 2 
adult S.venezuelensjs excretory/secretory antigen pool 3 
third-stage heterogonic S.ratti homogenate antigen pool 1 
third-stage homogonic S.ratti homogenate antigen pool 1 
third-stage S.venezuelensjs homogenate antigen pool 1 
pt 8 
adult heterogonic S.ratti excretory/secretory antigen pool 1 
adult homogonjc S.ratti excretory/secretory antigen pool 2 
adult S.venezuelensis excretory/secretory antigen pool 3 
third-stage heterogonic S.ratti homogenate antigen pool 2 
third-stage hornogonic S.ratti homogenate antigen pool 2 
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8:5 Protein determination of antigens 
The protein concentration of the antigens was determined using a micro-Lowry 
assay (Section 2:8, Chapter 2, page 43 ) 	In order to calculate the protein 
concentration of the test sample from the results obtained a standard curve, 
using the results of the protein standards, was plotted and the best straight 
line fitted by eye The concentration of the test sample was read off this 
curve and unfortunately no protein was present. An example of the results 
obtained is shown in Fig,8:1 where the concentration of a heterogonic S,ratti 
antigen was determined. 
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Example of the results from a Lowry assay 
concentration of antigen 47,ug/ml 
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8:6 Statistical analysis of data 
Since extensive analysis was carried out on the results of each experiment 
only the type of tests carried out on one experiment are included as an 
example, the results of other experiment were treated in the same manner. 
periment 8, heterogonic S,ratti priming cells 
Table 8:6(i) 
Two-level nested anova comparing activity of unstimulated cells from infected 
and uninfected rats 
Day 12 
Source of Variation df SS MS 	F 
Among ups. 1 38.143 38.143 12.08 
Among Subgps. 3 9.472 3,157 10.12 
Within 25 7.788 0.312 
Total 29 55,403 
F (13)=l0.13 5% 	F(325 )=7.45 0.1% 
Day 16 
Source of Variation df SS MS 	F 
Among Gps. 1 10.978 10.978 	4.62 
Among Subgps. 4 9,504 2.376 30,86 
Within 30 2,304 0.077 
Total 35 22.786 




Two-level nested anova comparing response of infected and uninfected rats 
to concanavalin A stimulation 
Table 8:6(u) 
Day 12  
Source of Variation 	df 
Among Gps, 	 1 
Among Subgps 0 3 
Within 	 25 
Total 29 
SS 	MS 	F 
0.000002 0000002 I?25xl0 




Source of Variation df SS MS 	F 
Among Gps 1 254.858 254858 0.87 
Among Subgps. 4 1177,983 294,496 	177407 
Within 24 3.956 0,166 
Total 29 1436827 
F (424)=659 01% 
Day 16, omitting rat 4 
Source of Variation 	df 	SS 
Among Gps 	 1 7.125 
Among Subgps. 	 3 	1.478 
Within 	 20 1.996 





F (13 )=10013 5% 
	
F(320)=4 0 94 1% 
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Table 8:6(iii) 
Two-level nested anova comparing response of uninfected and infected 
cells to stimulation with heterogonic S,ratti excretory/secretory antigen 
Day 12  
Source of Variation 	df 
Among Gps. 	 1 
Among Subgps. 3 













Source of Variation 	df 
Among Gps. 	 1 
Among Subgps. 4 
Within 	 30 
Total 35 











F (430 )=2.69 5% 
Table 8:6(iv) 
Two-level nested anova c2m24 
infected rats to stimulation w 
te ant 
a) Day 12 
Source of Variation 	df 
Among Gps. 	 1 
Among Subgps. 3 
Within 	 25 
Total 29 
F (1,3 
of cells from uninfected and 












b) Day 16 
Source of Variation df SS MS ^ 	F 
Among Cps, 1 807.045 807,045 ,34 
Among Subgps. 3 119,003 39.668 	2,03 
Within 15 292.675 19.512 
Total 19 1218,724 
F (13)=17.4 5% 	F(315)=3.29 5% 
Table 8:6(v) 
Two-way anova comparing response of cells from infected rats to 
stimulation with adult excretory/secretory antigens 
a) Day 12  
Source of Variation df SS MS F 
Among Cols, 2 177,876 88.938 2.39 
Among Rows 2 496.793 248.397 6,68 
Interaction 4 63.077 15,769 0,42 
Among Gps, 8 737,746 92.218 
Within 45 1673,763 37.195 
Total 2411,509 
F (240 )=3.23 5% 	F(240)5.18 1% 
b) Day 16 
Source of Variation df SS MS F 
Among Cols, 2 63.886 31,943 0.814 
Among Rows 2 266,101 133,050 3,39 
Interaction 4 443,838 110,958 2,83 
Among Gps, 8 773,818 96,727 
Within 45 1766,910 39,265 
Total 2540,729 
F (240 )=3.23 5% 
	
F (4,40 )=2.61 5% 
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c) Day 16 - Single classification anova on data because of significant 
interaction 
1) heterogonic S,ratti antigen 
Source of Variation 	df 	SS 	MS 	F 
Among Gps, 	 2 34,474 17,237 
Within 	 15 	684,145 	45,610 
Total 718,620 
homogonic S,ratti antigen 
Source of Variation 	df 	SS 	MS 	F 
Among Ops. 	 2 87999 4.500 ?ii 
Within 	 15 	 42,488 
Total 
S0venezuelensis antigen 
Source of Variation 	df 	SS 
Among Gps. 	 2 6660459 
Within 	 15 	445,442 
Total 1111,900 





Table 8:6 (vi) 
Two-way anova comparing response of cells from infected rats C2 
stimulation with third-stage larval antigens 
Day 12, rats 1 and 5 only 
Source of Variation df SS MS F 
Among Cols, 1 7.560 7.560 
Among Rows 1 508.115 508.116 14.80 
Interaction 1 95.401 95.401 2.78 
Among Gps, 3 611.077 203,692 
Within 20 686.628 34.331 
Total 1297.705 
F (120 )=14.82 0.1% F (120)=4.35 	5% 
Day 16 - 2 rats only 
Source of Variation df 55 MS F 
Among Cols, 1 0.227 0.277 1?13 
Among Rows 1 0,022 0.022 0.09 
Interaction 1 0.056 0.056 0.023 
Among Gps. 3 0,355 0.118 
Within 20 4.903 0.245 
Total 5.258 
F (120 )=4.35 5% 
day 16 - All rats 
Source of Variation df 55 MS 	F 
Among Cols, 1 1,153 7.153 	7.43 
Among Rows 2 0,375 0.187 1.21 
Interaction 2 0,614 0,307 	0.72 
Among Gps. 5 2.142 0,428 
Within 6 0,932 
Total 3.074 
F (16 )=5.99 5% F (2,6 )=5.14 	5% 
36 
Table 8:6(vii) 
Two-level anova comparing response of cells from infected rats to 
stimulation with heterogonic adult and third-stage larval antigens  
a) Day 12  
Source of Variation df SS MS 
Among Cols,, 1 14,887 14,,887 036 
Among Rows 2 219,,025 109.512 2,,61 
Interaction 2 45,,487 22.744 054 
Among Gps0 5 279,399 55.880 
Within 30 1257161 41,905 
Total 1536.599 
F (23Ø)=332 5% 
b) Day 16 - 2 rats only 
Source of Variation df SS MS F 
Among Cols,, 1 73,,675 73.675 367 
Among Rows 1 1,,193 1,193 006 
Interaction 1 1,,005 1,005 0,,05 
Among Gps. 3 75,872 25,,291 
Within 20 401.863 20,,093 
Total 477,,735 
F(120)=4.35 5% 
C) Day 16 - all rats 
Source of Variation df SS MS F 
Among Cols,, 1 40.150 40,,528 0.058 
Among Rows 2 25.056 12.528 0,954 
Interaction 2 33.049 16.524 126 
Among Gps 5 98,255 19,,651 
Within 6 78.773 13.129 
Total 177.029 
F 16)=5.99 5% 	F(2,6 )5.14 5% 
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